concept_id	concept_synonym_name	language_concept_id
762802	Malignant mesothelioma of the tunica vaginalis (disorder)	4180186
762803	Central visual impairment (disorder)	4180186
762805	Severe myoclonic epilepsy in infancy, non-intractable	4180186
762805	Dravet syndrome, non-refractory	4180186
762805	Severe myoclonic epilepsy in infancy, non-refractory (disorder)	4180186
762805	Dravet syndrome, non-intractable	4180186
762810	Impaired urinary bladder capacity (finding)	4180186
762810	Decreased urinary bladder volume	4180186
762810	Diminished urinary bladder capacity	4180186
762810	Decreased urinary bladder capacity	4180186
762811	Cerebral venous thrombosis of cortical vein without infarction (disorder)	4180186
762812	Tonic seizures, refractory (finding)	4180186
762812	Tonic seizures, intractable	4180186
762812	Tonic seizures, refractory (disorder)	4180186
762814	Temporal lobe epilepsy, non-refractory (disorder)	4180186
762814	Temporal lobe epilepsy, non-intractable	4180186
762815	Taking medication for chronic disease (finding)	4180186
762816	Taking one medication for chronic disease (finding)	4180186
762816	Taking single medication for chronic disease	4180186
762820	Recommendation to monitor vital signs	4180186
762820	Recommendation to monitor physiologic parameters (procedure)	4180186
762827	Post-traumatic epilepsy, non-intractable	4180186
762827	Post-traumatic epilepsy, non-refractory (disorder)	4180186
762830	Atonic seizure, non-refractory (disorder)	4180186
762830	Atonic seizure, non-intractable	4180186
762833	Medication summary (record artifact)	4180186
762835	Active ingredient availability decreased due to interaction (finding)	4180186
762836	Durable medical equipment supplier dialysis programme	4180186
762836	DME - Durable medical equipment supplier dialysis program	4180186
762836	Durable medical equipment supplier dialysis program (regime/therapy)	4180186
762838	Patient medically unfit to receive information (finding)	4180186
762840	Arteriovenous graft route (qualifier value)	4180186
762842	Employee group health insurance coverage (finding)	4180186
762844	Maternal active tuberculosis (situation)	4180186
762845	Maternal varicella infection (situation)	4180186
762846	Maternal history of therapy (situation)	4180186
762847	Medication dose changed (situation)	4180186
762849	Medication dosing interval changed (situation)	4180186
762850	Medication dosing interval decreased (situation)	4180186
762856	Herbal supplement started (situation)	4180186
762857	Medication changed to therapeutic equivalent (situation)	4180186
762858	Medication changed to therapeutic equivalent on formulary (situation)	4180186
762859	Documentation of mental health medication action plan (procedure)	4180186
762861	Documentation of pulmonary disorder medication action plan (procedure)	4180186
762862	Documentation of chronic obstructive pulmonary disorder medication action plan (procedure)	4180186
762862	Documentation of chronic obstructive pulmonary disease medication action plan	4180186
762865	Documentation of heart failure medication action plan (procedure)	4180186
762866	Documentation of coronary heart disease medication action plan (procedure)	4180186
762867	Documentation of metabolic disorder medication action plan (procedure)	4180186
762867	Documentation of metabolic disease medication action plan	4180186
762868	Documentation of gout medication action plan (procedure)	4180186
762869	Documentation of dyslipidemia medication action plan (procedure)	4180186
762873	Documentation of HIV - human immunodeficiency virus infection medication action plan	4180186
762873	Documentation of human immunodeficiency virus infection medication action plan (procedure)	4180186
762876	Documentation of immunologic disorder medication action plan (procedure)	4180186
762877	Documentation of hematologic disorder medication action plan (procedure)	4180186
762877	Documentation of haematologic disorder medication action plan	4180186
762880	Documentation of rheumatic disease medication action plan (procedure)	4180186
762881	Documentation of renal disease medication action plan	4180186
762881	Documentation of renal disorder medication action plan (procedure)	4180186
762882	Documentation of smoking cessation medication action plan (procedure)	4180186
762887	Neoplasm of prostate primary tumor staging category T2a	4180186
762887	Neoplasm of prostate primary tumor staging category T2a: Involves one-half of one lobe or less (finding)	4180186
762887	Neoplasm of prostate staging category T2a: Involves one-half of one lobe or less	4180186
762888	Neoplasm of breast primary tumor staging category T0	4180186
762888	Neoplasm of breast staging category T0: No evidence of primary tumor	4180186
762888	Neoplasm of breast primary tumor staging category T0: No evidence of primary tumor (finding)	4180186
762889	Neoplasm of breast primary tumor staging category T1mi: Tumor <=1 mm in greatest dimension (finding)	4180186
762889	Neoplasm of breast primary tumor staging category T1mi	4180186
762889	Neoplasm of breast staging category T1mi: Tumor <=1 mm in greatest dimension	4180186
762892	Neoplasm of breast staging category M0: No clinical or radiographic evidence of distant metastasis	4180186
762892	Neoplasm of breast distant metastasis staging category M0: No clinical or radiographic evidence of distant metastasis (finding)	4180186
762892	Neoplasm of breast distant metastasis staging category M0	4180186
762894	Neoplasm of breast staging category N3 as per American Joint Committee on Cancer 7th edition	4180186
762894	Neoplasm of breast regional lymph node staging category N3	4180186
762894	Neoplasm of breast regional lymph node staging category N3 as per American Joint Committee on Cancer 7th edition (finding)	4180186
762895	Neoplasm of breast regional lymph node staging category N0	4180186
762895	Neoplasm of breast staging category N0: No regional lymph node metastasis	4180186
762895	Neoplasm of breast regional lymph node staging category N0: No regional lymph node metastasis (finding)	4180186
762897	Neoplasm of colon staging category T1: Tumor invades submucosa	4180186
762897	Neoplasm of colon primary tumor staging category T1	4180186
762897	Neoplasm of colon primary tumor staging category T1: Tumor invades submucosa (finding)	4180186
762898	Neoplasm of colon primary tumor staging category T2: Tumor invades muscularis propria (finding)	4180186
762898	Neoplasm of colon staging category T2: Tumor invades muscularis propria	4180186
762898	Neoplasm of colon primary tumor staging category T2	4180186
762899	Neoplasm of colon primary tumor staging category T3	4180186
762899	Neoplasm of colon primary tumor staging category T3: Tumor invades through muscularis propria into pericolorectal tissues (finding)	4180186
762899	Neoplasm of colon staging category T3: Tumor invades through muscularis propria into pericolorectal tissues	4180186
762901	Neoplasm of colon staging category T4b: Tumor directly invades or is adherent to other organ or structure	4180186
762901	Neoplasm of colon primary tumor staging category T4b: Tumor directly invades or is adherent to other organ or structure (finding)	4180186
762901	Neoplasm of colon primary tumor staging category T4b	4180186
762903	Neoplasm of colon regional lymph node staging category N1c	4180186
762903	Neoplasm of colon regional lymph node staging category N1c: Tumor deposit(s) in subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis (finding)	4180186
762903	Neoplasm of colon staging category N1c: Tumor deposit(s) in subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis	4180186
762903	Neoplasm of colon regional lymph node staging category N1	4180186
762905	Neoplasm of colon distant metastasis staging category M0	4180186
762905	Neoplasm of colon staging category M0: No distant metastasis	4180186
762905	Neoplasm of colon distant metastasis staging category M0: No distant metastasis (finding)	4180186
762906	Discharge to rehabilitation center	4180186
762906	Discharge to rehabilitation facility (procedure)	4180186
762909	Anaphylaxis due to Haemophilus influenzae type b vaccine	4180186
762909	Anaphylactic shock due to HiB - Haemophilus influenzae type b vaccine	4180186
762909	Anaphylactic reaction due to Haemophilus influenzae type b vaccine	4180186
762909	Anaphylaxis due to Haemophilus influenzae type b vaccine (disorder)	4180186
762911	Medicaid coverage (finding)	4180186
762913	Medicare coverage (finding)	4180186
762914	Complex febrile seizure, non-intractable	4180186
762914	Complex febrile seizure, non-refractory (finding)	4180186
762917	Concentric annular tear of intervertebral disc	4180186
762917	Concentric tear of the annulus fibrosis of intervertebral disc (disorder)	4180186
762918	Transverse annular tear of intervertebral disc	4180186
762918	Transverse tear of the annulus fibrosis of intervertebral disc (disorder)	4180186
762920	Tulip pollen	4180186
762920	Tulipa pollen (substance)	4180186
762921	Tulipa pollen allergen (substance)	4180186
762921	Tulip pollen allergen	4180186
762922	Popliteal cyst fluid (specimen)	4180186
762923	Tissue specimen from mass (specimen)	4180186
762924	Combined nasopharyngeal and oropharyngeal swab (specimen)	4180186
762924	Combined nasopharyngeal and oropharyngeal swab	4180186
762924	Nasopharyngeal and oropharyngeal swab (specimen)	4180186
762925	Avulsion fracture of lateral condyle of tibia (disorder)	4180186
762925	Segond fracture	4180186
762926	Occlusion of internal carotid artery (disorder)	4180186
762927	Specimen preservation (procedure)	4180186
762929	SNP - Single nucleotide polymorphism analysis	4180186
762929	Single nucleotide polymorphism analysis (procedure)	4180186
762930	Peritoneal dialysis catheter tunnel (morphologic abnormality)	4180186
762931	Nasal washings (specimen)	4180186
762934	Cerebral infarction due to posterior cerebral artery occlusion (disorder)	4180186
762939	Peritoneal dialysis access failure (disorder)	4180186
762940	Arteriovenous graft removed (situation)	4180186
762941	Chronic chest pain (finding)	4180186
762944	Arteriovenous fistula removed (situation)	4180186
762946	Patient requires hospitalization (finding)	4180186
762948	Simple febrile seizure, non-refractory (finding)	4180186
762950	Three dimensional conformal radiotherapy (procedure)	4180186
762953	Persistent urogenital sinus, low confluence (disorder)	4180186
762954	Post-radiotherapy cerebral vasculopathy (disorder)	4180186
762956	Grand mal status epilepticus, non-refractory (disorder)	4180186
762956	Convulsive status epilepticus, non-refractory	4180186
762956	Generalized tonic-clonic status epilepticus, non-refractory	4180186
762956	Grand mal status epilepticus, non-intractable	4180186
762958	Secondary narcolepsy (disorder)	4180186
762960	Secondary narcolepsy with cataplexy (disorder)	4180186
762963	Myoclonic seizure, refractory (disorder)	4180186
762963	Myoclonic seizure, intractable	4180186
762964	Chronic infiltrative lung disease	4180186
762964	Chronic interstitial lung disease (disorder)	4180186
762965	Acute cerebellar ataxia of childhood	4180186
762965	Acute cerebellar ataxia of childhood (disorder)	4180186
762966	Clinically isolated syndrome of brainstem (disorder)	4180186
762968	Excision of pterygium with amnion graft (procedure)	4180186
762972	History of bidirectional superior cavopulmonary (Glenn) anastomosis	4180186
762972	History of bidirectional superior cavopulmonary anastomosis (situation)	4180186
762973	Hypertensive end stage renal disease (disorder)	4180186
762973	End stage renal disease due to hypertension	4180186
762975	Acute tic disorder (disorder)	4180186
762976	Primary generalized epilepsy, non-refractory	4180186
762976	Idiopathic generalized epilepsy, non-refractory (disorder)	4180186
762976	Idiopathic generalized epilepsy, non-intractable	4180186
762977	Complex partial status epilepticus, refractory (disorder)	4180186
762977	Psychomotor status, refractory	4180186
762977	Complex partial status epilepticus, intractable	4180186
762979	Atypical absence seizure, refractory (finding)	4180186
762979	Atypical absence seizure, refractory (disorder)	4180186
762979	Atypical absence seizure, intractable	4180186
762980	Atypical absence seizure, non-refractory (finding)	4180186
762980	Atypical absence seizure, non-refractory (disorder)	4180186
762980	Atypical absence seizure, non-intractable	4180186
762981	Benign childhood epilepsy with centrotemporal spikes, non-intractable	4180186
762981	Benign rolandic epilepsy, non-refractory	4180186
762981	Benign childhood epilepsy with centrotemporal spikes, non-refractory (disorder)	4180186
762983	Semantic relationship type (foundation metadata concept)	4180186
762985	Antibiotic given for suspected neonatal sepsis (situation)	4180186
762986	Fetal intrapartum death after first assessment (event)	4180186
762987	Death certification and verification by physician (procedure)	4180186
762990	Antepartum fetal death with continued labor (event)	4180186
762991	Antepartum fetal death with cessation of labor (event)	4180186
762993	Surfactant replacement therapy (procedure)	4180186
762998	Excessive muscarinic activity (disorder)	4180186
763000	Discharge to acute care hospital (procedure)	4180186
763003	Vertebral artery occlusion with infarction (disorder)	4180186
763005	Referral for home safety evaluation (procedure)	4180186
763006	Open (qualifier value)	4180186
763007	Family history of endometriosis (situation)	4180186
763007	Family history: endometriosis	4180186
763009	Multiple and bilateral precerebral arterial occlusion with infarction (disorder)	4180186
763011	Pneumonia due to Influenza A virus (disorder)	4180186
763014	Middle cerebral artery occlusion (disorder)	4180186
763018	Organic encopresis (finding)	4180186
763020	Hepatitis with hepatic coma (disorder)	4180186
763021	Chronic hepatitis C with hepatic coma	4180186
763021	Chronic viral hepatitis C with hepatic coma (disorder)	4180186
763023	Calculus of gallbladder and bile duct with cholecystitis (disorder)	4180186
763025	Right recurrent acute suppurative otitis media	4180186
763025	Recurrent acute suppurative otitis media of right ear (disorder)	4180186
763027	Sepsis of newborn due to Streptococcus agalactiae (disorder)	4180186
763027	Sepsis of newborn due to group B Streptococcus	4180186
763031	Left vesicoureteric junction (body structure)	4180186
763034	Medication administered during labor (situation)	4180186
763035	Vertebral artery occlusion without infarction (disorder)	4180186
763039	Landau-Kleffner syndrome, refractory	4180186
763039	Acquired aphasia with epilepsy, refractory	4180186
763039	Acquired epileptic aphasia, intractable	4180186
763039	Acquired epileptic aphasia, refractory (disorder)	4180186
763041	Juvenile myoclonic epilepsy, non-refractory (disorder)	4180186
763041	Juvenile myoclonic epilepsy, non-intractable	4180186
763041	Janz syndrome, non-refractory	4180186
763045	Medication therapy management information sent to health care provider (situation)	4180186
763046	Medication reminder device configuration	4180186
763046	Medication reminder device set-up (procedure)	4180186
763047	Prophylactic medication needed	4180186
763047	Preventive medication therapy needed (situation)	4180186
763048	Medication taken to treat adverse reaction to medication	4180186
763048	Medication taken to treat adverse drug reaction (finding)	4180186
763049	Neuroendocrine carcinoma, metastatic (morphologic abnormality)	4180186
763052	Not taking medication for chronic disease (finding)	4180186
763053	Patient condition appropriate for non-medication therapy (finding)	4180186
763056	Cancer risk assessment	4180186
763056	Assessment for risk of cancer (procedure)	4180186
763056	Assessment for risk of neoplastic disease	4180186
763059	Nutrition supplement therapy (regime/therapy)	4180186
763061	Multi-trace element supplement therapy (regime/therapy)	4180186
763061	Providing multiple trace element minerals, based on suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. (Source: International Dietetics and Nutrition Terminology (IDNT) Reference Manual, edition 4; ISBN #978-0-88091-467-3).	4180186
763062	Vitamin supplement therapy (regime/therapy)	4180186
763065	Galactose modified diet (regime/therapy)	4180186
763069	Fat modified diet (regime/therapy)	4180186
763070	Liquid diet (regime/therapy)	4180186
763073	Dietary fluid modified diet (regime/therapy)	4180186
763073	Increase or decrease in fluid content of the diet. (Source: Academy of Nutrition and Dietetics Nutrition Informatics Committee 2013)	4180186
763074	Mineral modified diet (regime/therapy)	4180186
763075	Protein modified diet (regime/therapy)	4180186
763075	Increase or decrease in protein content of the diet. (Source: Academy of Nutrition and Dietetics Nutrition Informatics Committee 2013)	4180186
763082	Documentation of past medical history (procedure)	4180186
763083	Directly observed therapy for tuberculosis (procedure)	4180186
763084	Fall due to seizure (event)	4180186
763086	History of antiretroviral therapy during labour and delivery	4180186
763086	History of antiretroviral therapy during labor and delivery (situation)	4180186
763087	Sleeps in sitting position due to orthopnoea	4180186
763087	Sleeps in sitting position due to orthopnea (finding)	4180186
763092	Insomnia due to anxiety and fear (disorder)	4180186
763093	Carotid artery stenosis without infarction (disorder)	4180186
763095	Posterior inferior cerebellar artery occlusion with infarction (disorder)	4180186
763096	Epilepsia partialis continua, non-refractory	4180186
763096	Simple partial status epilepticus, non-refractory (disorder)	4180186
763096	Simple partial status epilepticus, non-intractable	4180186
763098	New medication therapy needed for condition (situation)	4180186
763100	Neoplasm of breast regional lymph node staging category pN3	4180186
763100	Neoplasm of breast staging category pN3 as per American Joint Committee on Cancer 7th edition	4180186
763100	Neoplasm of breast regional lymph node staging category pN3 as per American Joint Committee on Cancer 7th edition (finding)	4180186
763101	Moderate-intensity statin therapy (procedure)	4180186
763102	Neoplasm of breast regional lymph node staging category pN0(i+)	4180186
763102	Neoplasm of breast staging category pN0(i+): Regional lymph node isolated tumor cell clusters detected by hematoxylin and eosin stain or immunohistochemical methods	4180186
763102	Neoplasm of breast regional lymph node staging category pN0(i+): Regional lymph node isolated tumor cell clusters detected by hematoxylin and eosin stain or immunohistochemical methods (finding)	4180186
763103	Neoplasm of breast regional lymph node staging category pN0(i-)	4180186
763103	Neoplasm of breast staging category pN0(i-): No regional lymph node metastasis histologically, negative immunohistochemically	4180186
763103	Neoplasm of breast regional lymph node staging category pN0(i-): No regional lymph node metastasis histologically, negative immunohistochemically (finding)	4180186
763104	Neoplasm of breast staging category T4a: Extension to the chest wall, not including only adherence and/or invasion to pectoralis muscle	4180186
763104	Neoplasm of breast primary tumor staging category T4a	4180186
763104	Neoplasm of breast primary tumor staging category T4a: Extension to the chest wall, not including only adherence and/or invasion to pectoralis muscle (finding)	4180186
763106	Neoplasm of breast staging category T4d: Inflammatory carcinoma involving >=1/3 of skin of breast	4180186
763106	Neoplasm of breast primary tumor staging category T4d: Inflammatory carcinoma involving >=1/3 of skin of breast (finding)	4180186
763106	Neoplasm of breast primary tumor staging category T4d	4180186
763108	Neoplasm of breast primary tumor staging category Tis: Paget's disease of the breast with no tumor	4180186
763108	Neoplasm of breast primary tumor staging category Tis (Paget's) (finding)	4180186
763110	Neoplasm of breast staging category NX: Regional lymph nodes cannot be assessed	4180186
763110	Neoplasm of breast regional lymph node staging category NX: Regional lymph nodes cannot be assessed (finding)	4180186
763110	Neoplasm of breast regional lymph node staging category NX	4180186
763118	Neoplasm of breast staging category N3a: Metastasis in ipsilateral infraclavicular lymph node(s)	4180186
763118	Neoplasm of breast regional lymph node staging category N3a: Metastasis in ipsilateral infraclavicular lymph node(s) (finding)	4180186
763118	Neoplasm of breast regional lymph node staging category N3a	4180186
763121	Neoplasm of colon primary tumor staging category TX: Primary tumor cannot be assessed (finding)	4180186
763121	Neoplasm of colon primary tumor staging category TX	4180186
763121	Neoplasm of colon staging category TX: Primary tumor cannot be assessed	4180186
763125	Neoplasm of colon distant metastasis staging category M1a	4180186
763125	Neoplasm of colon distant metastasis staging category M1a: Metastasis confine to one organ or site (finding)	4180186
763125	Neoplasm of colon staging category M1a: Metastasis confine to one organ or site	4180186
763127	Neoplasm of prostate staging category NX: regional lymph nodes not assessed	4180186
763127	Neoplasm of prostate regional lymph node staging category NX: regional lymph nodes not assessed (finding)	4180186
763127	Neoplasm of prostate regional lymph node staging category NX	4180186
763130	Neoplasm of prostate distant metastasis staging category M0	4180186
763130	Neoplasm of prostate staging category M0: No distant metastasis	4180186
763130	Neoplasm of prostate distant metastasis staging category M0: No distant metastasis (finding)	4180186
763134	Neoplasm of prostate distant metastasis staging category M1b: Metastasis to bone (finding)	4180186
763134	Neoplasm of prostate distant metastasis staging category M1b	4180186
763134	Neoplasm of prostate staging category M1b: Metastasis to bone	4180186
763135	Neoplasm of prostate primary tumor staging category TX	4180186
763135	Neoplasm of prostate staging category TX: Primary tumor cannot be assessed	4180186
763135	Neoplasm of prostate primary tumor staging category TX: Primary tumor cannot be assessed (finding)	4180186
763136	Neoplasm of prostate primary tumor staging category T2b: Tumor involves more than one-half of one lobe but not both lobes (finding)	4180186
763136	Neoplasm of prostate staging category T2b: Tumor involves more than one-half of one lobe but not both lobes	4180186
763136	Neoplasm of prostate primary tumor staging category T2b	4180186
763137	Neoplasm of prostate primary tumor staging category T2c	4180186
763137	Neoplasm of prostate staging category T2c: Tumor involves both lobes	4180186
763137	Neoplasm of prostate primary tumor staging category T2c: Tumor involves both lobes (finding)	4180186
763138	Neoplasm of prostate staging category pT3a: Extraprostatic extension or microscopic invasion of bladder neck	4180186
763138	Neoplasm of prostate primary tumor staging category pT3a	4180186
763138	Neoplasm of prostate primary tumor staging category pT3a: Extraprostatic extension or microscopic invasion of bladder neck (finding)	4180186
763140	Neoplasm of prostate primary tumor staging category pT4: Invasion of rectum, levator muscles, and/or pelvic wall (finding)	4180186
763140	Neoplasm of prostate staging category pT4: Invasion of rectum, levator muscles, and/or pelvic wall	4180186
763140	Neoplasm of prostate primary tumor staging category pT4	4180186
763143	Hippurate-negative Campylobacter jejuni/Campylobacter coli (organism)	4180186
763144	Acid-fast bacteria present (finding)	4180186
763145	Microbial isolate sent to CDC - Centers for Disease Control and Prevention for testing	4180186
763145	Microbial isolate sent to Centers for Disease Control and Prevention for testing (situation)	4180186
763146	Dialysis program certification pending (finding)	4180186
763149	Thrombophlebitis of anastomosing ven of Labbe	4180186
763149	Thrombophlebitis of superior anastomotic vein (disorder)	4180186
763149	Thrombophlebitis of vein of Labbe	4180186
763151	Simple partial seizure with motor dysfunction, non-intractable	4180186
763151	Simple partial seizure with motor dysfunction, non-refractory (disorder)	4180186
763155	Vesicle fluid swab	4180186
763155	Swab of fluid from vesicle (specimen)	4180186
763156	Lactose modified diet (regime/therapy)	4180186
763165	Sepsis associated with internal vascular access (disorder)	4180186
763169	Unsaturated fat (substance)	4180186
763170	Monounsaturated fat (substance)	4180186
763171	Polyunsaturated fat (substance)	4180186
763173	Increased fat diet (regime/therapy)	4180186
763174	Decreased fat diet (regime/therapy)	4180186
763176	Polyunsaturated fat modified diet (regime/therapy)	4180186
763177	Saturated fat modified diet (regime/therapy)	4180186
763179	Increased monounsaturated fat diet (regime/therapy)	4180186
763180	Decreased monounsaturated fat diet (regime/therapy)	4180186
763181	Decreased polyunsaturated fat diet (regime/therapy)	4180186
763185	Increased fiber diet (regime/therapy)	4180186
763185	Increased fibre diet	4180186
763188	Increased soluble fibre diet	4180186
763188	Increased soluble fiber diet (regime/therapy)	4180186
763192	Boron modified diet (regime/therapy)	4180186
763193	Calcium modified diet (regime/therapy)	4180186
763196	Chromium modified diet (regime/therapy)	4180186
763199	Fluoride modified diet (regime/therapy)	4180186
763204	Phosphorus modified diet (regime/therapy)	4180186
763205	Potassium modified diet (regime/therapy)	4180186
763206	Selenium modified diet (regime/therapy)	4180186
763208	Zinc modified diet (regime/therapy)	4180186
763209	Increased calcium diet (regime/therapy)	4180186
763210	Decreased calcium diet (regime/therapy)	4180186
763212	Increased copper diet (regime/therapy)	4180186
763213	Decreased copper diet (regime/therapy)	4180186
763216	Increased iron diet (regime/therapy)	4180186
763218	Increased magnesium diet (regime/therapy)	4180186
763224	Decreased sodium diet (regime/therapy)	4180186
763225	Increased zinc diet (regime/therapy)	4180186
763227	Provides foods of known protein content to meet the need of the individual in consistent amounts and/or consistent times. (Source: Academy of Nutrition and Dietetics Nutrition Informatics Committee 2013)	4180186
763227	Consistent protein diet (regime/therapy)	4180186
763229	Amino acid modified diet (regime/therapy)	4180186
763234	Leucine modified diet (regime/therapy)	4180186
763238	Threonine modified diet (regime/therapy)	4180186
763240	Decreased tyramine diet (regime/therapy)	4180186
763242	Valine modified diet (regime/therapy)	4180186
763246	Increased arginine diet (regime/therapy)	4180186
763249	Increased histidine diet (regime/therapy)	4180186
763251	Increased isoleucine diet (regime/therapy)	4180186
763254	Decreased lysine diet (regime/therapy)	4180186
763255	Increased methionine diet (regime/therapy)	4180186
763259	Increased tryptophan diet (regime/therapy)	4180186
763262	Increased valine diet (regime/therapy)	4180186
763264	Amino acid - dietary (substance)	4180186
763266	Intermittent ataxia (finding)	4180186
763268	The first 20 ml of voided urine. Used for Neisseria gonorrhea and Chlamydia trachomaitis testing	4180186
763268	First void urine specimen (specimen)	4180186
763272	Low cholesterol food (substance)	4180186
763274	Folic acid modified diet (regime/therapy)	4180186
763277	Riboflavin modified diet (regime/therapy)	4180186
763278	Thiamine modified diet (regime/therapy)	4180186
763278	Thiamin modified diet	4180186
763280	Vitamin C modified diet	4180186
763280	Ascorbic acid modified diet (regime/therapy)	4180186
763283	Increased biotin diet (regime/therapy)	4180186
763285	Increased folic acid diet (regime/therapy)	4180186
763288	Decreased niacin diet (regime/therapy)	4180186
763289	Increased pantothenic acid diet (regime/therapy)	4180186
763290	Decreased pantothenic acid diet (regime/therapy)	4180186
763293	Increased thiamin diet	4180186
763293	Increased thiamine diet (regime/therapy)	4180186
763296	Decreased vitamin A diet (regime/therapy)	4180186
763303	Decreased vitamin E diet (regime/therapy)	4180186
763305	Decreased vitamin K diet (regime/therapy)	4180186
763307	Palpable undescended testicle (disorder)	4180186
763309	Myoclonic astatic epilepsy, non-intractable	4180186
763309	Myoclonic astatic epilepsy, non-refractory (disorder)	4180186
763309	Myoclonic atonic epilepsy, non-refractory	4180186
763310	Vitamin supplement (substance)	4180186
763312	Folate supplement (substance)	4180186
763313	Niacin supplement (substance)	4180186
763316	Thiamin supplement	4180186
763316	Thiamine supplement (substance)	4180186
763317	Vitamin A supplement (substance)	4180186
763318	Vitamin B12 supplement (substance)	4180186
763319	Vitamin B6 supplement (substance)	4180186
763320	Vitamin C supplement (substance)	4180186
763321	Vitamin D supplement (substance)	4180186
763322	Vitamin E supplement (substance)	4180186
763324	Calcium supplement (substance)	4180186
763327	Cobalt supplement (substance)	4180186
763329	Iodine supplement (substance)	4180186
763330	Iron supplement (substance)	4180186
763333	Sodium supplement (substance)	4180186
763335	Multi-trace element supplement (substance)	4180186
763338	Niacin supplement therapy (regime/therapy)	4180186
763339	Pantothenic acid supplement therapy (regime/therapy)	4180186
763341	Vitamin A supplement therapy (regime/therapy)	4180186
763343	Vitamin B6 supplement therapy (regime/therapy)	4180186
763344	Vitamin C supplement therapy (regime/therapy)	4180186
763345	Vitamin D supplement therapy (regime/therapy)	4180186
763347	Vitamin K supplement therapy (regime/therapy)	4180186
763350	Chloride supplement therapy (regime/therapy)	4180186
763352	Cobalt supplement therapy (regime/therapy)	4180186
763353	Copper supplement therapy (regime/therapy)	4180186
763356	Iron supplement therapy (regime/therapy)	4180186
763357	Manganese supplement therapy (regime/therapy)	4180186
763358	Molybdenum supplement therapy (regime/therapy)	4180186
763362	Sulphur supplement therapy	4180186
763362	Sulfur supplement therapy (regime/therapy)	4180186
763364	Dietary fluid (substance)	4180186
763372	Modified beverage, medical food supplement therapy (regime/therapy)	4180186
763375	History of poor pregnancy outcome (situation)	4180186
763376	Local AIDS pharmaceutical assistance, APA, not ADAP (regime/therapy)	4180186
763379	Between one hundred and one - two hundred percent of the US federal poverty level (social concept)	4180186
763379	Between one hundred and one - two hundred percent of the US federal poverty level	4180186
763379	101-200% of the US federal poverty level (social concept)	4180186
763380	Between two hundred and one - three hundred percent of the US federal poverty level (social concept)	4180186
763380	Between two hundred and one - three hundred percent of the US federal poverty level	4180186
763380	201-300% of the US federal poverty level (social concept)	4180186
763384	Death in hospital-based emergency department (event)	4180186
763386	Death in nursing home (event)	4180186
763388	Death in residence	4180186
763388	Death in home (event)	4180186
763389	Prevotella oralis group (organism)	4180186
763391	History of previous intrauterine growth restricted newborn (situation)	4180186
763392	Tapering dose (qualifier value)	4180186
763395	Nocardia-like species	4180186
763395	Nocardia-like organism (organism)	4180186
763396	History of neurosis (situation)	4180186
763397	Suboptimal growth rate	4180186
763397	Below normal growth rate	4180186
763397	Below expected growth rate (finding)	4180186
763397	Decreased growth rate	4180186
763399	Predicted excessive energy intake (finding)	4180186
763403	Excessive parenteral nutrition infusion (finding)	4180186
763404	Bioactive substance intake finding (finding)	4180186
763404	Bioactive substance intake finding	4180186
763405	Inadequate bioactive substance intake (finding)	4180186
763409	Inadequate plant sterol ester intake (finding)	4180186
763411	Excessive beta glucan intake (finding)	4180186
763411	Excessive b-glucan intake	4180186
763414	Excessive plant stanol ester intake (finding)	4180186
763419	Non-nutritive food additive (substance)	4180186
763420	Plant stanol ester (substance)	4180186
763421	Management of plant stanol ester intake (procedure)	4180186
763422	Management of plant sterol ester intake (procedure)	4180186
763423	Management of soy protein intake (procedure)	4180186
763424	Management of psyllium intake (procedure)	4180186
763430	Inadequate pantothenic acid intake	4180186
763430	Inadequate intake of pantothenic acid (finding)	4180186
763432	Excessive vitamin B6 intake (finding)	4180186
763433	Excessive vitamin B12 intake (finding)	4180186
763435	Inadequate chloride intake (finding)	4180186
763436	Inadequate magnesium intake (finding)	4180186
763437	Inadequate phosphorus intake (finding)	4180186
763438	Inadequate sodium intake (finding)	4180186
763439	Inadequate sulfate intake (finding)	4180186
763439	Inadequate sulphate intake	4180186
763444	Inadequate intake of molybdenum (finding)	4180186
763444	Inadequate molybdenum intake	4180186
763445	Inadequate boron intake (finding)	4180186
763449	Excessive magnesium intake (finding)	4180186
763450	Excessive sulfate intake (finding)	4180186
763450	Excessive sulphate intake	4180186
763451	Excessive fluoride intake	4180186
763451	Excessive intake of fluoride (finding)	4180186
763452	Excessive intake of iodine (finding)	4180186
763452	Excessive iodine intake	4180186
763453	Excessive intake of selenium (finding)	4180186
763453	Excessive selenium intake	4180186
763454	Excessive intake of manganese (finding)	4180186
763454	Excessive manganese intake	4180186
763455	Excessive intake of chromium (finding)	4180186
763455	Excessive chromium intake	4180186
763456	Excessive boron intake (finding)	4180186
763459	Health belief model (qualifier value)	4180186
763463	Social support (qualifier value)	4180186
763465	Relapse prevention (qualifier value)	4180186
763466	Rewards and contingency management (qualifier value)	4180186
763467	Counselling about nutrition using cognitive-behavioural theoretical approach	4180186
763467	Counseling about nutrition using cognitive-behavioral theoretical approach (procedure)	4180186
763467	Counseling about nutrition using cognitive behavioral theoretical approach	4180186
763467	Counselling about nutrition using cognitive behavioural theoretical approach	4180186
763467	Counseling about nutrition using cognitive behavioral theoretical approach (regime/therapy)	4180186
763469	Counselling about nutrition using health belief model	4180186
763469	Counseling about nutrition using health belief model (procedure)	4180186
763469	Counseling about nutrition using health belief model (regime/therapy)	4180186
763470	Counselling about nutrition using transtheoretical model and stages of change approach	4180186
763470	Counseling about nutrition using transtheoretical model and stages of change approach (procedure)	4180186
763470	Counseling about nutrition using transtheoretical model and stages of change approach (regime/therapy)	4180186
763471	Counseling about nutrition using motivational interviewing strategy (procedure)	4180186
763471	Counselling about nutrition using motivational interviewing strategy	4180186
763471	Counseling about nutrition using motivational interviewing technique	4180186
763471	Counseling about nutrition using motivational interviewing technique (regime/therapy)	4180186
763471	Counselling about nutrition using motivational interviewing technique	4180186
763473	Counseling about nutrition using problem solving strategy (procedure)	4180186
763473	Counselling about nutrition using problem solving strategy	4180186
763473	Counseling about nutrition using problem solving strategy (regime/therapy)	4180186
763474	Counselling about nutrition using social support strategy	4180186
763474	Counseling about nutrition using social support strategy (procedure)	4180186
763474	Counseling about nutrition using social support strategy (regime/therapy)	4180186
763476	Counseling about nutrition using stimulus control strategy (procedure)	4180186
763476	Counselling about nutrition using stimulus control strategy	4180186
763476	Counseling about nutrition using stimulus control strategy (regime/therapy)	4180186
763477	Counselling about nutrition using cognitive restructuring strategy	4180186
763477	Counseling about nutrition using cognitive restructuring strategy (procedure)	4180186
763477	Counseling about nutrition using cognitive restructuring strategy (regime/therapy)	4180186
763478	Counselling about nutrition using relapse prevention strategy	4180186
763478	Counseling about nutrition using relapse prevention strategy (procedure)	4180186
763478	Counseling about nutrition using relapse prevention strategy (regime/therapy)	4180186
763479	Counselling about nutrition using rewards and contingency management strategy	4180186
763479	Counseling about nutrition using rewards and contingency management strategy (procedure)	4180186
763479	Counseling about nutrition using rewards and contingency management strategy (regime/therapy)	4180186
763482	Management of concentration of enteral nutrition (procedure)	4180186
763484	Management of volume of enteral nutrition (procedure)	4180186
763485	Management of schedule of enteral nutrition (procedure)	4180186
763486	Management of route of enteral nutrition (procedure)	4180186
763488	Management of flushing of feeding tube (procedure)	4180186
763489	Management of composition of parenteral nutrition (procedure)	4180186
763490	Management of concentration of parenteral nutrition (procedure)	4180186
763491	Management of delivery rate of parenteral nutrition (procedure)	4180186
763492	Management of schedule of parenteral nutrition (procedure)	4180186
763493	Management of route of parenteral nutrition (procedure)	4180186
763494	Management of volume of parenteral nutrition (procedure)	4180186
763498	Modular lipid enteral formula component (product)	4180186
763501	Hard food (substance)	4180186
763502	Sticky food (substance)	4180186
763503	Thin pureed food (substance)	4180186
763506	Excessive phosphorus intake (finding)	4180186
763507	Excessive copper intake	4180186
763507	Excessive intake of copper (finding)	4180186
763510	Inadequate mineral intake (finding)	4180186
763512	Limited food acceptance (finding)	4180186
763517	Lactobacillus-like gram positive bacillus (organism)	4180186
763519	Salmonella, Shigella and Campylobacter not isolated (finding)	4180186
763523	Bacillus species not Bacillus anthracis or Bacillus cereus (organism)	4180186
763525	Mycobacterium franklinii (organism)	4180186
763527	Autosomal dominant nocturnal frontal lobe epilepsy, non-refractory (disorder)	4180186
763527	Autosomal dominant nocturnal frontal lobe epilepsy, non-intractable	4180186
763527	ADNFLE - Autosomal dominant nocturnal frontal lobe epilepsy, non-refractory	4180186
763528	Fungal infection associated with peritoneal dialysis catheter (disorder)	4180186
763530	Edentulous mandible bone height greater than or equal to 21mm (finding)	4180186
763533	Edentulous mandible bone height 15mm to 20 mm (finding)	4180186
763536	Patient transfer to psychiatric hospital (procedure)	4180186
763540	Annona muricata fruit	4180186
763540	Soursop (substance)	4180186
763542	Musk melon (substance)	4180186
763546	Purple food dye	4180186
763546	Purple food coloring (substance)	4180186
763546	Purple food colouring	4180186
763547	Black food coloring (substance)	4180186
763547	Black food colouring	4180186
763547	Black food dye	4180186
763549	Allura red AC	4180186
763549	Food red 17	4180186
763549	FD and C red 40 (substance)	4180186
763551	Norovirus genogroup II (organism)	4180186
763551	Norovirus GII	4180186
763552	Turnip greens (substance)	4180186
763554	Honeydew melon (substance)	4180186
763557	Deer meat	4180186
763557	Venison (substance)	4180186
763558	Arugula (substance)	4180186
763559	Collard greens (substance)	4180186
763561	Crustacean (substance)	4180186
763562	Measurement of wound size (procedure)	4180186
763563	Hot pepper (substance)	4180186
763565	Pimiento	4180186
763565	Pimento (substance)	4180186
763566	Non-dairy creamer (substance)	4180186
763567	Tapioca pudding (substance)	4180186
763568	Sugarbeet	4180186
763568	Sugar beet (substance)	4180186
763570	Non-iodized salt (substance)	4180186
763571	Iodised salt	4180186
763571	Iodized salt (substance)	4180186
763572	Eggnog (substance)	4180186
763577	Frog leg (substance)	4180186
763581	Sterilized water infant formula (product)	4180186
763582	Hypoallergenic infant formula (product)	4180186
763583	Leucine-free infant formula (product)	4180186
763585	Phenylalanine-free infant formula (product)	4180186
763586	Lysine and tryptophan-free infant formula (product)	4180186
763591	Reduced lactose infant formula (product)	4180186
763594	Modular formula component (product)	4180186
763595	Modular protein formula component (product)	4180186
763597	Modular carbohydrate formula component (product)	4180186
763599	Dinkel wheat	4180186
763599	Spelt (substance)	4180186
763600	Triticale (substance)	4180186
763603	Worcestershire sauce (substance)	4180186
763605	Italian dressing (substance)	4180186
763609	Khorasan wheat (substance)	4180186
763613	Sea urchin - dietary (substance)	4180186
763613	Uni	4180186
763614	Gelato (substance)	4180186
763619	Popsicle (substance)	4180186
763621	American cheese (substance)	4180186
763622	Pancake (substance)	4180186
763623	Fruit nectar (substance)	4180186
763624	Cookie (substance)	4180186
763625	Cooked vegetable (substance)	4180186
763627	Cooked fruit (substance)	4180186
763628	Cold cereal (substance)	4180186
763629	Energy drink (substance)	4180186
763630	Reduced fat ice cream (substance)	4180186
763631	Reduced sugar ice cream (substance)	4180186
763632	Probiotic yogurt (substance)	4180186
763633	Fish surimi (substance)	4180186
763634	Seitan	4180186
763634	Wheat gluten (substance)	4180186
763643	Barnacle - dietary	4180186
763643	Barnacle - dietary (substance)	4180186
763645	Methionine-free formula (product)	4180186
763646	Lysine and tryptophan-free formula (product)	4180186
763647	Phenylalanine-free formula (product)	4180186
763648	Isoleucine, leucine and valine-free infant formula (product)	4180186
763649	Menu selection assistance (procedure)	4180186
763650	Human milk fortifier (product)	4180186
763652	Non-essential amino acid free formula (product)	4180186
763654	Modular energy formula component (product)	4180186
763655	Generalized epilepsy with febrile seizures plus, refractory (disorder)	4180186
763655	Generalized epilepsy with febrile seizures plus, intractable	4180186
763656	Generalized epilepsy with febrile seizures plus, non-refractory (disorder)	4180186
763656	Generalized epilepsy with febrile seizures plus, non-intractable	4180186
763657	Caper (substance)	4180186
763660	Capable of very heavy physical activity (finding)	4180186
763662	Capable of light physical activity (finding)	4180186
763664	Nutrition environment management (procedure)	4180186
763666	Feeding environment meal service management (procedure)	4180186
763667	Feeding environment room temperature management (procedure)	4180186
763669	Feeding environment distraction management (procedure)	4180186
763671	Feeding environment lighting management (procedure)	4180186
763675	Does without difficulty (qualifier value)	4180186
763677	Does with much difficulty (qualifier value)	4180186
763677	Has much difficulty doing	4180186
763679	Three to six times a week (qualifier value)	4180186
763679	3-6 times a week	4180186
763681	Four or more nights a week (qualifier value)	4180186
763683	Composition of nutritional intake of carbohydrate inappropriate (finding)	4180186
763684	Composition of nutritional intake of protein inappropriate (finding)	4180186
763685	Composition of nutritional intake of fat inappropriate (finding)	4180186
763686	Non-shiga toxin producing Escherichia coli (organism)	4180186
763690	Extreme	4180186
763690	Very severely	4180186
763690	Very severe (qualifier value)	4180186
763691	Referral for physical therapy (procedure)	4180186
763692	Never (qualifier value)	4180186
763692	None of the time	4180186
763692	Not at all	4180186
763693	Very mild pain (finding)	4180186
763694	Slightly worse (qualifier value)	4180186
763694	A little worse	4180186
763699	Nearly every day (qualifier value)	4180186
763699	Almost daily	4180186
763700	Most of the time (qualifier value)	4180186
763701	Annual wellness visit (procedure)	4180186
763702	A good bit of the time (qualifier value)	4180186
763703	Repeatedly non-reactive (qualifier value)	4180186
763705	Vaccination delayed (finding)	4180186
763710	Receives quite a bit of social support (finding)	4180186
763711	Receives no social support (finding)	4180186
763713	Collaborating in nutrition therapy (procedure)	4180186
763714	Family history of paternal hip fracture (situation)	4180186
763714	Family history of hip fracture in father	4180186
763715	Has a little bit of difficulty doing	4180186
763715	Does with slight difficulty	4180186
763715	Has slight difficulty doing (qualifier value)	4180186
763718	Activity totally limited (finding)	4180186
763722	Activity not at all limited (finding)	4180186
763723	Moderate limitation	4180186
763723	Activity moderately limited (finding)	4180186
763724	Four or more times a week (qualifier value)	4180186
763724	More than half the days per week	4180186
763725	Activity extremely limited (finding)	4180186
763726	Nutrition impaired due to limited access to nutrition related supplies (finding)	4180186
763727	Nutrition impaired due to limited access to healthful foods (finding)	4180186
763731	Parenteral nutrition administration method inappropriate (finding)	4180186
763732	Nutrition-related laboratory result interpretation education (procedure)	4180186
763733	Modification of nutritional regime (regime/therapy)	4180186
763736	Nutrition impaired due to imbalance of nutrients (finding)	4180186
763736	Imbalance of nutrients	4180186
763738	At risk for breastfeeding difficulty (finding)	4180186
763739	At risk for excessive intake of multiple nutrients (finding)	4180186
763742	Pretty good	4180186
763742	Moderately good (qualifier value)	4180186
763745	Has no difficulty doing (qualifier value)	4180186
763746	Postural headache (finding)	4180186
763751	Hickory smoked food (substance)	4180186
763752	Coffee bean (substance)	4180186
763754	Cucumber pickle (substance)	4180186
763755	Cells per 100 white blood cells	4180186
763755	Cells per 100 white blood cells (qualifier value)	4180186
763755	Cells/100 WBCs	4180186
763759	Technical nutrition education (procedure)	4180186
763760	Verbalizes understanding (finding)	4180186
763761	Feeding intention - formula (finding)	4180186
763763	Age more than 40 years, african american male (finding)	4180186
763765	Left after triage (finding)	4180186
763767	Third sex	4180186
763767	Gender non-conforming identity	4180186
763767	Identifies as non-conforming gender (finding)	4180186
763767	Gender-fluid	4180186
763767	Genderqueer	4180186
763767	Identifies as neither exclusively male nor female	4180186
763768	Identifies as male gender (finding)	4180186
763768	Male gender identity	4180186
763768	Male identity	4180186
763769	Increased resting metabolic rate (finding)	4180186
763770	Scratchy	4180186
763770	Scratchy sensation (qualifier value)	4180186
763772	Adopted name (qualifier value)	4180186
763774	Assigned name (qualifier value)	4180186
763776	Patronymic	4180186
763776	Patronym	4180186
763776	Patronymic name (qualifier value)	4180186
763777	Legal name (qualifier value)	4180186
763780	Invalid name (qualifier value)	4180186
763782	Well child visit, newborn less than 8 days old (procedure)	4180186
763783	Acquired left hallux varus (disorder)	4180186
763784	Acquired left hallux valgus (disorder)	4180186
763786	Closed fracture of right tibial spine	4180186
763786	Closed fracture of spine of right tibia (disorder)	4180186
763787	Within thirty days of surgery (qualifier value)	4180186
763787	Within 30 days of surgery	4180186
763788	CTCAE - Common terminology criteria for adverse events	4180186
763788	National Cancer Institute common terminology criteria for adverse events (assessment scale)	4180186
763791	CTCAE grade 3	4180186
763791	Common terminology criteria for adverse events grade 3 (finding)	4180186
763792	Fracture of right radius (disorder)	4180186
763793	Closed subcapital fracture of left femur (disorder)	4180186
763794	Open fracture of proximal end of right ulna (disorder)	4180186
763796	Closed bicondylar fracture of left tibial plateau	4180186
763796	Closed bicondylar fracture of plateau of left tibia (disorder)	4180186
763797	Closed fracture of metacarpal bone of left hand (disorder)	4180186
763798	Open fracture of great toe of left foot (disorder)	4180186
763799	Cerebellar meningioma	4180186
763799	Meningioma of cerebellum (disorder)	4180186
763802	Open avulsion fracture of anterior inferior iliac spine	4180186
763802	Open avulsion fracture of anterior inferior spine of ilium (disorder)	4180186
763804	Closed fracture of left leg	4180186
763804	Closed fracture of left lower limb (disorder)	4180186
763805	Closed fracture of right lower limb (disorder)	4180186
763805	Closed fracture of right leg	4180186
763808	Fracture of left upper limb (disorder)	4180186
763810	Closed fracture of distal phalanx of finger of left hand (disorder)	4180186
763812	Follow-up medical care not recommended (situation)	4180186
763813	Follow-up medical care sought (situation)	4180186
763815	Tree material (substance)	4180186
763816	Sumac material (substance)	4180186
763818	Ryegrass material (substance)	4180186
763818	Lolium material	4180186
763820	Artemisia material	4180186
763820	Sagebrush material (substance)	4180186
763822	Helianthus material	4180186
763822	Sunflower material (substance)	4180186
763827	Sequoioideae material	4180186
763827	Redwood tree material (substance)	4180186
763828	Quercus material	4180186
763828	Oak tree material (substance)	4180186
763832	Evergreen tree material (substance)	4180186
763833	Syringa material	4180186
763833	Lilac material (substance)	4180186
763835	Cockroach material (substance)	4180186
763836	Chigger material (substance)	4180186
763839	Rabbit material (substance)	4180186
763841	Sea cucumber material (substance)	4180186
763841	Holothuroidea material	4180186
763842	Reduviidae material (substance)	4180186
763843	Russian thistle material (substance)	4180186
763844	Leech material (substance)	4180186
763846	Mosquito saliva (substance)	4180186
763848	Seashell	4180186
763848	Sea shell (substance)	4180186
763849	Rosewood (substance)	4180186
763849	Dalbergia wood	4180186
763850	Lint (substance)	4180186
763852	Fabric freshener (substance)	4180186
763853	Deer hide (substance)	4180186
763856	Betula pollen allergen	4180186
763856	Birch pollen allergen (substance)	4180186
763860	Multidrug resistant Acinetobacter baumannii (organism)	4180186
763861	Management of nutrition-related complementary and/or alternative medicine (procedure)	4180186
763863	Management of nutrition-related prescription medication (procedure)	4180186
763864	Closed subcapital fracture of right femur (disorder)	4180186
763868	Fire ant venom	4180186
763868	Solenopsis venom (substance)	4180186
763869	Transparent dressing (physical object)	4180186
763872	Silk adhesive tape (physical object)	4180186
763881	Procedure carried out at different service or facility (situation)	4180186
763881	Procedure performed elsewhere	4180186
763883	Strain of shoulder muscle (disorder)	4180186
763884	Strain of muscle of upper arm (disorder)	4180186
763885	Monitoring of physiological parameters started (situation)	4180186
763888	Referred by emergency department physician (finding)	4180186
763892	Reason for transfer (finding)	4180186
763893	Transfer due to insurance provider requirement or request (finding)	4180186
763895	Transfer due to need for higher level care	4180186
763895	Transfer due to need for specialized care (finding)	4180186
763898	Repair of right hip joint	4180186
763898	Arthroplasty of right hip joint (procedure)	4180186
763900	Transition from home-health care to home	4180186
763900	Transition from home-health care to self-care (finding)	4180186
763901	Clinically undetermined (qualifier value)	4180186
763903	Trauma ICU	4180186
763903	Trauma intensive care unit (environment)	4180186
763906	Hospital admission, transfer from intermediate care facility (procedure)	4180186
763909	Transition from self-care to home-health care (finding)	4180186
763909	Transition from home to home-health care	4180186
763918	Patient transfer to non-psychiatric hospital (procedure)	4180186
763920	Herniation of nucleus pulposus of cervical intervertebral disc (disorder)	4180186
763921	Herniation of nucleus pulposus of thoracic intervertebral disc (disorder)	4180186
763922	Herniation of nucleus pulposus of thoracic intervertebral disc without myelopathy (situation)	4180186
763923	Herniation of nucleus pulposus of cervical intervertebral disc without myelopathy (situation)	4180186
763925	Methicillin resistant Staphylococcus aureus screen positive (finding)	4180186
763926	Chronic thrombosis of superficial vein of left lower extremtiy	4180186
763926	Chronic thrombosis of superficial vein of left lower extremtiy (disorder)	4180186
763927	Voluntary patient transfer to psychiatric hospital (procedure)	4180186
763937	Normal weight in childhood (finding)	4180186
763939	History of cerebral meningioma (situation)	4180186
763940	Left before treatment complete (finding)	4180186
763943	Hospital admission from observation unit (procedure)	4180186
763946	Total replacement of left hip joint (procedure)	4180186
763947	Family history: Paternal grandfather alive and well (situation)	4180186
763948	Family history: paternal grandmother alive and well (situation)	4180186
763948	Family history: Paternal grandmother alive and well (situation)	4180186
763949	Family history: maternal grandfather alive and well (situation)	4180186
763949	Family history: Maternal grandfather alive and well (situation)	4180186
763950	Family history: maternal grandmother alive and well (situation)	4180186
763950	Family history: Maternal grandmother alive and well (situation)	4180186
763951	Transfer to psychiatric hospital, willingness undocumented (procedure)	4180186
763952	Abnormal shape of condyloid process of mandible	4180186
763952	Abnormal shape of condyloid process of mandible (disorder)	4180186
763953	Harmful oral hygeine habit (finding)	4180186
763956	Straw-colored urine (finding)	4180186
763957	Straw color (qualifier value)	4180186
763958	Red-colored urine (finding)	4180186
763966	History of total replacement of right hip joint (situation)	4180186
763967	Urine smell sweet (finding)	4180186
763968	Distention of jugular vein (finding)	4180186
763968	Dilation of jugular vein	4180186
763969	Seedy stool (finding)	4180186
763970	Frothy stool (finding)	4180186
763977	Dark brown color (qualifier value)	4180186
763978	Orange stool	4180186
763978	Orange feces (finding)	4180186
763980	Dark red faeces	4180186
763980	Dark red feces (finding)	4180186
763981	Bright red color (qualifier value)	4180186
763986	Long-term current use of hormonal contraceptive (situation)	4180186
763988	Discharge from nursing home (procedure)	4180186
763992	Admission to inpatient rehabilitation facility (procedure)	4180186
763993	Durable power of attorney for healthcare (observable entity)	4180186
763994	Electronic notification of encounter via patient portal (procedure)	4180186
763994	Electronic notification in patient portal	4180186
763995	Comprehensive diabetic foot examination (regime/therapy)	4180186
763996	Urine consistency frothy (finding)	4180186
763998	Unable to void urine (finding)	4180186
763998	Unable to pass urine	4180186
764000	Coherent speech (finding)	4180186
764002	Twelfth cranial nerve abnormal (finding)	4180186
764008	Nephrology service (qualifier value)	4180186
764011	Benign hypertensive heart disease and chronic kidney disease	4180186
764011	Benign hypertensive heart disease and chronic renal disease (disorder)	4180186
764012	Primary care physician notified of procedure (situation)	4180186
764013	Primary care physician notified of test result (situation)	4180186
764014	Long-term current use of selective estrogen receptor modulator (situation)	4180186
764015	Long-term current use of antithrombotic (situation)	4180186
764016	Acute deep venous thrombosis of upper extremity after coronary artery bypass graft (disorder)	4180186
764018	Labour and delivery oral intake plan	4180186
764018	Labor and delivery oral intake plan (record artifact)	4180186
764020	Preparation level (qualifier value)	4180186
764021	Unprepared	4180186
764021	Not prepared (qualifier value)	4180186
764022	Very prepared (qualifier value)	4180186
764023	Moderately prepared (qualifier value)	4180186
764028	Referral to tobacco use cessation counselor (procedure)	4180186
764030	Referral to tobacco use quit line (procedure)	4180186
764031	Remainder of life (qualifier value)	4180186
764032	No advance directive (finding)	4180186
764033	Moderate motivation (finding)	4180186
764035	Able to control portion size (finding)	4180186
764036	Entombment	4180186
764036	Patient status determination, deceased and entombed (finding)	4180186
764045	Somatic dysfunction of bilateral lower extremties (finding)	4180186
764046	Somatic dysfunction of bilateral upper extremities (finding)	4180186
764049	Somatic dysfunction of right chest wall (finding)	4180186
764050	Somatic dysfunction of bilateral chest wall (finding)	4180186
764051	Somatic dysfunction of right sternochondral region (finding)	4180186
764052	Somatic dysfunction of left sternochondral region (finding)	4180186
764053	Somatic dysfunction of bilateral sternochondral regions (finding)	4180186
764055	Pressure ulcer of right lower extemity	4180186
764055	Pressure ulcer of right lower limb (disorder)	4180186
764056	Mass of muscle of left lower limb (finding)	4180186
764057	Disorder of tendon of biceps of left upper limb (disorder)	4180186
764057	Left biceps tendon disorder	4180186
764058	Disorder of artery of upper limb	4180186
764058	Disorder of artery of upper extremity (disorder)	4180186
764058	Arterial disorder of upper limb	4180186
764060	Perioperative administration of steroid (procedure)	4180186
764061	Focused ultrasound ablation using magnetic resonance imaging guidance (procedure)	4180186
764061	Magnetic resonance-guided focused ultrasound	4180186
764062	Electrical stimulation of occipital nerve (procedure)	4180186
764065	Osteomyelitis of left humerus (disorder)	4180186
764068	Death in nursing home or long term care facility (event)	4180186
764069	Death in hospital-based emergency department or outpatient department (event)	4180186
764070	Medication list inaccurate (finding)	4180186
764073	Congenital absence of soft tissue of distal phalanx of finger (disorder)	4180186
764075	Partially able (qualifier value)	4180186
764076	Villous arthritis of hand (disorder)	4180186
764077	High intensity (qualifier value)	4180186
764078	Marginal zone lymphoma of axillary lymph node (disorder)	4180186
764079	Mass of joint of right elbow (finding)	4180186
764081	Clostridium difficile toxin not detected (finding)	4180186
764083	Single-lumen airway device	4180186
764083	Single lumen supraglottic airway device (physical object)	4180186
764085	Immobilization using long board (procedure)	4180186
764086	Insertion of single lumen supraglottic airway device (procedure)	4180186
764086	Insertion of Single Lumen Supraglottic Airway Device (procedure)	4180186
764087	Decreased intraocular pressure of bilateral eyes (finding)	4180186
764088	Caregiver unable to obtain copy of document (finding)	4180186
764091	Disorder of left sacroiliac joint (disorder)	4180186
764091	Arthropathy of left sacroiliac joint	4180186
764093	Discoid meniscus of right knee (disorder)	4180186
764096	Patient has difficulty administering medication (finding)	4180186
764097	Ulcer of left lower leg due to postphlebitic syndrome (disorder)	4180186
764098	Irradiation cystitis without hematuria (disorder)	4180186
764099	Abdominal aortic aneurysm 3.0 to 5.0 centimeters in female (disorder)	4180186
764103	Cigarette smoker (5-9 cigarettes/day) (finding)	4180186
764105	Then remove	4180186
764105	Then remove - dosing instruction fragment (qualifier value)	4180186
764110	Patient unable to read medication label (finding)	4180186
764111	No history of retinopathy in past year (situation)	4180186
764113	Congenital absence of right eye	4180186
764113	Anophthalmos of right eye (disorder)	4180186
764115	Behind left ear (qualifier value)	4180186
764116	Behind both ears (qualifier value)	4180186
764117	Pain of right shoulder blade (finding)	4180186
764117	Right scapulalgia	4180186
764118	Spontaneous rupture of right tympanic membrane co-occurrent and due to acute suppurative otitis media (disorder)	4180186
764118	Spontaneous rupture of right ear drum co-occurrent and due to acute suppurative otitis media	4180186
764120	Allergic conjunctivitis of left eye (disorder)	4180186
764121	Infection of left ear (disorder)	4180186
764122	Immobilization using short extrication splint (procedure)	4180186
764126	Abdominal aortic aneurysm screening done (situation)	4180186
764128	Pre-partum vaginal blood specimen (specimen)	4180186
764129	Meningococcal group B vaccine	4180186
764129	Meningococcus group B vaccine (product)	4180186
764132	Steatite dust (substance)	4180186
764132	Soapstone dust	4180186
764133	Exposure to soapstone dust (event)	4180186
764138	Prophylactic mastectomy of left breast (procedure)	4180186
764139	Subungual hematoma of left thumb (disorder)	4180186
764142	Hunting (qualifier value)	4180186
764143	Adverse reaction caused by meningococcal group B vaccine (disorder)	4180186
764148	Protrusion of drug implant (disorder)	4180186
764151	Smokeless tobacco non-user (finding)	4180186
764155	Disorder of right lower limb	4180186
764155	Disorder of right lower extremity (disorder)	4180186
764156	Disorder of left lower limb	4180186
764156	Disorder of left lower extremity (disorder)	4180186
764157	Adult victim of neglect (finding)	4180186
764160	Responds to repeated stimulation (finding)	4180186
764160	Arouses to repeated stimulation	4180186
764161	Opens eyes spontaneously (finding)	4180186
764162	Responds to vigorous stimulation (finding)	4180186
764162	Arouses to vigorous stimulation	4180186
764163	Medication therapy management information sent to primary care pharmacist (situation)	4180186
764165	Medication care plan sent to hospital pharmacist (situation)	4180186
764169	Gathering of past medical history (procedure)	4180186
764170	Gathering of current medication list (procedure)	4180186
764171	Enrollment in co-pay assistance program (procedure)	4180186
764173	Development of medication-related goals (procedure)	4180186
764174	Development of medication-related action plan (procedure)	4180186
764177	Gathering of adverse drug event history (procedure)	4180186
764178	Referred by emergency department nurse practitioner (finding)	4180186
764179	Referred by emergency department physician assistant (finding)	4180186
764183	Patient record scanned into electronic record (finding)	4180186
764187	Multiple family members (person)	4180186
764188	Dietary education for arthritis (procedure)	4180186
764189	No history of diabetic retinopathy in past year (situation)	4180186
764190	Sample of medication administered (situation)	4180186
764190	Medication sample given	4180186
764191	Counseling about diagnositic imaging findings (procedure)	4180186
764193	Health supervision of healthy infant (regime/therapy)	4180186
764194	Health supervision of healthy child (regime/therapy)	4180186
764195	Tobacco use in mother complicating puerperium (finding)	4180186
764196	Tobacco use in mother complicating pregnancy (finding)	4180186
764199	Tobacco smoking in mother complicating pregnancy (finding)	4180186
764200	Alert from SIRS (systemic inflammatory response syndrome monitoring system) received	4180186
764200	Alert from systemic inflammatory response syndrome monitoring system received (situation)	4180186
764202	Amputation of thumb of right hand (procedure)	4180186
764203	Amputation of thumb of left hand (procedure)	4180186
764204	Acute myelopathy (disorder)	4180186
764204	Acute spinal cord disorder	4180186
764205	Recurrent infection	4180186
764205	Recurrent infectious disease (disorder)	4180186
764211	Health evaluation of new immigrant (procedure)	4180186
764212	Ayurveda	4180186
764212	Ayurvedic medicine (regime/therapy)	4180186
764214	Paid work in United States armed forces (finding)	4180186
764214	Paid work in United States armed forces	4180186
764215	Paid work in United States federal government (finding)	4180186
764215	Paid work in United States federal government	4180186
764217	Unpaid work not self-employed (finding)	4180186
764218	Improbable (qualifier value)	4180186
764220	Moderately probable (qualifier value)	4180186
764221	Highly probable (qualifier value)	4180186
764223	Maiden name (qualifier value)	4180186
764224	Professional name (qualifier value)	4180186
764225	Recurrent cancer	4180186
764225	Recurrent malignant neoplastic disease (disorder)	4180186
764227	Long-term current use of opiate analgesic drug (situation)	4180186
764228	Anti-NMDA (N-methyl D-Aspartate) receptor encephalitis	4180186
764228	Autoimmune encephalitis caused by N-methyl D-aspartate receptor antibody (disorder)	4180186
764231	Gender, age, AFP-L3, α fetoprotein and des-carboxy-prothrombin score (assessment scale)	4180186
764231	GALAD score	4180186
764232	Imaging finding reviewed (situation)	4180186
764233	Review of imaging finding (procedure)	4180186
764238	Amputation of left great toe	4180186
764238	Amputation of left hallux (procedure)	4180186
764239	Partial amputation of right hand (procedure)	4180186
764241	Evening shift worker (finding)	4180186
764243	Paid work in state government (finding)	4180186
764245	Transition of care from emergency department to long term care (finding)	4180186
764246	Transition of care from emergency department to acute care (finding)	4180186
764248	Transition of care from emergency department to self-care (finding)	4180186
764251	Transition of care from home health to emergency department (finding)	4180186
764252	Transition of care from self-care to emergency department (finding)	4180186
764253	Drug not available	4180186
764253	Medication not available (finding)	4180186
764254	Medication not available from manufacturer (finding)	4180186
764254	Drug not available from manufacturer	4180186
764255	Medication not available from pharmacy (finding)	4180186
764255	Drug not available from pharmacy	4180186
764256	Drug not available from pharmacy supplier	4180186
764256	Medication not available from pharmacy supplier (finding)	4180186
764257	Drug not available from wholesaler	4180186
764257	Medication not available from wholesaler (finding)	4180186
764261	Patient new to facility (finding)	4180186
764262	Acquired deformity of left hip following removal of prosthesis (disorder)	4180186
764263	Reconstruction of head of right radius (procedure)	4180186
764265	Congenital megaprepuce (disorder)	4180186
764267	Discussed with specialist (situation)	4180186
764272	Arthritis medication review (procedure)	4180186
764273	Opioid medication review (procedure)	4180186
764276	Rothman index (observable entity)	4180186
764280	Education about skin disorder	4180186
764280	Education about dermatological disorder (procedure)	4180186
764281	Education about arthritis (procedure)	4180186
764282	Education about anxiety (procedure)	4180186
764283	Education about medication dose (procedure)	4180186
764284	Education about herbal supplement (procedure)	4180186
764285	Education about dietary supplement (procedure)	4180186
764287	Education about elastomeric infusion pump (procedure)	4180186
764290	Primary care pharmacist (person)	4180186
764291	Infusion pharmacist (person)	4180186
764293	Dispensing pharmacist (person)	4180186
764295	Videoconference encounter	4180186
764295	Videotelephony encounter (procedure)	4180186
764298	Medication changed to lower cost therapeutic equivalent (situation)	4180186
764299	Discussed with payor (situation)	4180186
764301	Discussed with prescriber (situation)	4180186
764302	Discussed with care coordinator (situation)	4180186
764306	Medication dose changed in response to renal function (situation)	4180186
764307	Medication dose changed in response to liver function (situation)	4180186
764308	Stricture of male urethra following trauma (disorder)	4180186
764308	Male posttraumatic urethral stricture	4180186
764309	Discontinued medication without order (finding)	4180186
764310	Peripartum period (qualifier value)	4180186
764315	Left through knee amputation	4180186
764315	Disarticulation of left knee (procedure)	4180186
764315	Disarticulation at left knee	4180186
764317	Development of medication-related action plan with patient (procedure)	4180186
764320	Adverse drug interaction with herbal supplement (disorder)	4180186
764321	Adverse drug interaction with dietary supplement (disorder)	4180186
764322	Medication obtained (situation)	4180186
764326	Deficient knowledge of medication administration (finding)	4180186
764327	Deficient knowledge of medication storage (finding)	4180186
764330	Referral for occupational therapy (procedure)	4180186
764331	Referral for management of asthma (procedure)	4180186
764332	Referral to primary care provider (procedure)	4180186
764334	Referral for care coordination (procedure)	4180186
764337	In-person encounter (procedure)	4180186
764341	Education about genetic predispostion to disease (procedure)	4180186
764343	Education about timing of medication administration (procedure)	4180186
764346	Recommendation to change medication to lower cost therapeutic equivalent (procedure)	4180186
764347	Medication dose changed to sliding scale (situation)	4180186
764349	Taking high risk medication (finding)	4180186
764350	Medication serum levels outside of reference range (finding)	4180186
764351	Emergency medical treatment and active labor act medical screening examination (procedure)	4180186
764351	EMTATA (Emergency medical treatment and active labor act medical screening) examination	4180186
764353	Documentation of medication-related goals (procedure)	4180186
764354	Documentation of medication care plan (procedure)	4180186
764355	Documentation of allergy history (procedure)	4180186
764356	Evaluation of medication-related care plan (procedure)	4180186
764359	Evaluation of pharmacogenetic result (procedure)	4180186
764360	Fracture of left lower limb (disorder)	4180186
764364	Model for end-stage liver disease (assessment scale)	4180186
764364	MELD-Model for end-stage liver disease	4180186
764365	Cannot afford medication	4180186
764365	Unable to afford medication (finding)	4180186
764367	Evaluation of medication-related goal (procedure)	4180186
764368	Medication education at discharge (procedure)	4180186
764369	Assessment of risk for drug therapy problem (procedure)	4180186
764370	Evaluation of medication-related action plan (procedure)	4180186
764370	Assessment of medication-related action plan	4180186
764371	Medication active ingredient availability increased due to interaction (finding)	4180186
764377	Medication non-adherence due to hearing impairment (finding)	4180186
764378	Pathological fracture of left ulna due to osteoporosis (disorder)	4180186
764381	Immunization series complete (finding)	4180186
764382	Medication dose too low based on pharmacogenetic finding (finding)	4180186
764384	Medication dose too high based on hepatic function (finding)	4180186
764387	Implemented (qualifier value)	4180186
764388	Clarification requested (qualifier value)	4180186
764390	Wound undermining (observable entity)	4180186
764391	Neisseria gonorrhoeae nucleic acid not detected (finding)	4180186
764392	Has same sex partner (finding)	4180186
764393	Not sure of desire to become pregnant (finding)	4180186
764397	Chlamydia trachomatis nucleic acid detected (finding)	4180186
764398	Contraception using lactation amonorrhea method (finding)	4180186
764399	Patient record requested by general practitioner (finding)	4180186
764399	Patient record requested by primary care physician	4180186
764400	Rwandan franc (qualifier value)	4180186
764401	Insomnia severity index (assessment scale)	4180186
764404	Augmentation of maxillary sinus	4180186
764404	Sinus graft	4180186
764404	Augmentation of maxillary sinus (procedure)	4180186
764404	Sinus lift	4180186
764406	Assessment of pregnancy status (procedure)	4180186
764407	Whole brain radiation therapy (regime/therapy)	4180186
764408	End date (observable entity)	4180186
764409	Draft order status	4180186
764409	Draft order status (qualifier value)	4180186
764410	Order entered in error (qualifier value)	4180186
764411	Order on hold (qualifier value)	4180186
764411	Order on hold	4180186
764414	Refuses to discontinue medication (finding)	4180186
764416	Medication quantity changed to three month supply (situation)	4180186
764417	Behavior monitoring (regime/therapy)	4180186
764423	Sexually abstinent (finding)	4180186
764427	Open fracture of right upper extremity	4180186
764427	Open fracture of right upper limb (disorder)	4180186
764429	Exposure to cytomegalovirus (event)	4180186
764432	Depression screening not done (situation)	4180186
764438	Swab from face (specimen)	4180186
764439	Swab from knee region (specimen)	4180186
764441	Swab from foot (specimen)	4180186
764443	Swab from forearm (specimen)	4180186
764447	Occlusion of left posterior communicating artery (disorder)	4180186
764447	Obstruction of left posterior communicating artery	4180186
764454	Bone structure of right lower limb (body structure)	4180186
764455	Structure of left pelvic vein (body structure)	4180186
764456	Neisseria gonorrhoeae inconclusive (finding)	4180186
764456	Neisseria gonorrhoeae equivocal	4180186
764457	Chlamydia trachomatis inconclusive (finding)	4180186
764457	Chlamydia trachomatis equivocal	4180186
764459	Deoxyribonucleic acid mismatch repair (finding)	4180186
764459	Deoxyribonucleic acid mismatch repair	4180186
764460	Total resection of visible brain tumor (procedure)	4180186
764462	Dose-adjusted EPOCH - etoposide-prednisolone-oncovin-clyclophosphamide-hydroxydaunorubicin	4180186
764462	Dose-adjusted etoposide-prednisolone-oncovin-clyclophosphamide-hydroxydaunorubicin	4180186
764462	Dose-adjusted etoposide-prednisolone-oncovin-clyclophosphamide-hydroxydaunorubicin (regime/therapy)	4180186
764463	History of Guillain-Barre syndrome due to influenza immunization (situation)	4180186
764465	Death certification by medical examiner or coroner (procedure)	4180186
764467	Patient status determination, deceased with hospital disposition of fetal remains (finding)	4180186
764468	Continuous dependence on chewing tobacco (disorder)	4180186
764470	Episodic dependence on snuff use (disorder)	4180186
764474	Male relying on female contraception (finding)	4180186
764477	Cultured cells specimen (specimen)	4180186
764480	Warrant Officer 1	4180186
764480	Warrant Officer W1	4180186
764480	United States Military Warrant Officer W1 (qualifier value)	4180186
764480	W1	4180186
764480	WO1	4180186
764480	United States Military Warrant Officer W1	4180186
764482	CWO3	4180186
764482	United States Military Warrant Officer W3	4180186
764482	Warrant Officer 3	4180186
764482	CW3	4180186
764482	United States Military Warrant Officer W3 (qualifier value)	4180186
764482	Warrant Officer W3	4180186
764482	W3	4180186
764483	Warrant Officer W4	4180186
764483	CW4	4180186
764483	W4	4180186
764483	United States Military Warrant Officer W4 (qualifier value)	4180186
764483	United States Military Warrant Officer W4	4180186
764483	Warrant Officer 4	4180186
764483	CWO4	4180186
764484	Warrant Officer 5	4180186
764484	United States Military Warrant Officer W5	4180186
764484	United States Military Warrant Officer W5 (qualifier value)	4180186
764484	W5	4180186
764484	CW5	4180186
764484	Warrant Officer W5	4180186
764484	CWO5	4180186
764485	United States Military Commissioned Officer pay grade (qualifier value)	4180186
764485	United States Military Commissioned Officer pay grade	4180186
764488	Captain	4180186
764488	CPT	4180186
764488	Lieutenant	4180186
764488	Capt	4180186
764488	United States Military Commissioned Officer O3	4180186
764488	United States Military Commissioned Officer O3 (qualifier value)	4180186
764488	LT	4180186
764488	O3	4180186
764489	United States Military Commissioned Officer O5	4180186
764489	Commander	4180186
764489	LTC	4180186
764489	Lt Col	4180186
764489	O5	4180186
764489	CDR	4180186
764489	LtCol	4180186
764489	United States Military Commissioned Officer O5 (qualifier value)	4180186
764489	Lieutenant Colonel	4180186
764491	Brig Gen	4180186
764491	BG	4180186
764491	BGen	4180186
764491	RDML	4180186
764491	O7	4180186
764491	Brigadier General	4180186
764491	Rear Admiral Lower Half	4180186
764491	United States Military Commissioned Officer O7	4180186
764491	United States Military Commissioned Officer O7 (qualifier value)	4180186
764492	VADM	4180186
764492	O9	4180186
764492	United States Military Commissioned Officer O9 (qualifier value)	4180186
764492	Lt Gen	4180186
764492	United States Military Commissioned Officer O9	4180186
764492	LTG	4180186
764492	LtGen	4180186
764492	Lieutenant General	4180186
764492	Vice Admiral	4180186
764493	United States Military Commissioned Officer O10 (qualifier value)	4180186
764493	O10	4180186
764493	Gen	4180186
764493	General	4180186
764493	Admiral	4180186
764493	GEN	4180186
764493	United States Military Commissioned Officer O10	4180186
764493	ADM	4180186
764495	Normal menarche (finding)	4180186
764499	Occlusion of left carotid artery by embolus (disorder)	4180186
764499	Occlusion of left carotid artery by embolus	4180186
764503	Occlusion of cerebral vein by nonpyogenic thrombus (disorder)	4180186
764505	Occlusion of left vertebral artery by thrombus (disorder)	4180186
764505	Occlusion of left vertebral artery by thrombus	4180186
764508	Proficient in English (finding)	4180186
764509	Not proficient in English (finding)	4180186
764510	Airman basic	4180186
764510	E1	4180186
764510	Private	4180186
764510	United States Military enlisted E1	4180186
764510	Seaman Recruit	4180186
764510	United States Military enlisted E1 (qualifier value)	4180186
764511	Airman First Class	4180186
764511	Private First Class	4180186
764511	E3	4180186
764511	United States Military enlisted E3 (qualifier value)	4180186
764511	United States Military enlisted E3	4180186
764511	PFC	4180186
764511	A1C	4180186
764511	SN	4180186
764511	Lance Corporal	4180186
764511	Seaman	4180186
764511	Lcpl	4180186
764513	Residual tumor present (finding)	4180186
764515	United States Military enlisted E6 (qualifier value)	4180186
764515	TSgt	4180186
764515	PO1	4180186
764515	SSGT	4180186
764515	Petty Officer First Class	4180186
764515	United States Military enlisted E6	4180186
764515	SSgt	4180186
764515	Staff Sergeant	4180186
764515	Technical Sergeant	4180186
764515	E6	4180186
764516	Sergeant First Class	4180186
764516	Gunnery Sergeant	4180186
764516	MSgt	4180186
764516	CPO	4180186
764516	SFC	4180186
764516	United States Military enlisted E7 (qualifier value)	4180186
764516	Master Sergeant	4180186
764516	United States Military enlisted E7	4180186
764516	GySgt	4180186
764516	E7	4180186
764516	Chief Petty Officer	4180186
764517	1SG	4180186
764517	SMSgt	4180186
764517	United States Military enlisted E8	4180186
764517	Senior Chief Petty Officer	4180186
764517	MSgt	4180186
764517	MSG	4180186
764517	Senior Master Sergeant	4180186
764517	E8	4180186
764517	United States Military enlisted E8 (qualifier value)	4180186
764517	SCPO	4180186
764517	First Sergeant	4180186
764517	Master Sergeant	4180186
764520	Color of wound discharge (observable entity)	4180186
764522	Structure of wall of splenic artery (body structure)	4180186
764525	Disorder of both eyes	4180186
764525	Disorder of bilateral eyes (disorder)	4180186
764530	Homocysteine level above reference range	4180186
764530	Homocysteine level above reference range (finding)	4180186
764532	Liver of normal size	4180186
764532	Liver of normal size (finding)	4180186
764533	Dorsogluteal region (body structure)	4180186
764536	Adverse reaction to anesthetic agent during dental procedure (disorder)	4180186
764538	Family history of adverse reaction to anesthetic agent (situation)	4180186
764539	Screening for fetal alcohol spectrum disorder (procedure)	4180186
764542	Neuromusculoskeletal medicine (qualifier value)	4180186
764542	Osteopathic neuromusculoskeletal medicine	4180186
764545	Family history of malignant tumor of rectum (situation)	4180186
764545	Family history of rectal cancer	4180186
764547	Family history of self abuse (situation)	4180186
764550	Family history of acne (situation)	4180186
764552	Family history of basal cell carcinoma of skin (situation)	4180186
764553	Family history of congenital sensorineural hearing loss (situation)	4180186
764554	Family history of Tourette's syndrome	4180186
764554	Family history of Gilles de la Tourette syndrome (situation)	4180186
764555	Family history of fibromyalgia (situation)	4180186
764556	Family history of Wilson disease (situation)	4180186
764556	Family history of WD-Wilson disease	4180186
764557	Family history of complication of anesthesia (situation)	4180186
764559	Family history of obsessive-compulsive disorder (situation)	4180186
764560	Family history of victim of physical abuse (situation)	4180186
764561	Family history of infertility (situation)	4180186
764564	Family history of dysmorphism (situation)	4180186
764565	Family history of drug abuse (situation)	4180186
764566	Length of arm span	4180186
764566	Length of arm span (observable entity)	4180186
764566	Arm span (observable entity)	4180186
764571	Electro-analgesia using Scrambler therapy (regime/therapy)	4180186
764577	Rotating shift worker without nights (finding)	4180186
764579	Chronic obstructive pulmonary disease assessment test	4180186
764579	Chronic obstructive pulmonary disease assessment test (assessment scale)	4180186
764582	Congenital malformation of right external ear (disorder)	4180186
764584	Labor and delivery plan (record artifact)	4180186
764585	Anesthesia and pain medication during labor plan (record artifact)	4180186
764586	Abalone (substance)	4180186
764589	Covering attending physician	4180186
764589	Locum tenens attending physician (occupation)	4180186
764589	Locum tenens attending physician	4180186
764590	Locum tenens admitting physician	4180186
764590	Covering admitting physician	4180186
764590	Locum tenens admitting physician (occupation)	4180186
764592	Non-traumatic rupture of tendon of left hand (disorder)	4180186
764599	Lump in upper inner quadrant of right breast (finding)	4180186
764599	Upper inner quadrant lump of right breast	4180186
764601	Structure of axillary tail of left breast (body structure)	4180186
764603	Lump of axillary tail of left breast (finding)	4180186
764608	Preprocedural examination (procedure)	4180186
764609	Preprocedural examination done (situation)	4180186
764611	Recommendation to discontinue medication (procedure)	4180186
764612	Recommendation to discontinue dietary supplement (procedure)	4180186
764614	Dietary supplement discontinued (situation)	4180186
764624	One week (qualifier value)	4180186
764626	Recommendation to start over-the-counter medication (procedure)	4180186
764627	Two weeks (qualifier value)	4180186
764631	Three weeks (qualifier value)	4180186
764633	Six months (qualifier value)	4180186
764634	Tinnitus of right ear (finding)	4180186
764635	Sand sample	4180186
764635	Sand specimen (specimen)	4180186
764637	Baby food sample	4180186
764637	Baby food specimen (specimen)	4180186
764638	Whey sample	4180186
764638	Whey specimen (specimen)	4180186
764640	Palliative care education (procedure)	4180186
764641	Active mental health treatment preference declaration (finding)	4180186
764642	Pit latrine (physical object)	4180186
764644	Pit latrine without slab (physical object)	4180186
764649	Rabbit blood agar (substance)	4180186
764651	Campylobacter sheep blood agar (substance)	4180186
764657	Blister of periwound skin (finding)	4180186
764659	Lowenstein-Jensen medium with iron (substance)	4180186
764661	Brain-heart infusion agar (substance)	4180186
764661	Brain-heart Infusion agar (substance)	4180186
764662	Chopped meat agar (substance)	4180186
764665	In-law	4180186
764665	Parent in-law (person)	4180186
764666	Sacral mass	4180186
764666	Mass of sacrum (disorder)	4180186
764673	Mycoplasma SP4 Broth Medium	4180186
764673	SP4 broth (substance)	4180186
764676	Primary care appointment not available (finding)	4180186
764678	Compression fracture of lumbosacral spine (disorder)	4180186
764681	Stapled skin wound (finding)	4180186
764683	Unable to afford visit copayment (finding)	4180186
764684	Temporal lobe epilepsy with mesial temporal sclerosis (disorder)	4180186
764686	Charcoal seller (occupation)	4180186
764688	Red-green tinged lochia (finding)	4180186
764691	Vegetable seller (occupation)	4180186
764692	Difficulty obtaining refills (finding)	4180186
764693	Vinyl strips (substance)	4180186
764694	Uses multiple pharmacies (finding)	4180186
764695	Increase number of perfusion exchanges per 24 hours (procedure)	4180186
764696	Skin wound closed with sterile strip	4180186
764696	Skin wound closed with sterile strip (finding)	4180186
764697	Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
764699	Glycerol saline solution (medicinal product)	4180186
764702	Bedroom with bathroom on second level (finding)	4180186
764703	Thrombosis of superior cerebellar artery (disorder)	4180186
764706	Verbalizes no understanding (finding)	4180186
764706	Verbalizes lack of understanding	4180186
764707	Ruptured aneurysm of intracranial artery (disorder)	4180186
764710	Thrombophlebitis of transverse sinus (disorder)	4180186
764711	Lack of running water in house (finding)	4180186
764712	Thrombophlebitis of internal cerebral vein (disorder)	4180186
764715	Thrombophlebitis of internal jugular vein (disorder)	4180186
764718	Parquet wood flooring (substance)	4180186
764720	Patient has difficulty preparing medication (finding)	4180186
764725	Thrombosis of posterior inferior cerebellar artery (disorder)	4180186
764731	Brachyfacial (finding)	4180186
764733	Cyst of male periurethral tissue (disorder)	4180186
764736	Patient alters dosing schedule for convenience (finding)	4180186
764738	Uses remote weight monitoring scale (finding)	4180186
764739	Class II occlusal scheme, partially dentate	4180186
764739	Moderately compromised partially dentate occlusal scheme (disorder)	4180186
764741	Patient departed facility (finding)	4180186
764742	Education about insulin administration site rotation (procedure)	4180186
764743	Family history of hepatic cirrhosis	4180186
764743	Family history of cirrhosis of liver (situation)	4180186
764745	Patient lost or discarded written information (finding)	4180186
764746	Patient refuses to release medical information (situation)	4180186
764750	Copy of legal document obtained (finding)	4180186
764751	Copy of document requested (situation)	4180186
764753	Patient unable to obtain copy of document (finding)	4180186
764755	History of laser refractive surgery (situation)	4180186
764758	At risk for heritable disorder (finding)	4180186
764759	Family history of hereditary disease carrier state (situation)	4180186
764760	Unable to control portion size (finding)	4180186
764761	History of cerebral artery occlusive disease without infarction (situation)	4180186
764763	SNOMED CT to ICD-10-CM rule-based mapping module (core metadata concept)	4180186
764764	ICD-10-CM map category reference set (foundation metadata concept)	4180186
764765	ICD-10-CM complex map reference set (foundation metadata concept)	4180186
764768	Pharmacokinetic consultation (procedure)	4180186
764770	No preference (qualifier value)	4180186
764773	History of repair of hypoplastic left heart by Norwood operation (situation)	4180186
764774	History of Amplatzer repair of atrial septal defect (situation)	4180186
764775	Medication therapy management recommendation refused by prescriber (situation)	4180186
764776	Blue green discharge from wound	4180186
764776	Blue green discharge from wound (finding)	4180186
764776	Bluish green drainage from wound	4180186
764777	Medication therapy management recommendation refused by patient (situation)	4180186
764781	Acute myeloid leukemia, minimal differentiation, FAB M0 in remission (disorder)	4180186
764783	Stuart's transport medium (substance)	4180186
764784	Convenient (qualifier value)	4180186
764785	Cost prohibitive (qualifier value)	4180186
764788	Amies transport medium (substance)	4180186
764789	Amies charcoal transport medium (substance)	4180186
764791	Modified Cary Blair medium (substance)	4180186
764792	Regan-Lowe transport medium (substance)	4180186
764794	Sodium azide (substance)	4180186
764797	Mass of hard palate (disorder)	4180186
764798	Family history of hemoglobinopathy C (situation)	4180186
764799	Family history of congenital anomaly of ear (situation)	4180186
764801	Family history of sex chromosome translocation (situation)	4180186
764806	Carrier of Charcot-Marie-Tooth disease (finding)	4180186
764808	Carrier of glycogen storage disease (finding)	4180186
764809	Carrier of mitochondrial defect (finding)	4180186
764810	Carrier of myotonic dystrophy (finding)	4180186
764813	Monoplegia of nondominant lower limb due to and following ischemic cerebrovascular accident (disorder)	4180186
764813	Monoplegia of nondominant leg as late effect of ischemic stroke	4180186
764814	Monoplegia of dominant arm as late effect of ischemic stroke	4180186
764814	Monoplegia of dominant upper limb due to and following ischemic cerebrovascular accident (disorder)	4180186
764816	Hemiplegia of dominant side due to and following hemorrhagic cerebrovascular accident (disorder)	4180186
764816	Hemiplegia of dominant side as late effect of hemorrhagic stroke	4180186
764819	Vertigo as late effect of hemorrhagic stroke	4180186
764819	Vertigo due to and following hemorrhagic cerebrovascular accident (disorder)	4180186
764819	Vertigo due to and following hemorrhagic cerebrovascular accident (finding)	4180186
764820	Monoplegia of leg as late effect of ischemic stroke	4180186
764820	Monoplegia of lower limb due to and following ischemic cerebrovascular accident (disorder)	4180186
764821	Charcot-Marie-Tooth Neuropathy Type 4 (disorder)	4180186
764822	Family history of gastroschisis (situation)	4180186
764823	Age-related nuclear cataracts of both eyes	4180186
764823	Bilateral age-related nuclear cataracts (disorder)	4180186
764829	Allergic conjunctivitis of both eyes	4180186
764829	Allergic conjunctivitis of bilateral eyes (disorder)	4180186
764830	Allergic conjunctivitis of right eye (disorder)	4180186
764832	Vitreous floaters of left eye (disorder)	4180186
764834	Family history of hemophilia A (situation)	4180186
764834	Family history of hereditary factor VIII deficiency	4180186
764837	History of failed arthroplasty of ankle (situation)	4180186
764839	Diffuse non-Hodgkin's lymphoma Lugano stage 1	4180186
764839	Diffuse non-Hodgkin's lymphoma Lugano stage I (disorder)	4180186
764839	Diffuse large b-cell lymphoma stage I	4180186
764841	Family history of congenital stenosis of aorta (situation)	4180186
764842	History of insufficient prenatal care (situation)	4180186
764842	History of inadequate prenatal care	4180186
764843	Low grade lymphoma, stage II	4180186
764843	Low grade lymphoma, stage 2 (finding)	4180186
764849	Monoplegia of leg as late effect of embolic stroke	4180186
764849	Monoplegia of lower limb due to and following embolic cerebrovascular accident (disorder)	4180186
764850	Monoplegia of nondominant upper limb due to and following embolic cerebrovascular accident (disorder)	4180186
764850	Monoplegia of nondominant arm as late effect of embolic stroke	4180186
764853	Hemiplegia of dominant side as late effect of embolic stroke	4180186
764853	Hemiplegia of dominant side due to and following embolic cerebrovascular accident (disorder)	4180186
764854	Acute pain following mastectomy (finding)	4180186
764855	Sequoioideae pollen (substance)	4180186
764855	Sequoioideae pollen	4180186
764859	Family history of transposition of great vessels (situation)	4180186
764862	Silk suture allergen (substance)	4180186
764863	After breakfast (qualifier value)	4180186
764866	Family history of pulmonary valvular stenosis	4180186
764866	Family history of pulmonic valve stenosis (situation)	4180186
764869	Synthetic suture allergen (substance)	4180186
764870	Exposure to viral meningitis (event)	4180186
764871	Reduced ejection fraction co-occurrent and due to acute on chronic heart failure (disorder)	4180186
764873	Reduced ejection fraction co-occurrent and due to acute heart failure (disorder)	4180186
764874	Acute on chronic heart failure co-occurrent with normal ejection fraction (disorder)	4180186
764876	Chronic heart failure co-occurrent with normal ejection fraction (disorder)	4180186
764879	Polyester suture allergen (substance)	4180186
764880	Inclusion cyst of skin of shoulder (disorder)	4180186
764881	Mass of hip region (finding)	4180186
764882	Thrombosis of jugular vein (disorder)	4180186
764884	Diabetic education not done (situation)	4180186
764886	Vicryl suture allergen (substance)	4180186
764887	Embolism of abdominal aorta (disorder)	4180186
764888	Polypropylene suture allergen (substance)	4180186
764889	Cotton suture allergen (substance)	4180186
764890	Not Preventable (qualifier value)	4180186
764892	2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (disorder)	4180186
764893	Mentha x piperita	4180186
764893	Mentha x piperita (substance)	4180186
764895	Tetanus vaccination not done (situation)	4180186
764896	Narcotics anonymous (qualifier value)	4180186
764897	Callus of periwound skin (finding)	4180186
764897	Hyperkeratosis of periwound skin	4180186
764898	Infirmary care site (environment)	4180186
764899	Compression fracture of thoracic vertebra, nontraumatic (disorder)	4180186
764901	Residential treatment center (environment)	4180186
764902	Hearing laboratory (environment)	4180186
764903	Pediatric anesthesiology service (qualifier value)	4180186
764904	Pediatric allergy and immunology service (qualifier value)	4180186
764906	Ethylmalonic encephalopathy protein 1 deficiency (disorder)	4180186
764908	Pediatric cardiology service (qualifier value)	4180186
764909	Pediatric pathology service (qualifier value)	4180186
764911	Pediatric medical toxicology service (qualifier value)	4180186
764912	Pediatric critical care service (qualifier value)	4180186
764913	Osteosarcoma of bone of upper limb (disorder)	4180186
764915	Plaster (substance)	4180186
764916	Convalescent care facility (environment)	4180186
764917	Optic nerve and photoreceptor degeneration (disorder)	4180186
764918	Continuing care retirement community (environment)	4180186
764919	Pyogenic bacterial arthritis of elbow (disorder)	4180186
764920	Pyogenic bacterial arthritis of hip (disorder)	4180186
764922	Follicular dendritic sarcoma of intraabdominal lymph node (disorder)	4180186
764924	Infection of hemodialysis temporary catheter (disorder)	4180186
764925	Ovarian cancer genetic marker of susceptibility positive (finding)	4180186
764932	Fistula of joint of shoulder (disorder)	4180186
764933	Virus not detected (finding)	4180186
764935	Primary malignant glioma of brain (disorder)	4180186
764936	Primary extramedullary malignant tumor of spinal cord (disorder)	4180186
764937	Skin ulcer of right thigh (disorder)	4180186
764938	Influenza A virus not detected (finding)	4180186
764940	Dysplasia of limb (disorder)	4180186
764942	Influenza A virus subtype H1 not detected (finding)	4180186
764944	Blister of lip (disorder)	4180186
764945	Cystic dermoid choristoma of frontonasal region (disorder)	4180186
764948	Family history of cancer of the mouth	4180186
764948	Family history of cancer of the oral cavity (situation)	4180186
764949	Persistent asthma, well controlled (disorder)	4180186
764953	Colorless drainage from wound	4180186
764953	Colorless discharge from wound (finding)	4180186
764956	Squamous cell carcinoma metastatic to pleura (disorder)	4180186
764957	Small cell carcinoma metastatic to skin (disorder)	4180186
764960	Influenza A virus inconclusive (finding)	4180186
764963	Family history of ventricular aneurysm (situation)	4180186
764965	Neoplasm of nerve of hand (disorder)	4180186
764966	Family history of left ventricular noncompaction cardiomyopathy (situation)	4180186
764968	Urinary tract infection following procedure (disorder)	4180186
764968	Postprocedural urinary tract infection	4180186
764969	History of tissue graft heart valve replacement (situation)	4180186
764973	Mild left ventricular systolic dysfunction (disorder)	4180186
764974	Congenital arteriovenous malformation of the duodenum and jejunum (disorder)	4180186
764975	Every 4-6 hours as required	4180186
764975	Every 4-6 hours as needed	4180186
764975	Every four to six hours as required (qualifier value)	4180186
764975	Every four to six hours as needed	4180186
764977	Congenital dilatation of lobar intrahepatic bile duct with obstruction (disorder)	4180186
764979	Nontraumatic compartment syndrome of upper limb (disorder)	4180186
764980	Nontraumatic abdominal compartment syndrome (disorder)	4180186
764981	Primary malignant neoplasm of ileocaecal valve	4180186
764981	Primary malignant neoplasm of ileocecal valve (disorder)	4180186
764982	Severe left ventricular systolic dysfunction (disorder)	4180186
764986	Total perforation of bilateral tympanic membranes (disorder)	4180186
764986	Total perforation of bilateral eardrums	4180186
764987	Dysfunction of left eustachian tube (disorder)	4180186
764988	Polyp of left external auditory canal	4180186
764988	Polyp of left external auditory canal (disorder)	4180186
764990	Disorder of left middle ear (disorder)	4180186
764992	Infection of right ear (disorder)	4180186
764996	Inflammation of right labyrinth structure caused by virus	4180186
764996	Inflammation of right labyrinth structure caused by virus (disorder)	4180186
764997	Closed fracture of epiphyseal plate of distal end of left femur (disorder)	4180186
765000	Closed fracture of multiple left and right ribs (disorder)	4180186
765000	Closed fracture of multiple bilateral ribs	4180186
765001	Closed fracture of third metacarpal bone of right hand (disorder)	4180186
765002	Closed fracture of fifth metacarpal bone of left hand (disorder)	4180186
765003	Ankylosis of right temporomandibular joint (disorder)	4180186
765004	Recurrent subluxation of bilateral temporomandibular joints (disorder)	4180186
765007	Closed fracture of left pilon (disorder)	4180186
765008	Closed fracture of neck of fourth metacarpal of left hand (disorder)	4180186
765009	Closed fracture of right humerus (disorder)	4180186
765012	Closed fracture of cuboid bone of right foot (disorder)	4180186
765014	Closed fracture of right femoral condyle	4180186
765014	Closed fracture of condyle of right femur (disorder)	4180186
765015	Closed fracture of left femur (disorder)	4180186
765016	Closed fracture of proximal phalanx of little finger of left hand (disorder)	4180186
765016	Closed fracture of proximal phalanx of left little finger	4180186
765017	Closed fracture of trapezium bone of left wrist (disorder)	4180186
765018	Closed fracture of left wrist (disorder)	4180186
765018	Closed left wrist fracture	4180186
765020	Laceration of right hand (disorder)	4180186
765021	Disorder of skeletal system co-occurrent and due to Marfan syndrome (disorder)	4180186
765023	Neonatal adrenal hemorrhage (disorder)	4180186
765024	Pyogenic bacterial arthritis of hand (disorder)	4180186
765026	History of revision of arthroplasty of head of left radius (situation)	4180186
765027	Bilateral radial neuropathy	4180186
765027	Disorder of bilateral radial nerves (disorder)	4180186
765027	Disorder of bilateral radial nerves	4180186
765028	Dissection of splenic artery (disorder)	4180186
765029	Thyrotoxic exophthalmos without thyrotoxic crisis (disorder)	4180186
765029	Thyrotoxic exophthalmos without thyrotoxic storm	4180186
765030	History of psychotic disorder (situation)	4180186
765030	History of psychosis	4180186
765031	Pathological fracture of left clavicle (disorder)	4180186
765033	Stress fracture of metatarsal bone of left foot (disorder)	4180186
765033	Stress fracture of left metatarsal bone	4180186
765041	Awaiting transplantation of organ (situation)	4180186
765043	Swelling of right ear structure (finding)	4180186
765044	Reactive arthritis of spine (disorder)	4180186
765045	Sprain of right foot (disorder)	4180186
765050	Excision of mass from thigh (procedure)	4180186
765051	Glaucoma of right eye (disorder)	4180186
765052	Trigger finger of left hand (disorder)	4180186
765053	Lump in right breast (finding)	4180186
765053	Mass in right breast	4180186
765055	Benign carcinoid tumor of descending colon (disorder)	4180186
765057	Nonstageable pressure ulcer of right foot (disorder)	4180186
765058	Malignant carcinoid tumor of large intestine (disorder)	4180186
765064	Talipes of right foot (disorder)	4180186
765067	Congenital genu varum of bilateral knees (disorder)	4180186
765067	Congenital genu varum of both knees	4180186
765069	Iridocyclitis of right eye (disorder)	4180186
765072	Dermatitis of left eyelid caused by herpes simplex virus (disorder)	4180186
765076	Intractable menstrual status migrainosus (disorder)	4180186
765078	Retinitis pigmentosa of right eye (disorder)	4180186
765082	Acquired deformity of right rib (disorder)	4180186
765083	Exophoria of bilateral eyes (disorder)	4180186
765083	Exophoria of both eyes	4180186
765084	Sensory deprivation exotropia of left eye (disorder)	4180186
765086	Anterior ischemic optic neuropathy of left eye (disorder)	4180186
765091	Contracture of left eye socket (disorder)	4180186
765092	Knuckle pad of left hand (disorder)	4180186
765095	Sinus tarsi syndrome of right ankle (disorder)	4180186
765098	Mass of joint of right shoulder (finding)	4180186
765100	Pain of right acromioclavicular joint (finding)	4180186
765101	Pain of left shoulder blade (finding)	4180186
765101	Left scapulalgia	4180186
765102	Open fracture of distal phalanx of little finger of right hand (disorder)	4180186
765106	Open fracture of first metacarpal bone of left hand	4180186
765106	Open fracture of metacarpal bone of left thumb (disorder)	4180186
765108	Open bimalleolar fracture of right ankle (disorder)	4180186
765110	Gastroesophageal reflux disease co-occurrent and due to diaphragmatic hernia	4180186
765110	Gastroesophageal reflux disease co-occurrent and due to diaphragmatic hernia (disorder)	4180186
765116	Loose body in left hip joint (disorder)	4180186
765117	Cellulitis of left eyelid (disorder)	4180186
765118	Congenital complete absence of right lower limb (disorder)	4180186
765121	Supracondylar fracture of left humerus (disorder)	4180186
765123	Primary malignant neoplasm of female right breast (disorder)	4180186
765124	Right conductive hearing loss (disorder)	4180186
765127	Lesion of left sciatic nerve (disorder)	4180186
765133	Skilled nursing specialty (qualifier value)	4180186
765135	Dysphasia as late effect of spontaneous intracerebral hemorrhage	4180186
765135	Dysphasia due to and following non-traumatic intracerebral hemorrhage	4180186
765135	Dysphasia due to and following spontaneous intracerebral hemorrhage (disorder)	4180186
765136	History of endometriosis (situation)	4180186
765137	Prepatellar bursitis of right knee (disorder)	4180186
765138	Immune to diphtheria measured by serology	4180186
765138	Immune to diphtheria measured by serology (finding)	4180186
765139	Left deep peroneal neuropathy	4180186
765139	Disorder of left deep peroneal nerve (disorder)	4180186
765140	Entrapment neuropathy of right plantar nerve (disorder)	4180186
765142	Right ilioinguinal neuropathy	4180186
765142	Disorder of right ilioinguinal nerve (disorder)	4180186
765143	Neuraligia of left sciatic nerve	4180186
765143	Neuraligia of left sciatic nerve (finding)	4180186
765145	Swan-neck deformity of finger of right hand (disorder)	4180186
765145	Swan-neck deformity of right finger	4180186
765150	Acquired deformity of left finger (disorder)	4180186
765153	Chronic deep venous thrombosis of femoral vein of left lower extremity (disorder)	4180186
765153	Chronic deep venous thrombosis of femoral vein of left leg	4180186
765154	Chronic deep venous thrombosis of femoral vein of right lower extremity (disorder)	4180186
765154	Chronic deep venous thrombosis of femoral vein of right leg	4180186
765155	Acute deep venous thrombosis of bilateral ileofemoral veins (disorder)	4180186
765156	Acute deep venous thrombosis of tibial vein of right leg (disorder)	4180186
765157	Infection of implanted cardiac device (disorder)	4180186
765160	Mass of left lower quadrant of abdominal wall (disorder)	4180186
765161	Dacryocystitis of right lacrimal sac (disorder)	4180186
765167	Acute conjunctivitis of left eye (disorder)	4180186
765170	History of hypernephroma (situation)	4180186
765175	Paronychia of finger of right hand (disorder)	4180186
765176	Hemoglobin D/beta thalassemia disease (disorder)	4180186
765177	History of amputation of right lower limb (situation)	4180186
765181	Osteoporotic fracture of right fibula	4180186
765181	Pathological fracture of right fibula due to osteoporosis (disorder)	4180186
765182	Pathological fracture of right humerus due to neoplasm (disorder)	4180186
765189	Pathological fracture of right patella (disorder)	4180186
765192	Pathological fracture of right radius due to osteoporosis (disorder)	4180186
765192	Osteoporotic fracture of right radius	4180186
765195	Cellulitis of right hand (disorder)	4180186
765197	Enostosis of femur (disorder)	4180186
765200	Bilateral intermittent exotropia (disorder)	4180186
765201	Pain co-occurrent and due to varicose veins of bilateral legs (disorder)	4180186
765201	Pain co-occurrent and due to varicose veins of both legs	4180186
765201	Varicose veins of both legs with pain	4180186
765203	Weakness of right leg (disorder)	4180186
765203	Monoparesis of right leg	4180186
765206	Apophysitis of right calcaneum	4180186
765206	Apophysitis of os calcis of right foot (disorder)	4180186
765207	Pain co-occurrent and due to varicose veins of right leg (disorder)	4180186
765207	Varicose veins of right leg with pain	4180186
765208	Epiblepharon of both eyes	4180186
765208	Epiblepharon of bilateral eyes (disorder)	4180186
765210	Talipes valgus of left foot (disorder)	4180186
765212	Congenital genu valgum of left knee (disorder)	4180186
765222	Post-thrombotic syndrome of right lower extremity (disorder)	4180186
765222	Post-phlebitic syndrome of right lower extremity	4180186
765223	Non-traumatic rupture of tendon of biceps femoris of right lower extremity	4180186
765223	Non-traumatic rupture of tendon of biceps femoris of right lower extremity (disorder)	4180186
765223	Non-traumatic rupture of tendon of biceps femoris of right lower limb	4180186
765224	Cyst of right breast (disorder)	4180186
765225	Hamartoma of retina of right eye (disorder)	4180186
765227	Right subclavian vein stenosis (disorder)	4180186
765228	Chronic thrombosis of superficial veins of both legs	4180186
765228	Chronic thrombosis of superficial veins of both lower extremities (disorder)	4180186
765230	Acquired genu recurvatum of right knee (disorder)	4180186
765231	Chronic bucket handle tear of lateral meniscus of left knee (disorder)	4180186
765232	Enthesopathy of left ankle (disorder)	4180186
765233	Enthesopathy of left hip (disorder)	4180186
765234	Disorder of joint of right knee (disorder)	4180186
765234	Arthropathy of right knee	4180186
765237	Old total detachment of retina of left eye	4180186
765237	Old total retinal detachment of left eye	4180186
765237	Chronic total detachment of retina of left eye (disorder)	4180186
765239	Perforation of cornea of right eye (disorder)	4180186
765240	Disorder of cornea of right eye (disorder)	4180186
765240	Right keratopathy	4180186
765241	Cataract of lens capsule of bilateral eyes (disorder)	4180186
765242	Anterior subcapsular cataract of left eye (disorder)	4180186
765249	Pain of joint of bilateral lower legs (finding)	4180186
765249	Arthralgia of both lower legs	4180186
765249	Pain of joint of both lower legs	4180186
765250	Instability of joint of right hip (finding)	4180186
765251	Winged left scapula (finding)	4180186
765252	Mass of structure of right eye (finding)	4180186
765253	Pseudoesotropia of right eye (finding)	4180186
765255	Fibrocystic change of left breast (finding)	4180186
765256	Osteoarthritis of both acromioclavicular joints	4180186
765256	Osteoarthritis of bilateral acromioclavicular joints (disorder)	4180186
765258	Bilateral coxitis	4180186
765258	Bilateral arthritis of hip (disorder)	4180186
765259	Arthritis of right knee (disorder)	4180186
765262	Bursitis of right hip (disorder)	4180186
765264	Glaucoma of left eye (disorder)	4180186
765266	Pressure ulcer of toe of right foot stage 3 (disorder)	4180186
765267	Tendonitis of left shoulder (disorder)	4180186
765268	Pain of right calf (finding)	4180186
765270	Pain of both breasts	4180186
765270	Pain of bilateral breasts	4180186
765270	Mastodynia of both breasts	4180186
765270	Mastodynia of bilateral breasts (finding)	4180186
765271	Bilateral elbow joint pain (finding)	4180186
765271	Pain in both elbow joints	4180186
765272	Lymphoproliferative disorder following lung transplant (disorder)	4180186
765274	Arterial thoracic outlet syndrome of right subclavian artery (disorder)	4180186
765275	Recurrent subluxation of left temporomandibular joint (disorder)	4180186
765276	Chronic right maxillary sinusitis (disorder)	4180186
765277	Otitis externa of left external auditory canal caused by Candida species (disorder)	4180186
765279	Congenital abnormal shape of bilateral external ears (disorder)	4180186
765279	Congenital abnormal shape of bilateral external ears	4180186
765279	Congenital abnormal shape of both external ears	4180186
765280	Conjunctivitis of left eye caused by human herpes simplex virus (disorder)	4180186
765282	Fibromuscular hyperplasia of right carotid artery (disorder)	4180186
765283	Pain of right hand due to and following cerebrovascular accident (finding)	4180186
765283	Painful right hand as late effect of stroke	4180186
765283	Pain of right hand due to and following cerebrovascular accident (disorder)	4180186
765284	Thrombosis of right ulnar artery (disorder)	4180186
765288	Open fracture of middle phalanx of right middle finger	4180186
765288	Open fracture of middle phalanx of middle finger of right hand (disorder)	4180186
765290	Open fracture of shaft of left tibia (disorder)	4180186
765292	Open fracture of base of fifth metacarpal bone of left hand (disorder)	4180186
765293	Open fracture of fifth metatarsal bone of right foot (disorder)	4180186
765294	Open fracture of middle phalanx of little finger of left hand (disorder)	4180186
765294	Open fracture of middle phalanx of left little finger	4180186
765295	Open fracture of phalanx of ring finger of left hand (disorder)	4180186
765295	Open fracture of phalanx of left ring finger	4180186
765297	Open fracture of proximal phalanx of right ring finger	4180186
765297	Open fracture of proximal phalanx of ring finger of right hand (disorder)	4180186
765302	Chronic aneurysm of left popliteal vein (disorder)	4180186
765307	Open fracture of third metacarpal bone of left hand (disorder)	4180186
765308	Open subcapital fracture of left femur (disorder)	4180186
765308	Open subcapital fracture of left upper leg bone	4180186
765310	Acute perichondritis of left external ear (disorder)	4180186
765317	Method of wound closure (observable entity)	4180186
765324	Closed fracture of epiphyseal plate of distal right ulna (disorder)	4180186
765325	Closed fracture of base of left fifth metacarpal (disorder)	4180186
765326	Closed fracture of proximal physis of left humerus	4180186
765326	Closed fracture of epiphyseal plate of proximal left humerus (disorder)	4180186
765327	Closed fracture of medial malleolus of right ankle	4180186
765327	Closed fracture of medial malleolus of right distal tibia (disorder)	4180186
765329	Closed fracture of right fibula (disorder)	4180186
765330	Closed fracture of shaft of third metacarpal of right hand (disorder)	4180186
765332	Closed fracture of neck of fifth metacarpal bone of right hand (disorder)	4180186
765333	Closed fracture of medial epicondyle of right humerus (disorder)	4180186
765337	Closed fracture of metatarsal bone of left foot (disorder)	4180186
765338	Closed fracture of middle phalanx of lesser toe of right foot (disorder)	4180186
765344	Closed mallet fracture of distal phalanx of ring finger of right hand (disorder)	4180186
765346	Closed fracture of epiphyseal plate of distal end of left radius (disorder)	4180186
765347	Closed fracture of proximal end of left radius (disorder)	4180186
765349	One chronic disease (situation)	4180186
765355	History of congenital megaprepuce (situation)	4180186
765356	History of disruption of capsular ligament of knee (situation)	4180186
765359	Post-bariatric surgery diet (regime/therapy)	4180186
765365	Location of pressure ulcer (observable entity)	4180186
765366	Strain of left pectoral muscle (disorder)	4180186
765367	Sprain of ligament of right thumb	4180186
765367	Sprain of ligament of right thumb (disorder)	4180186
765367	Sprain of right thumb (disorder)	4180186
765368	Sprain of right rotator cuff capsule (disorder)	4180186
765369	Strain of flexor muscle of right hip (disorder)	4180186
765370	Strain of left quadriceps muscle (disorder)	4180186
765372	Family history of MHY-associated polyposis (situation)	4180186
765373	Severe nonproliferative retinopathy due to diabetes mellitus type 1 (disorder)	4180186
765375	Ischemic ankle ulcer due to diabetes mellitus type 2 (disorder)	4180186
765376	Long-term current use of anakinra (situation)	4180186
765381	Acute tear of lateral meniscus of right knee (disorder)	4180186
765384	Pain in both knees	4180186
765384	Bilateral knee pain (finding)	4180186
765385	Acute chest syndrome due to sickle cell-hemoglobin C disease with crisis (disorder)	4180186
765386	Excision of mass of groin region (procedure)	4180186
765386	Excision of mass of inguinal region	4180186
765387	Malignant carcinoid tumor of pancreas (disorder)	4180186
765389	History of childhood neglect (situation)	4180186
765390	History of cannabis abuse (situation)	4180186
765391	History of hallucinogen abuse (situation)	4180186
765394	Metatarsalgia of left foot (finding)	4180186
765395	Eucalyptus tree material (substance)	4180186
765404	Stenosis of middle cerebral artery (disorder)	4180186
765408	Bursitis of olecranon of left elbow (disorder)	4180186
765409	Distention of jugular vein absent (situation)	4180186
765411	Slightly prepared	4180186
765411	Somewhat prepared (qualifier value)	4180186
765416	Thrombosis of internal jugular vein (disorder)	4180186
765417	Mixed conductive and sensorineural hearing loss of right ear (disorder)	4180186
765418	Anticoagulation service (qualifier value)	4180186
765421	Hemarthrosis of right shoulder region (disorder)	4180186
765424	Tendonitis of left patellar tendon (disorder)	4180186
765427	Yard work (qualifier value)	4180186
765428	Adverse reaction caused by zoster vaccine (disorder)	4180186
765429	Discussion about refilling prescription (procedure)	4180186
765431	Eosinophilic bronchitis (disorder)	4180186
765433	Recurrent infectious disease caused by virus	4180186
765433	Recurrent viral disease	4180186
765433	Recurrent infectious disease caused by virus (disorder)	4180186
765440	Referred by dietician (finding)	4180186
765443	Referral for management of cholesterol (procedure)	4180186
765444	Order status values (qualifier value)	4180186
765445	Open wound of skin (finding)	4180186
765447	Finding related to pregnancy intention (finding)	4180186
765449	Depression screening using Patient Health Questionnaire Two-Item score	4180186
765449	Depression screening using Patient Health Questionnaire Two-Item score (procedure)	4180186
765450	Decolonization (regime/therapy)	4180186
765451	Continuous dependence on cigarette smoking (disorder)	4180186
765452	Silver diamine fluoride dental treatment (procedure)	4180186
765453	Injection of leuprolide acetate for twelve month period (regime/therapy)	4180186
765453	Injection of leuprolide acetate for twelve month period	4180186
765454	Fascial pattern (observable entity)	4180186
765455	Family history of myopathy	4180186
765455	Family history of disorder of skeletal and/or smooth muscle (situation)	4180186
765457	Received certificate of high school equivalency (finding)	4180186
765457	Passed general educational development tests	4180186
765457	Passed GED - general educational development tests	4180186
765458	Pressure ulcer of left lower limb (disorder)	4180186
765458	Pressure ulcer of left lower limb	4180186
765461	Monoplegia of right dominant lower limb due to and following cerebrovascular accident (disorder)	4180186
765461	Monoplegia of right dominant leg as late effect of stroke	4180186
765462	Monoplegia of right dominant arm as late effect of stroke	4180186
765462	Monoplegia of right dominant upper limb due to and following cerebrovascular accident (disorder)	4180186
765464	Immature arteriovenous fistula (disorder)	4180186
765465	Hospital inpatient stay within past 30 days (situation)	4180186
765466	Hordeolum externum of upper eyelid of right eye (disorder)	4180186
765466	External hordeolum of upper eyelid of right eye	4180186
765467	Documentation of current medications (procedure)	4180186
765467	Current medications documented	4180186
765468	Meningococcal conjugate vaccination (procedure)	4180186
765468	Neisseria meningitidis conjugate vaccination	4180186
765468	Meningococcus conjugate vaccination	4180186
765468	Meningococcal conjugate immunization	4180186
765471	Neuralgia of left iliohypogastric nerve (finding)	4180186
765475	Abscess of tendon sheath of left hand (disorder)	4180186
765476	Cellulitis of right orbit (disorder)	4180186
765479	Failed encounter - line busy when call returned (finding)	4180186
765480	Recommendation to change medication dosing interval (procedure)	4180186
765480	Advice to change medication dosing interval	4180186
765484	Unable to afford blood pressure monitor (finding)	4180186
765485	Ulnar neuropathy of left arm (disorder)	4180186
765487	Acute allergic conjunctivitis of left eye	4180186
765487	Acute atopic conjunctivitis of left eye (disorder)	4180186
765495	Occlusion and stenosis of middle cerebral artery without infarction (disorder)	4180186
765497	Clonic seizure, refractory (finding)	4180186
765497	Clonic seizure, intractable	4180186
765498	Unable to afford weight scale (finding)	4180186
765499	Written consent completed (finding)	4180186
765500	Carrier of nonsyndromic deafness (finding)	4180186
765501	Carrier of galactosemia (finding)	4180186
765502	Acquired right claw foot (disorder)	4180186
765503	Photopsia of right eye (disorder)	4180186
765503	Vitreous flashes of right eye	4180186
765505	Vitreous detachment of left eye (disorder)	4180186
765506	Periorbital oedema of left eye	4180186
765506	Periorbital edema of left eye (disorder)	4180186
765507	Bilateral posterior vitreous detachment (disorder)	4180186
765510	Clonic seizure, non-intractable	4180186
765510	Clonic seizure, non-refractory (finding)	4180186
765511	Typical absence seizure, refractory (finding)	4180186
765511	Typical absence seizure, intractable	4180186
765511	Typical absence seizure, refractory (disorder)	4180186
765514	Tonic-clonic seizure, refractory (finding)	4180186
765514	Tonic-clonic seizure, intractable	4180186
765515	Cerebral infarction due to basilar artery stenosis (disorder)	4180186
765519	History of Duchenne muscular dystrophy (situation)	4180186
765520	Contracture of left elbow joint (disorder)	4180186
765522	Family history of allergic rhinitis (situation)	4180186
765523	Modified food, medical food supplement therapy (regime/therapy)	4180186
765527	Age-related nuclear cataract of left eye (disorder)	4180186
765530	Inadequate intake of fluoride (finding)	4180186
765530	Inadequate fluoride intake	4180186
765531	Stimulus control (qualifier value)	4180186
765532	Modular carbohydrate enteral formula component (product)	4180186
765533	Glaucoma due to diabetes mellitus type 1 (disorder)	4180186
765538	Chronic deep venous thrombosis of left upper extremity (disorder)	4180186
765539	Chronic deep vein thrombosis of right axillary vein (disorder)	4180186
765540	Acute deep venous thrombosis of left femoral vein (disorder)	4180186
765542	Chronic deep venous thrombosis of bilateral ileofemoral veins (disorder)	4180186
765543	Chronic deep venous thrombosis of left ileofemoral vein (disorder)	4180186
765545	Chronic deep venous thrombosis of right internal jugular vein (disorder)	4180186
765546	Acute deep venous thrombosis of bilateral tibial veins (disorder)	4180186
765548	Newborn service (qualifier value)	4180186
765551	Medication taken at higher dose than recommended (finding)	4180186
765552	Transport medium (substance)	4180186
765553	History of Senning procedure	4180186
765553	History of atrial inversion using atrial wall (situation)	4180186
765553	History of Senning operation	4180186
765556	Phenylalanine and tyrosine-free formula (product)	4180186
765559	History of angioedema (situation)	4180186
765561	Derangement of lateral meniscus of left knee (disorder)	4180186
765564	At risk for inadequate intake of multiple nutrients (finding)	4180186
765565	Functional quadriplegia due to multiple sclerosis (disorder)	4180186
765566	Peritoneal dialysis care plan (regime/therapy)	4180186
765569	Persistent urogenital sinus, high confluence (disorder)	4180186
765571	Non-essential amino acid free infant formula (product)	4180186
765573	Postoperative heterotopic calcification of muscle (disorder)	4180186
765577	AED - automatic external cardiac defibrillator	4180186
765577	Automatic external cardiac defibrillator (physical object)	4180186
765578	Foreign body in eye (disorder)	4180186
765579	Heart infusion broth (substance)	4180186
765579	HI - heart infusion broth	4180186
765579	Heart Infusion Broth (substance)	4180186
765580	Deficient knowledge of healthcare alternatives (finding)	4180186
765580	Patient unaware of healthcare alternatives	4180186
765581	2 to 4 times	4180186
765581	Two to four times (qualifier value)	4180186
765582	Secondary kyphosis deformity of spine (disorder)	4180186
765582	Secondary kyphosis deformity of spine	4180186
765586	Saffron - spice (substance)	4180186
765586	Saffron	4180186
765589	Club wheat (substance)	4180186
765590	Edamame	4180186
765590	Immature soybean (substance)	4180186
765591	Implant	4180186
765591	Implant - dosing instruction imperative (qualifier value)	4180186
765592	Behind right ear (qualifier value)	4180186
765593	Erosion of tongue caused by citrus fruit (finding)	4180186
765594	Appointed healthcare surrogate (person)	4180186
765594	Appointed healthcare proxy	4180186
765595	Hiking (qualifier value)	4180186
765596	CIED - Cardiac implantable electronic device reprogramming due to surgery	4180186
765596	Cardiac implantable electronic device reprogramming due to surgery (procedure)	4180186
765599	Documentation of adverse drug event history (procedure)	4180186
765602	Macula observable (observable entity)	4180186
765603	Standardized adult depression screening tool completed (situation)	4180186
765605	Neoplasm of breast primary tumor staging category T4c: Both T4a and T4b (finding)	4180186
765607	Influenza due to Influenza A virus with upper respiratory signs (disorder)	4180186
765608	Calculus of gallbladder and bile duct with acute and chronic cholecystitis (disorder)	4180186
765609	Vertebral artery stenosis without infarction (disorder)	4180186
765610	Landau-Kleffner syndrome, non-refractory	4180186
765610	Acquired epileptic aphasia, non-intractable	4180186
765610	Acquired epileptic aphasia, non-refractory (disorder)	4180186
765610	Acquired aphasia with epilepsy, non-refractory	4180186
765616	General healthful diet (regime/therapy)	4180186
765618	Glucose water infant formula (product)	4180186
765619	Methionine and valine-free and low in isoleucine and threonine formula (product)	4180186
765620	Self-employed paid work (finding)	4180186
765621	Former name (qualifier value)	4180186
765622	Arthropathy of right elbow (disorder)	4180186
765623	Amputation of right arm through wrist (procedure)	4180186
765624	Amputation of right great toe	4180186
765624	Amputation of right hallux (procedure)	4180186
765625	Transition of care from emergency department to hospice (finding)	4180186
765626	Transition of care from long term care to emergency department (finding)	4180186
765627	Family history of tall stature (situation)	4180186
765628	Recommendation refused	4180186
765628	Recommendation declined	4180186
765628	Recommendation refused (situation)	4180186
765630	Education about medication indication (procedure)	4180186
765631	Education about pharmacokinetics (procedure)	4180186
765635	Medication dose changed in response to pharmacogenetic findings (situation)	4180186
765636	Medication care plan discussed with primary care provider (situation)	4180186
765641	Referral to health plan representative (procedure)	4180186
765644	Recommendation to monitor patient satisfaction (procedure)	4180186
765645	Antimicrobial medication monitoring (regime/therapy)	4180186
765646	Influenza virus not isolated (finding)	4180186
765649	Patient unable to contact provider office (finding)	4180186
765651	Primary spindle cell carcinoma of urinary bladder (disorder)	4180186
765652	Macular edema absent (situation)	4180186
765654	Discharge to healthcare facility for hospice care (procedure)	4180186
765655	Referral to clinical psychologist (procedure)	4180186
765657	Asthma attack education (procedure)	4180186
765658	Maternal active tuberculosis - untreated (situation)	4180186
765659	Mother receiving cancer chemotherapy (situation)	4180186
765660	Mother receiving antimetabolite therapy (situation)	4180186
765666	Increased polyunsaturated fat diet (regime/therapy)	4180186
765667	Decreased trans fat diet (regime/therapy)	4180186
765668	Decreased fibre diet	4180186
765668	Decreased fiber diet (regime/therapy)	4180186
765669	Manganese modified diet (regime/therapy)	4180186
765671	Increased protein diet (regime/therapy)	4180186
765672	Increased homocysteine diet (regime/therapy)	4180186
765674	Increased leucine diet (regime/therapy)	4180186
765675	Feeding environment table height management (procedure)	4180186
765676	Medication non-compliance due to visual impairment (finding)	4180186
765677	Declines to state contraceptive method (finding)	4180186
765678	Order aborted	4180186
765678	Order aborted (qualifier value)	4180186
765681	Swab from scalp (specimen)	4180186
765682	Swab from upper arm (specimen)	4180186
765689	MG	4180186
765689	O8	4180186
765689	RADM	4180186
765689	Maj Gen	4180186
765689	MajGen	4180186
765689	Major General	4180186
765689	United States Military Commissioned Officer O8 (qualifier value)	4180186
765689	Rear Admiral Upper Half	4180186
765689	United States Military Commissioned Officer O8	4180186
765695	Neuroma of face (disorder)	4180186
765696	Body mass index follow-up planning not done (situation)	4180186
765697	Recommendation to change medication dose (procedure)	4180186
765697	Advice to change medication dose	4180186
765702	Low insoluble fibre food	4180186
765702	Low insoluble fiber food (substance)	4180186
765707	Some of the time (qualifier value)	4180186
765708	Poorly controlled (qualifier value)	4180186
765713	Family history of tic (situation)	4180186
765714	Family history of paranoid disorder (situation)	4180186
765715	Family history of ataxia (situation)	4180186
765719	Lower outer quadrant lump of left breast	4180186
765719	Lump in lower outer quadrant of left breast (finding)	4180186
765720	Lower inner quadrant lump of right breast	4180186
765720	Lump in lower inner quadrant of right breast (finding)	4180186
765723	No mechanism for timely refill (finding)	4180186
765725	History of general anesthesia (situation)	4180186
765727	Fetal anticonvulsant syndrome	4180186
765727	Fetus affected by placental transfer of anticonvulsant (disorder)	4180186
765727	Foetus affected by placental transfer of anticonvulsant	4180186
765727	Foetal anticonvulsant syndrome	4180186
765730	Discussion about care plan (procedure)	4180186
765731	Increased vitamin B12 diet (regime/therapy)	4180186
765735	Nutrition impaired (finding)	4180186
765736	Advanced practice midwife (occupation)	4180186
765737	One year (qualifier value)	4180186
765739	Mucopurulent conjunctivitis of right eye (disorder)	4180186
765740	Family history of trisomy 18 syndrome (situation)	4180186
765742	Infected urachal cyst (disorder)	4180186
765742	Infected allantoic cyst	4180186
765745	Intraperitoneal rupture of bladder (disorder)	4180186
765747	Sodium supplement therapy (regime/therapy)	4180186
765748	Zinc supplement therapy (regime/therapy)	4180186
765749	Feeding intention - breast and formula (finding)	4180186
765751	Seafood sample	4180186
765751	Seafood specimen (specimen)	4180186
765752	Surgical incision wound of skin (finding)	4180186
765753	Wang's semisolid medium (substance)	4180186
765755	Primary right vesicoureteral reflux grade 4 measured by voiding cystourethrography (disorder)	4180186
765755	Primary right vesicoureteral reflux grade 4 measured by VCUG - voiding cystourethrography	4180186
765755	Primary right vesico-ureteric reflux grade 4 measured by voiding cystourethrography	4180186
765759	Increased fluid diet (regime/therapy)	4180186
765760	Medical food (substance)	4180186
765761	Female identity	4180186
765761	Identifies as female gender (finding)	4180186
765761	Female gender identity	4180186
765763	Acquired left hallux rigidus (disorder)	4180186
765764	Well child visit, newborn 8 to 28 days old (procedure)	4180186
765766	CTCAE grade 5	4180186
765766	Common terminology criteria for adverse events grade 5 (finding)	4180186
765768	Moderate intensity (qualifier value)	4180186
765770	Patient has difficulty distinguishing between medications (finding)	4180186
765773	Polyarthritis associated with haemochromatosis	4180186
765773	Polyarthritis associated with hemochromatosis (disorder)	4180186
765773	Arthritis of hemochromatosis	4180186
765777	Air force dialysis program (regime/therapy)	4180186
765778	Greater than three hundred percent of the US federal poverty level (social concept)	4180186
765778	Greater than three hundred percent of the US federal poverty level	4180186
765778	Greater than 300% of the US federal poverty level (social concept)	4180186
765778	Greater than 300% of the US federal poverty level	4180186
765779	Latrine (physical object)	4180186
765784	Campylobacter-thioglycolate broth (substance)	4180186
765787	Generalized convulsive epilepsy, non-refractory (disorder)	4180186
765787	Epilepsy with tonic-clonic seizures, non-refractory	4180186
765787	Generalized convulsive epilepsy, non-intractable	4180186
765790	Patient advised to seek medical care	4180186
765790	Recommendation to seek medical care (procedure)	4180186
765794	White or yellow-green tinged lochia (finding)	4180186
765798	More effective medication therapy available (finding)	4180186
765800	History of repair of aneurysm of abdominal aorta using endovascular stent graft (situation)	4180186
765800	History of endovascular stent graft for repair of abdominal aortic aneurysm	4180186
765801	Intravasation (morphologic abnormality)	4180186
765802	Inadequate soy protein intake (finding)	4180186
765803	Plant sterol ester (substance)	4180186
765804	Management of beta glucan intake (procedure)	4180186
765807	Coral material (substance)	4180186
765809	Animal saliva (substance)	4180186
765810	Isothiazolinone (substance)	4180186
765811	Birch pollen (substance)	4180186
765811	Betula pollen	4180186
765812	Family history of Graves disease (situation)	4180186
765812	Family history of Graves' disease	4180186
765813	Pyogenic bacterial arthritis of patella (disorder)	4180186
765814	History of embolic stroke without residual deficits (situation)	4180186
765817	Inadequate intake of chromium (finding)	4180186
765817	Inadequate chromium intake	4180186
765819	Excessive cobalt intake (finding)	4180186
765820	Transtheoretical model and stages of change (qualifier value)	4180186
765826	Eggshell (substance)	4180186
765827	Multiphasic ADEM - acute disseminated encephalomyelitis	4180186
765827	Multiphasic acute disseminated encephalomyelitis (disorder)	4180186
765829	Severe medical complication (disorder)	4180186
765829	Severe medical complication (finding)	4180186
765830	Patient psychologically unfit to receive information (finding)	4180186
765831	Herpes simplex infection of skin of breast (disorder)	4180186
765832	Cognitive behavioral theory (qualifier value)	4180186
765835	Direction of communication (qualifier value)	4180186
765836	Hospital admission, transfer from assisted living facility (procedure)	4180186
765837	Middlebrook 7H10 agar (substance)	4180186
765839	Medication dose increased (situation)	4180186
765840	Medication dosing interval increased (situation)	4180186
765841	Over-the-counter medication started (situation)	4180186
765843	Administration of dietary supplement (procedure)	4180186
765845	Documentation of geriatric syndrome medication action plan (procedure)	4180186
765846	Thick pureed food (substance)	4180186
765850	Beta-hemolytic Streptococcus, non-group B (organism)	4180186
765851	Coagulase-negative Staphylococcus, not Staphylococcus epidermidis (organism)	4180186
765852	Referral to prosthetist (procedure)	4180186
765858	Caliber-persistent labial artery (morphologic abnormality)	4180186
765858	Caliber-persistent labial artery	4180186
765858	Retained caliber labial artery	4180186
765860	Documentation of oncologic disorder medication action plan (procedure)	4180186
765860	Documentation of neoplastic disorder medication action plan	4180186
765864	Neoplasm of colon staging category N2: Metastasis in 4 or more regional lymph nodes	4180186
765864	Neoplasm of colon regional lymph node staging category N2	4180186
765864	Neoplasm of colon regional lymph node staging category N2: Metastasis in 4 or more regional lymph nodes (finding)	4180186
765865	Bacterial infection associated with peritoneal dialysis catheter (disorder)	4180186
765866	Emergency hospital admission from observation unit (procedure)	4180186
765868	Pickled beet (substance)	4180186
765869	Private midwife (occupation)	4180186
765872	Complex febrile seizure, refractory (finding)	4180186
765872	Complex febrile seizure, intractable	4180186
765876	Graham cracker (substance)	4180186
765878	Hemp milk (substance)	4180186
765879	Long-term current use of antiplatelet drug (situation)	4180186
765881	Loss of protective sensation of skin of foot co-occurrent with peripheral vascular disease of foot (finding)	4180186
765881	Loss of protective sensation of skin of foot co-occurrent with peripheral vascular disease of foot	4180186
765882	Removal from state	4180186
765882	Patient status determination, deceased and removed from state (finding)	4180186
765883	Somatic dysfunction of trunk region (finding)	4180186
765885	Gynecological examination normal (finding)	4180186
765886	Cranial nerves three, four and six abnormal (finding)	4180186
765887	Stiffness of bilateral wrist joints (finding)	4180186
765888	Acute-on-chronic respiratory failure following trauma (disorder)	4180186
765889	Chronic otitis media of left ear (disorder)	4180186
765890	Closed fracture of third metacarpal bone of left hand (disorder)	4180186
765892	Laceration of right thigh (disorder)	4180186
765893	Osteoporotic fracture of left humerus	4180186
765893	Pathological fracture of left humerus due to osteoporosis (disorder)	4180186
765898	Neoplasia following lung transplant (disorder)	4180186
765899	Dissection of cerebral artery	4180186
765899	Dissecting aneurysm of cerebral artery (disorder)	4180186
765900	Mycobacterial isolate specimen (specimen)	4180186
765904	Bilateral primary open angle glaucoma (disorder)	4180186
765904	Primary open angle glaucoma of both eyes	4180186
765905	Keratitis of right eye caused by herpes simplex virus (disorder)	4180186
765907	Occlusion and stenosis of middle cerebral artery with infarction (disorder)	4180186
765909	Medication therapy management information sent (situation)	4180186
765910	Decreased soluble fiber diet (regime/therapy)	4180186
765910	Decreased soluble fibre diet	4180186
765911	Increased sodium diet (regime/therapy)	4180186
765913	Magnesium supplement therapy (regime/therapy)	4180186
765916	Sensory deprivation exotropia of right eye (disorder)	4180186
765917	Infiltrate of cornea of left eye (disorder)	4180186
765917	Left corneal infiltrate	4180186
765918	Posterior subcapsular polar cataract of bilateral eyes (disorder)	4180186
765918	Posterior subcapsular polar cataract of both eyes	4180186
765919	Instability of joint of right wrist (finding)	4180186
765921	Allergy to hornet venom (finding)	4180186
765924	Modified amino acid composition infant formula (product)	4180186
765925	Three or more times a day (qualifier value)	4180186
765929	Daily before dinner (qualifier value)	4180186
908213	Accidental Injury	4180186
908213	Accident Injuries	4180186
908213	Accident Injury	4180186
908213	Injuries, Accident	4180186
908213	Injuries, Accidental	4180186
908213	Injury, Accident	4180186
908213	Injury, Accidental	4180186
908214	Ado Trastuzumab Emtansine	4180186
908214	huN901DM1	4180186
908214	huN901 DM1	4180186
908214	huN901-DM1	4180186
908214	Kadcyla	4180186
908214	Trastuzumab DM1	4180186
908214	Trastuzumab-DM1	4180186
908214	Trastuzumab DM1 Conjugate	4180186
908214	Trastuzumab-DM1 Conjugate	4180186
908214	Trastuzumab Emtansine	4180186
908215	Cytoecetes phagocytophila	4180186
908215	Ehrlichia equi	4180186
908215	Ehrlichia phagocytophila	4180186
908215	HGE Agent	4180186
908216	Asthma Chronic Obstructive Pulmonary Disease Overlap Syndrome	4180186
908216	Asthma COPD Overlap Syndrome	4180186
908216	Asthma-COPD Overlap Syndrome	4180186
908216	Asthma-COPD Overlap Syndromes	4180186
908216	Overlap Syndrome, Asthma-COPD	4180186
908218	ARFID	4180186
908218	Food Neophobia	4180186
908218	Food Neophobias	4180186
908218	Neophobia, Food	4180186
908219	Birdshot Chorioretinitis	4180186
908219	Birdshot Chorioretinopathies	4180186
908219	Birdshot Retinochoroiditides	4180186
908219	Birdshot Retinochoroiditis	4180186
908219	Birdshot Retinochoroidopathies	4180186
908219	Birdshot Retinochoroidopathy	4180186
908219	Chorioretinitis, Birdshot	4180186
908219	Chorioretinopathy, Birdshot	4180186
908219	Retinochoroiditis, Birdshot	4180186
908219	Retinochoroidopathy, Birdshot	4180186
908220	Body Contouring Surgeries	4180186
908220	Body Contouring Surgery	4180186
908220	Body Contour Surgeries	4180186
908220	Body Contour Surgery	4180186
908220	Body Lift Surgeries	4180186
908220	Body Lift Surgery	4180186
908220	Contouring, Body	4180186
908220	Contouring Surgeries, Body	4180186
908220	Contouring Surgery, Body	4180186
908220	Contour Surgeries, Body	4180186
908220	Contour Surgery, Body	4180186
908220	Lift Surgeries, Body	4180186
908220	Lift Surgery, Body	4180186
908220	Surgeries, Body Contour	4180186
908220	Surgeries, Body Contouring	4180186
908220	Surgeries, Body Lift	4180186
908220	Surgery, Body Contour	4180186
908220	Surgery, Body Contouring	4180186
908220	Surgery, Body Lift	4180186
908221	Body Image Dissatisfaction	4180186
908221	Body Image Dissatisfactions	4180186
908221	Body Image, Negative	4180186
908221	Body Images, Negative	4180186
908221	Dissatisfaction, Body	4180186
908221	Dissatisfaction, Body Image	4180186
908221	Dissatisfactions, Body Image	4180186
908221	Image Dissatisfaction, Body	4180186
908221	Image Dissatisfactions, Body	4180186
908221	Image, Negative Body	4180186
908221	Images, Negative Body	4180186
908221	Negative Body Image	4180186
908221	Negative Body Images	4180186
908224	Autoimmune Urticaria	4180186
908224	Autoimmune Urticaria, Chronic	4180186
908224	Autoimmune Urticarias	4180186
908224	Chronic Autoimmune Urticaria	4180186
908224	Chronic Autoimmune Urticarias	4180186
908224	Chronic Idiopathic Urticaria	4180186
908224	Chronic Idiopathic Urticarias	4180186
908224	Chronic Spontaneous Urticaria	4180186
908224	Chronic Spontaneous Urticarias	4180186
908224	Chronic Urticaria, Idiopathic	4180186
908224	Chronic Urticarias	4180186
908224	Idiopathic Chronic Urticaria	4180186
908224	Idiopathic Chronic Urticarias	4180186
908224	Idiopathic Urticaria, Chronic	4180186
908224	Spontaneous Urticaria, Chronic	4180186
908224	Urticaria, Autoimmune	4180186
908224	Urticaria, Chronic	4180186
908224	Urticaria, Chronic Autoimmune	4180186
908224	Urticaria, Chronic Idiopathic	4180186
908224	Urticaria, Chronic Spontaneous	4180186
908224	Urticaria, Idiopathic Chronic	4180186
908227	Cleft, Cyclodialysis	4180186
908227	Cleft, Persistent Cyclodialysis	4180186
908227	Cyclodialyses, Traumatic	4180186
908227	Cyclodialysis Cleft	4180186
908227	Cyclodialysis Cleft, Persistent	4180186
908227	Cyclodialysis, Traumatic	4180186
908227	Persistent Cyclodialysis Cleft	4180186
908227	Persistent Cyclodialysis Clefts	4180186
908227	Traumatic Cyclodialysis	4180186
908228	Cytokine Release Syndromes	4180186
908228	Cytokine Storm	4180186
908228	Cytokine Storms	4180186
908228	Cytokine Storm Syndrome	4180186
908228	Hypercytokinemia	4180186
908228	Hypercytokinemias	4180186
908230	Needling, Dry	4180186
908232	Exudative Vitreoretinopathy, Familial	4180186
908232	Familial Exudative Vitreoretinopathy	4180186
908232	Vitreoretinopathy, Familial Exudative	4180186
908232	XL-FEVR	4180186
908232	X Linked Familial Exudative Vitreoretinopathy	4180186
908232	X-Linked Familial Exudative Vitreoretinopathy	4180186
908233	Globus Hystericus	4180186
908233	Globus Pharyngeus	4180186
908233	Globus Sensations	4180186
908233	Sensation, Globus	4180186
908234	Acute Interstitial Pneumonia	4180186
908234	Acute Interstitial Pneumonias	4180186
908234	Acute Interstitial Pneumonitides	4180186
908234	Acute Interstitial Pneumonitis	4180186
908234	Hamman Rich Disease	4180186
908234	Hamman-Rich Disease	4180186
908234	Hamman Rich Syndrome	4180186
908234	Interstitial Pneumonia, Acute	4180186
908234	Interstitial Pneumonitis, Acute	4180186
908234	Pneumonia, Acute Interstitial	4180186
908234	Pneumonitis, Acute Interstitial	4180186
908236	B-Lymphotropic Viruses, Human	4180186
908236	B-Lymphotropic Virus, Human	4180186
908236	Chromosomally Integrated Human Herpesvirus 6	4180186
908236	Chromosomally Integrated Human Herpesvirus 6A	4180186
908236	Chromosomally Integrated Human Herpesvirus 6B	4180186
908236	ciHHV6	4180186
908236	ciHHV-6	4180186
908236	ciHHV6A	4180186
908236	ciHHV-6A	4180186
908236	ciHHV6B	4180186
908236	ciHHV-6B	4180186
908236	HBLV	4180186
908236	Herpesvirus 6A, Human	4180186
908236	Herpesvirus 6B, Human	4180186
908236	HHV6	4180186
908236	HHV-6	4180186
908236	HHV6A	4180186
908236	HHV-6A	4180186
908236	HHV6B	4180186
908236	HHV-6B	4180186
908236	Human betaherpesvirus 6	4180186
908236	Human betaherpesvirus 6A	4180186
908236	Human betaherpesvirus 6B	4180186
908236	Human betaherpesvirus 6s	4180186
908236	Human B Lymphotropic Virus	4180186
908236	Human B-Lymphotropic Virus	4180186
908236	Human B-Lymphotropic Viruses	4180186
908236	Human Herpesvirus 6	4180186
908236	Human Herpesvirus 6A	4180186
908236	Human Herpesvirus 6B	4180186
908236	iciHHV6	4180186
908236	iciHHV-6	4180186
908236	iciHHV6A	4180186
908236	iciHHV-6A	4180186
908236	iciHHV6B	4180186
908236	iciHHV-6B	4180186
908236	Inherited Chromosomally Integrated Human Herpesvirus 6	4180186
908236	Inherited Chromosomally Integrated Human Herpesvirus 6A	4180186
908236	Inherited Chromosomally Integrated Human Herpesvirus 6B	4180186
908239	Hematopoietin 1	4180186
908239	Hematopoietin-1	4180186
908239	IL-1 alpha	4180186
908239	Interleukin 1alpha	4180186
908239	Interleukin 1 alpha	4180186
908239	Interleukin-1 alpha	4180186
908241	Psychotherapy, Interpersonal	4180186
908242	Cerebromedullospinal Disconnection	4180186
908242	Cerebromedullospinal Disconnections	4180186
908242	Locked In Syndrome	4180186
908242	Locked-In Syndromes	4180186
908242	Ventral Pontine Syndrome	4180186
908242	Ventral Pontine Syndromes	4180186
908244	Dysfunction, Meibomian Gland	4180186
908244	Meibomian Gland Dysfunctions	4180186
908244	MG Dysfunction	4180186
908244	MG Dysfunctions	4180186
908245	Choroiditis, Multifocal	4180186
908248	Hypoplasia, Optic Nerve	4180186
908248	Superior Segmental Optic Hypoplasia	4180186
908248	Superior Segmental Optic Nerve Hypoplasia	4180186
908255	Arteriolar Macroaneurysm, Retinal	4180186
908255	Macroaneurysm, Retinal	4180186
908255	Macroaneurysm, Retinal Arterial	4180186
908255	Macroaneurysm, Retinal Arteriolar	4180186
908255	Retinal Arterial Macroaneurysms	4180186
908255	Retinal Arteriolar Macroaneurysm	4180186
908255	Retinal Arteriolar Macroaneurysms	4180186
908255	Retinal Macroaneurysm	4180186
908255	Retinal Macroaneurysms	4180186
908255	Ruptured Retinal Arterial Macroaneurysm	4180186
908256	Merycism	4180186
908256	Rumination Disorder	4180186
908256	Rumination Disorders	4180186
908256	Rumination Syndromes	4180186
908257	Pursennid	4180186
908257	Senna Glycoside	4180186
908257	Sennoside	4180186
908257	Sennoside A&B	4180186
908257	Sennoside A+B Calcium	4180186
908257	Sennoside A&B, Calcium Salt	4180186
908257	Sennoside A Calcium	4180186
908257	Sennoside A Calcium and Sennoside B Calcium	4180186
908257	Sennoside A, Calcium Salt	4180186
908257	Sennoside A, Calcium Salt (1:1)	4180186
908257	Sennoside B Calcium	4180186
908257	Sennoside B, Calcium Salt	4180186
908257	Sennosides A and B	4180186
908257	Sennosides A and B Acids	4180186
908257	Senokot	4180186
908258	Dystocia, Fetal Shoulder	4180186
908258	Dystocia, Shoulder	4180186
908258	Fetal Shoulder Dystocia	4180186
908258	Fetal Shoulder Dystocias	4180186
908258	Shoulder Dystocia, Fetal	4180186
908258	Shoulder Dystocias	4180186
908261	Near-Infrared Spectrometries	4180186
908261	Near-Infrared Spectrometry	4180186
908261	Near-Infrared Spectroscopies	4180186
908261	Near-Infrared Spectroscopy	4180186
908261	NIR Spectroscopies	4180186
908261	NIR Spectroscopy	4180186
908261	Spectrometries, Near-Infrared	4180186
908261	Spectrometry, Near Infrared	4180186
908261	Spectrometry, Near-Infrared	4180186
908261	Spectroscopies, Near-Infrared	4180186
908261	Spectroscopies, NIR	4180186
908261	Spectroscopy, Near Infrared	4180186
908261	Spectroscopy, NIR	4180186
908264	Chromesthesia	4180186
908264	Chromesthesias	4180186
908264	Colored Hearing Synesthesia	4180186
908264	Colored Hearing Synesthesias	4180186
908264	Grapheme Color Synesthesia	4180186
908264	Grapheme-Color Synesthesia	4180186
908264	Grapheme-Color Synesthesias	4180186
908264	Hearing Synesthesia, Colored	4180186
908264	Hearing Synesthesias, Colored	4180186
908264	Ideaesthesia	4180186
908264	Ideaesthesias	4180186
908264	Ideasthesia	4180186
908264	Ideasthesias	4180186
908264	Lexical Gustatory Synesthesia	4180186
908264	Lexical-Gustatory Synesthesia	4180186
908264	Lexical-Gustatory Synesthesias	4180186
908264	Synesthesia, Colored Hearing	4180186
908264	Synesthesia, Grapheme-Color	4180186
908264	Synesthesia, Lexical-Gustatory	4180186
908264	Synesthesias	4180186
908264	Synesthesias, Colored Hearing	4180186
908264	Synesthesias, Grapheme-Color	4180186
908264	Synesthesias, Lexical-Gustatory	4180186
908266	Neuropathy, Toxic Optic	4180186
908266	Ocular Toxicity	4180186
908266	Optic Neuropathy, Toxic	4180186
908266	Toxicity, Ocular	4180186
908266	Toxic Optic Neuropathies	4180186
908268	Complex Single Ventricle	4180186
908268	Complex Single Ventricles	4180186
908268	Univentricular Hearts	4180186
908268	Ventricle, Complex Single	4180186
908269	Uveal Effusion Syndromes	4180186
908270	Systolic Dysfunction, LV	4180186
908270	LV Systolic Dysfunctions	4180186
908270	LV Systolic Dysfunction	4180186
908270	LV Dysfunctions	4180186
908270	LV Dysfunction	4180186
908270	LV Diastolic Dysfunctions	4180186
908270	LV Diastolic Dysfunction	4180186
908270	Left Ventricular Systolic Dysfunction	4180186
908270	Left Ventricular Diastolic Dysfunction	4180186
908270	Dysfunction, LV Systolic	4180186
908270	Dysfunction, LV Diastolic	4180186
908270	Dysfunction, LV	4180186
908270	Diastolic Dysfunction, LV	4180186
908270	Dysfunction, Left Ventricular	4180186
908270	Left Ventricular Dysfunction	4180186
908270	Left Ventricular Dysfunctions	4180186
908272	Complete Genome Sequencing	4180186
908272	Genome Sequencing, Complete	4180186
908272	Genome Sequencing, Whole	4180186
908272	Sequencing, Complete Genome	4180186
908272	Sequencing, Whole Genome	4180186
908273	1-(2-(1H-benzo(d)imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea	4180186
908273	Daurismo	4180186
908273	PF-04449913	4180186
908274	HC Yellow No. 4	4180186
908274	N,O-di(2-hydroxyethyl)-2-amino-5-nitrophenol	4180186
908276	Autosomal Recessive Spastic Ataxia With Leukoencephalopathy	4180186
908277	Autosomal dominant partial epilepsy with auditory features	4180186
908277	Epilepsy, Lateral Temporal Lobe, Autosomal Dominant	4180186
908277	Epilepsy, Partial, With Auditory Features	4180186
908279	PT-141	4180186
908279	Vyleesi	4180186
908281	10,11-dimethoxystrychnine	4180186
908281	bruzin	4180186
908281	dimethoxystrychnine	4180186
908281	Strychnidin-10-one, 2,3-dimethoxy-	4180186
908284	O-demethylcolchicine	4180186
908285	Pitt-Hopkins-Like Syndrome 1	4180186
908285	PTHSL1	4180186
908287	5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole	4180186
908287	AN2728	4180186
908287	AN-2728	4180186
908287	Eucrisa	4180186
908291	Nubeqa	4180186
908291	ODM-201	4180186
908291	ORM-16497	4180186
908291	ORM-16555	4180186
908293	dibutylstannane	4180186
908293	dibutyltin	4180186
908293	poly(di-(n-butyl))stannane	4180186
908294	C12-E9	4180186
908294	dodecyl nonaoxyethylene ether	4180186
908296	Balversa	4180186
908296	JNJ-42756493	4180186
908297	Kataved	4180186
908297	(-)-Ketamine	4180186
908297	L-Ketamine	4180186
908297	(S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone	4180186
908297	S-Ketamine	4180186
908297	Spravato	4180186
908299	Fatco Syndrome	4180186
908300	Strabismus from Superior Oblique Palsy	4180186
908300	Superior Oblique Oculomotor Palsy, Familial Congenital	4180186
908300	Trochlear Nerve Palsy, Familial Congenital	4180186
908302	Spinocerebellar ataxia associated with localized amyotrophy of the hands, sensorineural deafness and spastic paraparesis	4180186
908303	Voraxaze	4180186
908307	Complex congenital heart defect, renal agenesis, and cleft lip and palate	4180186
908307	Holzgreve syndrome	4180186
908308	Huntington-Like Neurodegenerative Disorder 1	4180186
908308	Huntington-Like Neurodegenerative Disorder, Autosomal Dominant	4180186
908308	Prion Disease, Early-Onset, With Prominent Psychiatric Features	4180186
908313	DX-2930	4180186
908313	SHP-643	4180186
908313	Takhzyro	4180186
908314	dodecyl acetate	4180186
908315	Calpainopathy	4180186
908315	Leyden-Moebius muscular dystrophy	4180186
908315	LGMD2	4180186
908315	LGMD2A	4180186
908315	Limb-girdle muscular dystrophy type 2	4180186
908315	Muscular Dystrophy, Limb-Girdle, Type 2	4180186
908315	Muscular Dystrophy, Limb-Girdle, Type 2A	4180186
908315	Muscular dystrophy, pelvofemoral	4180186
908315	Myositis, Eosinophilic	4180186
908327	Oculoauriculofrontonasal dysplasia	4180186
908329	osimertinib mesylate	4180186
908329	osimertinib mesilate	4180186
908329	N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1)	4180186
908329	N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide	4180186
908329	mereletinib mesylate	4180186
908329	mereletinib mesilate	4180186
908329	mereletinib	4180186
908329	AZD9291 mesylate	4180186
908329	AZD-9291 mesylate	4180186
908329	AZD-9291	4180186
908329	AZD9291	4180186
908329	Tagrisso	4180186
908334	AHZ-zinc	4180186
908334	beta-alanyl-L-histidinato zinc	4180186
908334	N-(3-aminopropionyl)-L-histidinato zinc	4180186
908334	Z 103	4180186
908334	Z-103	4180186
908334	zinc carnosine	4180186
908334	zinc L-carnosine	4180186
908334	zinc L-carnosine complex	4180186
908334	zinc N-(3-aminopropionyl)histidine	4180186
908338	Keratoderma and spastic paralysis	4180186
908338	Punctate keratoderma and spastic paralysis	4180186
908339	Inherited congenital bilateral atresia of the external auditory canal, congenital bilateral vertical talus and increased interocular distance	4180186
908340	Pelvic dysplasia associated with arthrogrypotic changes in the lower extremities	4180186
908340	Pelvic hypoplasia, and arthrogrypotic changes in the lower limbs	4180186
908341	Tibial hemimelia-split hand-foot syndrome	4180186
908344	AMG785	4180186
908344	AMG 785	4180186
908344	AMG-785	4180186
908344	CDP7851	4180186
908344	CDP 7851	4180186
908344	CDP-7851	4180186
908344	evenity	4180186
908344	romosozumab-aqqg	4180186
908347	1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid	4180186
908347	BAF312	4180186
908347	BAF-312	4180186
908347	Mayzent	4180186
908348	(2R)-2-amino-3-phenylpropyl carbamate	4180186
908348	benzenepropanol, beta-amino-, carbamate (ester), (betaR)-	4180186
908351	Stickler syndrome nonocular type	4180186
908351	Stickler Syndrome, Nonocular Type	4180186
908351	Stickler Syndrome, Type III	4180186
908355	Thoraco-Limb Dysplasia	4180186
908357	(3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide	4180186
908357	ABT-494	4180186
908357	Rinvoq	4180186
908358	Osteopathia striata associated with familial dermopathy and white forelock	4180186
957441	Spondyloarthritis, Axial	4180186
957441	Spondyloarthritides, Axial	4180186
957441	AxSpA	4180186
957441	Axial Spondyloarthritides	4180186
957442	3,4-Benzpyrene	4180186
957442	3,4 Benzpyrene	4180186
957442	3,4-Benzopyrene	4180186
957442	3,4 Benzopyrene	4180186
957443	Odors, Body	4180186
957443	Bromhidrosis	4180186
957443	Bromhidroses	4180186
957443	Body Odors	4180186
957445	Corticobasal Syndrome	4180186
957445	Cortico-basal Ganglionic Degeneration	4180186
957445	Cortico basal Ganglionic Degeneration	4180186
957445	Cortico-basal Degeneration	4180186
957445	Cortico basal Degeneration	4180186
957449	Estra-1,3,5(10)-triene-3,15,16,17-tetrol, (15alpha,16alpha,17beta)-	4180186
957449	15-alpha-Hydroxy-Estriol	4180186
957449	15 alpha Hydroxy Estriol	4180186
957449	15 alpha-Hydroxyestriol	4180186
957449	15 alpha Hydroxyestriol	4180186
957452	Sideropenias	4180186
957452	Sideropenia	4180186
957452	Latent Iron Deficiency	4180186
957452	Latent Iron Deficiencies	4180186
957452	Iron Deficiency, Latent	4180186
957452	Iron Deficiency	4180186
957452	Iron Deficiencies, Latent	4180186
957452	Hypoferritinemias	4180186
957452	Hypoferritinemia	4180186
957452	Deficiency, Latent Iron	4180186
957452	Deficiency, Iron	4180186
957452	Deficiencies, Latent Iron	4180186
957452	Deficiencies, Iron	4180186
957454	Non-Clonal Mast Cell Activation Syndrome	4180186
957454	Non Clonal Mast Cell Activation Syndrome	4180186
957454	Nonclonal Mast Cell Activation Syndrome	4180186
957454	Non-Clonal Mast Cell Activation Disorder	4180186
957454	Non Clonal Mast Cell Activation Disorder	4180186
957454	nc-MCAS	4180186
957454	nc MCAS	4180186
957454	Mast Cell Activation Syndromes	4180186
957454	Idiopathic Mast Cell Activation Disorder	4180186
957457	Orthorexia	4180186
957457	Obsessive Healthy Eating	4180186
957457	Nervosa, Orthorexia	4180186
957457	Healthy Eating, Obsessive	4180186
957459	Cocculin	4180186
957459	3,6-Methano-8H-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3H)-dione, hexahydro-2a-hydroxy-9-(1-hydroxy-1-methylethyl)-8b-methyl-, (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8aS*,8bbeta,9S*))-, compd. with (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8	4180186
957463	Urogenital Disease	4180186
957463	Genitourinary Diseases	4180186
957463	Genitourinary Disease	4180186
957463	Disease, Urogenital	4180186
957463	Disease, Genitourinary	4180186
957464	divinyl	4180186
957464	butadiene	4180186
957470	1,8-dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione	4180186
957473	Neuronopathy, Distal Hereditary Motor, With Pyramidal Features	4180186
957479	SRP-4045	4180186
957479	amondys 45	4180186
957480	Luteinizing Hormone-Releasing Hormone, Deficiency of, with Ataxia	4180186
957480	LHRH Deficiency and Ataxia	4180186
957480	Gordon Holmes Syndrome	4180186
957483	Trisomy 7p	4180186
957483	Duplication 7p	4180186
957484	Trisomy 7q	4180186
957484	Duplication 7q	4180186
957485	Cole-Carpenter Syndrome	4180186
957489	Forxiga	4180186
957489	Farxiga	4180186
957489	BMS-512148	4180186
957489	BMS 512148	4180186
957489	BMS512148	4180186
957489	(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol	4180186
957489	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	4180186
957492	di-isononyl adipate	4180186
957497	kerendia	4180186
957497	BAY 94-8862	4180186
957499	paradise citrus seed	4180186
957499	grapefruit seed	4180186
957499	citrus x paradisi seed extract	4180186
957499	citrus x paradisi seed	4180186
957499	citrus paradisi seed extract	4180186
957499	citrus paradisi seed	4180186
957502	3,5'-diallyl-4,2'-dihydroxybiphenyl	4180186
957502	(1,1'-biphenyl)-2,4'-diol, 3',5-di-2-propen-1-yl-	4180186
957503	SCY-078	4180186
957503	MK-3118	4180186
957503	brexafemme	4180186
957505	truseltiq	4180186
957505	NVP-BGJ398	4180186
957505	BGJ398	4180186
957505	3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea	4180186
957507	(Z)-jasmone	4180186
957507	(Z)-3-methyl-2-(2-pentenyl)-2-cyclopenten-1-one	4180186
957507	cis-jasmone	4180186
957507	2-Cyclopenten-1-one, 3-methyl-2-((2Z)-2-penten-1-yl)-	4180186
957509	PbCl2	4180186
957509	lead chloride, (37)lead-labeled	4180186
957509	lead chloride, (35)lead-labeled	4180186
957509	lead chloride, (35)lead, 1-(37)chlorine-labeled	4180186
957511	zynlonta	4180186
957511	loncastuximab tesirine-lpyl	4180186
957511	ADCT-402	4180186
957513	5,5'-diallyl-2,2'-dihydroxybiphenyl	4180186
957515	pepaxto	4180186
957515	melphalan-flufenamide	4180186
957519	Peripheral motor neuropathy associated with autonomic dysfunction	4180186
957519	Motor Neuropathy, Peripheral, with Dysautonomia	4180186
957519	Lisker Garcia Ramos syndrome	4180186
957521	octyl cyanoacrylate	4180186
957521	ocrylate	4180186
957521	ocrilate	4180186
957521	n-octyl-cyanoacrylate	4180186
957521	Dermabond	4180186
957521	2-propenoic acid, 2-cyano-, octyl ester	4180186
957521	2-octyl cyanoacrylate	4180186
957521	2-octylcyanoacrylate	4180186
957525	Empaveli	4180186
957525	APL-2 peptide	4180186
957529	Petty Laxova Wiedemann syndrome	4180186
957529	Gorlin-Chaudhry-Moss syndrome	4180186
957529	Gorlin Chaudhry Moss syndrome	4180186
957529	GCM syndrome	4180186
957529	Craniofacial dysostosis, patent ductus arteriosus, hypertrichosis, hypoplasia of labia majora, dental and eye anomalies	4180186
957532	sabinene, (1R)-isomer	4180186
957535	lumakras	4180186
957535	AMG-510	4180186
957535	AMG 510	4180186
957535	AMG510	4180186
957535	6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-((2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl)pyrido(2,3-d)pyrimidin-2-one	4180186
957541	Spiro(cyclohexane-1,9'(6'H)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-	4180186
957541	cosela	4180186
957541	2'-((5-(4-Methyl-1-piperazinyl)-2-pyridinyl)amino)-7',8'-dihydro-6'H-spiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one	4180186
957542	KPT335	4180186
957542	(2Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)prop-2-enehydrazide	4180186
957542	2-propenoic acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-, 2-(2-pyridinyl)hydrazide, (2Z)-	4180186
957542	KPT-335	4180186
957629	Hyposmia	4180186
957629	Loss of Smell	4180186
957629	Smell Loss	4180186
957630	Aortic Heart Disease	4180186
957630	Aortic Heart Diseases	4180186
957630	Aortic Valve Diseases	4180186
957630	Aortic Valve Disorder	4180186
957630	Aortic Valve Disorders	4180186
957630	Aortic Valvular Heart Disease	4180186
957630	Aortic Valvular Heart Disorder	4180186
957630	Heart Disease, Aortic	4180186
957630	Valve Disease, Aortic	4180186
957630	Valve Disorder, Aortic	4180186
957634	ALTE Apparent Life Threatening Event	4180186
957634	ALTE Apparent Life-Threatening Event	4180186
957634	Apparent Life Threatening Event	4180186
957634	Apparent Life-Threatening Event	4180186
957634	Apparent Life-Threatening Events	4180186
957634	BRUE Brief, Resolved, Unexplained Event	4180186
957634	Idiopathic Apparent Life Threatening Event	4180186
957634	Idiopathic Apparent Life-Threatening Event	4180186
957634	Infantile Apparent Life Threatening Event	4180186
957634	Infantile Apparent Life-Threatening Event	4180186
957634	Life-Threatening Event, Apparent	4180186
957634	Life-Threatening Events, Apparent	4180186
957635	Methane, tetrachloro-	4180186
957635	Tetrachloride, Carbon	4180186
957635	Tetrachloromethane	4180186
957637	Athlete Heart	4180186
957637	Athlete Heart Syndrome	4180186
957637	Athlete's Heart	4180186
957637	Athletes Heart	4180186
957637	Athlete's Heart Syndrome	4180186
957637	Athletes Heart Syndrome	4180186
957637	Athlete's Heart Syndromes	4180186
957637	Athletic Bradycardia	4180186
957637	Bradycardia, Athletic	4180186
957637	Cardiomegaly, Exercise Induced	4180186
957637	Enlargement, Physiological Heart	4180186
957637	Exercise-Induced Cardiomegalies	4180186
957637	Exercise-Induced Cardiomegaly	4180186
957637	Heart, Athlete's	4180186
957637	Heart Enlargement, Physiological	4180186
957637	Physiological Heart Enlargement	4180186
957637	Physiological Heart Enlargements	4180186
957638	Severe Acute Respiratory Syndrome Coronavirus 2 Infection	4180186
957638	2019 nCoV Disease	4180186
957638	2019-nCoV Disease	4180186
957638	2019-nCoV Diseases	4180186
957638	2019 nCoV Infection	4180186
957638	2019-nCoV Infection	4180186
957638	2019-nCoV Infections	4180186
957638	2019 Novel Coronavirus Disease	4180186
957638	2019 Novel Coronavirus Infection	4180186
957638	Coronavirus Disease 19	4180186
957638	Coronavirus Disease-19	4180186
957638	Coronavirus Disease 2019	4180186
957638	COVID19	4180186
957638	COVID 19	4180186
957638	COVID 19 Pandemic	4180186
957638	COVID-19 Pandemic	4180186
957638	COVID-19 Pandemics	4180186
957638	COVID 19 Virus Disease	4180186
957638	COVID-19 Virus Disease	4180186
957638	COVID-19 Virus Diseases	4180186
957638	COVID 19 Virus Infection	4180186
957638	COVID-19 Virus Infection	4180186
957638	COVID-19 Virus Infections	4180186
957638	Disease 2019, Coronavirus	4180186
957638	Disease, 2019-nCoV	4180186
957638	Disease, COVID-19 Virus	4180186
957638	Infection, 2019-nCoV	4180186
957638	Infection, COVID-19 Virus	4180186
957638	Infection, SARS-CoV-2	4180186
957638	Pandemic, COVID-19	4180186
957638	SARS Coronavirus 2 Infection	4180186
957638	SARS CoV 2 Infection	4180186
957638	SARS-CoV-2 Infection	4180186
957638	SARS-CoV-2 Infections	4180186
957638	Virus Disease, COVID-19	4180186
957638	Virus Infection, COVID-19	4180186
957640	Cardio embolic Stroke	4180186
957640	Cardio-embolic Stroke	4180186
957640	Cardioembolic Stroke	4180186
957640	Cardio-embolic Strokes	4180186
957640	Cardioembolic Strokes	4180186
957640	Embolic Strokes	4180186
957640	Stroke, Cardioembolic	4180186
957640	Stroke, Cardio-embolic	4180186
957640	Stroke, Embolic	4180186
957640	Strokes, Cardioembolic	4180186
957640	Strokes, Cardio-embolic	4180186
957640	Strokes, Embolic	4180186
957642	Analysis, Hair	4180186
957642	Analysis, Hair Mineral	4180186
957642	Hair Mineral Analysis	4180186
957642	Mineral Analysis, Hair	4180186
957644	Acute Ischemic Stroke	4180186
957644	Acute Ischemic Strokes	4180186
957644	Cryptogenic Embolism Stroke	4180186
957644	Cryptogenic Embolism Strokes	4180186
957644	Cryptogenic Ischemic Stroke	4180186
957644	Cryptogenic Ischemic Strokes	4180186
957644	Cryptogenic Stroke	4180186
957644	Cryptogenic Strokes	4180186
957644	Embolism Stroke, Cryptogenic	4180186
957644	Ischaemic Stroke	4180186
957644	Ischaemic Strokes	4180186
957644	Ischemic Stroke, Acute	4180186
957644	Ischemic Stroke, Cryptogenic	4180186
957644	Ischemic Strokes	4180186
957644	Stroke, Acute Ischemic	4180186
957644	Stroke, Cryptogenic	4180186
957644	Stroke, Cryptogenic Embolism	4180186
957644	Stroke, Cryptogenic Ischemic	4180186
957644	Stroke, Ischaemic	4180186
957644	Stroke, Ischemic	4180186
957644	Stroke, Wake-up	4180186
957644	Wake up Stroke	4180186
957644	Wake-up Stroke	4180186
957644	Wake-up Strokes	4180186
957646	Lactobacillus brevis	4180186
957647	Lactobacillus paracasei	4180186
957648	Logotherapies	4180186
957649	Episode, Manic	4180186
957649	Hypomania	4180186
957649	Hypomanias	4180186
957649	Hypomanic Episode	4180186
957649	Hypomanic Episodes	4180186
957649	Manias	4180186
957649	Manic Episode	4180186
957649	Manic Episodes	4180186
957649	Manic State	4180186
957651	Opiate Overdoses	4180186
957651	Opioid Overdose	4180186
957651	Opioid Overdoses	4180186
957651	Overdose, Opiate	4180186
957651	Overdose, Opioid	4180186
957652	Adnexal Torsion	4180186
957652	Adnexal Torsions	4180186
957652	Ovarian Torsions	4180186
957652	Torsion, Adnexal	4180186
957652	Torsion, Ovarian	4180186
957652	Torsions, Adnexal	4180186
957652	Torsions, Ovarian	4180186
957653	Ground Level Ozone	4180186
957653	Level Ozone, Ground	4180186
957653	Level Ozone, Low	4180186
957653	Low Level Ozone	4180186
957653	Ozone, Ground Level	4180186
957653	Ozone, Low Level	4180186
957653	Ozone, Tropospheric	4180186
957653	Tropospheric Ozone	4180186
957657	Aortic Valve, Quadricuspid	4180186
957657	Congenital Quadricuspid Aortic Valve	4180186
957657	Quadricuspid Aortic Valve Condition	4180186
957657	Quadricuspid Aortic Valve Disease	4180186
957657	Quadricuspid Aortic Valve Disorder	4180186
957657	Quadricuspid Aortic Valves	4180186
957657	Quadricuspid Aortic Valvular Disease	4180186
957659	Nose, Runny	4180186
957659	Runny Nose	4180186
957661	1,3-Benzodioxole, 5-(2-propenyl)-	4180186
957661	4 Allyl 1,2 methylenedioxybenzene	4180186
957661	4-Allyl-1,2-methylenedioxybenzene	4180186
957661	4-Allyl-1,2-methylenedioxybenzenes	4180186
957661	Safrol	4180186
957661	Safroles	4180186
957661	Safrols	4180186
957661	Shikimol	4180186
957661	Shikimols	4180186
957663	Infection, SFTS Virus	4180186
957663	Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection	4180186
957663	SFTS Virus Infection	4180186
957663	SFTS Virus Infections	4180186
957663	Virus Infection, SFTS	4180186
957665	Factors, Social	4180186
957665	Social Factor	4180186
957667	Acute Thrombotic Stroke	4180186
957667	Acute Thrombotic Strokes	4180186
957667	Stroke, Acute Thrombotic	4180186
957667	Stroke, Thrombotic	4180186
957667	Thrombotic Stroke, Acute	4180186
957667	Thrombotic Strokes	4180186
957669	Benign Scapuloperoneal Muscular Dystrophy with Early Contractures	4180186
957669	EDMD1	4180186
957669	Emerinopathies	4180186
957669	Emerinopathy	4180186
957669	Emery Dreifuss Muscular Dystrophy 1	4180186
957669	Emery Dreifuss Muscular Dystrophy, 1	4180186
957669	Emery-Dreifuss Muscular Dystrophy 1	4180186
957669	Emery-Dreifuss Muscular Dystrophy, 1	4180186
957669	Emery Dreifuss Muscular Dystrophy 1, X Linked	4180186
957669	Emery-Dreifuss Muscular Dystrophy 1, X-Linked	4180186
957669	Emery Dreifuss Muscular Dystrophy 6	4180186
957669	Emery-Dreifuss Muscular Dystrophy 6	4180186
957669	Emery Dreifuss Muscular Dystrophy 6, X Linked	4180186
957669	Emery-Dreifuss Muscular Dystrophy 6, X-Linked	4180186
957669	Emery Dreifuss Muscular Dystrophy, X Linked	4180186
957669	Emery-Dreifuss Muscular Dystrophy, X-Linked	4180186
957669	Muscular Dystrophy, Emery-Dreifuss, X-Linked	4180186
957669	Myopathy, X-Linked, With Postural Muscle Atrophy	4180186
957669	Scapuloperoneal Syndrome, X Linked	4180186
957669	Scapuloperoneal Syndrome, X-Linked	4180186
957669	X Linked Emery Dreifuss Muscular Dystrophy	4180186
957669	X-Linked Scapuloperoneal Syndrome	4180186
957669	XMPMA	4180186
957670	1,2-propanedithiol	4180186
957671	1,3-dibromo 5,5-dimethylhydantoin	4180186
957671	2,4-dibromo-5,5-dimethylhydantoin	4180186
957672	1,4,7,10-DOTA	4180186
957672	1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid	4180186
957672	1,4,7,10-tetraazacyclododecane--N,N',N'',N'''-tetraacetic acid	4180186
957672	1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane	4180186
957672	2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic acid	4180186
957672	CuDOTA	4180186
957672	DOTA	4180186
957672	DOTA acid	4180186
957672	tetraxetan	4180186
957673	diethylene ether	4180186
957673	dioxan	4180186
957673	dioxane	4180186
957673	p-dioxane	4180186
957674	3,7-dimethyloctan-3-ol	4180186
957674	tetrahydrolinalool	4180186
957678	2-methoxy-1-propanol	4180186
957678	2-methoxypropanol-1	4180186
957678	2-MP-1	4180186
957680	2-methylbutyrate	4180186
957680	2-methylbutyrate, (+-)-isomer	4180186
957680	2-methylbutyrate, sodium salt	4180186
957680	2-methylbutyric acid	4180186
957680	alpha-methylbutyrate	4180186
957680	RS-2-methylbutyrate	4180186
957683	methyl 2-nonynoate	4180186
957683	methyl octine carbonate	4180186
957686	Cardiomyopathy, Dilated, with Ataxia	4180186
957686	MGA5	4180186
957686	MGA, Type V	4180186
957695	2-pinene	4180186
957695	alpha-pinene, pinene	4180186
957695	Wilt Pruf	4180186
957696	aluminum trifluoride	4180186
957698	qing hao su	4180186
957698	huanghuahaosu	4180186
957698	artemisininum	4180186
957698	artemisinine	4180186
957698	(3R,5AS,6R,8AS,9R,12S,12aR)-3,6,9-trimethyloctahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one	4180186
957698	arteannuin	4180186
957698	qinghaosu	4180186
957698	quinghaosu	4180186
957698	quing hau sau	4180186
957699	ayvakit	4180186
957699	(1S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-5-pyrimidinyl)ethanamine	4180186
957699	5-Pyrimidinemethanamine, alpha-(4-fluorophenyl)-alpha-methyl-2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-, (alphaS)-	4180186
957699	BLU-285	4180186
957703	benzylamine hydrobromide	4180186
957703	benzylamine hydrochloride	4180186
957703	benzylamine monosulfate	4180186
957706	ESBA1008	4180186
957706	ESBA-1008	4180186
957706	RTH258	4180186
957706	RTH-258	4180186
957708	(4R)-2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine	4180186
957709	S-649266	4180186
957712	cupric nitrate	4180186
957716	Nephrolithiasis 2	4180186
957716	Nephrolithiasis, hypercalciuria, x-linked	4180186
957716	Nephrolithiasis, Hypercalciuric, X-Linked	4180186
957716	Nphl2	4180186
957716	Urolithiasis, Hypercalciuric, X-Linked	4180186
957717	Dermatophilus congolensis infection	4180186
957717	lumpy wool in sheep	4180186
957717	mycotic dermatitis in sheep	4180186
957717	rain scald in horses	4180186
957718	2,3-DDQ	4180186
957718	2,3-dichloro-5,6-dicyano-1,4-benzoquinone	4180186
957718	2,3-dichloro-5,6-dicyanobenzoquinone	4180186
957725	3-pyridinecarboxamide, N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-((4S)-2,2,4-trimethyl-1-pyrrolidinyl)-	4180186
957725	VX445	4180186
957725	VX-445	4180186
957726	N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide	4180186
957726	NMS-E628	4180186
957726	Rozlytrek	4180186
957726	RXDX-101	4180186
957728	evodiamine, (S)-isomer	4180186
957728	isoevodiamine	4180186
957729	1,3-dioxolane	4180186
957729	dioxolane	4180186
957730	1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-((phosphonooxy)methyl)-1H-pyrrolo(2,3-c)pyridin-3-yl)-	4180186
957730	(3-((4-Benzoyl-1-piperazinyl)(oxo)acetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-1-yl)methyl dihydrogen phosphate	4180186
957730	BMS-663068	4180186
957733	1-methyl-2-(phenylmethyl)-4(1H)- quinazolinone	4180186
957733	arborine	4180186
957734	gamma-D-glutamyl-L-tryptophan	4180186
957734	SCV-07	4180186
957737	alpha-caryophyllene	4180186
957737	alpha-humulene	4180186
957738	huperzine A, (5alpha,9beta,11Z)-(-)-isomer	4180186
957739	MEDI551	4180186
957739	MEDI-551	4180186
957741	beta-methyl-3-(1-methylethyl)benzenepropanal	4180186
957741	florhydral	4180186
957743	2,4,6-trifluoro-N-(6-((1-methylpiperidin-4-yl)carbonyl)pyridin-2yl)benzamide	4180186
957743	COL-144	4180186
957743	lasmiditan hydrochloride	4180186
957743	LY573144	4180186
957743	Reyvow	4180186
957745	(1R,2S)-2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide	4180186
957745	cyclopropanecarboxamide, 2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-	4180186
957745	dayvigo	4180186
957747	ITI-007	4180186
957747	ITI-722	4180186
957747	lumateperone tosylate	4180186
957748	ACE-536	4180186
957748	luspatercept-aamt	4180186
957748	Reblozyl	4180186
957748	RAP-536	4180186
957752	3,7,11-trimethyl-1,6,10-dodecatrien-3-ol	4180186
957752	nerolidol, (E)-isomer	4180186
957752	nerolidol, (S-(E))-isomer	4180186
957752	nerolidol, (S-(Z))-isomer	4180186
957752	nerolidol, (Z)-isomer	4180186
957752	peruviol	4180186
957755	oleoeuropeine	4180186
957755	oleoeuropein	4180186
957755	2-(3,4-dihydroxyphenyl)ethyl (2S-(2alpha,3E,4beta))-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetate	4180186
957756	ongentys	4180186
957756	2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide	4180186
957756	BIA 9-1067	4180186
957757	4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-benzonitrile	4180186
957757	benzonitrile, 4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-	4180186
957757	Isturisa	4180186
957757	LCI699	4180186
957757	(+)-Osilodrostat	4180186
957758	RPC1063	4180186
957758	zeposia	4180186
957759	2H-Pyrrolo(3',2':5,6)pyrido(4,3-d)pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)-	4180186
957759	INCB054828	4180186
957759	INCB-054828	4180186
957759	Pemazyre	4180186
957764	2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine	4180186
957764	PA 824	4180186
957764	PA-824	4180186
957764	PA824 cpd	4180186
957765	propanal	4180186
957765	propionaldehyde, 1-14C-labeled	4180186
957765	propionaldehyde, 2-14C-labeled	4180186
957775	bromelain, stem	4180186
957778	sulfonyl fluoride	4180186
957778	Vikane	4180186
957782	AZD1722	4180186
957782	RDX5791	4180186
957783	teprotumumab-trbw	4180186
957783	tepezza	4180186
957783	R1507	4180186
957783	R 1507	4180186
957783	R-1507	4180186
957783	R-1507 monoclonal antibody	4180186
957783	RO4858696	4180186
957783	RO-4858696	4180186
957783	RO-4858696000	4180186
957783	RO-4858696-000	4180186
957783	RO4858696-000	4180186
957783	RV001	4180186
957783	RV-001	4180186
957784	4-isopropylidene-1-methylcyclohexene	4180186
957785	barber's itch	4180186
957785	beard ringworm	4180186
957787	Hortaea werneckii infection	4180186
957794	2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-3-pyridinyl)methoxy)benzaldehyde	4180186
957794	GBT440	4180186
957794	Oxbryta	4180186
957795	(7S)-2-(4-phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide	4180186
957795	7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide	4180186
957795	BGB-3111	4180186
957795	Brukinsa	4180186
957796	0 paradol	4180186
957796	4-(4- hydroxy-3-methoxyphenyl)-2-butanone	4180186
957796	4-(4-hydroxy-3-methoxyphenyl)butan-2-one	4180186
957796	vanillylacetone	4180186
957796	vanillyl acetone	4180186
958608	1-Propanesulfonic acid, 3-(acetylamino)-	4180186
958608	Acamprosate Calcium	4180186
958608	Acamprostate	4180186
958608	Acetylhomotaurinate, Calcium	4180186
958608	Acetyl Homotaurinate, Calcium	4180186
958608	Acetylhomotaurine, Calcium	4180186
958608	Acetylhomotaurine, Sodium	4180186
958608	Aotal	4180186
958608	Calcium Acetylhomotaurinate	4180186
958608	Calcium Acetyl Homotaurinate	4180186
958608	Calcium Acetylhomotaurine	4180186
958608	Campral	4180186
958608	Campral EC	4180186
958608	N Acetylhomotaurine	4180186
958608	N-Acetylhomotaurine	4180186
958608	N-Acetylhomotaurine, Calcium (2:1) Salt	4180186
958608	N-Acetylhomotaurine, Magnesium (2:1) Salt	4180186
958608	N Acetylhomotaurine, Monolithium Salt	4180186
958608	N-Acetylhomotaurine, Monolithium Salt	4180186
958608	N Acetylhomotaurine, Monopotassium Salt	4180186
958608	N-Acetylhomotaurine, Monopotassium Salt	4180186
958608	N Acetylhomotaurine, Monosodium Salt	4180186
958608	N-Acetylhomotaurine, Monosodium Salt	4180186
958608	N-Acetylhomotaurine, Zinc (2:1) Salt	4180186
958608	Regtect	4180186
958608	Sodium Acetylhomotaurine	4180186
958608	Zulex	4180186
958609	Adenocarcinoma, Lung	4180186
958609	Adenocarcinomas, Lung	4180186
958609	Lung Adenocarcinoma	4180186
958609	Lung Adenocarcinomas	4180186
958610	2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-	4180186
958610	(2E)-N-(4-(3-Chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide	4180186
958610	Afatinib Dimaleate	4180186
958610	Afatinib Maleate	4180186
958610	BIBW2992	4180186
958610	BIBW 2992	4180186
958610	BIBW-2992	4180186
958610	BIBW 2992MA2	4180186
958610	BIBW 2992 MA2	4180186
958610	BIBW-2992MA2	4180186
958610	BIBW-2992-MA2	4180186
958610	BIBW2992 MA2	4180186
958610	Gilotrif	4180186
958616	1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-	4180186
958616	2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)	4180186
958616	Anastrazole	4180186
958616	Arimidex	4180186
958616	ICI D1033	4180186
958616	ZD1033	4180186
958616	ZD 1033	4180186
958616	ZD-1033	4180186
958616	Zeneca ZD 1033	4180186
958617	1-((4R,5R)-4,5-Dihydroxy-N2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-L-ornithine)-echinocandin B	4180186
958617	Eraxis	4180186
958617	LY303366	4180186
958617	LY 303366	4180186
958617	LY-303366	4180186
958620	Arsenic(III) Oxide	4180186
958620	Arsenic Oxide (As2O3)	4180186
958620	Arsenic Oxide (As4O6)	4180186
958620	Arsenolite	4180186
958620	Arsenous Anhydride	4180186
958620	As2O3	4180186
958620	As4O6	4180186
958620	Diarsenic Trioxide	4180186
958620	Naonobin	4180186
958620	Tetraarsenic Hexaoxide	4180186
958620	Tetra Arsenic Hexaoxide	4180186
958620	Tetra-Arsenic Hexaoxide	4180186
958620	Tetraarsenic Oxide	4180186
958620	Tetra Arsenic Oxide	4180186
958620	Tetra-Arsenic Oxide	4180186
958620	Trisenox	4180186
958620	Trixenox	4180186
958622	Butanedioic acid, mono((5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester	4180186
958622	Dihydroartemisinine 12 alpha succinate	4180186
958622	Dihydroartemisinine-12-alpha-succinate	4180186
958622	Dihydroartemisinin, Succinyl	4180186
958622	Malacef	4180186
958622	Malartin	4180186
958622	SM804	4180186
958622	SM 804	4180186
958622	SM-804	4180186
958622	Sodium Artesunate	4180186
958622	Succinyl Dihydroartemisinin	4180186
958624	AG013736	4180186
958624	AG 013736	4180186
958624	AG-013736	4180186
958624	Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-	4180186
958624	Inlyta	4180186
958627	Behavioral Rating Scale	4180186
958627	Behavioral Rating Scales	4180186
958627	Behavioral Test	4180186
958627	Behavioral Tests	4180186
958627	Behavior Rating Scales	4180186
958627	Behavior Test	4180186
958627	Behavior Tests	4180186
958627	Rating Scale, Behavior	4180186
958627	Rating Scale, Behavioral	4180186
958627	Rating Scales, Behavior	4180186
958627	Rating Scales, Behavioral	4180186
958627	Scale, Behavioral Rating	4180186
958627	Test, Behavior	4180186
958627	Test, Behavioral	4180186
958627	Tests, Behavior	4180186
958627	Tests, Behavioral	4180186
958628	3-methyl-TTNEB	4180186
958628	4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid	4180186
958628	LG69 compound	4180186
958628	LGD1069	4180186
958628	LGD 1069	4180186
958628	LGD-1069	4180186
958628	Targretin	4180186
958631	Aluminosilicate Anti-Diarrheal, Calcium	4180186
958631	Aluminosilicate, Calcium	4180186
958631	Aluminosilicate Clay, Calcium	4180186
958631	Anti-Diarrheal, Calcium Aluminosilicate	4180186
958631	Calcium Aluminosilicate Anti Diarrheal	4180186
958631	Calcium Aluminosilicate Anti-Diarrheal	4180186
958631	Calcium Aluminosilicate Clay	4180186
958631	CASAD	4180186
958631	Clay, Calcium Aluminosilicate	4180186
958634	14C-labeled Carvedilol	4180186
958634	2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-	4180186
958634	BM14190	4180186
958634	BM 14190	4180186
958634	BM-14190	4180186
958634	Carvedilol, (-)	4180186
958634	Carvedilol, (+)	4180186
958634	Carvedilol, 14C labeled	4180186
958634	Carvedilol, 14C-labeled	4180186
958634	Carvedilol Hydrochloride	4180186
958634	Carvedilol, (-)-isomer	4180186
958634	Carvedilol, (+-)-isomer	4180186
958634	Carvedilol, (+)-isomer	4180186
958634	Carvedilol, (R)-isomer	4180186
958634	Carvedilol, (S)-isomer	4180186
958634	Coreg	4180186
958634	Coropres	4180186
958634	Dilatrend	4180186
958634	Eucardic	4180186
958634	Kredex	4180186
958634	Querto	4180186
958635	Cancidas	4180186
958635	Caspofungin Acetate	4180186
958635	Caspofungin MSD	4180186
958635	L743872	4180186
958635	L 743872	4180186
958635	L 743,872	4180186
958635	L-743872	4180186
958635	L-743,872	4180186
958635	L743,872	4180186
958635	MK0991	4180186
958635	MK 0991	4180186
958635	MK-0991	4180186
958635	Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-	4180186
958637	Cauda Equina Syndromes	4180186
958639	Axépim	4180186
958639	BMY28142	4180186
958639	BMY 28142	4180186
958639	BMY-28142	4180186
958639	Cefepim	4180186
958639	Cefepime Hydrochloride	4180186
958639	Maxipime	4180186
958639	Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-	4180186
958639	Quadrocef	4180186
958640	7-(2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid	4180186
958640	7432 S	4180186
958640	7432-S	4180186
958640	Cedax	4180186
958640	SCH39720	4180186
958640	SCH 39720	4180186
958640	SCH-39720	4180186
958641	Cerebrospinal Fluid Drainage	4180186
958641	Cerebrospinal Fluid Drainage, Post Traumatic	4180186
958641	Cerebrospinal Fluid Drainage, Post-Traumatic	4180186
958641	Cerebrospinal Fluid Drainages	4180186
958641	Cerebrospinal Fluid Drainage, Spontaneous	4180186
958641	Cerebrospinal Fluid Drainage, Traumatic	4180186
958641	Cerebrospinal Fluid Leakage	4180186
958641	Cerebrospinal Fluid Leakage, Post Traumatic	4180186
958641	Cerebrospinal Fluid Leakage, Post-Traumatic	4180186
958641	Cerebrospinal Fluid Leakages	4180186
958641	Cerebrospinal Fluid Leakage, Spontaneous	4180186
958641	Cerebrospinal Fluid Leakage, Traumatic	4180186
958641	Cerebrospinal Fluid Leak, Post Traumatic	4180186
958641	Cerebrospinal Fluid Leak, Post-Traumatic	4180186
958641	Cerebrospinal Fluid Leaks	4180186
958641	Cerebrospinal Fluid Leak, Spontaneous	4180186
958641	Cerebrospinal Fluid Leak, Traumatic	4180186
958641	Drainage, Cerebrospinal Fluid	4180186
958641	Drainages, Cerebrospinal Fluid	4180186
958641	Fluid Drainage, Cerebrospinal	4180186
958641	Fluid Drainages, Cerebrospinal	4180186
958641	Fluid Leakage, Cerebrospinal	4180186
958641	Fluid Leakages, Cerebrospinal	4180186
958641	Fluid Leak, Cerebrospinal	4180186
958641	Fluid Leaks, Cerebrospinal	4180186
958641	Leakage, Cerebrospinal Fluid	4180186
958641	Leakages, Cerebrospinal Fluid	4180186
958641	Leak, Cerebrospinal Fluid	4180186
958641	Leaks, Cerebrospinal Fluid	4180186
958641	Spinal Cerebrospinal Fluid Leak	4180186
958641	Spinal Cerebrospinal Fluid Leak, Post Traumatic	4180186
958641	Spinal Cerebrospinal Fluid Leak, Post-Traumatic	4180186
958641	Spinal Cerebrospinal Fluid Leak, Spontaneous	4180186
958641	Spinal Cerebrospinal Fluid Leak, Traumatic	4180186
958643	2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-	4180186
958643	6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt	4180186
958643	Batrafen	4180186
958643	Ciclopiroxolamine	4180186
958643	Ciclopirox Olamine	4180186
958643	Cyclopirox	4180186
958643	Cyclopyroxolamine	4180186
958643	Dafnegin CSC	4180186
958643	Dafnegin-CSC	4180186
958643	HOE296	4180186
958643	HOE 296	4180186
958643	HOE-296	4180186
958643	Loprox	4180186
958643	Penlac	4180186
958644	1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine	4180186
958644	1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine	4180186
958644	Cidofovir Anhydrous	4180186
958644	Cidofovir, (+-)-isomer	4180186
958644	Cidofovir, (R)-isomer	4180186
958644	Cidofovir Sodium	4180186
958644	Cidofovir, Sodium Salt	4180186
958644	GS504	4180186
958644	GS 504	4180186
958644	GS-504	4180186
958644	HPMPC	4180186
958644	Phosphonic acid, (((1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-	4180186
958644	Vistide	4180186
958646	Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride	4180186
958646	AMG073	4180186
958646	AMG 073	4180186
958646	Cinacalcet Hydrochloride	4180186
958646	KRN 1493	4180186
958646	Sensipar	4180186
958648	2 Chloro 2' arabino fluoro 2' deoxyadenosine	4180186
958648	2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine	4180186
958648	2 Chloro 2' fluoroarabino 2' deoxyadenosine	4180186
958648	2-Chloro-2'-fluoroarabino-2'-deoxyadenosine	4180186
958648	2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine	4180186
958648	2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arbinofuranosyl)adenine	4180186
958648	9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-	4180186
958648	Cl-F-ara-A	4180186
958648	Clofarex	4180186
958648	Clolar	4180186
958648	Evoltra	4180186
958651	Cone Dystrophies	4180186
958651	Cone Dystrophies, Progressive	4180186
958651	Cone Dystrophies, Stationary	4180186
958651	Cone Dystrophy, Progressive	4180186
958651	Cone Dystrophy, Stationary	4180186
958651	Dystrophies, Cone	4180186
958651	Dystrophies, Progressive Cone	4180186
958651	Dystrophies, Stationary Cone	4180186
958651	Dystrophy, Cone	4180186
958651	Dystrophy, Progressive Cone	4180186
958651	Dystrophy, Stationary Cone	4180186
958651	Progressive Cone Dystrophies	4180186
958651	Progressive Cone Dystrophy	4180186
958651	Stationary Cone Dystrophies	4180186
958651	Stationary Cone Dystrophy	4180186
958655	4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid	4180186
958655	Exjade	4180186
958655	ICL670	4180186
958655	ICL 670	4180186
958655	ICL-670	4180186
958655	ICL670A	4180186
958655	ICL 670A	4180186
958655	ICL-670A	4180186
958656	1,2 Dimethyl 3 hydroxy 4 pyridinone	4180186
958656	1,2-Dimethyl-3-hydroxy-4-pyridinone	4180186
958656	1,2 Dimethyl 3 hydroxypyrid 4 one	4180186
958656	1,2-Dimethyl-3-hydroxypyrid-4-one	4180186
958656	1,2 Dimethyl 3 hydroxypyridin 4 one	4180186
958656	1,2-Dimethyl-3-hydroxypyridin-4-one	4180186
958656	3 Hydroxy 1,2 dimethyl 4 pyridinone	4180186
958656	3-Hydroxy-1,2-dimethyl-4-pyridinone	4180186
958656	4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-	4180186
958656	DMOHPO	4180186
958656	Ferriprox	4180186
958656	HDMPP	4180186
958657	1,2,2,2-Tetrafluoroethyl difluoromethyl ether	4180186
958657	Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-	4180186
958657	I653	4180186
958657	I 653	4180186
958657	I-653	4180186
958657	Suprane	4180186
958658	Behavior Therapy, Dialectical	4180186
958658	Dialectical Behavior Therapies	4180186
958661	1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-	4180186
958661	2-(5-sulfamoylaminomethylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid	4180186
958661	S4661	4180186
958661	S 4661	4180186
958661	S-4661	4180186
958662	Methanesulfonamide, N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-	4180186
958662	Multaq	4180186
958662	SR 33589	4180186
958662	SR 33589B	4180186
958664	DP178	4180186
958664	DP 178	4180186
958664	DP-178	4180186
958664	Fuzeon	4180186
958664	Pentafuside	4180186
958664	Peptide T20	4180186
958664	T20 Peptide	4180186
958664	T20, Peptide	4180186
958666	9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone	4180186
958666	Eplerenon	4180186
958666	Inspra	4180186
958666	Spiro(cyclopenta(7,8)phenanthro(4b,5-b)oxirene-7(3H),2'(3'H)-furan)-10-carboxylic acid, 2,4,4',4a,5',5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-4a,6a-dimethyl-2,5'-dioxo-, methyl ester, (4aS,4bR,5aR,6aS,7 R,9aS,9bR,10R)-	4180186
958667	7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-	4180186
958667	Epifibatide	4180186
958667	Epifibratide	4180186
958667	Integrelin	4180186
958667	Integrilin	4180186
958668	(4R,5R,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-yl)sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid	4180186
958668	Ertapenem Sodium	4180186
958668	Invanoz	4180186
958668	Invanz	4180186
958670	L791456	4180186
958670	L 791456	4180186
958670	2,3'-Bipyridine, 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-	4180186
958670	Arcoxia	4180186
958670	L-791456	4180186
958670	MK0663	4180186
958670	MK 0663	4180186
958670	MK-0663	4180186
958671	1,8 Cineol	4180186
958671	1,8-Cineol	4180186
958671	1,8 Cineole	4180186
958671	1,8-Cineole	4180186
958671	1,8 Epoxy p menthane	4180186
958671	1,8-Epoxy-p-menthane	4180186
958671	2-Oxabicyclo(2.2.2)octane, 1,3,3-trimethyl-	4180186
958671	Cineole	4180186
958671	Soledum	4180186
958673	AC 2993	4180186
958673	AC 2993 LAR	4180186
958673	Bydureon	4180186
958673	Byetta	4180186
958673	Ex4 Peptide	4180186
958673	Exendin 4	4180186
958673	Exendin-4	4180186
958673	ITCA 650	4180186
958673	Peptide, Ex4	4180186
958675	1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)	4180186
958675	9-(4-Acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine	4180186
958675	BRL42810	4180186
958675	BRL 42810	4180186
958675	BRL-42810	4180186
958675	Famvir	4180186
958676	1,3-Propanediol, 2-phenyl-, dicarbamate	4180186
958676	2 Phenyl 1,3 propanediol dicarbamate	4180186
958676	2-Phenyl-1,3-propanediol dicarbamate	4180186
958676	(3-Carbamoyloxy-2-phenyl-propyl) carbamate	4180186
958676	ADD03055	4180186
958676	ADD 03055	4180186
958676	ADD-03055	4180186
958676	Felbamyl	4180186
958676	Felbatol	4180186
958676	Taloxa	4180186
958676	W554	4180186
958676	W 554	4180186
958676	W-554	4180186
958677	D-Glucaric acid, iron(2+) salt (1:1)	4180186
958677	Ferric Saccharate	4180186
958677	Ferri Saccharate	4180186
958677	Ferri-Saccharate	4180186
958677	Hippiron	4180186
958677	Iron(III)-Hydroxide Sucrose Complex	4180186
958677	Iron Oxide (Saccharated)	4180186
958677	Iron Saccharate	4180186
958677	Iron-Saccharate	4180186
958677	Iron Sucrose	4180186
958677	Saccharated Ferric Oxide	4180186
958677	Venofer	4180186
958681	(2S,3S,4R,5R,6R)-6-((2R,3R,4R,5R,6R)-6-((2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl)oxy-5-sulfooxyoxan-3-yl)oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl)oxy-3-((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl)oxy-4,5-dihydroxyoxane-2-carboxylic acid	4180186
958681	Arixtra	4180186
958681	Fondaparinux Sodium	4180186
958681	Quixidar	4180186
958684	7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol	4180186
958684	Faslodex	4180186
958684	ICI182780	4180186
958684	ICI 182780	4180186
958684	ICI 182,780	4180186
958684	ICI-182780	4180186
958684	ZM182780	4180186
958684	ZM 182780	4180186
958684	ZM-182780	4180186
958685	Capacities, Functional Residual	4180186
958685	Capacity, Functional Residual	4180186
958685	Functional Residual Capacities	4180186
958685	Residual Capacities, Functional	4180186
958685	Residual Capacity, Functional	4180186
958689	Iressa	4180186
958689	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide	4180186
958689	ZD1839	4180186
958689	ZD 1839	4180186
958691	Coma Scale, Glasgow	4180186
958691	Scale, Glasgow Coma	4180186
958693	Appraisal, Health Risk	4180186
958693	Appraisals, Health Risk	4180186
958693	Health Risk Appraisal	4180186
958693	Health Risk Appraisals	4180186
958693	Health Status Index	4180186
958693	Health Status Indexes	4180186
958693	Health Status Indicator	4180186
958693	Health Status Indices	4180186
958693	Indexes, Health Status	4180186
958693	Index, Health Status	4180186
958693	Indicator, Health Status	4180186
958693	Indicators, Health Status	4180186
958693	Indices, Health Status	4180186
958693	Risk Appraisal, Health	4180186
958693	Risk Appraisals, Health	4180186
958695	Ceflatonin	4180186
958695	Cephalotaxine	4180186
958695	Cephalotaxine, O3-((2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methyl-1-oxoheptyl)-	4180186
958695	Homoharringtonine (3(R))-isomer	4180186
958695	Omacetaxine	4180186
958695	Omacetaxine Mepesuccinate	4180186
958695	Synribo	4180186
958696	Extraneal	4180186
958696	Icodial	4180186
958698	Autoimmune Disease, IgG4-Associated	4180186
958698	IgG4 Associated Autoimmune Disease	4180186
958698	IgG4-Associated Autoimmune Disease	4180186
958698	IgG4-Associated Autoimmune Diseases	4180186
958698	IgG4-RD	4180186
958698	IgG4 Related Disease	4180186
958698	IgG4-Related Disease	4180186
958698	IgG4-Related Diseases	4180186
958698	IgG4 Related Kidney Disease	4180186
958698	IgG4-Related Kidney Disease	4180186
958698	IgG4-Related Kidney Diseases	4180186
958698	IgG4 Related Sclerosing Disease	4180186
958698	IgG4-Related Sclerosing Disease	4180186
958698	IgG4-Related Sclerosing Diseases	4180186
958698	IgG4 Related Systemic Disease	4180186
958698	Immunoglobulin G4 Related Disease	4180186
958698	Immunoglobulin G4-Related Diseases	4180186
958698	Immunoglobulin G4 Related Kidney Disease	4180186
958698	Immunoglobulin G4-Related Kidney Disease	4180186
958698	Immunoglobulin G4 Related Sclerosing Disease	4180186
958698	Immunoglobulin G4-Related Sclerosing Disease	4180186
958698	Kidney Disease, IgG4-Related	4180186
958698	Sclerosing Disease, IgG4-Related	4180186
958699	Injury Severity Scores	4180186
958699	ISS Score	4180186
958699	Score, Injury Severity	4180186
958699	Scores, Injury Severity	4180186
958700	Capacities, Inspiratory	4180186
958700	Capacity, Inspiratory	4180186
958700	Inspiratory Capacities	4180186
958701	Inspiratory Reserve Volumes	4180186
958701	Reserve Volume, Inspiratory	4180186
958701	Reserve Volumes, Inspiratory	4180186
958701	Volume, Inspiratory Reserve	4180186
958701	Volumes, Inspiratory Reserve	4180186
958704	2H-3-Benzazepin-2-one, 3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-	4180186
958704	7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one	4180186
958704	Corlanor	4180186
958704	S16257	4180186
958704	S 16257	4180186
958704	S-16257	4180186
958704	S162572	4180186
958704	S 162572	4180186
958704	S 16257 2	4180186
958704	S 16257-2	4180186
958704	S-16257-2	4180186
958704	S162602	4180186
958704	S 162602	4180186
958704	S 16260 2	4180186
958704	S 16260-2	4180186
958704	S-16260-2	4180186
958706	N benzyl 2 acetamido 3 methoxypropionamide	4180186
958706	N-benzyl-2-acetamido-3-methoxypropionamide	4180186
958706	N benzyl AcMeOPrNH2	4180186
958706	N-benzyl-AcMeOPrNH2	4180186
958706	Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-	4180186
958706	Vimpat	4180186
958707	2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-	4180186
958707	3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione	4180186
958707	CC5013	4180186
958707	CC 5013	4180186
958707	CC-5013	4180186
958707	IMiD3 Cpd	4180186
958707	Revimid	4180186
958707	Revlimid	4180186
958709	1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-	4180186
958709	3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine	4180186
958709	3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine	4180186
958709	BW430C	4180186
958709	BW 430C	4180186
958709	BW-430C	4180186
958709	Crisomet	4180186
958709	Labileno	4180186
958709	Lamictal	4180186
958709	Lamiktal	4180186
958712	4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-	4180186
958712	Arava	4180186
958712	HWA486	4180186
958712	HWA 486	4180186
958712	HWA-486	4180186
958712	N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide	4180186
958712	SU101	4180186
958714	4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)	4180186
958714	Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-	4180186
958714	CGS20267	4180186
958714	CGS 20267	4180186
958714	CGS-20267	4180186
958714	Femara	4180186
958714	Fémara	4180186
958716	2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-	4180186
958716	Chirocaine	4180186
958716	Levobupivacaine Hydrochloride	4180186
958717	Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1S,2R)-	4180186
958717	Fetzima	4180186
958717	Levomilnacipran Hydrochloride	4180186
958721	All trans Lycopene	4180186
958721	All-trans-Lycopene	4180186
958721	LYCOMATO	4180186
958721	LYC O MATO	4180186
958721	LYC-O-MATO	4180186
958721	Lycopene, (13-cis)-isomer	4180186
958721	Lycopene, (7-cis,7'-cis,9-cis,9'-cis)-isomer -	4180186
958721	Lycopene, (cis)-isomer	4180186
958721	Prolycopene	4180186
958721	Pro Lycopene	4180186
958721	Pro-Lycopene	4180186
958721	psi, psi-Carotene	4180186
958724	Flow Rate, Maximal Expiratory	4180186
958724	Forced Expiratory Flow 0.2 1.2	4180186
958724	Forced Expiratory Flow 0.2-1.2	4180186
958724	Forced Expiratory Flow 200 1200	4180186
958724	Forced Expiratory Flow 200-1200	4180186
958724	MEFR	4180186
958726	Breathing Capacities, Maximal	4180186
958726	Breathing Capacity, Maximal	4180186
958726	Capacities, Maximal Breathing	4180186
958726	Capacity, Maximal Breathing	4180186
958726	Maximal Breathing Capacities	4180186
958726	Maximal Breathing Capacity	4180186
958726	Maximal Voluntary Ventilations	4180186
958726	MVV (Ventilation)	4180186
958726	Ventilation, Maximal Voluntary	4180186
958726	Ventilations, Maximal Voluntary	4180186
958726	Voluntary Ventilation, Maximal	4180186
958726	Voluntary Ventilations, Maximal	4180186
958729	2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide	4180186
958729	Masflex	4180186
958729	Miloxicam	4180186
958729	Mobec	4180186
958729	Mobic	4180186
958729	Mobicox	4180186
958729	Movalis	4180186
958729	Movicox	4180186
958729	Parocin	4180186
958729	Reumoxicam	4180186
958729	Uticox	4180186
958730	1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-	4180186
958730	3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid	4180186
958730	Merrem	4180186
958730	Penem	4180186
958730	Ronem	4180186
958730	SM7338	4180186
958730	SM 7338	4180186
958730	SM-7338	4180186
958732	FK463	4180186
958732	FK 463	4180186
958732	FK-463	4180186
958732	Micafungin Sodium	4180186
958732	Mycamine	4180186
958733	1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCl	4180186
958733	1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl	4180186
958733	Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(+-)-	4180186
958733	F2207	4180186
958733	F 2207	4180186
958733	F-2207	4180186
958733	Ixel	4180186
958733	Midalcipran	4180186
958733	Milnacipran Hydrochloride	4180186
958733	Savella	4180186
958735	BWB1090U	4180186
958735	BW B1090U	4180186
958735	BW B 1090U	4180186
958735	BW-B1090U	4180186
958735	BW-B 1090U	4180186
958735	BW-B-1090U	4180186
958735	BWB 1090U	4180186
958735	Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl))-, (1R,1'R)-	4180186
958735	Mivacron	4180186
958735	Mivacurium Chloride	4180186
958739	Carcinoma, Nasopharyngeal	4180186
958739	Carcinomas, Nasopharyngeal	4180186
958739	Nasopharyngeal Carcinomas	4180186
958740	A4166	4180186
958740	A 4166	4180186
958740	A-4166	4180186
958740	AY4166	4180186
958740	AY 4166	4180186
958740	AY-4166	4180186
958740	DJN 608	4180186
958740	D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-	4180186
958740	Fastic	4180186
958740	N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine	4180186
958740	Nate-Glinide	4180186
958740	Nateglinide, (cis,D-Phe)-isomer	4180186
958740	Nateglinide, (D-Phe)-isomer	4180186
958740	Senaglinide	4180186
958740	Starlix	4180186
958740	Starsis	4180186
958741	Cancer Staging	4180186
958741	Classifications, TNM	4180186
958741	Classification, TNM	4180186
958741	Staging, Cancer	4180186
958741	Staging, Neoplasm	4180186
958741	Staging Systems, TNM	4180186
958741	Staging System, TNM	4180186
958741	Staging, TNM	4180186
958741	Staging, Tumor	4180186
958741	Systems, TNM Staging	4180186
958741	System, TNM Staging	4180186
958741	TNM Classification	4180186
958741	TNM Classifications	4180186
958741	TNM Staging	4180186
958741	TNM Staging System	4180186
958741	TNM Staging Systems	4180186
958741	Tumor Staging	4180186
958742	Neurolymphomatoses	4180186
958742	Neurolymphomatoses, Primary	4180186
958742	Neurolymphomatosis, Primary	4180186
958742	Primary Neurolymphomatoses	4180186
958742	Primary Neurolymphomatosis	4180186
958744	2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine	4180186
958744	LY170052	4180186
958744	LY 170052	4180186
958744	LY-170052	4180186
958744	LY 170053	4180186
958744	Olanzapine Pamoate	4180186
958744	Zolafren	4180186
958744	Zyprexa	4180186
958747	4,5 Diphenyl 2 oxazolepropionic Acid	4180186
958747	4,5-Diphenyl-2-oxazolepropionic Acid	4180186
958747	Apo Oxaprozin	4180186
958747	Apo-Oxaprozin	4180186
958747	Danoprox	4180186
958747	Daypro	4180186
958747	Dayrun	4180186
958747	Rhoxal oxaprozin	4180186
958747	Rhoxal-oxaprozin	4180186
958747	Wy 21,743	4180186
958747	Wy-21,743	4180186
958749	1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-	4180186
958749	2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one	4180186
958749	2-QHBIQO	4180186
958749	Aloxi	4180186
958749	Palonosetron, (3R)-	4180186
958749	Palonosetron Hydrochloride	4180186
958749	Palonosetron, (R-(R*,R*))-isomer	4180186
958749	Palonosetron, (R-(R*,S*))-isomer	4180186
958749	Palonosetron, (S-(R*,S*))-isomer	4180186
958749	RS25233197	4180186
958749	RS 25233197	4180186
958749	RS 25233 197	4180186
958749	RS 25233-197	4180186
958749	RS-25233-197	4180186
958749	RS25233198	4180186
958749	RS 25233198	4180186
958749	RS 25233 198	4180186
958749	RS 25233-198	4180186
958749	RS-25233-198	4180186
958749	RS25259	4180186
958749	RS 25259	4180186
958749	RS-25259	4180186
958749	RS25259197	4180186
958749	RS 25259197	4180186
958749	RS 25259 197	4180186
958749	RS 25259-197	4180186
958749	RS-25259-197	4180186
958749	RS25259198	4180186
958749	RS 25259198	4180186
958749	RS 25259 198	4180186
958749	RS 25259-198	4180186
958749	RS-25259-198	4180186
958751	ABX-EGF MAb	4180186
958751	ABX EGF Monoclonal Antibody	4180186
958751	ABX-EGF Monoclonal Antibody	4180186
958751	Human Panitumumab Antibody	4180186
958751	Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer	4180186
958751	Monoclonal Antibody, ABX-EGF	4180186
958751	Panitumumab Antibody, Human	4180186
958751	Vectibix	4180186
958752	2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2E)-	4180186
958752	Farydak	4180186
958752	LBH589	4180186
958752	LBH 589	4180186
958752	NVP LBH589	4180186
958752	NVP-LBH589	4180186
958753	1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-	4180186
958753	BY1023	4180186
958753	BY 1023	4180186
958753	BY-1023	4180186
958753	Pantoprazole Sodium	4180186
958753	Protonix	4180186
958753	SKF96022	4180186
958753	SK&F96022	4180186
958753	SK&F 96022	4180186
958753	SK&F-96022	4180186
958753	SKF 96022	4180186
958753	SKF-96022	4180186
958754	Acetyl Hydroperoxide	4180186
958754	Acid, Peracetic	4180186
958754	Acid, Peroxyacetic	4180186
958754	Acid, Peroxyethanoic	4180186
958754	Desoxone1	4180186
958754	Desoxone 1	4180186
958754	Desoxone-1	4180186
958754	Dialax	4180186
958754	Ethaneperoxoic acid	4180186
958754	Peracetate, Sodium	4180186
958754	Peracetate, Zinc	4180186
958754	Peracetic Acid, Sodium Salt	4180186
958754	Peroxyacetic Acid	4180186
958754	Peroxyethanoic Acid	4180186
958754	Sodium Peracetate	4180186
958754	Zinc Peracetate	4180186
958755	2-Hexadecen-1-ol, 3,7,11,15-tetramethyl-, (R-(R*,R*-(E)))-	4180186
958759	3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol	4180186
958759	Aethoxysclerol	4180186
958759	Aethoxysklerol	4180186
958759	Aetoxisclerol	4180186
958759	alpha-Dodecyl-omega-hydroxypoly(oxy-1,2ethanediyl)	4180186
958759	Atossisclerol	4180186
958759	Atoxysclerol	4180186
958759	Brij30	4180186
958759	Brij 30	4180186
958759	Brij-30	4180186
958759	Dodecyl Ethyleneglycol Monoether	4180186
958759	Dodecyl Ethyleneglycol Monoethers	4180186
958759	Ether, Nonaethyleneglycol Monododecyl	4180186
958759	Ether, Polyethylene Glycol-7-lauryl	4180186
958759	Ether, Polyoxyethylene-4-dodecyl	4180186
958759	Ether, Polyoxyethylene 9-lauryl	4180186
958759	Ether, Polyoxyethylene Lauryl	4180186
958759	Ether, Tetraethyleneglycol Lauryl	4180186
958759	Ethoxysclerol	4180186
958759	Ethyleneglycol Monoether, Dodecyl	4180186
958759	Hydroxypolyethoxydodecane	4180186
958759	Laureth	4180186
958759	Laureth 1	4180186
958759	Laureth-1	4180186
958759	Laureth 4	4180186
958759	Laureth-4	4180186
958759	Laureth 7	4180186
958759	Laureth-7	4180186
958759	Laureth 9	4180186
958759	Laureth-9	4180186
958759	Laureths	4180186
958759	Lauromacrogol	4180186
958759	Lauromacrogol 400	4180186
958759	Lauromacrogols	4180186
958759	Lauryl Ether, Tetraethyleneglycol	4180186
958759	Lubrol 12A9	4180186
958759	Lubrol PX	4180186
958759	Lubrol-PX	4180186
958759	Monododecyl Ether, Nonaethyleneglycol	4180186
958759	Monoether, Dodecyl Ethyleneglycol	4180186
958759	Nonaethyleneglycol Monododecyl Ether	4180186
958759	Nonaethylene Glycol Monododecyl Ether	4180186
958759	Nonaethyleneglycol Monododecyl Ethers	4180186
958759	Polidocanols	4180186
958759	Polyethylene Glycol 7 lauryl Ether	4180186
958759	Polyethylene Glycol-7-lauryl Ether	4180186
958759	Polyethylene Glycol-7-lauryl Ethers	4180186
958759	Polyethylene Glycol Monododecyl Ether	4180186
958759	Polyoxyethylene 4 dodecyl Ether	4180186
958759	Polyoxyethylene-4-dodecyl Ether	4180186
958759	Polyoxyethylene(4) Lauryl Ether	4180186
958759	Polyoxyethylene 9 lauryl Ether	4180186
958759	Polyoxyethylene 9-lauryl Ether	4180186
958759	Polyoxyethylene 9-lauryl Ethers	4180186
958759	Polyoxyethylenedodecyl Ether	4180186
958759	Polyoxyethylenedodecyl Ethers	4180186
958759	Polyoxyethylene Lauryl Ether	4180186
958759	Polyoxyethylene Lauryl Ethers	4180186
958759	Tetraethylene Glycol Dodecyl Ether	4180186
958759	Tetraethyleneglycol Lauryl Ether	4180186
958759	Tetraethyleneglycol Lauryl Ethers	4180186
958759	Thesit	4180186
958760	PLGA Acids	4180186
958760	PLGA Acid	4180186
958760	Acids, PLGA	4180186
958760	Acid, PLGA	4180186
958760	Copolymer, PL-PG	4180186
958760	Copolymer, Polylactic-co-glycolic Acid	4180186
958760	Copolymers, PL-PG	4180186
958760	Copolymers, Polylactic-co-glycolic Acid	4180186
958760	LactoSorb	4180186
958760	PLGA Compound	4180186
958760	PLGA Compounds	4180186
958760	PLG Polymer	4180186
958760	PLG Polymers	4180186
958760	PL PG Copolymer	4180186
958760	PL-PG Copolymer	4180186
958760	PL-PG Copolymers	4180186
958760	Poly (D,L-lactic-co-glycolic Acid)	4180186
958760	Poly(DL-lactide-co-glycolic Acid)	4180186
958760	Poly(D,L-lactide-co-glycolide)	4180186
958760	Poly(Glycolide-co-lactide)	4180186
958760	Polylactic Acid Polyglycolic Acid Copolymer	4180186
958760	Poly (Lactic-co-glycolic Acid) -	4180186
958760	Poly(Lactic-co-glycolic Acid)	4180186
958760	Polylactic co glycolic Acid Copolymer	4180186
958760	Polylactic-co-glycolic Acid Copolymer	4180186
958760	Polylactic-co-glycolic Acid Copolymers	4180186
958760	Poly L lactic polyglycolic Acid	4180186
958760	Poly-L-lactic-polyglycolic Acid	4180186
958760	Poly-L-lactic-polyglycolic Acids	4180186
958760	Poly(L-lactide)-co-glycolide	4180186
958760	Polymer, PLG	4180186
958760	Polymers, PLG	4180186
958760	RG 502	4180186
958762	Abdomino perineal Excision	4180186
958762	Abdomino-perineal Excision	4180186
958762	Abdominoperineal Excision	4180186
958762	Abdomino-perineal Excisions	4180186
958762	Abdominoperineal Excisions	4180186
958762	Abdominoperineal Rectum Excision	4180186
958762	Abdomino Perineal Rectum Excision	4180186
958762	Abdomino-Perineal Rectum Excision	4180186
958762	Abdominoperineal Rectum Excisions	4180186
958762	Abdomino-Perineal Rectum Excisions	4180186
958762	Abdominoperineal Resection	4180186
958762	Abdomino Perineal Resection	4180186
958762	Abdomino-Perineal Resection	4180186
958762	Abdominoperineal Resections	4180186
958762	Abdomino-Perineal Resections	4180186
958762	Excision, Abdominoperineal	4180186
958762	Excision, Abdomino-perineal	4180186
958762	Excision, Abdominoperineal Rectum	4180186
958762	Excision, Abdomino-Perineal Rectum	4180186
958762	Excision, Rectum	4180186
958762	Excisions, Abdomino-Perineal Rectum	4180186
958762	Proctectomies	4180186
958762	Rectum Excision	4180186
958762	Rectum Excision, Abdominoperineal	4180186
958762	Rectum Excision, Abdomino-Perineal	4180186
958762	Rectum Excisions	4180186
958762	Rectum Resection	4180186
958762	Rectum Resections	4180186
958762	Resection, Abdominoperineal	4180186
958762	Resection, Abdomino-Perineal	4180186
958762	Resection, Rectum	4180186
958762	Resections, Abdominoperineal	4180186
958763	QUALYs	4180186
958763	QUALY	4180186
958763	QALYs	4180186
958763	Adjusted Life Year	4180186
958763	Adjusted Life Years	4180186
958763	Equivalents, Healthy Years	4180186
958763	Healthy Years Equivalent	4180186
958763	Healthy Years Equivalents	4180186
958763	Life Year, Adjusted	4180186
958763	Life Year, Quality-Adjusted	4180186
958763	Life Years, Adjusted	4180186
958763	Life Years, Quality-Adjusted	4180186
958763	Quality Adjusted Life Year	4180186
958763	Quality-Adjusted Life Year	4180186
958763	Quality Adjusted Life Years	4180186
958763	Years, Adjusted Life	4180186
958766	1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester	4180186
958766	3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester	4180186
958766	GI87084B	4180186
958766	GI 87084B	4180186
958766	GI-87084B	4180186
958766	Remifentanil Hydrochloride	4180186
958766	Remifentanil Monohydrochloride	4180186
958766	Ultiva	4180186
958767	Dead Space, Respiratory	4180186
958767	Dead Spaces, Respiratory	4180186
958767	Respiratory Dead Spaces	4180186
958767	Space, Respiratory Dead	4180186
958767	Spaces, Respiratory Dead	4180186
958771	1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate	4180186
958771	2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate	4180186
958771	2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate	4180186
958771	Actonel	4180186
958771	Atelvia	4180186
958771	Bisphosphonate Risedronate Sodium	4180186
958771	Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-	4180186
958771	Risedronate	4180186
958771	Risedronate Sodium	4180186
958771	Risedronate Sodium, Bisphosphonate	4180186
958771	Risedronic Acid, Monosodium Salt	4180186
958771	Sodium, Bisphosphonate Risedronate	4180186
958774	2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-	4180186
958774	5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate	4180186
958774	Avandia	4180186
958774	BRL49653	4180186
958774	BRL 49653	4180186
958774	BRL-49653	4180186
958774	Rosiglitazone Maleate	4180186
958775	Self Neglect	4180186
958776	Ultane	4180186
958776	BAX 3084	4180186
958776	Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl Ether	4180186
958776	Fluoromethyl Hexafluoroisopropyl Ether	4180186
958776	Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-	4180186
958776	Sevorane	4180186
958778	2,3 Dehydrosilybin	4180186
958778	2,3-Dehydrosilybin	4180186
958778	4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-	4180186
958778	Alepa forte	4180186
958778	Alepa-forte	4180186
958778	Ardeyhepan	4180186
958778	Cefasilymarin	4180186
958778	Durasilymarin	4180186
958778	HepaBesch	4180186
958778	Hepa loges	4180186
958778	Hepa-loges	4180186
958778	Hepa Merz Sil	4180186
958778	Hepa-Merz Sil	4180186
958778	Hepar Pasc	4180186
958778	Hepar-Pasc	4180186
958778	Heparsyx	4180186
958778	Heplant	4180186
958778	Lagosa	4180186
958778	Legalon Forte	4180186
958778	Silibin	4180186
958778	Silibinin	4180186
958778	Silibinin A	4180186
958778	Silibinin B	4180186
958778	Silybin A	4180186
958778	Silybin B	4180186
958778	Silybinin	4180186
958779	Position, Seated	4180186
958779	Position, Sitting	4180186
958779	Positions, Seated	4180186
958779	Seated Position	4180186
958779	Seated Positions	4180186
958779	Sitting	4180186
958779	Sitting Positions	4180186
958780	Anhydrous Sodium Citrate	4180186
958780	Citra pH	4180186
958780	Monosodium Citrate	4180186
958780	Sodium Citrate, Anhydrous	4180186
958780	Sodium Citrate Dihydrate	4180186
958780	Sodium Citrate Monobasic	4180186
958780	Trisodium Citrate Dihydrate	4180186
958782	Carcinoma, Squamous Cell of Head and Neck	4180186
958782	Head and Neck Squamous Cell Carcinoma	4180186
958782	Head And Neck Squamous Cell Carcinomas	4180186
958782	HNSCC	4180186
958782	Hypopharyngeal Squamous Cell Carcinoma	4180186
958782	Laryngeal Squamous Cell Carcinoma	4180186
958782	Oral Cavity Squamous Cell Carcinoma	4180186
958782	Oral Squamous Cell Carcinoma	4180186
958782	Oral Squamous Cell Carcinomas	4180186
958782	Oral Tongue Squamous Cell Carcinoma	4180186
958782	Oropharyngeal Squamous Cell Carcinoma	4180186
958782	Squamous Cell Carcinoma, Head And Neck	4180186
958782	Squamous Cell Carcinoma of Larynx	4180186
958782	Squamous Cell Carcinoma of the Head and Neck	4180186
958782	Squamous Cell Carcinoma of the Larynx	4180186
958782	Squamous Cell Carcinoma of the Mouth	4180186
958782	Squamous Cell Carcinoma of the Nasal Cavity	4180186
958784	6-Perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt	4180186
958784	Bridion	4180186
958784	Gamma-cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-octathio-	4180186
958784	Org 25969	4180186
958784	Sugammadex Sodium	4180186
958787	5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide	4180186
958787	SU011248	4180186
958787	SU 011248	4180186
958787	SU-011248	4180186
958787	SU11248	4180186
958787	SU 11248	4180186
958787	SU-11248	4180186
958787	Sunitinib Malate	4180186
958787	Sutent	4180186
958789	3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)phenol	4180186
958789	Nucynta	4180186
958789	Tapentadol Hydrochloride	4180186
958791	1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione	4180186
958791	2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-5-methyl-	4180186
958791	beta L 2' Deoxythymidine	4180186
958791	beta-L-2'-Deoxythymidine	4180186
958791	Telbivudin	4180186
958791	Tyzeka	4180186
958792	(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-	4180186
958792	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid	4180186
958792	BIBR 277	4180186
958792	BIBR-277	4180186
958792	Micardis	4180186
958792	Pritor	4180186
958793	8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one	4180186
958793	CCRG81045	4180186
958793	CCRG 81045	4180186
958793	CCRG-81045	4180186
958793	M&B39831	4180186
958793	M&B 39831	4180186
958793	M&B-39831	4180186
958793	Methazolastone	4180186
958793	NSC362856	4180186
958793	NSC 362856	4180186
958793	NSC-362856	4180186
958793	Temodal	4180186
958793	Temodar	4180186
958793	Temozolomide Hexyl Ester	4180186
958793	TMZA-HE	4180186
958793	TMZ Bioshuttle	4180186
958793	TMZ-Bioshuttle	4180186
958794	Metalyse	4180186
958794	TNKase	4180186
958795	1-Naphthalenemethanamine, N-((2E)-6,6-dimethyl-2-hepten-4-yn-1-yl)-N-methyl-	4180186
958795	DA 5505	4180186
958795	(E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride	4180186
958795	Lamisil	4180186
958795	SF86327	4180186
958795	SF 86327	4180186
958795	SF 86 327	4180186
958795	SF 86-327	4180186
958795	SF-86-327	4180186
958795	TDT067	4180186
958795	TDT 067	4180186
958795	TDT-067	4180186
958795	Terbinafine Hydrochloride	4180186
958795	Terbinafine, (Z)-	4180186
958795	Terbinafine, (Z)-isomer	4180186
958799	3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl)-, (3R)-	4180186
958799	Gabitril	4180186
958799	N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid	4180186
958799	NO 328	4180186
958799	NO-328	4180186
958799	NO 329	4180186
958799	NO-329	4180186
958799	(R)-(4,4-bis(3-Methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, Hydrochloride	4180186
958799	Tiagabine Hydrochloride	4180186
958799	Tiagabine, (S)-isomer	4180186
958800	1,2-cyclopentanediol, 3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-	4180186
958800	3-(7-((2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol	4180186
958800	AZD6140	4180186
958800	AZD 6140	4180186
958800	AZD-6140	4180186
958800	Brilinta	4180186
958800	Brilique	4180186
958802	2 Propenoic acid, 3 phenyl	4180186
958802	2-Propenoic acid, 3-phenyl-	4180186
958802	3-phenyl- 2-Propenoic acid	4180186
958802	Innohep	4180186
958802	Tinzaparin Sodium	4180186
958804	3,4 Dihydroxy 5' methyl 5 nitrobenzophenone	4180186
958804	3,4-Dihydroxy-5'-methyl-5-nitrobenzophenone	4180186
958804	Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-	4180186
958804	Ro407592	4180186
958804	Ro 407592	4180186
958804	Ro 40 7592	4180186
958804	Ro 40-7592	4180186
958804	Ro-40-7592	4180186
958804	SOM0226	4180186
958804	Tasmar	4180186
958805	7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine	4180186
958805	Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-	4180186
958805	OPC41061	4180186
958805	OPC 41061	4180186
958805	OPC-41061	4180186
958805	Samsca	4180186
958806	2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate	4180186
958806	Epitomax	4180186
958806	McN4853	4180186
958806	McN 4853	4180186
958806	McN-4853	4180186
958806	Topamax	4180186
958806	USL255	4180186
958807	1-Isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea	4180186
958807	1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea	4180186
958807	3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-	4180186
958807	Demadex	4180186
958807	Torasemide	4180186
958808	Capacities, Total Lung	4180186
958808	Capacity, Total Lung	4180186
958808	Lung Capacities, Total	4180186
958808	Lung Capacity, Total	4180186
958808	Total Lung Capacities	4180186
958809	Ecteinascidin 743	4180186
958809	ET743	4180186
958809	ET 743	4180186
958809	ET-743	4180186
958809	NSC 684766	4180186
958809	Yondelis	4180186
958810	Halstead Category Test	4180186
958810	Halstead-Reitan Battery	4180186
958810	Halstead-Reitan Neuropsychological Battery	4180186
958810	Seashore Rhythm Test	4180186
958810	Speech Sounds Perception Test	4180186
958810	Tactual Performance Test	4180186
958812	2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-	4180186
958812	5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione) - T	4180186
958812	CS045	4180186
958812	CS 045	4180186
958812	CS-045	4180186
958812	Prelay	4180186
958812	Rezulin	4180186
958815	Ganciclovir L valyl Ester	4180186
958815	Ganciclovir L-valyl Ester	4180186
958815	L-Valine, 2-((2-amino-3,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester	4180186
958815	Valcyt	4180186
958815	Valcyte	4180186
958815	Valganciclovir Hydrochloride	4180186
958816	1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-	4180186
958816	PLX4032	4180186
958816	PLX 4032	4180186
958816	R05185426	4180186
958816	RG7204	4180186
958816	RG 7204	4180186
958816	RG-7204	4180186
958816	Zelboraf	4180186
958817	Ratios, Ventilation-Perfusion	4180186
958817	Ratio, Ventilation-Perfusion	4180186
958817	Ventilation Perfusion Ratio	4180186
958817	Ventilation-Perfusion Ratios	4180186
958820	5' Nor anhydrovinblastine	4180186
958820	5'-Nor-anhydrovinblastine	4180186
958820	C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-	4180186
958820	KW2307	4180186
958820	KW 2307	4180186
958820	KW-2307	4180186
958820	Navelbine	4180186
958820	Vinorelbine Tartrate	4180186
958822	18F-SAHA	4180186
958822	18F Suberoylanilide Hydroxamic Acid	4180186
958822	18F-Suberoylanilide Hydroxamic Acid	4180186
958822	M344	4180186
958822	MK0683	4180186
958822	MK 0683	4180186
958822	MK-0683	4180186
958822	N1 Hydroxy N8 phenyloctanediamide	4180186
958822	N1-Hydroxy-N8-phenyloctanediamide	4180186
958822	NHNPODA	4180186
958822	N Hydroxy N' phenyloctanediamide	4180186
958822	N-Hydroxy-N'-phenyloctanediamide	4180186
958822	Suberanilohydroxamic Acid	4180186
958822	Suberoylanilide Hydroxamic Acid	4180186
958822	Suberoyl Anilide Hydroxamic Acid	4180186
958822	Zolinza	4180186
958824	Brief Cognitive Status Exam	4180186
958826	CGP-42446	4180186
958826	2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid	4180186
958826	CGP42446	4180186
958826	CGP 42446	4180186
958826	CGP 42'446	4180186
958826	CGP-42'446	4180186
958826	CGP42'446	4180186
958826	CGP 42446A	4180186
958826	Zoledronate	4180186
958826	Zoledronic Acid Anhydrous	4180186
958826	Zometa	4180186
958828	1,2-Benzisoxazole-3-methanesulfonamide	4180186
958828	3 Sulfamoylmethyl 1,2 benzisoxazole	4180186
958828	3-Sulfamoylmethyl-1,2-benzisoxazole	4180186
958828	AD810	4180186
958828	AD 810	4180186
958828	AD-810	4180186
958828	CI912	4180186
958828	CI 912	4180186
958828	CI-912	4180186
958828	Zonegran	4180186
958828	Zonisamide Monosodium	4180186
958829	3,5-BTPE	4180186
958831	4-hydroxybenzenemethanol	4180186
958831	4-(Hydroxymethyl)phenol	4180186
958831	4-methylol phenol	4180186
958831	gastrodigenin	4180186
958831	p-hydroxybenzyl alcohol	4180186
958832	8-chlorotheophylline, sodium salt	4180186
958832	S8CT	4180186
958832	sodium-8-chlorotheophylline	4180186
958835	Aicardi Goutieres syndrome	4180186
958835	Aicardi-Goutieres Syndrome 1	4180186
958835	Aicardi-Goutieres Syndrome 2	4180186
958835	Cree Encephalitis	4180186
958835	Encephalopathy with Basal Ganglia Calcification	4180186
958835	Familial Infantile Encephalopathy with Intracranial Calcification and Chronic Cerebrospinal Fluid Lymphocytosis	4180186
958835	Pseudo-TORCH syndrome	4180186
958835	Pseudotoxoplasmosis syndrome	4180186
958837	Miosis, Congenital, with Spastic Ataxia	4180186
958839	Atkin Flaitz Patil Smith syndrome	4180186
958839	Atkin-Flaitz syndrome	4180186
958839	Mental retardation, X-linked, 21	4180186
958839	Mental Retardation, X-Linked 21	4180186
958839	Mental retardation X-linked Atkin type	4180186
958839	Mental retardation X-linked, Atkin type	4180186
958839	Mental retardation, X-linked, nonspecific	4180186
958839	Mental retardation, X-linked nonspecific, type 1	4180186
958839	MRX21	4180186
958839	X-linked mental retardation syndrome, Atkin type	4180186
958840	Russell Weaver Bull syndrome	4180186
958841	Choroideremia deafness obesity	4180186
958841	Choroideremia, obesity, and congenital deafness	4180186
958841	Choroideremia with Deafness and Obesity	4180186
958844	Bird-Headed Dwarfism, Montreal Type	4180186
958844	Bird-headed dwarfism with features of premature senility	4180186
958845	Birk-Barel Syndrome	4180186
958845	Mental Retardation with Hypotonia and Facial Dysmorphism	4180186
958846	Bos1	4180186
958846	BO syndrome 1	4180186
958846	Branchiootic dysplasia	4180186
958846	Branchiootic Syndrome 1	4180186
958847	burosumab-TWZA	4180186
958847	Crysvita	4180186
958847	KRN23	4180186
958847	KRN-23	4180186
958852	Trisomy 14 mosaic	4180186
958852	Trisomy 14 mosaicism	4180186
958852	Trisomy 14 mosaicism syndrome	4180186
958853	Trisomy 15 mosaicism	4180186
958853	Uniparental disomy of 15	4180186
958856	Ring chromosome 7	4180186
958856	Ring chromosome 7 syndrome	4180186
958858	Duplication 8p	4180186
958858	Trisomy 8p	4180186
958860	Chudley Rozdilsky syndrome	4180186
958860	Chudley syndrome	4180186
958866	Deafness, Conductive, with Ptosis and Skeletal Anomalies	4180186
958866	Jackson Barr syndrome	4180186
958868	Bitrex	4180186
958868	denatonium benzoate	4180186
958868	denatonium chloride	4180186
958871	Braftovi	4180186
958871	LGX818	4180186
958879	2-EHEC	4180186
958879	ethyl 2-hydroxyethyl ether cellulose	4180186
958880	EHEC cpd	4180186
958881	N-ETHYLUREA	4180186
958888	palmitaldehyde	4180186
958888	palmitoyl aldehyde	4180186
958889	Hartsfield Syndrome	4180186
958891	Hu-5A8	4180186
958891	ibalizumab-uiyk	4180186
958891	TMB-355	4180186
958891	TNX-355	4180186
958891	Trogarzo	4180186
958895	AG-120	4180186
958895	N-((1S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxo-L-prolinamide	4180186
958895	Tibsovo	4180186
958895	AG120	4180186
958896	Ichthyosis alopecia eclabion ectropion mental retardation	4180186
958896	Ichthyosis With Alopecia, Eclabion, Ectropion, And Mental Retardation	4180186
958902	Receptaculum Nelumbinis	4180186
958904	Macrocrania, obesity, ocular abnormalities (retinal coloboma and nystagmus)	4180186
958904	Macrosomia, Obesity, Macrocephaly, And Ocular Abnormalities	4180186
958904	MOMO syndrome	4180186
958908	Ectrodactyly, spastic paraplegia and mental retardation	4180186
958908	Jancar syndrome	4180186
958908	Mental retardation, spasticity and transverse limb defects	4180186
958909	Wolff mental retardation syndrome	4180186
958909	Wolff type Mental retardation	4180186
958909	Wolff Zimmermann syndrome	4180186
958910	methyl hydrogen fumarate	4180186
958910	bafiertam	4180186
958910	methylhydrogenfumarate	4180186
958914	n-butyl maleate	4180186
958915	Mental retardation, truncal Obesity, Retinal dystrophy and Micropenis	4180186
958915	Mental Retardation, Truncal Obesity, Retinal Dystrophy, And Micropenis	4180186
958917	Ataxia-Pancytopenia Syndrome	4180186
958919	Keipert Syndrome	4180186
958921	Alacrimia-choreoathetosis-liver dysfunction syndrome	4180186
958921	Congenital disorder of deglycosylation	4180186
958921	Congenital disorder of glycosylation, type Iv	4180186
958922	Microcephaly and Spontaneous Chromosome Instability without Immunodeficiency	4180186
958922	RAD50 Deficiency	4180186
958923	acetic acid octyl ester	4180186
958924	Oblique facial clefts	4180186
958924	Oculomaxillofacial dysplasia with oblique facial clefts	4180186
958924	Richieri Costa Gorlin syndrome	4180186
958928	Familial oto-facio-cervical dysmorphia	4180186
958928	Fara Chlupackova syndrome	4180186
958928	Ofc Syndrome	4180186
958930	Impulsin	4180186
958930	MimyX	4180186
958930	N-(2-hydroxyethyl)palmitate	4180186
958930	N-palmitoylethanolamine	4180186
958930	palmitoylethanolamide	4180186
958930	palmitylethanolamide	4180186
958932	ALN-TTR02	4180186
958932	Onpattro	4180186
958933	PFMe-cyclopentane	4180186
958935	Trichodermodysplasia with dental alterations	4180186
958938	ACC With Abnormal Genitalia	4180186
958938	Corpus Callosum, Agenesis of, with Abnormal Genitalia	4180186
958940	Radio-renal syndrome	4180186
958941	radium chloride Ra 223	4180186
958941	Xofigo	4180186
958943	82Rb radioisotope	4180186
958943	Rb-82 radioisotope	4180186
958948	Spinocerebellar ataxia 18	4180186
958950	22Na radioisotope	4180186
958950	Na-22 radioisotope	4180186
958954	Sca10	4180186
958954	SCA10 Spinocerebellar Ataxia 10	4180186
958959	SCA19 Spinocerebellar ataxia 19	4180186
958962	Cerebellar ataxia, autosomal dominant, FGF14-related	4180186
958962	SCA27 Spinocerebellar ataxia 27	4180186
958964	Aplasia of cerebellar vermis	4180186
958964	Cerebellar ataxia, congenital, nonprogressive, autosomal dominant	4180186
958964	Cerebellar ataxia, early-onset, nonprogressive	4180186
958964	Cerebellar vermis aplasia	4180186
958964	SCA29 Spinocerebellar Ataxia 29	4180186
958965	SCA30 Spinocerebellar ataxia 30	4180186
958972	Brachydactyly with Joint Dysplasia	4180186
958972	Liebenberg Syndrome	4180186
958973	WR238605	4180186
958973	tafenoquine succinate, (R)-	4180186
958973	SB252263-AX	4180186
958973	SB252263AX	4180186
958973	(R)-tafenoquine succinate	4180186
958973	butanedioic acid, compd. with N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1), (R)-	4180186
958973	butanedioic acid, compd. with N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)	4180186
958973	Arakoda	4180186
958973	SB-252263-AX	4180186
958973	SB-252263AX	4180186
958973	Krintafel	4180186
958973	N(4)-(2,6-dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine	4180186
958973	tafenoquine maleate	4180186
958973	tafenoquine succinate	4180186
958973	WR 238605	4180186
958973	WR-238605	4180186
958975	thallium (+3) acetate	4180186
958975	thallium acetate (4:1:1)	4180186
958975	thallous acetate	4180186
958977	Ilumya	4180186
958977	MK-3222	4180186
958977	SCH 900222	4180186
958977	SCH-900222	4180186
958982	1,2-oxaborinane-6-acetic acid, 2-hydroxy-3-((2-(2-thienyl)acetyl)amino)-, (3R,6S)-	4180186
958984	Hemangioma, Intraosseous	4180186
958984	Vascular Malformation Osseous	4180186
958986	Cleft Limb Heart Malformation Syndrome	4180186
958986	Cleft-Limb-Heart Malformation Syndrome	4180186
958986	Verloove Vanhorick Brubakk syndrome	4180186
958991	Sex-linked mental retardation, short stature, obesity and hypogonadism	4180186
979195	1,2 Dihexadecyl sn Glycerophosphocholine	4180186
979195	1,2-Dihexadecyl-sn-Glycerophosphocholine	4180186
979195	1,2 Dipalmitoyl Glycerophosphocholine	4180186
979195	1,2-Dipalmitoyl-Glycerophosphocholine	4180186
979195	1,2 Dipalmitoylphosphatidylcholine	4180186
979195	3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxohexadecyl)oxy)-, inner salt, 4-oxide	4180186
979195	Dipalmitoylglycerophosphocholine	4180186
979195	Dipalmitoyllecithin	4180186
979195	Dipalmitoylphosphatidylcholine	4180186
979195	Dipalmitoyl Phosphatidylcholine	4180186
979195	Phosphatidylcholine, Dipalmitoyl	4180186
979196	2 Hydroxypropyl beta cyclodextrin	4180186
979196	2 Hydroxypropyl-beta-cyclodextrin	4180186
979196	Betadex, Hydroxypropyl	4180186
979196	beta Hydroxypropylcyclodextrin	4180186
979196	beta-Hydroxypropylcyclodextrin	4180186
979196	HPbetaCD	4180186
979196	HP-beta-CD	4180186
979196	Hydroxypropyl beta cyclodextrin	4180186
979196	Hydroxypropyl-beta-cyclodextrin	4180186
979196	Hydroxypropyl Betadex	4180186
979201	alpha D Galactopyranosidase	4180186
979201	alpha-D-Galactopyranosidase	4180186
979201	alpha D Galactosidase	4180186
979201	alpha-D-Galactosidase	4180186
979201	alpha-D-galactoside galactohydrolase	4180186
979201	alpha Galactisidase	4180186
979201	alpha-Galactisidase	4180186
979201	alpha Galactosidase	4180186
979201	alpha Galactosidase A	4180186
979201	alpha-Galactosidase A	4180186
979201	alpha Galactosidases	4180186
979201	alpha-Galactosidases	4180186
979201	Beano	4180186
979201	Melibiase	4180186
979203	5 L Isoleucine Angiotensin II	4180186
979203	5-L-Isoleucine Angiotensin II	4180186
979203	ANG-(1-8)Octapeptide	4180186
979203	Angiotensin-(1-8) Octapeptide	4180186
979203	Angiotensin II, 5-L-Isoleucine	4180186
979203	Angiotensin II, Ile(5)-	4180186
979203	Angiotensin II, Isoleucine(5)-	4180186
979203	Angiotensin II, Val(5)-	4180186
979203	Angiotensin II, Valine(5)-	4180186
979203	Isoleucine(5)-Angiotensin	4180186
979203	Isoleucyl(5)-Angiotensin II	4180186
979203	Valyl(5)-Angiotensin II	4180186
979207	Aphasias, Primary Progressive	4180186
979207	Mesulam's Syndrome	4180186
979207	Mesulam Syndrome	4180186
979207	Primary Progressive Aphasia	4180186
979207	Primary Progressive Aphasias	4180186
979207	Progressive Aphasia, Primary	4180186
979207	Progressive Aphasias, Primary	4180186
979207	Syndrome, Mesulam	4180186
979207	Syndrome, Mesulam's	4180186
979212	Bacilan	4180186
979212	Dipel	4180186
979212	Thuricide	4180186
979220	Blood Cultures	4180186
979220	Blood Culture Test	4180186
979220	Blood Culture Tests	4180186
979220	Culture, Blood	4180186
979220	Cultures, Blood	4180186
979220	Culture Test, Blood	4180186
979220	Culture Tests, Blood	4180186
979220	Test, Blood Culture	4180186
979220	Tests, Blood Culture	4180186
979222	Brain Injury, Diffuse	4180186
979222	Cerebral Injuries, Diffuse	4180186
979222	Cerebral Injury, Diffuse	4180186
979222	Diffuse Axonal Brain Injury	4180186
979222	Diffuse Brain Injuries	4180186
979222	Diffuse Brain Injury	4180186
979222	Diffuse Cerebral Injuries	4180186
979222	Diffuse Cerebral Injury	4180186
979223	Brain Injury, Traumatic	4180186
979223	Brain Trauma	4180186
979223	Brain Traumas	4180186
979223	Encephalopathies, Traumatic	4180186
979223	Encephalopathy, Traumatic	4180186
979223	Injury, Brain, Traumatic	4180186
979223	TBIs (Traumatic Brain Injuries)	4180186
979223	TBI (Traumatic Brain Injuries)	4180186
979223	TBI (Traumatic Brain Injury)	4180186
979223	Trauma, Brain	4180186
979223	Traumas, Brain	4180186
979223	Traumatic Brain Injuries	4180186
979223	Traumatic Brain Injury	4180186
979223	Traumatic Encephalopathies	4180186
979223	Traumatic Encephalopathy	4180186
979224	Brainstem Hematomas, Traumatic	4180186
979224	Brainstem Hematoma, Traumatic	4180186
979224	Brain Stem Hematoma, Traumatic	4180186
979224	Brainstem Hemorrhage, Post-Traumatic	4180186
979224	Brain Stem Hemorrhage, Post Traumatic	4180186
979224	Brain Stem Hemorrhage, Post-Traumatic	4180186
979224	Brainstem Hemorrhage, Traumatic	4180186
979224	Bulbar Hemorrhage, Traumatic	4180186
979224	Hemorrhage, Brain Stem, Traumatic	4180186
979224	Hemorrhage, Post-Traumatic Brainstem	4180186
979224	Hemorrhage, Traumatic Bulbar	4180186
979224	Hemorrhage, Traumatic Medullary	4180186
979224	Medullary Hemorrhage, Traumatic	4180186
979224	Midbrain Hemorrhage, Traumatic	4180186
979224	Pontine Hemorrhage, Traumatic	4180186
979224	Post Traumatic Brainstem Hemorrhage	4180186
979224	Post-Traumatic Brainstem Hemorrhage	4180186
979224	Post Traumatic Brain Stem Hemorrhage	4180186
979224	Post-Traumatic Brain Stem Hemorrhage	4180186
979224	Traumatic Brainstem Hematoma	4180186
979224	Traumatic Brain Stem Hematoma	4180186
979224	Traumatic Brainstem Hematomas	4180186
979224	Traumatic Brainstem Hemorrhage	4180186
979224	Traumatic Brain Stem Hemorrhage	4180186
979224	Traumatic Bulbar Hemorrhage	4180186
979224	Traumatic Medullary Hemorrhage	4180186
979224	Traumatic Midbrain Hemorrhage	4180186
979224	Traumatic Pontine Hemorrhage	4180186
979225	LCIS, Lobular Carcinoma In Situ	4180186
979225	Lobular Carcinoma In Situ	4180186
979227	Bunions	4180186
979229	Candida metapsilosis	4180186
979229	Candida orthopsilosis	4180186
979229	Candida parapsilosis Complex	4180186
979229	Candida parapsilosis Group	4180186
979229	C. metapsilosis	4180186
979229	C. orthopsilosis	4180186
979229	C. parapsilosis	4180186
979229	C. parapsilosis Complex	4180186
979229	Mycocandida parapsilosis	4180186
979229	Mycotorula parapsilopsis	4180186
979236	Closed Fracture Reductions	4180186
979236	Closed Reduction, Fracture	4180186
979236	Fracture Closed Reduction	4180186
979236	Fracture Closed Reductions	4180186
979236	Fracture Reduction, Closed	4180186
979236	Fracture Reductions, Closed	4180186
979236	Reduction, Fracture Closed	4180186
979236	Reductions, Fracture Closed	4180186
979240	Angiographies, Computed Tomography	4180186
979240	Angiographies, CT	4180186
979240	Angiography, Computed Tomography	4180186
979240	Angiography, CT	4180186
979240	Computed Tomography Angiographies	4180186
979240	CT Angiographies	4180186
979240	CT Angiography	4180186
979240	Tomography Angiographies, Computed	4180186
979240	Tomography Angiography, Computed	4180186
979242	Conservative Management	4180186
979242	Conservative Managements	4180186
979242	Conservative Therapies	4180186
979242	Conservative Therapy	4180186
979242	Conservative Treatments	4180186
979242	Management, Conservative	4180186
979242	Managements, Conservative	4180186
979242	Therapies, Conservative	4180186
979242	Therapy, Conservative	4180186
979242	Treatment, Conservative	4180186
979242	Treatments, Conservative	4180186
979243	Medical Contraindication	4180186
979243	Medical Contraindications	4180186
979243	Physical Agent Contraindication	4180186
979243	Physical Agent Contraindications	4180186
979243	Contraindication	4180186
979243	Contraindication, Medical	4180186
979243	Contraindication, Physical Agent	4180186
979243	Contraindications, Medical	4180186
979243	Contraindications, Physical Agent	4180186
979243	Agent Contraindication, Physical	4180186
979243	Agent Contraindications, Physical	4180186
979244	Coxa Magnas	4180186
979244	Deformities, Femoral Head	4180186
979244	Deformity, Femoral Head	4180186
979244	Femoral Head Deformities	4180186
979244	Femoral Head Deformity	4180186
979246	Crush Fracture	4180186
979246	Crush Fractures	4180186
979246	Crush Injury	4180186
979246	Fracture, Crush	4180186
979246	Fractures, Crush	4180186
979246	Injuries, Crush	4180186
979246	Injury, Crush	4180186
979247	Arthritides, Crystal	4180186
979247	Arthritides, Crystalline	4180186
979247	Arthritis, Crystal	4180186
979247	Arthritis, Crystalline	4180186
979247	Arthropathies, Crystal	4180186
979247	Arthropathies, Crystalline	4180186
979247	Arthropathy, Crystal	4180186
979247	Arthropathy, Crystalline	4180186
979247	Crystal Arthritides	4180186
979247	Crystal Arthritis	4180186
979247	Crystal Arthropathy	4180186
979247	Crystalline Arthritides	4180186
979247	Crystalline Arthritis	4180186
979247	Crystalline Arthropathies	4180186
979247	Crystalline Arthropathy	4180186
979249	Avulsion Injuries, Skin	4180186
979249	Avulsion Injury, Skin	4180186
979249	Avulsion, Skin	4180186
979249	Avulsions, Skin	4180186
979249	Degloving Injury	4180186
979249	Degloving Wound	4180186
979249	Degloving Wounds	4180186
979249	Injuries, Degloving	4180186
979249	Injuries, Skin Avulsion	4180186
979249	Injury, Degloving	4180186
979249	Injury, Skin Avulsion	4180186
979249	Skin Avulsion	4180186
979249	Skin Avulsion Injuries	4180186
979249	Skin Avulsion Injury	4180186
979249	Skin Avulsions	4180186
979249	Wound, Degloving	4180186
979249	Wounds, Degloving	4180186
979250	Diastases, Muscle	4180186
979250	Muscle Diastases	4180186
979250	Muscle Diastasis	4180186
979250	Myodiastases	4180186
979250	Myodiastasis	4180186
979251	DASH Diet	4180186
979251	DASH Diets	4180186
979251	Dietary Approaches To Stop Hypertension Diet	4180186
979251	Diet, DASH	4180186
979251	Diets, DASH	4180186
979255	Antibiotic Resistance, Neoplasm	4180186
979255	Antineoplastic Agent Resistance	4180186
979255	Antineoplastic Drug Resistance	4180186
979255	Drug Resistance, Antineoplastic	4180186
979255	Neoplasm Drug Resistance	4180186
979255	Resistance, Antineoplastic Agent	4180186
979255	Resistance, Antineoplastic Drug	4180186
979258	Streptococcus faecium	4180186
979259	Enthesopathies	4180186
979260	Primary Hypertensions	4180186
979260	Primary Hypertension	4180186
979260	Hypertensions, Primary	4180186
979260	Hypertension, Primary	4180186
979260	Hypertension, Essential	4180186
979262	Face Transplant	4180186
979262	Face Transplantation	4180186
979262	Face Transplantations	4180186
979262	Face Transplants	4180186
979262	Facial Transplant	4180186
979262	Facial Transplantations	4180186
979262	Facial Transplants	4180186
979262	Transplantation, Face	4180186
979262	Transplantation, Facial	4180186
979262	Transplantations, Face	4180186
979262	Transplantations, Facial	4180186
979262	Transplant, Face	4180186
979262	Transplant, Facial	4180186
979262	Transplants, Face	4180186
979262	Transplants, Facial	4180186
979264	Fasciectomy	4180186
979265	Transplants, Intestinal Microbiota	4180186
979265	Transplants, Intestinal Microbiome	4180186
979265	Transplants, Fecal Microbiota	4180186
979265	Transplant, Intestinal Microbiota	4180186
979265	Transplant, Intestinal Microbiome	4180186
979265	Transplant, Fecal Microbiota	4180186
979265	Transplantations, Intestinal Microbiota	4180186
979265	Transplantations, Intestinal Microbiome	4180186
979265	Transplantations, Fecal Microbiome	4180186
979265	Transplantation, Intestinal Microbiota	4180186
979265	Transplantation, Intestinal Microbiome	4180186
979265	Transplantation, Fecal Microbiome	4180186
979265	Transfers, Intestinal Microbiome	4180186
979265	Transfers, Fecal Microbiota	4180186
979265	Transfer, Intestinal Microbiome	4180186
979265	Transfer, Fecal Microbiota	4180186
979265	Microbiota Transplants, Intestinal	4180186
979265	Microbiota Transplants, Fecal	4180186
979265	Microbiota Transplant, Intestinal	4180186
979265	Microbiota Transplant, Fecal	4180186
979265	Microbiota Transplantations, Intestinal	4180186
979265	Microbiota Transplantation, Intestinal	4180186
979265	Microbiota Transfers, Fecal	4180186
979265	Microbiota Transfer, Fecal	4180186
979265	Microbiome Transplants, Intestinal	4180186
979265	Microbiome Transplant, Intestinal	4180186
979265	Microbiome Transplantations, Intestinal	4180186
979265	Microbiome Transplantations, Fecal	4180186
979265	Microbiome Transplantation, Intestinal	4180186
979265	Microbiome Transplantation, Fecal	4180186
979265	Microbiome Transfers, Intestinal	4180186
979265	Microbiome Transfer, Intestinal	4180186
979265	Intestinal Microbiota Transplants	4180186
979265	Intestinal Microbiota Transplantations	4180186
979265	Intestinal Microbiota Transplantation	4180186
979265	Intestinal Microbiota Transplant	4180186
979265	Intestinal Microbiome Transplants	4180186
979265	Intestinal Microbiome Transplantations	4180186
979265	Intestinal Microbiome Transplantation	4180186
979265	Intestinal Microbiome Transplant	4180186
979265	Intestinal Microbiome Transfers	4180186
979265	Intestinal Microbiome Transfer	4180186
979265	Fecal Microbiota Transplants	4180186
979265	Fecal Microbiota Transplant	4180186
979265	Fecal Microbiota Transfers	4180186
979265	Fecal Microbiota Transfer	4180186
979265	Fecal Microbiome Transplantations	4180186
979265	Fecal Microbiome Transplantation	4180186
979265	Donor Feces Infusion	4180186
979265	Donor Feces Infusions	4180186
979265	Fecal Microbiota Transplantations	4180186
979265	Fecal Transplant	4180186
979265	Fecal Transplantation	4180186
979265	Fecal Transplantations	4180186
979265	Fecal Transplants	4180186
979265	Feces Infusion, Donor	4180186
979265	Feces Infusions, Donor	4180186
979265	Infusion, Donor Feces	4180186
979265	Infusions, Donor Feces	4180186
979265	Intestinal Microbiota Transfer	4180186
979265	Intestinal Microbiota Transfers	4180186
979265	Microbiota Transfer, Intestinal	4180186
979265	Microbiota Transfers, Intestinal	4180186
979265	Microbiota Transplantation, Fecal	4180186
979265	Microbiota Transplantations, Fecal	4180186
979265	Transfer, Intestinal Microbiota	4180186
979265	Transfers, Intestinal Microbiota	4180186
979265	Transplantation, Fecal	4180186
979265	Transplantation, Fecal Microbiota	4180186
979265	Transplantations, Fecal	4180186
979265	Transplantations, Fecal Microbiota	4180186
979265	Transplant, Fecal	4180186
979265	Transplants, Fecal	4180186
979267	Food, Sensitivity	4180186
979267	Intolerance, Food	4180186
979268	Debilities	4180186
979268	Debility	4180186
979268	Frailness	4180186
979268	Frailties	4180186
979268	Frailty Syndrome	4180186
979270	Head Heave Test	4180186
979270	Head Heave Tests	4180186
979270	Head Impulse Tests	4180186
979270	Head Thrust Test	4180186
979270	Head Thrust Tests	4180186
979270	Test, Head Heave	4180186
979270	Test, Head Impulse	4180186
979270	Test, Head Thrust	4180186
979270	Tests, Head Heave	4180186
979270	Tests, Head Impulse	4180186
979270	Tests, Head Thrust	4180186
979271	Heavy Metal Poisonings	4180186
979271	Metal Poisoning, Heavy	4180186
979271	Metal Poisonings, Heavy	4180186
979271	Poisoning, Heavy Metal	4180186
979271	Poisonings, Heavy Metal	4180186
979272	Encephalitis, Nipah Virus	4180186
979272	Hendra Virus Infection	4180186
979272	Hendra Virus Infections	4180186
979272	Henipavirus Infection	4180186
979272	Infection, Hendra Virus	4180186
979272	Infection, Henipavirus	4180186
979272	Infection, Nipah Virus	4180186
979272	Infection, NiV	4180186
979272	Nipah Virus Encephalitis	4180186
979272	Nipah Virus Infection	4180186
979272	NiV Infection	4180186
979272	NiV Infections	4180186
979272	Virus Encephalitis, Nipah	4180186
979272	Virus Infection, Hendra	4180186
979272	Virus Infection, Nipah	4180186
979272	Virus Infections, Hendra	4180186
979273	HBOC Syndrome	4180186
979273	HBOC Syndromes	4180186
979273	Syndrome, HBOC	4180186
979273	Syndromes, HBOC	4180186
979274	HTLV-I Infection	4180186
979274	HTLV I Infections	4180186
979274	Human T lymphotropic Virus 1 Infection	4180186
979274	Human T-lymphotropic Virus 1 Infection	4180186
979274	Human T lymphotropic Virus 1 Infections	4180186
979274	Human T-lymphotropic Virus 1 Infections	4180186
979274	Infection, HTLV-I	4180186
979274	Infections, HTLV I	4180186
979274	Infections, HTLV-I	4180186
979278	AL Amyloidoses	4180186
979278	AL Amyloidosis	4180186
979278	Amyloidoses, Primary	4180186
979278	Amyloidoses, Primary Systemic	4180186
979278	Amyloidosis, Immunoglobulin Light chain	4180186
979278	Amyloidosis, Immunoglobulin Light-chain	4180186
979278	Amyloidosis, Primary	4180186
979278	Amyloidosis, Primary Systemic	4180186
979278	Immunoglobulin Light-chain Amyloidoses	4180186
979278	Immunoglobulin Light chain Amyloidosis	4180186
979278	Primary Amyloidoses	4180186
979278	Primary Amyloidosis	4180186
979278	Primary Systemic Amyloidoses	4180186
979278	Primary Systemic Amyloidosis	4180186
979278	Systemic Amyloidoses, Primary	4180186
979278	Systemic Amyloidosis, Primary	4180186
979279	Infusion Site Adverse Event	4180186
979279	Infusion Site Adverse Reaction	4180186
979279	Infusion Site Reaction	4180186
979279	Infusion Site Reactions	4180186
979279	Injection Site Adverse Event	4180186
979279	Injection Site Event	4180186
979279	Injection Site Events	4180186
979279	Injection Site Reactions	4180186
979283	Anti CTLA 4 MAb Ipilimumab	4180186
979283	Anti-CTLA-4 MAb Ipilimumab	4180186
979283	Ipilimumab, Anti-CTLA-4 MAb	4180186
979283	MDX010	4180186
979283	MDX 010	4180186
979283	MDX-010	4180186
979283	MDX CTLA 4	4180186
979283	MDX-CTLA-4	4180186
979283	Yervoy	4180186
979284	Keratectomies	4180186
979285	Infection, Klebsiella	4180186
979285	Infections, Klebsiella	4180186
979285	Klebsiella Infection	4180186
979288	Anal Sphincterotomy, Internal	4180186
979288	Internal Anal Sphincterotomies	4180186
979288	Internal Anal Sphincterotomy	4180186
979288	Internal Sphincterotomies	4180186
979288	Internal Sphincterotomy	4180186
979288	Lateral Internal Anal Sphincterotomy	4180186
979288	Lateral Internal Sphincterotomies	4180186
979288	Lateral Sphincterotomies	4180186
979288	Lateral Sphincterotomy	4180186
979288	Sphincterotomy, Internal	4180186
979288	Sphincterotomy, Lateral	4180186
979288	Sphincterotomy, Lateral Internal	4180186
979290	Malacoplakias	4180186
979290	Malakoplakia	4180186
979290	Malakoplakias	4180186
979294	Medically Unexplained Symptom	4180186
979294	Somatic Symptom	4180186
979294	Somatic Symptoms	4180186
979294	Symptom, Medically Unexplained	4180186
979294	Symptoms, Medically Unexplained	4180186
979294	Symptom, Somatic	4180186
979294	Symptoms, Somatic	4180186
979294	Unexplained Symptom, Medically	4180186
979294	Unexplained Symptoms, Medically	4180186
979295	Ayurvedic Medicine	4180186
979295	Hindu Medicine	4180186
979295	Medicine, Hindu	4180186
979295	Medicine, Siddha	4180186
979295	Siddha Medicine	4180186
979296	Chinese Medicine, Traditional	4180186
979296	Chinese Traditional Medicine	4180186
979296	Chung I Hsueh	4180186
979296	Hsueh, Chung I	4180186
979296	Tongue Assessment, Traditional	4180186
979296	Tongue Diagnoses, Traditional	4180186
979296	Tongue Diagnosis, Traditional	4180186
979296	Traditional Chinese Medicine	4180186
979296	Traditional Medicine, Chinese	4180186
979296	Traditional Tongue Assessment	4180186
979296	Traditional Tongue Assessments	4180186
979296	Traditional Tongue Diagnoses	4180186
979296	Traditional Tongue Diagnosis	4180186
979296	Zhong Yi Xue	4180186
979299	Carboxylase Deficiencies, Combined	4180186
979299	Carboxylase Deficiencies, Multiple	4180186
979299	Carboxylase Deficiency, Combined	4180186
979299	Carboxylase Deficiency, Multiple	4180186
979299	Combined Carboxylase Deficiencies	4180186
979299	Combined Carboxylase Deficiency	4180186
979299	Deficiencies, Combined Carboxylase	4180186
979299	Deficiencies, Multiple Carboxylase	4180186
979299	Deficiency, Combined Carboxylase	4180186
979299	Deficiency, Multiple Carboxylase	4180186
979299	Multiple Carboxylase Deficiencies	4180186
979303	Nephrolithotomies, Percutaneous	4180186
979303	Percutaneous Nephrolithotomies	4180186
979303	Percutaneous Nephrolithotomy	4180186
979304	Kidney Incision	4180186
979304	Kidney Incisions	4180186
979304	Nephrostomies	4180186
979304	Nephrostomy	4180186
979304	Nephrotomies	4180186
979304	Pyelostomies	4180186
979304	Pyelostomy	4180186
979304	Pyelotomies	4180186
979304	Pyelotomy	4180186
979305	Heminephroureterectomies	4180186
979305	Heminephroureterectomy	4180186
979305	Nephroureterectomies	4180186
979305	Nephro-ureterectomies	4180186
979305	Nephro ureterectomy	4180186
979305	Nephro-ureterectomy	4180186
979305	Ureteronephrectomies	4180186
979305	Ureteronephrectomy	4180186
979306	Chewing Gum, Nicotine	4180186
979306	Nicorette	4180186
979306	Nicotine Chewing Gums	4180186
979307	Discharge, Nipple	4180186
979307	Discharges, Nipple	4180186
979307	Nipple Discharges	4180186
979313	Arachis Oil	4180186
979313	Ground Nut Oil	4180186
979313	Nut Oil, Ground	4180186
979313	Oil, Arachis	4180186
979313	Oil, Ground Nut	4180186
979313	Oil, Peanut	4180186
979314	Sociophobias	4180186
979314	Sociophobia	4180186
979314	Social Evaluation Phobias	4180186
979314	Social Evaluation Phobia	4180186
979314	Social Evaluation Fear	4180186
979314	Phobia, Social Evaluation	4180186
979314	Fear of Social Evaluation	4180186
979314	Evaluation Fear, Social	4180186
979314	Anxiety Disorder, Social	4180186
979314	Disorder, Social Anxiety	4180186
979314	Social Anxiety Disorder	4180186
979314	Social Anxiety Disorders	4180186
979314	Social Phobia	4180186
979314	Social Phobias	4180186
979321	Preventive Surgical Procedure	4180186
979321	Preventive Surgical Procedures	4180186
979321	Procedure, Preventive Surgical	4180186
979321	Procedure, Prophylactic Surgical	4180186
979321	Procedures, Preventive Surgical	4180186
979321	Procedures, Prophylactic Surgical	4180186
979321	Prophylactic Surgical Procedure	4180186
979321	Surgical Procedure, Preventive	4180186
979321	Surgical Procedure, Prophylactic	4180186
979321	Surgical Procedures, Preventive	4180186
979321	Surgical Procedures, Prophylactic	4180186
979323	Ch'i Kung	4180186
979323	Qi Gong	4180186
979328	Bran Oil, Rice	4180186
979328	Oil, Rice Bran	4180186
979330	Infection, Roseolovirus	4180186
979330	Infections, Roseolovirus	4180186
979330	Roseolovirus Infection	4180186
979333	boulardii, Saccharomyces	4180186
979333	boulardius, Saccharomyces	4180186
979333	Saccharomyces boulardius	4180186
979334	Salmonella enterica serovar enteritidis	4180186
979337	Albumin Human	4180186
979337	Albumin, Human	4180186
979337	Albumin, Human Serum	4180186
979337	Human Albumin	4180186
979337	Human, Albumin	4180186
979337	Human Serum Albumin	4180186
979338	Injuries, Shoulder	4180186
979338	Injury, Shoulder	4180186
979338	Shoulder Injury	4180186
979338	SLAP Tear	4180186
979338	SLAP Tears	4180186
979338	Superior Labrum from Anterior to Posterior Injuries	4180186
979338	Tear, SLAP	4180186
979338	Tears, SLAP	4180186
979339	CT Scan, SPECT	4180186
979339	CT Scans, SPECT	4180186
979339	CT SPECT	4180186
979339	CT SPECTs	4180186
979339	CT SPECT Scan	4180186
979339	CT SPECT Scans	4180186
979339	Scan, CT SPECT	4180186
979339	Scans, CT SPECT	4180186
979339	Scan, SPECT CT	4180186
979339	Scans, SPECT CT	4180186
979339	SPECT CT	4180186
979339	SPECT, CT	4180186
979339	SPECT CT Scan	4180186
979339	SPECT CT Scans	4180186
979339	SPECT Scan, CT	4180186
979339	SPECT Scans, CT	4180186
979339	SPECTs, CT	4180186
979340	Examination, Slit Lamp	4180186
979340	Examinations, Slit Lamp	4180186
979340	Microscopy, Slit Lamp	4180186
979340	Slit Lamp Examination	4180186
979340	Slit Lamp Examinations	4180186
979343	beta-D-Galactopyranoside, (3beta)-solanid-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3))-	4180186
979344	TIBOLA	4180186
979344	African Tick Bite Fever	4180186
979344	African Tick-Bite Fever	4180186
979344	Far Eastern Spotted Fever	4180186
979344	Fever, African Tick-Bite	4180186
979344	Fever, Japanese Spotted	4180186
979344	Fevers, Japanese Spotted	4180186
979344	Fever, Spotted	4180186
979344	Fevers, Spotted	4180186
979344	Flinders Island Spotted Fever	4180186
979344	Infection, Rickettsia aeschlimannii	4180186
979344	Infection, Rickettsia africae	4180186
979344	Infection, Rickettsia akari	4180186
979344	Infection, Rickettsia australis	4180186
979344	Infection, Rickettsia slovaca	4180186
979344	Infections, Rickettsia aeschlimannii	4180186
979344	Infections, Rickettsia africae	4180186
979344	Infections, Rickettsia akari	4180186
979344	Infections, Rickettsia australis	4180186
979344	Infections, Rickettsia slovaca	4180186
979344	Japanese Spotted Fever	4180186
979344	Japanese Spotted Fevers	4180186
979344	Lymphadenopathies, Tick-Borne	4180186
979344	Lymphadenopathy, Tick-Borne	4180186
979344	North Asian Tick Typhus	4180186
979344	Queensland Tick Typhus	4180186
979344	Rickettsia aeschlimannii Infection	4180186
979344	Rickettsia aeschlimannii Infections	4180186
979344	Rickettsia africae Infection	4180186
979344	Rickettsia africae Infections	4180186
979344	Rickettsia akari Infection	4180186
979344	Rickettsia akari Infections	4180186
979344	Rickettsia australis Infection	4180186
979344	Rickettsia australis Infections	4180186
979344	Rickettsialpox	4180186
979344	Rickettsia slovaca Infection	4180186
979344	Rickettsia slovaca Infections	4180186
979344	Spotted Fever	4180186
979344	Spotted Fever Group Rickettsioses	4180186
979344	Spotted Fever, Japanese	4180186
979344	Spotted Fevers	4180186
979344	Tick-Bite Fever, African	4180186
979344	Tick-Borne Lymphadenopathies	4180186
979344	Tick Borne Lymphadenopathy	4180186
979344	Tick-Borne Lymphadenopathy	4180186
979344	Tick Typhus, Queensland	4180186
979344	Typhus, Queensland Tick	4180186
979346	Artery Stenoses, Pulmonary	4180186
979346	Artery Stenosis, Pulmonary	4180186
979346	Pulmonary Artery Stenoses	4180186
979346	Pulmonary Artery Stenosis	4180186
979346	Stenoses, Pulmonary Artery	4180186
979356	Clostridial Neurotoxin	4180186
979356	Clostridium tetani Toxin	4180186
979356	Neurotoxin, Clostridial	4180186
979356	Tetanus Toxins	4180186
979356	Toxin, Clostridium tetani	4180186
979356	Toxins, Tetanus	4180186
979356	Toxin, Tetanus	4180186
979357	Tetraploid	4180186
979357	Tetraploidies	4180186
979357	Tetraploids	4180186
979359	Transcatheter Aortic Valve Implantation	4180186
979361	Wolfram	4180186
979362	Doppler Ultrasonography	4180186
979362	Doppler Ultrasound	4180186
979362	Doppler Ultrasound Imaging	4180186
979362	Doppler Ultrasound Imagings	4180186
979362	Doppler Ultrasounds	4180186
979362	Imaging, Doppler Ultrasound	4180186
979362	Imagings, Doppler Ultrasound	4180186
979362	Ultrasound, Doppler	4180186
979362	Ultrasound Imaging, Doppler	4180186
979362	Ultrasound Imagings, Doppler	4180186
979362	Ultrasounds, Doppler	4180186
979365	Nitrate, Uranium	4180186
979365	Nitrate, Uranyl	4180186
979365	Uranium, bis(nitrato-O)dioxo-, (T-4)-	4180186
979365	Uranium Nitrate	4180186
979369	His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	4180186
979369	Intestinal Peptide, Vasoactive	4180186
979369	Intestinal Polypeptide, Vasoactive	4180186
979369	Peptide, Vasoactive Intestinal	4180186
979369	Peptide, Vasointestinal	4180186
979369	Polypeptide, Vasoactive Intestinal	4180186
979369	Vasoactive Intestinal Polypeptide	4180186
979369	Vasointestinal Peptide	4180186
979369	VIP (Vasoactive Intestinal Peptide)	4180186
979374	1,1',1'',1'''-(ethylenedinitrilo)tetra-2-propanol monotosylate	4180186
979374	N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine	4180186
979374	Quadrol	4180186
979374	tetrahydroxypropyl ethylenediamine	4180186
979377	1,4-diphenyl-1,3-butadiene	4180186
979377	(E,E')-1,4-diphenyl-1,3-butadiene	4180186
979384	2,3-dihydroxybenzoate	4180186
979384	2,3-dihydroxy benzoic acid	4180186
979384	2-pyrocatechuic acid	4180186
979384	2-pyrocatechuic acid, sodium salt	4180186
979384	dihydroxybenzoic acid	4180186
979384	ferri-2,3-dihydroxybenzoic acid	4180186
979384	o-pyrocatechuic acid	4180186
979388	2-aminophenol, hydrochloride	4180186
979388	2-aminophenol, ion (1+)	4180186
979388	2-aminophenol, monopotassium salt	4180186
979388	2-aminophenol, monosodium salt	4180186
979388	o-aminophenol	4180186
979388	ortho-aminophenol	4180186
979390	boscalid	4180186
979391	2-fucosyllactose	4180186
979391	lactose, 2'-O-fucosyl-	4180186
979395	2-oxo-4-thiazolidine carboxylic acid	4180186
979395	2-oxothiazolidine-4-carboxylate	4180186
979395	2-oxothiazolidine-4-carboxylic acid, (R)-isomer	4180186
979395	2-oxothiazolidine-4-carboxylic acid, (S)-isomer	4180186
979395	4-Thiazolidinecarboxylic acid, 2-oxo-	4180186
979395	L-2-OTZD-4-CXA	4180186
979395	L-2-oxothiazolidine-4-carboxylate	4180186
979395	oxothiazolidinecarboxylic acid	4180186
979395	Procysteine	4180186
979398	CCC dysplasia	4180186
979398	Craniocerebellocardiac dysplasia	4180186
979398	Dandy-Walker-like malformation with atrioventricular septal defect	4180186
979398	Ritscher Schinzel syndrome	4180186
979398	Ritscher-Schinzel Syndrome	4180186
979399	phenylethyl resorcinol	4180186
979401	4-anisaldehyde, 1,2,3,4,5,6-(14)C6-labeled	4180186
979401	4-anisaldehyde, 18O-labeled	4180186
979401	4-anisaldehyde, formyl-(14)C-labeled	4180186
979401	4-methoxybenzaldehyde	4180186
979401	anisaldehyde	4180186
979401	benzaldehyde, 4-methoxy-	4180186
979401	p-anisaldehyde	4180186
979401	para-anisaldehyde	4180186
979401	p-methoxybenzaldehyde	4180186
979403	alpha-isobutylphenethyl alcohol	4180186
979403	benzylisobutylcarbinol	4180186
979403	COE 2031	4180186
979403	COE-2031	4180186
979403	FEMA 2208	4180186
979403	FEMA-2208	4180186
979406	7-ADCA	4180186
979406	7-aminodeacetoxycephalosporanic acid	4180186
979406	7-desacetoxyaminocephalosporanic acid	4180186
979410	Ablepharon-Macrostomia Syndrome	4180186
979412	Vici syndrome	4180186
979416	acetyl dipeptide-1 cetyl ester	4180186
979417	Achalasia microcephaly syndrome	4180186
979417	Achalasia-Microcephaly Syndrome	4180186
979420	Elejalde syndrome	4180186
979422	Palagonia type of acrofacial dysostosis	4180186
979428	Pseudopapilledema, Ocular Hypotelorism, Blepharophimosis, and Hand Anomalies	4180186
979430	ACRPV	4180186
979431	Acrorenal-Mandibular Syndrome	4180186
979431	Acro-renal-uterine-mandibular syndrome	4180186
979431	Acrorenal-Uterine-Mandibular Syndrome	4180186
979431	Split hand and split foot with mandibular hypoplasia	4180186
979431	Split-Hand And Split-Foot With Mandibular Hypoplasia	4180186
979434	Citrin deficiency	4180186
979434	Citrullinemia, Type II, Adult-Onset	4180186
979437	Al-Awadi-Raas-Rothschild Syndrome	4180186
979437	Al Awadi Rass Rothschild syndrome	4180186
979437	Limb-Pelvis Hypoplasia-Aplasia syndrome	4180186
979437	Limb-Pelvis-Hypoplasia-Aplasia Syndrome	4180186
979437	Schinzel phocomelia syndrome	4180186
979437	Ulna and fibula absence of with severe limb deficiency	4180186
979437	Ulna And Fibula, Absence Of, With Severe Limb Deficiency	4180186
979439	Albinism, Ocular, With Late-Onset Sensorineural Deafness	4180186
979439	Albinism, Ocular, With Sensorineural Deafness	4180186
979439	Deafness and ocular albinism	4180186
979439	Ocular albinism with sensorineural deafness	4180186
979439	Waardenburg Syndrome, Type Ii, With Ocular Albinism, Autosomal Recessive	4180186
979439	Ws2-Oa	4180186
979443	Alopecia, psychomotor epilepsy, pyorrhea, and mental subnormality	4180186
979443	Congenital universal alopecia, epilepsy, mental subnormality and pyorrhea	4180186
979443	Shokeir syndrome	4180186
979444	4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one	4180186
979444	alpha-ionone, (E)-isomer	4180186
979444	alpha-ionone, (E)-(+-)-isomer	4180186
979444	alpha-ionone, (+)-iosmer	4180186
979445	2 alpha ketoglutarate dehydrogenase deficiency	4180186
979445	2-Ketoglutarate Dehydrogenase Deficiency	4180186
979445	Oxoglutaricaciduria	4180186
979445	Oxoglutaric Aciduria	4180186
979447	AMME Complex	4180186
979454	Angel-shaped phalango-epiphyseal dysplasia	4180186
979454	Angel-Shaped Phalangoepiphyseal Dysplasia	4180186
979455	Ankyloblepharon Filiforme Adnatum and Cleft Palate	4180186
979455	Ankyloblepharon filiforme adnatum cleft palate	4180186
979455	Ankyloblepharon filiforme congenitum	4180186
979455	Congenital filiform fusion of the eyelids with cleft palate and-or cleft lip	4180186
979457	Anophthalmia-Plus Syndrome	4180186
979457	Fryns anophthalmia syndrome	4180186
979457	Fryns Microphthalmia Syndrome	4180186
979457	Microphthalmia with Facial Clefting	4180186
979459	AICC complex	4180186
979459	antiinhibitor coagulant complex	4180186
979459	anti-inhibitory coagulant complex	4180186
979459	factor eight inhibitor bypassing activity	4180186
979459	factor VIII inhibitor bypassing activity	4180186
979459	factor VIII inhibitor bypassing fraction	4180186
979459	Feiba	4180186
979459	FEIBA-VH	4180186
979462	Aplasia Cutis Congenita of Limbs, Recessive	4180186
979462	Congenital absence of skin on the upper or lower limbs	4180186
979462	Recessive aplasia cutis congenita of the limbs	4180186
979467	Aristada	4180186
979468	Grange Occlusive Arterial Syndrome	4180186
979470	Arthrogryposis, distal, type 6	4180186
979470	Familial hand abnormality and sensori-neural deafness	4180186
979471	AMCD1	4180186
979471	Arthrogryposis, distal, type 1	4180186
979471	Arthrogryposis Multiplex Congenita, Distal, Type I	4180186
979471	Distal arthrogryposis, type 1	4180186
979471	Distal Arthrogryposis Type 1	4180186
979473	AMC, neurogenic type	4180186
979473	Arthrogryposis Multiplex Congenita, Neurogenic Type	4180186
979473	Neurogenic type of AMC	4180186
979474	Arthrogryposis Multiplex Congenita With Whistling Face	4180186
979474	Illium syndrome	4180186
979474	Illum Syndrome	4180186
979474	Lethal autosomal recessive arthrogryposis multiplex congenita with whistling face and calcifications of the nervous system	4180186
979475	ARCS	4180186
979475	ARCS1	4180186
979475	ARC syndrome	4180186
979475	Arthrogryposis multiplex congenita, renal dysfunction, and cholestasis	4180186
979475	Arthrogryposis, Renal Dysfunction, And Cholestasis	4180186
979475	Arthrogryposis, renal dysfunction, and cholestasis 1	4180186
979477	Aoiii	4180186
979477	Atelosteogenesis Type Iii	4180186
979479	Athabaskan Brainstem Dysgenesis Syndrome	4180186
979479	Bosley-Salih-Alorainy Syndrome	4180186
979479	Navajo brainstem syndrome	4180186
979481	Alpha-Thalassemia-Mental Retardation Syndrome, Nondeletion Type	4180186
979481	Alpha thalassemia mental retardation syndrome, non deletion type, X-linked	4180186
979481	Alpha-Thalassemia-Mental Retardation Syndrome, Nondeletion Type, X-Linked	4180186
979481	Alpha Thalassemia-Mental Retardation, X-Linked	4180186
979481	Alpha Thalassemia X-Linked Intellectual Disability Syndrome	4180186
979481	Alpha-thalassemia X-linked mental retardation syndrome	4180186
979481	Alpha Thalassemia X-Linked Mental Retardation Syndrome	4180186
979481	ATR non deletion type	4180186
979481	ATR, Nondeletion Type	4180186
979481	ATRX Syndrome	4180186
979481	X-linked alpha thalassemia mental retardation syndrome	4180186
979481	X-Linked Alpha-Thalassemia Mental Retardation Syndrome	4180186
979481	XLMR-Hypotonic Face Syndrome	4180186
979483	Cleft lip with progressive retinopathy	4180186
979487	Bamforth-Lazarus syndrome	4180186
979487	Hypothyroidism, athyroidal, with spiky hair and cleft palate	4180186
979487	Hypothyroidism cleft palate	4180186
979487	Hypothyroidism, Thyroidal, With Spiky Hair And Cleft Palate	4180186
979490	HDR syndrome	4180186
979490	Hypoparathyroidism, Sensorineural Deafness, And Renal Disease	4180186
979490	Nephrosis, nerve deafness, and hypoparathyroidism	4180186
979491	BLS, Type I	4180186
979491	HLA Class I Deficiency	4180186
979494	2-(((4-dimethylamino)phenyl)azo)-1,3-dimethyl-1H-imidazolium chloride	4180186
979499	BIW-8405	4180186
979499	Fasenra	4180186
979499	MEDI 563	4180186
979499	MEDI-563	4180186
979502	Benign Congenital Muscular Dystrophy	4180186
979502	Benign Congenital Myopathy with Contractures	4180186
979502	Muscular dystrophy, benign congenital	4180186
979502	Myopathy, benign congenital, with contractures	4180186
979503	BEVYXXA	4180186
979503	N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide	4180186
979503	PRT054021	4180186
979507	cupric di(1,10-phenanthroline)	4180186
979507	(o-phenanthroline) cupric	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, diacetate salt	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, diacetate salt, (SP-4-1)-isomer	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, dinitrate	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, diperchlorate	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, sulfate (1:1)	4180186
979507	Cu(OP)2	4180186
979507	Cu(Phen)2	4180186
979515	Vasterbotten Dystrophy	4180186
979517	Brachydactylous dwarfs of Mseleni	4180186
979519	Brachydactyly, Farabee type	4180186
979519	Brachydactyly, Type A1	4180186
979519	Farabee-Type Brachydactyly	4180186
979520	Brachydactyly, Type A2	4180186
979520	Brachymesophalangy 2	4180186
979520	Brachymesophalangy Ii	4180186
979520	Mohr-Wriedt type brachydactyly	4180186
979521	Brachydactyly, Type A6	4180186
979521	Osebold-Remondini syndrome	4180186
979530	acid blue 9	4180186
979530	blue 4	4180186
979530	blue no. 1	4180186
979530	brilliant blue Al (3:1) salt	4180186
979530	brilliant blue, aluminium salt	4180186
979530	brilliant blue diammonium salt	4180186
979530	brilliant blue dipotassium salt	4180186
979530	brilliant blue, disodium salt	4180186
979530	brilliant blue FCF	4180186
979530	brilliant blue FCF, diammonium salt	4180186
979530	brilliant blue potassium, sodium salt	4180186
979530	caries check blue	4180186
979530	C.I. 42090	4180186
979530	CI 42090	4180186
979530	D & C blue no.4	4180186
979530	DC blue no. 4	4180186
979530	erioglaucine	4180186
979530	F D & C blue #1	4180186
979530	FD&C blue No.1	4180186
979530	food blue 2	4180186
979535	Bilateral choanal atresia, cardiac defects, deafness, and dysmorphic appearance	4180186
979536	2-(butylamino)propan-2-yl)phosphinic acid	4180186
979536	butaphosphan	4180186
979539	Campomelia, Cumming Type	4180186
979539	Cervical lymphocele with bowed long bones	4180186
979539	Cumming syndrome	4180186
979545	epsilon-caprolactone	4180186
979545	epsilon-captolactamium hydrogen sulfate	4180186
979548	Cardiomyopathy, Dilated, With Woolly Hair And Keratoderma	4180186
979548	Carvajal syndrome	4180186
979548	DCWHK	4180186
979548	Epidermolytic palmoplantar keratoderma, woolly hair, and dilated cardiomyopathy	4180186
979548	Palmoplantar keratoderma with left ventricular cardiomyopathy and woolly hair	4180186
979549	3-(trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea	4180186
979549	cariprazine HCl	4180186
979549	cariprazine hydrochloride	4180186
979549	N'-(trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-N,N-dimethylurea monohydrochloride	4180186
979549	RGH-188	4180186
979549	trans-4-(2-(4-(2,3-dichlorophenyl)piperazine-1-yl)-ethyl)-N,N-dimethylcarbamoyl-cyclohexyl-amine hydrochloride	4180186
979549	Vraylar	4180186
979551	Gastric Leiomyosarcoma, Pulmonary Chondroma, and Extraadrenal Paraganglioma	4180186
979555	Cataract-Microcornea Syndrome	4180186
979555	Microcornea cataract syndrome	4180186
979555	Microcornea-Cataract Syndrome	4180186
979557	8-epicedrol	4180186
979562	ceric oxide (Ce2O3)	4180186
979562	ceric oxide (CeO)	4180186
979562	cerium dioxide	4180186
979562	cerium oxide	4180186
979562	cerium oxide (CeO2)	4180186
979562	nanoceria	4180186
979563	Ceroid Lipofuscinosis, Neuronal, Cathepsin D-Deficient	4180186
979563	Neuronal Ceroid Lipofuscinosis, Congenital	4180186
979563	Neuronal Ceroid Lipofuscinosis Due To Cathepsin D Deficiency	4180186
979570	Charcot-Marie-Tooth Disease, Autosomal Dominant, Type 2B	4180186
979570	Charcot-Marie-Tooth disease, axonal, Type 2B	4180186
979570	Charcot-Marie-Tooth disease, neuronal, Type 2B	4180186
979570	Charcot-Marie-Tooth Neuropathy, Type 2B	4180186
979570	CMT2B	4180186
979570	CMT 2B	4180186
979570	Hereditary motor and sensory neuropathy 2 B (HMSN 2 B)	4180186
979570	Hereditary Motor And Sensory Neuropathy IIB	4180186
979570	HMSN2B	4180186
979570	HMSN IIB	4180186
979570	Peripheral sensory neuropathy, autosomal dominant (PSN)	4180186
979572	ARCMT2B	4180186
979572	Charcot-Marie-Tooth disease, axonal, autosomal recessive, B2	4180186
979572	Charcot-Marie-Tooth Disease, Axonal, Autosomal Recessive, Type B2	4180186
979572	Charcot-Marie-Tooth disease, axonal, Type 2B2	4180186
979572	Charcot-Marie-Tooth disease, neuronal, Type 2B2	4180186
979572	Charcot-Marie-Tooth Neuropathy, Type 2B2	4180186
979572	CMT2B2	4180186
979572	CMT 2B2	4180186
979575	Charcot-Marie-Tooth disease, demyelinating, autosomal recessive	4180186
979575	Charcot-Marie-Tooth Neuropathy, Type 4a	4180186
979575	CMT4A	4180186
979576	Charcot-Marie-Tooth Disease, Autosomal Recessive, With Focally Folded Myelin Sheaths, Autosomal Recessive, Type 4b1	4180186
979576	Charcot-Marie-Tooth disease, Type 4B	4180186
979576	Charcot-Marie-Tooth Neuropathy, Type 4B1	4180186
979576	CMT4B	4180186
979576	CMT4B1	4180186
979583	Brain-Lung-Thyroid Syndrome	4180186
979583	Choreoathetosis And Congenital Hypothyroidism	4180186
979589	17q21.31 Deletion Syndrome	4180186
979589	17q21.31 Microdeletion Syndrome	4180186
979589	Chromosome 17q21.31 Microdeletion Syndrome	4180186
979589	Koolen-De Vries Syndrome	4180186
979589	Koolen Syndrome	4180186
979589	Microdeletion 17q21.31 Syndrome	4180186
979589	Monosomy 17q21.31	4180186
979590	Duplication 17p	4180186
979590	Trisomy 17p	4180186
979591	Deletion 2q24	4180186
979591	Monosomy 2q24	4180186
979592	Deletion 3q13	4180186
979592	Monosomy 3q13	4180186
979593	Microdeletion 3q29 Syndrome	4180186
979595	Deletion 5q35	4180186
979595	Monosomy 5q35	4180186
979598	Chromosome 9, tetrasomy 9p mosaicism	4180186
979598	Mosaic tetrasomy 9p	4180186
979598	Tetrasomy 9p	4180186
979598	Tetrasomy, short arm of chromosome 9	4180186
979600	CJC1295	4180186
979600	CJC-1295	4180186
979601	Capillary Malformation Of The Lower Lip, Lymphatic Malformation Of Face And Neck, Asymmetry Of Face And Limbs, And Partial-Generalized Overgrowth	4180186
979601	Clapo	4180186
979601	Lopez-Gutierrez Syndrome	4180186
979603	2-Pyridinecarboxylic acid, 3,6-dichloro-	4180186
979603	3,6-dichloropicolinic acid	4180186
979603	clopyralide	4180186
979603	Dowco 290	4180186
979603	Lontrel	4180186
979604	Cerebellar vermis hypo-aplasia, Oligophrenia, Ataxia congenital, Coloboma, and Hepatic fibrosis	4180186
979604	Cerebellar Vermis Hypo-Aplasia, Oligophrenia, Congenital Ataxia, Ocular Coloboma, And Hepatic Fibrosis	4180186
979606	coco-betaine	4180186
979606	cocobetaine, sodium salt	4180186
979606	coconut betaine	4180186
979608	Cerebral, ocular, dental, auricular, and skeletal syndrome	4180186
979608	Cerebral, Ocular, Dental, Auricular, Skeletal Anomalies Syndrome	4180186
979610	Coloboma Of Macula With Type B Brachydactyly	4180186
979610	Sorsby syndrome	4180186
979612	Carbohydrate-deficient glycoprotein syndrome, type 4	4180186
979612	CDG1D	4180186
979612	Congenital Disorder Of Glycosylation, Type ID	4180186
979616	Congenital Disorder of Glycosylation, Type IJ	4180186
979617	Congenital Disorder Of Glycosylation, Type IK	4180186
979621	CDG2E	4180186
979621	CDGIIE	4180186
979621	CDG IIE	4180186
979621	Congenital Disorder Of Glycosylation, Type IIE	4180186
979622	CDG2G	4180186
979622	CDGIIG	4180186
979622	CDG IIG	4180186
979622	Congenital Disorder Of Glycosylation, Type IIG	4180186
979623	CDG2B	4180186
979623	CDGIIB	4180186
979623	CDG IIB	4180186
979623	Glucosidase I Deficiency	4180186
979628	acid blue 90	4180186
979628	brilliant blue G	4180186
979628	C.I. 42655	4180186
979628	coomassie blue G	4180186
979628	Coomassie brilliant blue G250	4180186
979628	Coomassie brilliant blue G 250	4180186
979628	serva blue G	4180186
979628	supranol cyanine G	4180186
979628	xylene brilliant cyanine G	4180186
979629	9-cordyceposidoadenine	4180186
979629	3'-deoxyadenosine	4180186
979629	cordycepene	4180186
979629	cordycepine	4180186
979631	Corneal-Cerebellar Syndrome	4180186
979631	Corneal dystrophy with spinocerebellar degeneration	4180186
979631	Der kaloustian Jarudi Khoury syndrome	4180186
979631	Spinocerebellar degeneration and corneal dystrophy	4180186
979634	Band-Shaped And Whorled Microcystic Corneal Epithelial Dystrophy	4180186
979634	Lisch Epithelial Corneal Dystrophy	4180186
979637	Toriello-Carey Syndrome	4180186
979638	Congenital shortness of the costocoracoid ligament	4180186
979638	Costocoracoid Ligament, Congenitally Short	4180186
979645	CDAGS syndrome	4180186
979647	Craniosynostosis, Boston-Type	4180186
979647	Warman Mulliken Hayward syndrome	4180186
979648	Complex of anomalies involving the cranium and brain	4180186
979650	Cryptomicrotia-Brachydactyly Syndrome	4180186
979650	Cryptomicrotia brachydactyly syndrome excess fingertip arch	4180186
979650	Tonoki Ohura Niikawa syndrome	4180186
979651	1-hydroxycyclopentyl-alpha- phenylacetic acid beta-dimethylaminoethyl ester	4180186
979651	Cyclopent	4180186
979651	G.T. 92	4180186
979653	1,2,3,4,5,6-hexahydro-1,5-methano-8H- pyrido(1,2-a)(1,5)diazocin-8-one	4180186
979653	3-hydroxy-11-norcytisine	4180186
979653	citizine	4180186
979653	cystisin	4180186
979653	cytisine dihydrochloride, trihydrate	4180186
979653	cytisine hydrochloride	4180186
979653	cytisine hydrochloride, hydrate	4180186
979653	cytisine tetrahydrochloride, trihydrate	4180186
979653	cytiton	4180186
979653	Tabex	4180186
979653	Tsitizin	4180186
979654	Czech Dysplasia	4180186
979654	Progressive Pseudorheumatoid Dysplasia with Hypoplastic Toes	4180186
979654	Pseudorheumatoid dysplasia, progressive, with hypoplastic toes	4180186
979654	Spondyloarthropathy with Short Third and Fourth Toes	4180186
979658	Goiter, Multinodular, Cystic Renal Disease, and Digital Anomalies	4180186
979658	Multinodular goiter, cystic renal disease, and digital anomalies	4180186
979658	Multinodular Goiter-Cystic Renal Disease-Digital Anomalies	4180186
979659	Darzalex	4180186
979659	humax-CD38	4180186
979659	humax-CD 38	4180186
979664	Autosomal recessive sensorineural hearing impairment, dizziness, and hypodontia	4180186
979664	Congenital profound sensorineural deafness and oligodontia	4180186
979664	Deafness-Oligodontia Syndrome	4180186
979669	Dermatoosteolysis, Kirghizian Type	4180186
979669	Kirghizian Dermatoosteolysis	4180186
979677	Dicarboxylic aminoaciduria	4180186
979677	Dicarboxylic amino aciduria	4180186
979677	Dicarboxylicamino Aciduria	4180186
979677	Glutamate and aspartate transport defect	4180186
979677	Glutamate-Aspartate Transport Defect	4180186
979677	Inborn error of glutamic and aspartate transport	4180186
979683	dimethyl p-phthalate	4180186
979683	dimethylterephthalate	4180186
979683	dimethyl terephthalate	4180186
979685	1-octadecanaminium, N,N-dimethyl-N-octadecyl-	4180186
979685	DDBAS compound	4180186
979685	dimethyl-dioctadecyl-ammonium bromide	4180186
979685	dimethyldioctadecylammonium bromide	4180186
979685	dimethyldioctadecylammonium chloride	4180186
979685	dimethyldioctadecylammonium methyl sulfate	4180186
979685	dimethyldioctadecylammonium sulfate	4180186
979685	dimethyldistearylammonium	4180186
979685	dimethyldistearylammonium bisulfate	4180186
979685	dimethyldistearylammonium bromide	4180186
979685	dioctadecyldimethylammonium	4180186
979685	dioctadecyl dimethylammonium bromide	4180186
979685	dioctadecyldimethylammonium chloride	4180186
979685	dioctadecyldimethylammonium ion	4180186
979685	distearyldimethylammonium	4180186
979685	distearyl dimethyl ammonium bromide	4180186
979685	distearyldimethylammonium bromide	4180186
979685	distearyldimonium	4180186
979685	distearyldimonium chloride	4180186
979685	DODAB	4180186
979685	DSDAC cpd	4180186
979686	dimethyldisulfide	4180186
979686	methyl disulfide	4180186
979691	Chromosome 10, distal trisomy 10q	4180186
979691	Chromosome 10, Partial Trisomy 10q24-qter	4180186
979691	Chromosome 10, Trisomy 10q2	4180186
979691	Distal Duplication 10q	4180186
979692	1,2-divinylbenzene	4180186
979692	divinylbenzene	4180186
979693	Phocomelia, Thrombocytopenia, Encephalocele, Urogenital Malformations	4180186
979693	Von Voss-Cherstvoy Syndrome	4180186
979696	Mexoryl XL	4180186
979696	Silatrizole	4180186
979699	DYT16	4180186
979700	Paroxysmal Exercise-Induced Dystonia	4180186
979700	Paroxysmal Exertion-Induced Dyskinesia	4180186
979701	Dopa-Responsive Dystonia	4180186
979701	Dopa-responsive dystonia, autosomal dominant	4180186
979701	Dystonia 5	4180186
979701	Dystonia, Dopa-responsive, autosomal dominant	4180186
979701	Dystonia-Parkinsonism with diurnal fluctuation	4180186
979701	Dystonia, progressive, with diurnal variation	4180186
979701	Hereditary Progressive Dystonia with Marked Diurnal Fluctuation	4180186
979701	Segawa syndrome, autosomal dominant	4180186
979702	Parkinson Disease 14, Autosomal Recessive	4180186
979703	Ectodermal Dysplasia-Ectrodactyly-Macular Dystrophy	4180186
979703	EEM Syndrome	4180186
979704	Ectodermal dysplasia- skin fragility syndrome	4180186
979704	Mcgrath syndrome	4180186
979712	ACE910	4180186
979712	ACE-910	4180186
979712	emicizumab-kxwh	4180186
979712	Hemlibra	4180186
979714	Epidermolysis Bullosa Simplex and Limb-Girdle Muscular Dystrophy	4180186
979714	Epidermolysis Bullosa Simplex with Muscular Dystrophy	4180186
979716	Ebs-Pa	4180186
979716	Ebs With Pyloric Atresia	4180186
979719	Ataxia, Periodic Vestibulocerebellar	4180186
979719	Periodic Vestibulocerebellar Ataxia	4180186
979723	Corneal Erosions, Recurring Hereditary	4180186
979724	Erythrokeratodermia Variabilis, Kamouraska Type	4180186
979725	Erythrokeratodermia ataxia	4180186
979725	Giroux Barbeau Syndrome	4180186
979732	Eastman Bixler syndrome	4180186
979733	Bindewald Ulmer Muller syndrome	4180186
979734	Familial cavernous hemangioma	4180186
979734	Familial cerebral cavernous angioma	4180186
979735	Factor V And Factor VIII, Combined Deficiency Of	4180186
979735	Factor V And Factor VIII, Combined Deficiency Of, With Normal Protein C And Protein C Inhibitor	4180186
979735	Multiple Coagulation Factor Deficiency I	4180186
979735	Combined Deficiency of Factor V and Factor VIII	4180186
979735	F5F8D	4180186
979735	MCFD1	4180186
979735	FMFD1	4180186
979735	FMFD I	4180186
979736	Osteochondritis Dissecans, Short Stature, and Early-Onset Osteoarthritis	4180186
979739	Femur, Unilateral Bifid, With Monodactylous Ectrodactyly	4180186
979739	Gollop-Wolfgang complex	4180186
979740	Bay 68138	4180186
979740	ethyl 4-(methylthio)m-tolyl isopropylphosphoroamidate	4180186
979740	Nemacur	4180186
979740	phenamiphos	4180186
979750	Anterior Opercular Syndrome	4180186
979750	Bilateral Anterior Opercular Syndrome	4180186
979750	Congenital Foix-Chavany-Marie syndrome	4180186
979750	Facio-Labio-Pharyngo-Glosso-Laryngo-Brachial Paralysis	4180186
979750	Facio-Pharyngo-Glossal Diplegia with Automatic-Voluntary Movement Dissociation	4180186
979750	Opercular Syndrome, Anterior	4180186
979750	Pseudobulbar Paralysis, Cortical Type	4180186
979752	Congenital heart disease, deafness, and skeletal malformations	4180186
979752	Mitral Regurgitation, Conductive Deafness, and Fusion of Cervical Vertebrae and of Carpal and Tarsal Bones	4180186
979753	Emend for injection	4180186
979753	fosaprepitant dimeglumine	4180186
979753	L 785,298	4180186
979753	L-785,298	4180186
979753	L785,298	4180186
979754	Mental retardation-deafnes, skeletal abnormalities, coarse face with full lips	4180186
979754	Mental Retardation, Sensorineural Deafness, Skeletal Abnormalities, And Coarse Face With Full Lips	4180186
979756	Macrocephaly with Spastic Paraplegia and Distinctive Craniofacial Appearance	4180186
979758	fumidil B	4180186
979766	2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (2E)-	4180186
979766	geraniol acetate	4180186
979766	geraniol acetate, (E)-isomer	4180186
979766	geraniol acetate, (Z)-isomer	4180186
979766	nerol acetate	4180186
979766	neryl acetate	4180186
979767	EGb761	4180186
979767	EGb 761	4180186
979767	EGb-761	4180186
979767	GBE 761	4180186
979767	GBE-761	4180186
979767	GBE 761 ONC	4180186
979767	Ginkgo biloba extract 761	4180186
979767	Ginkgo leaf extract	4180186
979767	Rokan	4180186
979767	Tanakan	4180186
979767	Tebofortran	4180186
979767	Tebokan	4180186
979767	Tebonin	4180186
979770	1,2,3,4,6-penta-O-acetyl-alpha-D-glucopyranoside	4180186
979770	beta-D-glucose pentaacetate	4180186
979770	glucose pentaacetate, (alpha-D)-isomer	4180186
979770	glucose pentaacetate, (beta-(D))-isomer	4180186
979770	glucose pentaacetate, (D)-isomer	4180186
979770	penta-O-acetyl-alpha-D-glucopyranose	4180186
979770	penta-O-acetylglucopyranose	4180186
979771	2,3-epoxypropyl methacrylate	4180186
979771	monomethacrylate propylene oxide	4180186
979771	Sta-Lock	4180186
979772	gE protein, VZV	4180186
979772	glycoprotein E, human herpesvirus 3	4180186
979772	glycoprotein E, VZV	4180186
979772	glycoprotein gE, VZV	4180186
979772	glycoprotein gp1, varicella-zoster virus	4180186
979772	glycoprotein I VZV	4180186
979772	gp1 VZV	4180186
979772	ORF68 protein, VZV	4180186
979772	varicella zoster virus glycoprotein E	4180186
979772	varicella-zoster virus glycoprotein gp1	4180186
979772	VZV gE	4180186
979772	VZV gp1	4180186
979775	Goldberg-Shprintzen syndrome	4180186
979779	Habrodysplasia	4180186
979779	Osteocraniosplenic syndrome	4180186
979779	Osteocraniostenosis	4180186
979779	Skeletal dysplasia, lethal, with gracile bones	4180186
979781	1-(2-(4-(2-ethyl-4,6-dimethylimidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)-3-(4-methylphenyl)sulfonylurea	4180186
979783	Hoepffner dreyer reimers syndrome	4180186
979783	Insulin, Insulin-Like Growth Factor I, and Epidermal Growth Factor Deficiency	4180186
979783	Peptide growth factors deficiency	4180186
979783	Peptidic growth factors deficiency	4180186
979783	Werner-Like Syndrome due to Combined Growth Factor Deficiency	4180186
979786	CNTO 1959	4180186
979786	CNTO-1959	4180186
979786	Tremfya	4180186
979789	Hidrotic ectodermal dysplasia Halal type	4180186
979790	Microcephaly cleft palate autosomal dominant	4180186
979791	Cholestasis-pigmentary retinopathy-cleft palate syndrome	4180186
979792	Craniofacial digital genital anomalies	4180186
979792	Harrod syndrome	4180186
979794	Cardioskeletal syndrome, Kuwaiti type	4180186
979794	Congenital heart disease and skeletal malformations	4180186
979796	Brachydactyly and intraventricular conduction defect	4180186
979796	Upper limb malformations and congenital cardiac anomalies	4180186
979798	Hemochromatosis due to defect in transferrin receptor 2	4180186
979799	Hemochromatosis, autosomal dominant	4180186
979799	Hemochromatosis due to defect in ferroportin	4180186
979800	Coloboma of macula	4180186
979800	Agenesis of macula	4180186
979800	Macular coloboma	4180186
979803	ammonium hexafluorosilicate	4180186
979803	cesium hexafluosilicate	4180186
979803	hexafluorosilicate (2-)	4180186
979803	hexafluorosilicate, ammonium salt	4180186
979803	hexafluorosilicate, barium salt	4180186
979803	hexafluorosilicate, calcium salt	4180186
979803	hexafluorosilicate, magnesium salt	4180186
979803	hexafluorosilicate, magnesium salt, hydrate	4180186
979803	hexafluorosilicate, potassium salt	4180186
979803	hexafluorosilicate, sodium salt	4180186
979803	magnesium fluorosilicate	4180186
979803	magnesium hexafluorosilicate	4180186
979803	Na(2)SiF(6)	4180186
979803	sodium fluorosilicate	4180186
979803	sodium fluosilicate	4180186
979803	sodium hexafluorosilicate	4180186
979807	Astragali radix (Astragalus membranaceus)	4180186
979807	Astragalus membranaceus root	4180186
979807	Astragalus membranaceus root extract	4180186
979807	Astragalus membranaceus root powder	4180186
979807	Astragalus propinquus root	4180186
979807	Astragalus root (Astragalus propinquus)	4180186
979807	Huang Qi (Astragalus mongholicus Bunge)	4180186
979807	Huang Qi (Astragalus propinquus)	4180186
979807	membranous milkvetch root	4180186
979807	Mo Jia Huang Qi	4180186
979807	Phaca membranacea root	4180186
979807	Radix Astragali	4180186
979807	Radix Astragali seu Hedysari	4180186
979807	RAH extract	4180186
979810	Communicating hydrocephalus, endocardial fibroelastosis (EFE) and congenital cataracts	4180186
979815	Hyperinsulinism-hyperammonemia syndrome	4180186
979816	Deficiency of Methionine Adenosyltransferase	4180186
979816	Glycine N-Methyltransferase Deficiency	4180186
979816	GNMT Deficiency	4180186
979816	Hepatic Methionine Adenosyltransferase Deficiency	4180186
979816	Hypermethioninemia, Isolated Persistent	4180186
979816	Hypermethioninemia with Deficiency of S-Adenosylhomocysteine Hydrolase	4180186
979816	Methionine Adenosyltransferase Deficiency	4180186
979816	Methioninemia	4180186
979816	S-Adenosylhomocysteine Hydrolase Deficiency	4180186
979822	Hypomagnesemia, Familial, with Hypercalciuria, Nephrocalcinosis, and Severe Ocular Involvement	4180186
979822	Hypomagnesemia, Renal, with Ocular Involvement	4180186
979822	Macular Coloboma, Bilateral, with Hypercalciuria	4180186
979827	Hereditary hypotrichosis simplex	4180186
979829	3-((6-deoxymannopyranosyl)oxy)-7-(glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one	4180186
979831	Epidermolytic Ichthyosis, Annular	4180186
979840	IGF-I Resistance	4180186
979840	Somatomedin C, Resistance To	4180186
979840	Somatomedin, End-Organ Insensitivity To	4180186
979842	125I radioisotope	4180186
979842	I-125 radioisotope	4180186
979845	Coxopodopatellar Syndrome	4180186
979845	Scott-Taor syndrome	4180186
979845	Small patella syndrome	4180186
979847	Duplication-Inversion 15q11	4180186
979847	Idic(15)	4180186
979847	Inv Dup(15)	4180186
979847	Inverted Duplication 15	4180186
979847	Isodicentric Chromosome 15	4180186
979847	Non-Distal Tetrasomy 15q	4180186
979855	Fibromatosis gingival progressive deafness	4180186
979855	Fibromatosis, Gingival, With Progressive Deafness	4180186
979855	Gingival fibromatosis with progressive deafness	4180186
979855	Gingival fibromatosis with sensorineural hearing loss	4180186
979856	Cleft Lip-Palate With Abnormal Thumbs And Microcephaly	4180186
979856	Juberg-Hayward Syndrome	4180186
979856	OFDS VIII	4180186
979856	Oral-Facial-Digital Syndrome, Type VIII	4180186
979856	Oral-Facial-Digital Syndrome with Hypoplastic Epiglottis	4180186
979856	Orocraniodigital syndrome	4180186
979857	Osteopenia and sparse hair	4180186
979857	Osteopenia mental retardation sparse hair	4180186
979860	Cleft lip palate, facial, eye, heart and intestinal anomalies	4180186
979860	Long columella with cleft lip-palate and eye, heart, and intestinal anomalies	4180186
979861	Cataract mental retardation anal atresia urinary defects	4180186
979861	Congenital cataract with multiple congenital anomalies in a sibship	4180186
979864	Epithelioma, self-healing squamous, 1	4180186
979864	Ferguson-Smith Type epithelioma	4180186
979864	Multiple self-healing squamous epithelioma	4180186
979866	Cochin Jewish disorder	4180186
979866	Haim-Munk syndrome	4180186
979867	Pulmonic stenosis, brachytelephalangism, and calcification of cartilages	4180186
979871	Telecanthus, hypertelorism, strabismus, and pes cavus syndrome	4180186
979872	KRPPD Kufor Rakeb pallidopyramidal degeneration with supranuclear upgaze paresis and dementia	4180186
979872	Pallidopyramidal Degeneration with Supranuclear Upgaze Paresis and Dementia	4180186
979872	Parkinson disease 9	4180186
979878	Retinal Degeneration, Late-Onset, Autosomal Dominant	4180186
979879	3-beta-hydroxysteroid-delta(5)-desaturase deficiency	4180186
979879	Deficiency of 3-beta-hydroxysteroid-delta(5)-desaturase	4180186
979879	Sterol C5-Desaturase Deficiency	4180186
979881	Cox deficiency, French Canadian type	4180186
979881	Cox Deficiency, French-Canadian Type	4180186
979881	Cox deficiency, Saguenay Lac saint Jean type	4180186
979881	Cox Deficiency, Saguenay-Lac Saint-Jean Type	4180186
979881	Cytochrome c oxidase deficiency, French Canadian type	4180186
979881	Cytochrome C Oxidase Deficiency, French-Canadian Type	4180186
979881	Leigh Syndrome, French-Canadian Type	4180186
979881	Leigh syndrome, Saguenay Lac saint Jean type	4180186
979881	Leigh Syndrome, Saguenay-Lac Saint-Jean Type	4180186
979882	Ectodermal Dysplasia, Hypohidrotic, with Acanthosis Nigricans	4180186
979886	Lethal autosomal recessive syndrome of multiple congenital contractures	4180186
979886	Multiple contracture syndrome, Finnish type	4180186
979887	Erythroderma lethal congenital	4180186
979887	Erythroderma, Lethal Congenital	4180186
979888	Dentoleukoencephalopathy	4180186
979889	Leukodystrophy, Hypomyelinating, With Atrophy Of The Basal Ganglia And Cerebellum	4180186
979896	Mammary hypoplasia, ectrodactyly, and other hand-foot anomalies	4180186
979901	Short tarsus absence of lower eyelashes	4180186
979901	Short Tarsus with Absence of Lower Eyelashes	4180186
979902	Lowry-Maclean Syndrome	4180186
979902	Mental retardation, cleft palate, eventration of diaphragm, congenital heart defect, glaucoma, craniosynostosis, and growth failure	4180186
979903	Epiphyseal dysplasia, microcephaly and nystagmus	4180186
979903	Epiphyseal Dysplasia, Microcephaly, And Nystagmus	4180186
979903	Lowry-Wood Syndrome	4180186
979905	Cataracts and testicular failure	4180186
979905	Hypogonadism-Cataract Syndrome	4180186
979908	Steroid dehydrogenase deficiency dental anomalies	4180186
979910	MacDermot-Winter syndrome	4180186
979910	Prominent glabella microcephaly hypogenitalism	4180186
979912	AEZS-130	4180186
979912	Aib-DTrp-DgTrp-CHO	4180186
979912	Aib-Trp-gTrp-CHO	4180186
979912	aminoisobutyryl-tryptophyl-tryptophanamine-formyl	4180186
979912	ARD-07	4180186
979912	EP1572	4180186
979912	EP 1572	4180186
979912	EP-1572	4180186
979912	JMV1843	4180186
979912	JMV 1843	4180186
979912	JMV-1843	4180186
979912	macimorelin acetate	4180186
979912	Macrilen	4180186
979914	MACS Syndrome	4180186
979918	hausmannite	4180186
979918	manganese monoxide	4180186
979918	manganese oxide, hydrate	4180186
979918	manganomanganic oxide	4180186
979918	manganous-manganic oxide	4180186
979918	Mn3O4	4180186
979920	Blepharophimosis, arachnodactyly, and congenital contractures	4180186
979920	Marden Walker like syndrome without psychomotor retardation	4180186
979920	Marden-Walker-Like Syndrome Without Psychomotor Retardation	4180186
979920	Van den Ende Gupta syndrome	4180186
979920	Van Den Ende-Gupta Syndrome	4180186
979920	VDEGS	4180186
979921	heptadecanoic acid	4180186
979921	margaric acid, 1-(11)C-labeled	4180186
979921	margaric acid, nickel (2+) salt	4180186
979921	margaric acid, potassium salt	4180186
979921	margaric acid, sodium salt	4180186
979921	omega I-123 heptadecanoic acid	4180186
979923	Adducted thumb with mental retardation	4180186
979923	Clasped thumb and mental retardation	4180186
979923	Crash syndrome	4180186
979923	Gareis-Mason syndrome	4180186
979923	Genetic Diseases, X-Linkeds	4180186
979923	L1 Syndrome	4180186
979923	Masa Syndrome	4180186
979923	Mental Retardation, Aphasia, Shuffling Gait, Adducted Thumbs (MASA)	4180186
979923	Mental Retardation, Aphasia, Shuffling Gait, And Adducted Thumbs	4180186
979923	Spastic paraplegia, type 1	4180186
979923	Spg1	4180186
979923	Thumb, congenital clasped, with mental retardation	4180186
979923	X-Linked Complicated Hereditary Spastic Paraplegia Type 1	4180186
979923	X-Linked Corpus Callosum Agenesis	4180186
979923	X-Linked Hydrocephalus with Stenosis of the Aqueduct of Sylvius (Hsas)	4180186
979924	Leigh disease, maternally inherited	4180186
979924	Subacute necrotizing encephalomyelopathy maternally inherited	4180186
979926	Mental retardation, peculiar facies, kyphoscoliosis, diastasis recti, cryptorchidism, and congenital heart defect	4180186
979929	Cleft, median, of upper lip with polyps of facial skin and nasal mucosa	4180186
979929	Pai Levkoff syndrome	4180186
979929	Pai syndrome	4180186
979932	Cutaneous malignant melanoma and cerebral astrocytoma	4180186
979932	Melanoma and neural system tumor syndrome	4180186
979932	Melanoma-Astrocytoma Syndrome	4180186
979936	Carpenter-Waziri syndrome	4180186
979936	Chudley Lowry Hoar syndrome	4180186
979936	Chudley-Lowry Syndrome	4180186
979936	Chudley mental retardation syndrome	4180186
979936	Chudley syndrome 1	4180186
979936	Holmes-Gang syndrome	4180186
979936	Juberg-Marsidi Mental Retardation Syndrome	4180186
979936	Juberg Marsidi syndrome	4180186
979936	Juberg-Marsidi syndrome	4180186
979936	Mental retardation, x-linked, with growth retardation, deafness, and microgenitalism	4180186
979936	Mental Retradation, X-linked with Growth Delay, Deafness, Microgenitalism	4180186
979936	MRXHF1	4180186
979936	Smith-fineman-myers syndrome 1	4180186
979936	X-linked hypogonadism gynecomastia mental retardation	4180186
979936	X-Linked Mental Retardation-Hypotonic Facies Syndrome	4180186
979941	17beta-Hydroxysteroid Dehydrogenase Type 10 Deficiency	4180186
979941	17-Beta-Hydroxysteroid Dehydrogenase X Deficiency	4180186
979941	2-Methyl-3-Hydroxybutyric Aciduria	4180186
979941	2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency	4180186
979941	3-Hydroxy-2-Methylbutyryl-CoA Dehydrogenase Deficiency	4180186
979941	3-Hydroxyacyl-CoA Dehydrogenase II Deficiency	4180186
979941	3-Hydroxyacyl-CoA Dehydrogenase, Type 2, Deficiency	4180186
979941	Chorioathetosis With Mental Retardation And Abnormal Behavior	4180186
979941	HSD17B10 Deficiency	4180186
979941	Hydroxyacyl-CoA Dehydrogenase II Deficiency	4180186
979941	Hydroxyacyl-CoA Dehydrogenase, Type 2, Deficiency	4180186
979941	Mental Retardation With Chorioathetosis And Abnormal Behavior	4180186
979941	MRXS10	4180186
979942	Dandy-Walker malformation with mental retardation, basal ganglia disease, and seizures	4180186
979942	Mental retardation, X-linked, with Dandy-Walker malformation, basal ganglia disease, and seizures	4180186
979942	Pettigrew syndrome	4180186
979943	Cabezas Syndrome	4180186
979943	Cabezas X-Linked Mental Retardation Syndrome	4180186
979943	Mental Retardation, X-Linked, Syndromic 15	4180186
979943	Mental Retardation, X-Linked, With Short Stature, Small Testes, Muscle Wasting, And Tremor	4180186
979943	MRXS15	4180186
979944	Bosatria	4180186
979944	Nucala	4180186
979944	SB240563	4180186
979944	SB-240563	4180186
979945	Mesomelia synostoses	4180186
979945	Verloes-David syndrome	4180186
979953	9-octadecenoic acid, methyl ester, (9E)-	4180186
979953	9-octadecenoic acid (Z)-, methyl ester	4180186
979953	methyl elaidate	4180186
979953	methyl oleate, (E)-isomer	4180186
979953	oleic acid methyl ester	4180186
979954	dimethyl 4-nitrophenyl phosphate	4180186
979954	dimethyl p-nitrophenyl phosphate	4180186
979954	MEE 600	4180186
979954	methyl paraoxon	4180186
979955	Microcephalic primordial dwarfism and cataracts	4180186
979955	Microcephalic Primordial Dwarfism, Toriello Type	4180186
979956	Albinism-Microcephaly digital anomalies syndrome	4180186
979956	Albinism-Microcephaly-Digital Anomalies Syndrome	4180186
979956	Microcephaly-Albinism-Digital Anomalies Syndrome	4180186
979957	Microcephaly, mild mental retardation, short stature, and skeletal anomalies	4180186
979957	Microcephaly with Cervical Spine Fusion Anomalies	4180186
979961	benzamide, N-(2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-1-oxo-8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-10-yl)-N-methyl-, (8alpha,9beta,10beta,12alpha)-	4180186
979961	4'-N-benzoylstaurosporine	4180186
979961	4'-N-benzoyl staurosporine	4180186
979961	benzoylstaurosporine	4180186
979961	CGP 41251	4180186
979961	CGP 41 251	4180186
979961	CGP-41251	4180186
979961	N-((9S,10R,11R,13R)-10-methoxy-9-methyl-1-oxo-2,3,10,11,12,13-hexahydro-9,13-epoxy-1H,9H-diindolo(1,2,3-GH:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-11-yl)-n-methylbenzamide	4180186
979961	PKC412	4180186
979961	PKC 412	4180186
979961	PKC-412	4180186
979961	Rydapt	4180186
979965	99Mo radioisotope	4180186
979965	Mo-99 radioisotope	4180186
979966	1-amino-2-propanol	4180186
979966	isopropanolamine	4180186
979969	Hydronephrosis Due To Pujo	4180186
979969	Pelvi-ureteric junction obstruction	4180186
979969	Pelviureteric Junction Obstruction	4180186
979972	2,4,6-trinitro-1,3-dimethyl-5-tert-butylbenzene	4180186
979972	2,4,6-trinitro-3,5-dimethyl-tert-butylbenzene	4180186
979972	5-tert-butyl-2,4,6-trinitroxylene	4180186
979972	musk xylol	4180186
979978	CL 1700	4180186
979978	N-acetylcarnosine, (DL)-isomer	4180186
979978	N-acetyl-L-carnosine aluminum	4180186
979981	Spastic paraplegia, mental retardation and thin corpus callosum	4180186
979983	2-(2'-hydroxyoctadecanoylamino)-1,3,4-octadecanetriol	4180186
979983	ceramide 6	4180186
979983	ceramide AP	4180186
979983	DL-CER6	4180186
979984	benzin	4180186
979984	benzine	4180186
979984	petroleum ether	4180186
979986	Nasopalpebral Lipoma-Coloboma Syndrome	4180186
979986	Palpebral coloboma lipoma Syndrome	4180186
979986	Palpebral Coloboma-Lipoma Syndrome	4180186
979988	Congenital myopathy cleft palate and malignant hyperthermia	4180186
979988	Myopathy, Congenital, With Cleft Palate And Malignant Hyperthermia	4180186
979989	Keratosis palmoplantaris with arrhythmogenic cardiomyopathy	4180186
979989	Mal de Naxos	4180186
979989	Palmoplantar keratoderma with arrhythmogenic right ventricular cardiomyopathy and woolly hair	4180186
979989	Woolly hair, palmoplantar keratoderma, and cardiac abnormalities	4180186
979990	N-cyclohexyl-N'-phenylparaphenylenediamine	4180186
979991	11F8	4180186
979991	IMC-11F8	4180186
979991	IMC-11F8 monoclonal antibody	4180186
979991	Portrazza	4180186
979995	Freire-Maia Pinheiro Opitz syndrome	4180186
980004	n-hexane, 1-(13)C-labeled cpd	4180186
980004	n-hexane, 2-(13)C-labeled cpd	4180186
980004	n-hexane, 3-(13)C-labeled cpd	4180186
980005	nicotinuric acid, monosodium salt	4180186
980007	Chondrodysplasia pseudohermaphrodism syndrome	4180186
980007	Chondrodysplasia-pseudohermaphroditism syndrome	4180186
980007	Pseudohermaphrodism and chondrodysplasia	4180186
980008	lauroyl proline	4180186
980009	1-methyl-2-pyrrolidinone	4180186
980009	1-methyl-2-pyrrolidinone, 1-methyl-(14)C-labeled	4180186
980009	1-methyl-2-pyrrolidinone, 2,3,4,5-(14)C-labeled	4180186
980009	methyl pyrrolidone	4180186
980009	N-methyl-2-pyrrolidinone	4180186
980009	N-methyl-2-pyrrolidone	4180186
980009	N-methylpyrrolidinone	4180186
980009	pharmasolve	4180186
980012	Lissencephaly 2	4180186
980012	Lissencephaly syndrome, Norman-Roberts type	4180186
980017	Anthim	4180186
980017	ETI-204	4180186
980019	octadecane, 1-(14)C-labeled cpd	4180186
980019	octadecane, 14C-labeled cpd	4180186
980025	Boder syndrome	4180186
980025	Odontoma-Dysphagia Syndrome	4180186
980025	Odontomatosis (multiple odontomas) with dysphagia	4180186
980028	Congenital trichomegaly, pigmentary retinal degeneration, and short stature	4180186
980028	Eyelashes long mental retardation	4180186
980028	Oliver McFarlane syndrome	4180186
980028	Trichomegaly retina pigmentary degeneration dwarfism	4180186
980031	OMOD2	4180186
980031	Omodysplasia, Autosomal Dominant	4180186
980036	Opa3, Autosomal Dominant	4180186
980036	Optic Atrophy 3, Autosomal Dominant	4180186
980036	Optic atrophy, cataract, and neurologic disorder	4180186
980037	Optic atrophy 2	4180186
980037	Optic atrophy, non-Leber type, with early onset	4180186
980040	OFD9	4180186
980040	OFDS IX	4180186
980040	Oral-facial-digital syndrome 9	4180186
980040	Oral Facial Digital Syndrome, Type IX	4180186
980040	Oral-facial-digital syndrome with retinal abnormalities	4180186
980040	Orofaciodigital syndrome IX	4180186
980040	Orofaciodigital Syndrome, Type 9	4180186
980040	Orofaciodigital syndrome with retinal abnormalities	4180186
980041	Oral-Facial-Digital Syndrome, Type X	4180186
980041	Oral-Facial-Digital Syndrome with Fibular Aplasia	4180186
980041	Orofaciodigital Syndrome with Fibular Aplasia	4180186
980045	Dacryocystitis osteopoikilosis	4180186
980045	Gunal Seber Basaran syndrome	4180186
980047	1-cyclopropyl-8-methyl-7-(5-methyl-6-(methylamino)-3-pyridinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid	4180186
980047	xepi	4180186
980047	ozanex	4180186
980049	Median cleft upper lip, mental retardation and pugilistic facies	4180186
980049	W syndrome	4180186
980051	Diffuse palmoplantar keratoderma with deafness	4180186
980051	Focal palmoplantar keratoderma with sensorineural deafness	4180186
980051	Hereditary palmoplantar keratoderma with deafness	4180186
980051	Keratoderma palmoplantar deafness	4180186
980051	Keratoderma palmoplantar, with deafness	4180186
980051	Keratoderma, Palmoplantar, With Deafness	4180186
980051	Palmoplantar Hyperkeratosis-Deafness Syndrome	4180186
980051	Palmoplantar Hyperkeratosis-Hearing Loss Syndrome	4180186
980051	Palmoplantar keratoderma and sensorineural deafness	4180186
980051	Palmoplantar Keratoderma-Deafness Syndrome	4180186
980051	Palmoplantar Keratoderma-Hearing Loss Syndrome	4180186
980051	Ppk-Deafness Syndrome	4180186
980051	Ppk with Deafness	4180186
980056	Blepharonasofacial malformation syndrome	4180186
980057	RLY5016	4180186
980057	RLY 5016	4180186
980057	RLY-5016	4180186
980057	Veltassa	4180186
980059	3beta, 20-dihydroxy-5alpha-cevan-6-one	4180186
980059	fritillarine	4180186
980059	imperialine	4180186
980059	peiminine, (3beta,5alpha,17beta)-isomer	4180186
980059	peiminine, (3beta,5alpha,25alpha)-isomer	4180186
980059	peiminine hydrochloride, (3beta,5alpha,17beta)-isomer	4180186
980059	peiminine nitrate salt, (3beta,5alpha,17beta)-isomer	4180186
980059	sipeimine	4180186
980059	zhebeinone	4180186
980060	Cousin Syndrome	4180186
980060	Craniofacial Dysmorphism, Hypoplasia of Scapula and Pelvis, and Short Stature	4180186
980060	Pelvic shoulder dysplasia	4180186
980063	COVERNOX	4180186
980069	Short stature, mental retardation and multiple dysmorphisms	4180186
980071	Pfeiffer-Palm-Teller Syndrome	4180186
980073	1-phenyl-3-methyl-5-pyrazolone	4180186
980073	3H-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-	4180186
980073	3-methyl-1-phenyl-2-pyrazolin-5-one	4180186
980073	edarabone	4180186
980073	edaravone	4180186
980073	MCI 186	4180186
980073	MCI-186	4180186
980073	norantipyrine	4180186
980073	norphenazone	4180186
980073	Radicava	4180186
980074	FVAPFP	4180186
980074	hexapeptide-11	4180186
980077	PSAT Deficiency	4180186
980078	dimethyl N,N'-(((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)pyrrolidine-2,5-diyl)bis((6-fluoro-1h-benzimidazole-5,2-diyl)((2S)-pyrrolidine-2,1-diyl)((2S,3R)-3-methoxy-1-oxobutane-1,2-diyl)))biscarbamate	4180186
980078	ABT-530	4180186
980078	A-1325912.0	4180186
980080	Chitayat Meunier Hodgkinson syndrome	4180186
980080	Robin sequence with facial and digital anomalies	4180186
980081	Microcoria and congenital nephrotic syndrome	4180186
980081	Microcoria-Congenital Nephrotic Syndrome	4180186
980081	Nephrotic Syndrome, Congenital, With Ocular Abnormalities And Congenital Myasthenic Syndrome	4180186
980083	ACP103	4180186
980083	ACP 103	4180186
980083	ACP-103	4180186
980083	bis(1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate	4180186
980083	N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide	4180186
980083	Nuplazid	4180186
980083	pimavanserin tartrate	4180186
980083	urea, n-((4-fluorophenyl)methyl)-n-(1-methyl-4-piperidinyl)-n'-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)	4180186
980087	L-leucine, L-asparaginyl-L-alpha-aspartyl-L-alpha-glutamyl-L-cysteinyl-L-alpha-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4-12),(7-15)-bis(disulfide)	4180186
980087	SP-304	4180186
980087	Trulance	4180186
980088	PSP	4180186
980090	Czeizel Brooser syndrome	4180186
980090	Polydactyly-Myopia Syndrome	4180186
980090	Polydactyly, Postaxial, With Progressive Myopia	4180186
980090	Postaxial polydactyly-progressive myopia syndrome	4180186
980090	Postaxial Polydactyly with progressive myopia	4180186
980095	Pontocerebellar Hypoplasia, Type 1a	4180186
980095	Pontocerebellar Hypoplasia With Anterior Horn Cell Disease	4180186
980095	Pontocerebellar Hypoplasia With Infantile Spinal Muscular Atrophy	4180186
980101	potassium tellurite	4180186
980102	Chromosome 17p11.2 Duplication Syndrome	4180186
980102	Chromosome 17, trisomy 17p11 2	4180186
980102	Duplication 17p11 2	4180186
980102	Duplication 17p11.2 syndrome	4180186
980102	Potocki-Lupski syndrome (dup(17)(p11.2p11.2))	4180186
980102	Trisomy 17p11 2	4180186
980104	Urban Rogers Meyer syndrome	4180186
980104	Urban-Rogers-Meyer Syndrome	4180186
980106	Juvenile Primary Lateral Sclerosis	4180186
980106	Primary Lateral Sclerosis, Juvenile	4180186
980107	Orthostatic tremor, primary	4180186
980107	Shaky leg syndrome	4180186
980111	Aminopterin syndrome sine aminopterin	4180186
980113	Holoprosencephaly polydactyly syndrome	4180186
980113	Holoprosencephaly-Polydactyly Syndrome	4180186
980113	Pseudo trisomy 13 syndrome	4180186
980114	Khalifa Graham syndrome	4180186
980114	Pterygium colli and mental retardation with facial and digital anomalies	4180186
980117	Familial recurrent arthritis	4180186
980117	PAPA syndrome	4180186
980117	Pyogenic arthritis, pyoderma gangrenosum, and severe cystic acne	4180186
980117	Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, and Acne	4180186
980118	1-hydroxypyrene-3,6,8-trisulfonic acid	4180186
980118	8-hydroxy-1,3,6-pyrenetrisulfonic acid trisodium salt	4180186
980118	8-hydroxypyrene-1,3,6-trisulfonate	4180186
980118	8-hydroxypyrene-1,3,6-trisulfonic acid	4180186
980118	C.I. 59040	4180186
980118	CI 59040	4180186
980118	D.C. Green No. 8	4180186
980118	D&C Green No. 8	4180186
980118	D&C Green No. 8 free acid	4180186
980118	Green 8	4180186
980118	pyranine free acid	4180186
980119	1-phenyl-4-amino-5-chloropyridazin-6-one	4180186
980119	chlordiazon	4180186
980119	chloridazon	4180186
980119	PAC herbicide	4180186
980119	phenazon	4180186
980119	Pyramin	4180186
980120	Epileptic Encephalopathy, Neonatal, PNPO-Related	4180186
980120	PNPO Deficiency	4180186
980120	PNPO-Related Neonatal Epileptic Encephalopathy	4180186
980120	Pyridoxal 5'-Phosphate-Dependent Epilepsy	4180186
980120	Pyridoxine-5'-Phosphate Oxidase Deficiency	4180186
980120	Seizures, Pyridoxine-Resistant, PLP-Sensitive	4180186
980125	Ramos Arroyo Syndrome	4180186
980126	4-(4-hydroxyphenyl)butan-2-one	4180186
980126	4-hydroxybenzylacetone	4180186
980126	4-(p-hydroxyphenyl)-2-butanone	4180186
980126	betuligenol	4180186
980126	oxyphenalon	4180186
980126	p-hydroxybenzylacetone	4180186
980128	Rec(8) Syndrome	4180186
980128	Recombinant 8 Syndrome	4180186
980128	San Luis Valley recombinant chromosome 8 syndrome	4180186
980128	San Luis Valley syndrome	4180186
980134	Giant pelvic retroperitoneal liposarcoma	4180186
980134	Pelvic retroperitoneal liposarcoma	4180186
980136	Exudative retinopathy with bone marrow failure	4180186
980136	Revesz Syndrome	4180186
980137	Patterson-Lowry rhizomelic dysplasia	4180186
980137	Patterson Lowry syndrome	4180186
980137	Rhizomelic Dysplasia, Patterson-Lowry Type	4180186
980141	Richieri-Costa and Pereira form of acrofacial dysostosis	4180186
980141	Richieri-Costa-Pereira Syndrome	4180186
980141	Robin sequence with cleft mandible and limb anomalies	4180186
980145	Camptodactyly, joint contractures, facial skeletal defects	4180186
980145	Camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye	4180186
980146	AG014699	4180186
980146	AG 014699	4180186
980146	AG-014699	4180186
980146	PF-01367338	4180186
980146	Rubraca	4180186
980147	Caudal dysgenesis familial type	4180186
980147	Familial caudal dysgenesis	4180186
980150	Fibuloulnar aplasia or hypoplasia with renal abnormalities	4180186
980150	Fibulo ulnar hypoplasia renal anomalies	4180186
980152	Hirschsprung disease, deafness and polydactyly	4180186
980154	Simparica	4180186
980155	bis-acetatoamminedichlorocyclohexylamine platinum(IV)	4180186
980155	JM216	4180186
980155	JM 216	4180186
980155	JM-216	4180186
980155	Platinum, bis(acetato-O)amminedichloro(cyclohexanamine)-, (OC-6-43)-	4180186
980155	trans,cis,cis-bis(acetato)amminecyclohexylaminedichloroplatinum(IV)	4180186
980156	Microcephaly hypogammaglobulinemia abnormal immunity	4180186
980159	Finlay-Marks Syndrome	4180186
980159	Hereditary syndrome of lumpy scalp, odd ears and rudimentary nipples	4180186
980159	Scalp-Ear-Nipple Syndrome	4180186
980160	Skeletal Abnormalities, Cutis Laxa, Craniostenosis, Ambiguous Genitalia, Retardation, And Facial Abnormalities	4180186
980162	Blepharofacioskeletal Syndrome	4180186
980162	Cleft Palate, Hypotelorism, and Hypospadias	4180186
980162	Ocular Hypotelorism, Submucosal Cleft Palate, and Hypospadias	4180186
980164	Midline development field defects	4180186
980170	Microcephaly microcornea syndrome Seemanova type	4180186
980174	rybelsus	4180186
980174	Ozempic	4180186
980175	EAST syndrome	4180186
980175	Epilepsy, ataxia, sensorineural deafness and tubulopathy	4180186
980175	Epilepsy, Ataxia, Sensorineural Deafness, And Tubulopathy	4180186
980175	Seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance	4180186
980175	Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, And Electrolyte Imbalance	4180186
980176	SERKAL	4180186
980176	SERKAL Syndrome	4180186
980177	Mievis Verellen-Dumoulin syndrome	4180186
980178	Laryngeal and pharyngeal hypoplasia with omphalocele	4180186
980178	Pharynx and larynx hypoplasia with omphalocele	4180186
980178	Shprintzen-Goldberg omphalocele syndrome	4180186
980185	Congenital testicular deficiency	4180186
980188	Hereditary Spastic Paraplegia, Paraplegin Type	4180186
980188	Spastic Paraplegia 7	4180186
980190	SCA20 Spinocerebellar ataxia 20	4180186
980190	Spinocerebellar ataxia type 20	4180186
980190	Spinocerebellar Ataxia With Dysphonia	4180186
980190	Spinocerebellar Ataxia With Spasmodic Cough	4180186
980191	SCA25 Spinocerebellar ataxia 25	4180186
980191	Spinocerebellar ataxia type 25	4180186
980192	SCA26 Spinocerebellar ataxia 26	4180186
980192	Spinocerebellar ataxia type 26	4180186
980193	Ataxia-ocular apraxia 2	4180186
980193	Ataxia-oculomotor apraxia 2	4180186
980193	Ataxia with Oculomotor Apraxia	4180186
980193	SCAN2	4180186
980193	SCAR1	4180186
980193	Spinocerebellar Ataxia, Recessive, Non-Friedreich Type 1	4180186
980193	Spinocerebellar Ataxia with Axonal Neuropathy Type 2	4180186
980194	Cerebellar Granular Cell Hypoplasia and Mental Retardation, Congenital	4180186
980194	Cerebellar Hypoplasia, Nonprogressive Norman Type	4180186
980194	Cerebelloparenchymal Disorder III	4180186
980194	CPD3	4180186
980194	CPD III	4180186
980194	SCAR2	4180186
980194	Spinocerebellar Ataxia Autosomal Recessive 2	4180186
980195	Ataxia-deafness syndrome X-linked	4180186
980195	Ataxia-deafness syndrome, X-linked	4180186
980195	Schmidley syndrome	4180186
980195	Spinocerebellar Ataxia, X-Linked 3	4180186
980198	Aplasia of tibia with ectrodactyly	4180186
980198	Cleft hand absent tibia	4180186
980198	Cleft Hand And Absent Tibia	4180186
980198	Ectrodactyly with aplasia of long bones	4180186
980198	Split-Hand-Foot Malformation With Long Bone Deficiency 1	4180186
980198	Tibial aplasia with split-hand-split-foot deformity	4180186
980199	Deafness, Congenital, And Split Hands And Feet	4180186
980199	SHFM1D	4180186
980202	SEMD, Aggrecan Type	4180186
980205	SEMD, Shohat Type	4180186
980210	Odontochondrodysplasia	4180186
980214	Multiple non-erupting teeth, maxillo-zygomatical hypoplasia and other congenital defects	4180186
980214	Non erupted teeth with maxillary hypoplasia and genu valgum	4180186
980215	Facioauriculoradial dysplasia	4180186
980215	Phocomelia-ectrodactyly, ear malformation, deafness, and sinus arrhythmia	4180186
980216	Overhydrated Hereditary Stomatocytosis	4180186
980216	Potassium-Sodium Disorder Of Erythrocyte	4180186
980217	Bilateral Striatal Necrosis, Infantile	4180186
980217	Infantile bilateral striatal necrosis	4180186
980217	Striatal degeneration familial	4180186
980217	Striatal Degeneration, Familial	4180186
980217	Striatonigral Degeneration, Infantile	4180186
980218	82Sr radioisotope	4180186
980218	Sr-82 radioisotope	4180186
980219	85Sr radioisotope	4180186
980219	Sr-85 radioisotope	4180186
980221	sucrose palmitate	4180186
980222	6-perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt	4180186
980222	Bridion	4180186
980222	Org 25969	4180186
980222	Sugammadex sodium	4180186
980223	Atrophia Areata	4180186
980223	Helicoidal Peripapillary Chorioretinal Degeneration	4180186
980223	Peripapillary Chorioretinal Degeneration, Icelandic Type	4180186
980225	Cenani-Lenz Syndactyly	4180186
980225	Cenani-Lenz type syndactyly	4180186
980225	Cenani syndactylism	4180186
980225	Syndactyly type 7	4180186
980225	Syndactyly, Type VII	4180186
980226	Syndactyly, Malik-Percin Type	4180186
980226	Syndactyly, Type IX	4180186
980230	Syndactyly type 5	4180186
980230	Syndactyly with metacarpal and metatarsal fusion	4180186
980231	Heart-hand syndrome 2	4180186
980237	Brachycephalofrontonasal dysplasia	4180186
980237	Hypertelorism, Teebi type	4180186
980237	Teebi hypertelorism syndrome	4180186
980239	22q13.3 Deletion Syndrome	4180186
980239	22q13 Deletion Syndrome	4180186
980239	Chromosome 22q13.3 Deletion Syndrome	4180186
980239	Deletion 22q13.3 Syndrome	4180186
980239	Deletion 22q13 Syndrome	4180186
980239	Monosomy 22q13	4180186
980239	Phelan-McDermid Syndrome	4180186
980242	Mental Retardation, Severe, And Absent Nails Of Hallux And Pollex	4180186
980243	Craniofacial dysmorphism with ocular coloboma absent corpus callosum and aortic dilatation	4180186
980243	Craniofacial Dysmorphism With Ocular Coloboma, Absent Corpus Callosum, And Aortic Dilatation	4180186
980243	Dysmorphism, corpus callosum agenesis and colobomas	4180186
980245	Zimmer phocomelia	4180186
980245	Zimmer Taub Sova syndrome	4180186
980246	1,7-bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione	4180186
980247	VX-661	4180186
980249	Autosomal dominant thoracolaryngopelvic dysplasia	4180186
980249	Barnes syndrome	4180186
980253	5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione	4180186
980254	STAR Syndrome	4180186
980254	Syndactyly with Renal and Anogenital Malformations	4180186
980257	Mental retardation X-linked, Tranebjaerg type seizures and psoriasis	4180186
980257	X-linked mental retardation associated with psoriasis	4180186
980258	Dystrophic Epidermolysis Bullosa, Dominant Neonatal	4180186
980258	Epidermolysis bullosa dystrophica, dominant neonatal form	4180186
980259	Hostaphat KW 340N	4180186
980260	4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-	4180186
980260	5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one	4180186
980261	n-tridecane	4180186
980266	Hereditary bone dysplasia with characteristic bowing and thickening of the distal ulna	4180186
980266	Metaphyseal Chondrodysplasia, Rosenberg Type	4180186
980266	Metaphyseal chondroplasia Rosenberg type	4180186
980266	Rosenberg Lohr syndrome	4180186
980267	40-O-(2-ethoxyethyl)rapamycin	4180186
980267	42-O-(2-ethoxyethyl) rapamycin	4180186
980267	Biolimus A9	4180186
980267	rapamycin, 42-O-(2-ethoxyethyl)-	4180186
980267	TRM-986	4180186
980270	2',3',5'-tri-O-acetyluridine	4180186
980270	PN401	4180186
980270	PN 401	4180186
980270	PN-401	4180186
980270	RG2133	4180186
980270	RG-2133	4180186
980270	triacetyluridine	4180186
980270	Xuriden	4180186
980271	(2R,3R,11BR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H- benzo(a)quinolizin-2-yl l-valinate	4180186
980271	Ingrezza	4180186
980271	NBI-98854	4180186
980271	valine 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester	4180186
980274	RG-7601	4180186
980274	4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide	4180186
980274	ABT-199	4180186
980274	benzamide, 4-(4-((2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl)methyl)-1-piperazinyl)-n-((3-nitro-4-(((tetrahydro-2h-pyran-4-yl)methyl)amino)phenyl)sulfonyl)-2-(1h-pyrrolo(2,3-b)pyridin-5-yloxy)-	4180186
980274	GDC-0199	4180186
980274	RG7601	4180186
980274	Venclexta	4180186
980275	Platyspondyly with amelogenesis imperfecta	4180186
980275	Skeletal dysplasia with amelogenesis imperfecta and platyspondyly	4180186
980276	Cerebro-Acro-Visceral Early lethality multiplex syndrome	4180186
980280	GS-9857	4180186
980282	Hirschsprung disease with pigmentary anomaly	4180186
980282	Shah-Waardenburg syndrome	4180186
980282	Waardenburg-Hirschsprung disease	4180186
980282	Waardenburg-Shah syndrome	4180186
980282	Waardenburg Syndrome, Type 4a	4180186
980282	Waardenburg Syndrome, Type Iva	4180186
980282	Waardenburg Syndrome With Hirschsprung Disease, Type 4a	4180186
980284	Anterior bowing of legs with dwarfism	4180186
980284	Bowing of legs, anterior, with dwarfism	4180186
980284	Toxopachyosteose diaphysaire tibio-peroniere	4180186
980284	Toxopachyosteosis	4180186
980284	Toxopachyoteose diaphysaire tibio peroniere	4180186
980284	Weismann Netter Stuhl syndrome	4180186
980284	Weismann-Netter Syndrome	4180186
980291	Craniofacial malformations, asymmetric, with polysyndactyly and abnormal skin and gut development	4180186
980291	Curry Jones syndrome	4180186
980291	Curry-Jones Syndrome	4180186
980292	Immunoneurologic Disorder, X-Linked	4180186
980292	Neonatal death immune deficiency	4180186
980292	Woods-Black-Norbury Syndrome	4180186
980292	X-linked immunoneurological disorder	4180186
980294	Radial-ulnar hypoplasia with bone marrow failure and-or leukemia	4180186
980294	WT Limb-Blood Syndrome	4180186
980295	133Xe radioisotope	4180186
980295	Xe-133 radioisotope	4180186
980296	1-((2-methylphenyl)azo)-2-naphthylamine	4180186
980298	Pancreatic hypoplasia diabetes heart disease	4180186
980299	Encephalopathy, fatal infantile, with olivopontocerebellar hypoplasia	4180186
980299	Olivopontocerebellar hypoplasia lethal type	4180186
980299	Pontocerebellar Hypoplasia Type 4	4180186
980300	169Yb radioisotope	4180186
980300	Yb-169 radioisotope	4180186
980301	Selective T-Cell Defect	4180186
980301	Zap70-Related Scid	4180186
980301	Zap70-Related Severe Combined Immunodeficiency	4180186
980301	Zeta-associated-protein 70 deficiency	4180186
980301	Zeta-Associated Protein 70 Deficiency	4180186
980304	sphalerite	4180186
980305	CLPED1	4180186
980305	Autosomal recessive ectodermal dysplasia	4180186
980305	Bustos Simosa Pinto Cisternas syndrome	4180186
980305	Cleft lip-palate-ectodermal dysplasia syndrome	4180186
980305	Ectodermal dysplasia, cleft lip and palate, mental retardation, and syndactyly	4180186
980305	Ectodermal dysplasia Margarita island type	4180186
980305	Ectodermal Dysplasia, Margarita Island Type	4180186
980305	Ectodermal dysplasia type 4	4180186
980305	Ectodermal Dysplasia, Type 4	4180186
980306	CHIME syndrome	4180186
1001444	Carolina Breast Cancer Study	4180186
1001449	Perceived Stress Scale-10	4180186
1001475	Ear.external	4180186
1001484	1-beta-D-galactosphingosine; Chemistry; Erythrocytes; Galactosylsphingosine; Globoid Cell Leukodystrophies; Globoid Cell Leukodystrophy; Krabbe disease; Leukodystrophy, Krabbe; Point in time; PSY; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Sphingosine galactoside; Substance content	4180186
1001484	Psychosine RBC-sCnt	4180186
1001484	神经鞘氨醇半乳糖苷:物质的量含量:时间点:红细胞:定量型	4182948
1001485	MR T+L-Spine WO+W contr	4180186
1001485	多层^不采用 & 采用对比剂:发现:时间点:胸部>脊椎.胸段 & 腹部>脊椎.腰段:文档型:MR	4182948
1001485	Abd; Abdo; Abdomen+; Abdominal; c; Contr; Contra; Contrst; Document; Dorsal spine; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; WC; WO & WC; WO+W contr; WWO	4180186
1001488	Variant unknown sig Bld/T	4180186
1001488	Blood; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Tx; Variant unknown sig; WB; Whole blood; Whole blood or Tissue	4180186
1001488	意义未知的变异:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1001489	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MEDS; Narrative; Point in time; Random; Report	4180186
1001489	药物建议:印象:时间点:^患者:叙述型	4182948
1001491	Bld flow; Bld flow vel; Bld flow.velocity; Blood flow vel.S1 wave; CARD.US; Cardiology; DOP; DOP.PW; DUPLEX; Dynamic; Echography; Point in time; Pulm v; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity; Ven; Venous	4180186
1001491	Pulm v Blood flow vel.S1 wave DOP.PW	4180186
1001491	血流速度.S1 波:速度:时间点:肺静脉:定量型:超声.多普勒.PW	4182948
1001495	4OHGlu/Creat Ur-sRto	4180186
1001495	4OHGlu; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1001495	4-羟基谷氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001498	little cE Ag RBC Ql	4180186
1001498	Antigen; Antigens; BLOOD BANK; c; Erythrocytes; little cE; little cE Ag; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Rh27; Screen	4180186
1001498	cE 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001508	Finding; Findings; Gestation; Gestations; Gravida; Nominal; Point in time; Pregnancies; Random; Survey; SURVEY.MTLHLTH; Sx	4180186
1001509	Gas + CO + Electrolytes Pnl BldA	4180186
1001509	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Elect; Electr; Electrolyte; Gas + CO + electrolytes Pnl; Gases; Lytes; Lytes Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001509	气体与一氧化碳与电解质组套:-:时间点:动脉全血:定量型	4182948
1001510	Busulfan AUC Pnl Plas	4180186
1001510	Busulfan AUC Pnl; DRUG/TOXICOLOGY; Drugs; Myleran; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; QNT; Quan; Quant; Quantitative; Studies; Study; Sutdies	4180186
1001510	白消安曲线下面积组套:-:检查过程持续时间:血浆:定量型	4182948
1001511	Avail tx for variant but not dx; Blood; Dx; Genetics; Genomic; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Tx; Unrelated therapy; WB; Whole blood; Whole blood or Tissue	4180186
1001511	Avail tx for variant but not dx Bld/T	4180186
1001511	与遗传变异相关但与患者诊断并不相关的可用治疗:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1001512	Clobazam metabolite; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; N-desmethylclobazam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001512	Norclobazam Ur Ql Scn	4180186
1001512	去甲基氯巴詹:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001513	R eye Dark rod adaptation tm	4180186
1001513	Dark rod adaptation tm; EYE.PX; Eyeball; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Rod intercept (TM); RT; Vision; Visual	4180186
1001513	黑暗介导的视杆细胞适应时间:时间:时间点:眼睛.右侧:定量型	4182948
1001515	LV ES vol A2C SP A-L	4180186
1001515	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001515	心脏收缩末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1001517	1 month; 1 month (30 days); 30 days; Durat; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001518	Pulm valve Regurg vel.early dia DOP.PW	4180186
1001518	Bld flow; Bld flow vel; Bld flow.velocity; CARD.US; Cardiology; Dias; Diast; Diastoli; DOP; DOP.PW; DUPLEX; Dynamic; Echography; Point in time; Pulm valve; Pulmonic valvular; QNT; Quan; Quant; Quantitative; Random; Regurg bld flow vel; Regurg vel.early dia; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity	4180186
1001518	反流血流速度.舒张早期:速度:时间点:肺动脉瓣:定量型:超声.多普勒.PW	4182948
1001519	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1001523	Cnt; Count; No; Num; Number; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
1001524	K Ag RBCCo Ql	4180186
1001524	Antigen; Antigens; BLOOD BANK; KEL1; Kell Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Screen	4180186
1001524	K 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1001529	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001530	Chemistry; Inflammatory Bowel Disease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Level; Mass concentration; MRP8/14; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheumatoid arthritis; S100A8/A9; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
1001530	Calprotectin Snv-mCnc	4180186
1001530	钙卫蛋白:质量浓度:时间点:滑液:定量型	4182948
1001533	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1001534	ABO Group infant Bld	4180186
1001534	ABO Gp^infant; Blood; BLOOD BANK; infant; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
1001534	ABO 血型^婴儿期期间:类型:时间点:全血:名义型	4182948
1001537	A baumannii DNA Bld Pos Ql NAA+probe	4180186
1001537	3 Self-Sustaining Sequence Replication; 3SR SR; A baumannii; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001537	鲍曼不动杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001538	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1001543	CLIN; CLIN.VET; Gases; O2; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Totl; Vet cage; Volfr; Volume fraction	4180186
1001543	O2/Gas.total VFr Vet cage	4180186
1001543	氧/气体.总计:体积分数:时间点:兽医用病畜隔离笼:定量型	4182948
1001544	17-Hydroxycorticosterone; 2M p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001544	Cortis 2M p 1 ug/kg CRH IV SerPl-mCnc	4180186
1001544	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后2分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1001545	4 weeks; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1001546	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Psychiatric; Random; Study report; Visit note	4180186
1001546	Psychiatric Diag study note	4180186
1001546	诊断性检查记录:发现:时间点:{环境}:文档型:精神病学	4182948
1001548	GCA SerPl-sCnc	4180186
1001548	Chemistry; GCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1001548	甘氨胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001549	H seoul IgM SerPl Ql Line blot	4180186
1001549	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H seoul; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seoul orthohantavirus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR	4180186
1001549	汉坦病毒 汉城型 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:线点印迹法	4182948
1001551	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1001552	DRUG/TOXICOLOGY; Drugs; Niravam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Xanax	4180186
1001552	Alpraz Ur Ql Scn	4180186
1001552	阿普唑仑:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001553	Clot; Clottable; COAGULATION; Coagulation assay; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; PT mix Pnl; QNT; Quan; Quant; Quantitative; Random; Study report; Tilt tube	4180186
1001553	PT mix Pnl PPP	4180186
1001553	凝血酶原时间混合检查组套:-:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1001556	Arm; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; Tot; Total maturity score; Totl; UE; Up; Upper extremity; Upper extremity joint; Xray; X-ray	4180186
1001556	XR Wrist+Hand Total maturity score	4180186
1001556	骨骼成熟度总评分:评分:时间点:上肢>腕部+手部:定量型:X射线摄影术	4182948
1001557	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Opioids Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Synth Opioids; Synthetic opioid; Synthetic opioids pnl; UA; UR; Urn	4180186
1001557	Synthetic opioids pnl Ur Cfm	4180186
1001557	合成阿片类药物组套:-:时间点:尿液:-:毒理学确认试验	4182948
1001558	Preferred lang + interp need	4180186
1001558	ADMIN; Pan; Panel; PANEL.ADMIN; Panl; Pnl; Point in time; Preferred lang + interp need; Random; Translator	4180186
1001558	首选语言和口译员需求:-:时间点:^患者:-	4182948
1001559	Activities of Daily Living; Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1001560	tr-Cinnamoylgly/Creat Ur-sRto	4180186
1001560	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; tr-Cinnamoylgly; UA; UCr; UR; Urn	4180186
1001560	反-肉桂酰甘氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001562	5 hours; 5.0Hr; 5HR; Chemistry; CR; Crea; Creat; Creat Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; UA; UCr; UR; Urn	4180186
1001562	Creat Pnl Ur	4180186
1001562	肌酐组套:-:5小时:尿液:-	4182948
1001564	ICS IgG Ser Ql IF	4180186
1001564	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cell surface; FA; Fluorescent antibody; Fluoresent; ICS; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Intercellular structure; Ordinal; Paraneoplastic pemphigus; Pemphigus; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Subs; Time Resolved Fluorescence; TRF	4180186
1001564	细胞间质 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
1001565	NOP56 GGCCTG Rpt Bld/T Ql	4180186
1001565	Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; NOP56 GGCCTG Rpt; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001565	NOP56 基因.GGCCTG 重复序列:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
1001566	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001572	2-Octenoate/Creat Ur-sRto	4180186
1001572	2-Octenoic acid; Chemistry; CR; Crea; Creat; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1001572	2-辛烯酸酯/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001575	Calc; Calculation; Chemistry; HUM; Humulin; IH7; Ins Sens Index; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
1001575	Ins Sens Index SerPl Calc-Rto	4180186
1001575	胰岛素敏感性指数:比率:时间点:血清/血浆:定量型:计算法	4182948
1001578	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; VP	4180186
1001578	Osmolality 2h p Vaso Ur	4180186
1001578	渗透压^在给予剂量后叶加压素之后2小时:渗透压:时间点:尿液:定量型	4182948
1001579	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TDCA	4180186
1001579	TDCA SerPl-sCnc	4180186
1001579	牛磺去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001581	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1001581	XR Trapezoid Bone dev stage	4180186
1001581	骨骼发育阶段:评分:时间点:上肢>腕部.小多角骨:定量型:X射线摄影术	4182948
1001583	HEDIS 2020 Urine Prot Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; PR; Prot; Random	4180186
1001583	HEDIS 2020 Urine Prot Tests	4180186
1001583	HEDIS 2020 取值集合 - 尿液蛋白检验项目:-:时间点:^患者:-	4182948
1001585	Centers for Medicare and Medicaid Assessment; Form version; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001586	Calc; Calculation; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1001586	Ceramide risk score Plas Calc	4180186
1001586	神经酰胺风险评分:评分:时间点:血浆:定量型:计算法	4182948
1001587	Activ; Actvty; Blood; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; NUDT15 gene prod met act imp; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001587	NUDT15 gene prod met act imp Bld/T-Imp	4180186
1001587	NUDT15 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
1001589	Blood; Gene studied w no variant found; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001589	Gene studied w no variant found Bld/T	4180186
1001589	经检查但未发现变异的基因:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1001594	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1001594	EBV DNA Bld NAA+probe-Log IU	4180186
1001594	Epstein Barr 病毒 DNA:对数型任意浓度:时间点:全血:定量型:探针法.基因扩增.靶向	4182948
1001596	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Sal; Salmonel; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001596	Salmonella DNA Bld Pos Ql NAA+probe	4180186
1001596	沙门菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001599	Contraindicated vaccine	4180186
1001599	Ident; Identifier; Nominal; Point in time; Random	4180186
1001599	禁忌疫苗类型:标识符:时间点:^患者:名义型	4182948
1001600	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS; Valley fever	4180186
1001600	Coccidioides IgG SerPl IA-aCnc	4180186
1001600	球孢子菌属单个未知种 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001602	Ortho surg Team Conf eval note	4180186
1001602	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Ortho surg Team; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Visit note	4180186
1001602	会议记录:发现:时间点:{环境}:文档型:矫形外科学.团队	4182948
1001603	Prim Med Lg B-cell lymph Tiss	4180186
1001603	原发性纵隔大B细胞淋巴瘤:似然性:时间点:组织与涂片:定量型	4182948
1001603	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; Lg B-cell lymph; PATHOLOGY; PMBCL; Point in time; Prim Med Lg B-cell lymph; QNT; Quan; Quant; Quantitative; Random; Risk; Tissue; Tissue, unspecified	4180186
1001605	Bacterial rpoB drug res mut Islt/Spm	4180186
1001605	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial rpoB drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001605	细菌 rpoB 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001606	ABO + Rh; ABO + Rh Pnl p transf rx; ABO group and Rh type; ABO+Rh Gp; After; Blood; BLOOD BANK; D phenotyping; D typing; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; PST; Random; React; Rh phenotyping; Rh typing; Rxn; Transf React; Transf React Pnl; Tx; WB; Whole blood	4180186
1001606	ABO + Rh Pnl p transf rx Bld	4180186
1001606	输血反应后ABO与Rh血型组套:-:时间点:全血:-	4182948
1001607	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1001608	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mec; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tramal; Ultram	4180186
1001608	traMADol Mec Ql Scn	4180186
1001608	曲马多:存在情况或阈值:时间点:胎便:序数型:毒理学筛查试验	4182948
1001610	Centers for Medicare and Medicaid Assessment; Drugs; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1001613	GFAP alpha IgG Titr CSF IF	4180186
1001613	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1001613	ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Pituitary glycoproteins; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Titer; Titered; Titre; Traumatic Brain Injuries; TRF; Ttr	4180186
1001614	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001614	Acetyl norfentanyl Ur Cfm-mCnc	4180186
1001614	乙酰基去甲基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001615	Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1001615	Observation Imp	4180186
1001615	观察结果解释:印象:时间点:XXX:名义型	4182948
1001616	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP	4180186
1001616	Creat 2h p Vaso SerPl-mCnc	4180186
1001616	肌酐^在给予剂量后叶加压素之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
1001617	Admin info; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001618	Blastomyces Ag Ur IA-mCnc	4180186
1001618	Antigen; Antigens; Blasto; Blastomycosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; spp; SUDS; UA; UR; Urn	4180186
1001618	芽生菌属单个未知种 抗原:质量浓度:时间点:尿液:定量型:免疫测定法	4182948
1001619	ADMIN; DOC.ADMIN; Document; Finding; Findings; Point in time; Random	4180186
1001619	Validation error details Doc	4180186
1001619	验证错误详情:发现:时间点:文档:文档型	4182948
1001620	Blood; HEMATOLOGY/CELL COUNTS; LM; Lymp; Lymph; Lymph Villous; Lympho; Lymphocyte; Lymphs; Lymphs%; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1001620	Lymph Villous Bld Ql Smear	4180186
1001620	淋巴细胞.绒毛:存在情况或阈值:时间点:全血:序数型:显微镜检查.光学	4182948
1001621	Validation error summary Doc	4180186
1001621	ADMIN; DOC.ADMIN; Document; Finding; Findings; Point in time; Random	4180186
1001621	验证错误摘要:发现:时间点:文档:文档型	4182948
1001622	Antigen; Antigens; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS; Valley fever	4180186
1001622	Coccidioides Ag SerPl IA-mCnc	4180186
1001622	球孢子菌属单个未知种 抗原:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001624	Platelet GP disorder Bld FC-Imp	4180186
1001624	Blood; CELL MARKERS; Dynamic; FC; gG; Glycoprot; Glycoproteins; GP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plat Gp; Platelet GP disorder; Platelets; Platelt; Plt; Point in time; Random; Report; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1001624	血小板糖蛋白疾病:印象:时间点:全血:叙述型:流式细胞测量术	4182948
1001627	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001628	EWSR1 gene Rear Tiss FISH	4180186
1001628	22q12 rearrangement; Document; Ewing Sarcoma; Ewing sarcoma breakpoint region 1; EWS; EWSCR; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Point in time; Primitive Neuroectodermal Tumor; Primitive Neuroectodermal Tumors; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified	4180186
1001628	EWSR1 基因重排:发现:时间点:组织与涂片:文档型:FISH	4182948
1001629	D Ag infant RBC Ql	4180186
1001629	Antigen; Antigens; BLOOD BANK; D Ag^infant; Dextro; Erythrocytes; infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rhesus; Screen	4180186
1001629	D 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1001630	Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; WOC	4180186
1001630	WOC Consult note	4180186
1001630	会诊记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
1001632	Document; DOP; DUPLEX; Echography; Finding; Findings; Imaging; Misc; Miscellaneous; Other; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
1001632	DOP Unsp region	4180186
1001632	多层:发现:时间点:XXX:文档型:超声.多普勒	4182948
1001633	After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001633	Breath methane p carb	4180186
1001633	甲烷/已呼出的气体^在给予剂量碳水化合物之后:体积分数:时间点:呼出的气体:定量型	4182948
1001634	4-MetPhenEthAcetFentanyl; Acetylfentanyl-4-methylphenethyl; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001634	4-MetPhenEthAcetFentanyl Ur Cfm-mCnc	4180186
1001634	4-甲基苯乙基乙酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001639	After; DRUG/TOXICOLOGY; Drugs; immed p busulfan; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
1001639	Busulfan immed p busulfan Plas-mCnc	4180186
1001639	白消安^紧接着在完成白消安输注之后:质量浓度:时间点:血浆:定量型	4182948
1001642	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001647	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001648	Addiction; C16H22N2O3; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; methyl 4-(N-propanoylanilino)piperidine-4-carboxylate; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001648	Norcarfentanil Ur Cfm-mCnc	4180186
1001648	4-(苯基丙酰氨基)哌啶-4-羧酸甲酯:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001650	SSD screen report	4180186
1001650	Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; SSD screen report; Sx	4180186
1001650	躯体症状障碍筛查报告:发现:时间点:^患者:文档型	4182948
1001651	Rh Ags+K Ag Pnl Bld	4180186
1001651	Blood; BLOOD BANK; D phenotyping; D typing; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh Ags+K Ag Pnl; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1001651	Rh抗原与K抗原组套:-:时间点:全血:-	4182948
1001654	Code Purple Recording Sheet; DOC.ONT; Document; Emerg procedure note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OB; Obstetric; Obstetrical emergency recording from; Point in time; Prenatal; Random; Visit note	4180186
1001654	OB Emerg procedure note	4180186
1001654	急诊操作记录:发现:时间点:{环境}:文档型:产科学	4182948
1001660	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
1001661	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Othr; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001664	Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
1001666	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
1001666	PA Epineph 5 umol/L PRP	4180186
1001666	血小板聚集.肾上腺素诱导型^5 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
1001671	Bipolar type	4180186
1001671	Bipolar type; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
1001671	双相障碍类型:类型:时间点:^患者:名义型	4182948
1001674	3 months; Cnt; Count; Number; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001675	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001676	CARD.US; Cardiac; Cardiology; DOP; DUPLEX; Echography; Hrt; Hrt ventr; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Sonogram; Sonograph; Sonography; Sys time; ULS; Ultrasound; Ventricular	4180186
1001676	RV Sys time DOP	4180186
1001676	心脏收缩时间:时间:时间点:心脏.心室.右侧:定量型:超声.多普勒	4182948
1001678	F tular; F tularensis; F. tularensis IgG + IgM; F. tularensis IgG+ IgM Pnl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; Tularemia	4180186
1001678	F. tularensis IgG+ IgM Pnl Ser	4180186
1001678	土拉弗朗西斯菌抗体.IgG 与 IgM 组套:-:时间点:血清:-	4182948
1001679	4-Fluorofentanyl; Addiction; C22H27FN2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide; parafluorofentanyl; p-Fluorofentanyl; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001679	4-Fluorofentanyl Ur Cfm-mCnc	4180186
1001679	4-氟芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001680	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001681	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001681	PROC Full Mut Anl Bld/T Seq	4180186
1001681	PROC 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1001682	(8;8)(HEY1,NCOA2); DNA; gene fusion; gene translocation; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation	4180186
1001682	(8;8)(HEY1,NCOA2) Tiss Ql	4180186
1001682	(8;8)(q13;q21)(HEY1,NCOA2) 融合转录物:存在情况或阈值:时间点:组织与涂片:序数型:分子遗传学类实验室方法	4182948
1001683	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1001683	自杀意图:发现:时间点:^患者:序数型	4182948
1001684	LV Max circ strain rate sys 3D US	4180186
1001684	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max circ strain rate sys; Max strain rate sys; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Sys.max; Syst; ULS; Ultrasound; Ventricular	4180186
1001684	环向应变速率.收缩期.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1001685	Chr 2 copy num; Chromosom; Chromosomes; Entitic; Entitic number; Fluorescent in situ hybridization; II; Molecular pathology; MOLPATH; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001685	Chr 2 copy num/nucleus EntNum Tiss FISH	4180186
1001685	染色体 2 拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
1001688	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1001691	Aryl sulfatase B; Arylsulfatase B; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Chondroitin sulfatase; Chondroitinase; Enzymatic activity ratio; Galactose-6-sulfate sulfatase; GalN6S; GalNAc6S sulfatase; GALNS; Maroteaux-Lamy disease; Morquio disease, type A; MPS VI; MPS VI A; Point in time; QNT; Quan; Quant; Quantitative; Random; rh4S; rhASB; UA; UR; Urn	4180186
1001691	Arylsulfatase B/GALNS Ur-cRto	4180186
1001691	N-乙酰半乳糖胺-4-硫酸酯酶/N-乙酰基半乳糖胺-6-硫酸酯酶:催化比率:时间点:尿液:定量型	4182948
1001692	Med records p auth denial	4180186
1001692	ADMIN; DOC.ADMIN; Document; Finding; Findings; Med records p auth denial; Point in time; Random	4180186
1001692	针对拒绝授权的医疗记录:发现:时间点:^患者:文档型	4182948
1001700	Antigen; Antigens; Blasto; Blastomycosis; Bronchial alveolar lavage; Bronchoalveolar lavage; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; spp; SUDS	4180186
1001700	Blastomyces Ag BAL IA-mCnc	4180186
1001700	芽生菌属单个未知种 抗原:质量浓度:时间点:支气管肺泡灌洗液:定量型:免疫测定法	4182948
1001701	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001702	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; K oxytoca; K oxytoca DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001702	K oxytoca DNA Bld Pos Ql NAA+probe	4180186
1001702	产酸克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001703	CLIN; Home accessibility mod panel; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1001703	Home accessibility mod panel	4180186
1001703	住宅无障碍改造组套:-:时间点:^患者:-	4182948
1001704	AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Arbitrary concentration; Chromogenic assay; Circulating anticoagulant; Coag; ENZY; Enzymatic assay; F8; Fac; Fact; Fact VIII; Fact VIII Inhib; Factor 8; Factor VIII clotting activity; FVIII; Inhib; Inhibit; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte cofactor A; VIII:C	4180186
1001704	Fact VIII Inhib PPP Chro-aCnc	4180186
1001704	凝血因子 VIII 抑制剂:任意型浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
1001705	3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide; Addiction; C16H22Cl2N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pink; Pinky; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; U4; UA; UR; Urn	4180186
1001705	U-47700 Ur Cfm-mCnc	4180186
1001705	U-47700:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001706	Microbiology; Misc; Miscellaneous; MuV; MuV RNA and N gene Pnl; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Ribonucleic acid; Spec; To be specified in another part of the message; Unspecified	4180186
1001706	MuV RNA and N gene Pnl Spec	4180186
1001706	流行性腮腺炎病毒 RNA & N 基因组套:-:时间点:XXX:-	4182948
1001707	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; Compx; Islt; Islt/Spm; Isol; M tb; M TB Cmplx; M tuberculosis; Molecular genetics; Mtb; MTB cmplx resist Pnl; Myco; Mycobact; Mycobacterium tuberculosum; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec; TB; Tuberculosis	4180186
1001707	MTB cmplx resist Pnl Islt/Spm	4180186
1001707	结核分枝杆菌复合菌群耐药性组套:-:时间点:分离株/标本:-:分子遗传学类实验室方法	4182948
1001710	Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001710	SLCO1B1 Mut Anl Bld/T	4180186
1001710	SLCO1B1 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001711	Red cabbage IgE Qn	4180186
1001711	紫甘蓝 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1001711	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brassica aleraceae; Brassica oleracea capitata; Brassica rubra; Cabbage; f216; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Red cabbage; Red cabbage Ab; Red cabbage IgE; Serum; SR	4180186
1001713	Breath methane 45M p carb	4180186
1001713	45M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001713	甲烷/已呼出的气体^在给予剂量碳水化合物之后45分钟:体积分数:时间点:呼出的气体:定量型	4182948
1001715	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001718	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001720	4-Methbutfentanyl; 4-Methoxybutyrfentanyl; 4-methoxy-Butyryl fentanyl; Addiction; C24H32N2O2; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001720	4-Methbutfentanyl Ur Cfm-mCnc	4180186
1001720	4-甲氧基丁酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001722	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001723	HF+TC Letter	4180186
1001723	DOC.ONT; Document; Finding; Findings; Heart function; HF+TC; Point in time; Random; TC	4180186
1001723	信函:发现:时间点:{环境}:文档型:心力衰竭+移植心脏病学	4182948
1001724	ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1001724	Pretomanid Susc Islt	4180186
1001724	培托马尼:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
1001727	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001732	Chemistry; GLCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1001732	GLCA SerPl-sCnc	4180186
1001732	甘氨石胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001734	C24:1 ceramide/C24 ceramide Plas-sRto	4180186
1001734	C24 ceramide; C24:1 ceramide; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio	4180186
1001734	N-神经酰基神经鞘氨醇/N-二十四烷酰基神经鞘氨醇:物质的量比率:时间点:血浆:定量型	4182948
1001736	出院摘要记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
1001736	Navigator D/C sum	4180186
1001736	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1001737	COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Mon; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS	4180186
1001737	Fibrin Monomer PPP IA-mCnc	4180186
1001737	纤维蛋白单体:质量浓度:时间点:贫血小板血浆:定量型:免疫测定法	4182948
1001738	AV Regurg fraction PISA	4180186
1001738	AO; AoV; AV; Calc; Calculation; CARD.US; Cardiology; DOP; DUPLEX; Echography; Frac; Fract; Fractionation; Fractions; Percent; Point in time; Proximal Isovelocity Surface Area; QNT; Quan; Quant; Quantitative; Random; Regurg fraction; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Volfr; Volume fraction	4180186
1001738	反流分数:体积分数:时间点:主动脉瓣:定量型:超声.多普勒+近端等速表面积计算法	4182948
1001742	AMPAR2 IgG Titr SerPl IF	4180186
1001742	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体.IgG:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
1001742	ABS; Aby; ACIF; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GluA2; GluR2; GluR-B; Hydrox; IFA; II; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalitis; OH; Pl; Plasma; Plsm; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1001743	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001745	XR Finger.5th.distl phlnx Bone dev stage	4180186
1001745	5th; 5th finger; Arm; Bone dev stage; EXT; Finger.5th; Finger.5th.distl phlnx; Imaging; little finger; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001745	骨骼发育阶段:评分:时间点:上肢>手指.第五.远节指骨:定量型:X射线摄影术	4182948
1001746	AmpC blaCMY-2 gene Islt/Spm Ql	4180186
1001746	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; II; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
1001746	细菌 beta-内酰胺耐药 AmpC blaCMY-2 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
1001747	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001748	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1001750	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001751	Blastomyces Ag CSF IA-mCnc	4180186
1001751	Antigen; Antigens; Blasto; Blastomycosis; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS	4180186
1001751	芽生菌属单个未知种 抗原:质量浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1001752	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001754	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001755	RFA Ext ves-Ul Views W contr IV	4180186
1001755	c; Contr; Contra; Contrst; Document; EXT; Ext ves-Ul; Extr ves; Extr-Ul; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Point in time; Radiology; Random; RFA; Vesl; Vessels.XXX; View; VWS; W contr IV; WC	4180186
1001755	多重视图^采用静脉注射对比剂:发现:时间点:肢体.单侧>肢体血管类:文档型:放射荧光透视法.血管造影术	4182948
1001757	4 weeks; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1001758	11OH-Testost; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001758	11OH-Testost SerPl-mCnc	4180186
1001758	11-羟基睾酮:质量浓度:时间点:血清/血浆:定量型	4182948
1001759	S marcescens DNA Bld Pos Ql NAA+probe	4180186
1001759	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S marcescens; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001759	粘质沙雷氏菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001760	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001762	Liver steatosis grade SerPl Ql	4180186
1001762	Chemistry; Finding; Findings; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001762	肝脂肪变性分级:发现:时间点:血清/血浆:序数型	4182948
1001763	ABO + Rh; ABO + Rh Pnl; ABO group and Rh type; ABO+Rh Gp; Blood - (umbilical) cord; BLOOD BANK; Cord (umbilical) blood; Cord bld; Cord blood; D phenotyping; D typing; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing	4180186
1001763	ABO + Rh Pnl BldCo	4180186
1001763	ABO与Rh血型组套:-:时间点:脐带全血:-	4182948
1001764	PDX1 Full Mut Anl Bld/T Seq	4180186
1001764	Blood; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Identity or presence; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Nominal; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001764	PDX1 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
1001769	CLIN; CLIN.VET; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature; Vet cage	4180186
1001769	Temp Vet cage	4180186
1001769	温度:温度:时间点:兽医用病畜隔离笼:定量型	4182948
1001771	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001771	轻度睡眠持续时间:时间:时间点:^患者:定量型	4182948
1001772	Integrative medicine Diag study note	4180186
1001772	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Integrated medicine; notes; Point in time; Random; Study report; Visit note	4180186
1001772	诊断性检查记录:发现:时间点:{环境}:文档型:整合医学	4182948
1001774	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001775	BP; Dias; Diast; Diastoli; HEDIS 2020 Diastolic BP; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1001775	HEDIS 2020 Diastolic BP	4180186
1001775	HEDIS 2020 取值集合 - 舒张压:-:时间点:^患者:-	4182948
1001776	Blood; CHD Multigene Anl; Dis; Diseases; Document; Dz; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001776	CHD Multigene Anl Bld/T	4180186
1001776	冠心病多基因分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001777	Arterial Stenosis; BP; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001779	Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; VZ; VZV; VZV Ab.IgM+total; Zoster	4180186
1001779	VZV Ab.IgM+total CSF Ql	4180186
1001779	水痘带状疱疹病毒抗体.IgM+总计:存在情况或阈值:时间点:脑脊液:序数型	4182948
1001780	Centers for Medicare and Medicaid Assessment; Deglutition; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
1001781	Admin info; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001783	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001784	Zolpidem phenyl-4-carb Ur Ql Scn	4180186
1001784	Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Edluar; Hypnogen; Ivedal; Lioran; Myslee; Nasen; Nytamel; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
1001784	唑吡坦 苯基-4-羧酸酯:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001785	Bacterial ahpC drug res mut Islt/Spm	4180186
1001785	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial ahpC drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001785	细菌 ahpC 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001786	Calories burned dur activity ?Tm	4180186
1001786	?Tm; Activ; Actvty; CLIN; dur activity; Energy/time; Movements; Power; QNT; Quan; Quant; Quantitative	4180186
1001786	已消耗的热量^在活动的过程中:功率:XXX:^患者:定量型	4182948
1001788	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001790	Cortisol p CRH stimulation Pnl SerPl	4180186
1001790	17-Hydroxycorticosterone; ACTH; ACTH RH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Corticotropin Releasing Factor; Cortisol p CRH stimulation Pnl; Cortrosyn; CRF; CRH; F; Horm; hydrocortisone; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim; Tumor marker	4180186
1001790	促肾上腺皮质激素释放激素刺激后皮质醇组套:-:时间点:血清/血浆:定量型	4182948
1001792	Burn Procedure note	4180186
1001792	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1001792	操作记录:发现:时间点:{环境}:文档型:烧伤管理	4182948
1001793	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001795	Chemistry; GDCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1001795	GDCA SerPl-sCnc	4180186
1001795	甘氨去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001797	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1001797	Navigator Phone Note	4180186
1001797	记录:发现:时间点:电话就医:文档型:医疗保健服务导航员	4182948
1001800	After; Clot; Clottable; Coag; Coagulation assay; Coagulation dilute Russell viper venom induced confirmatory test; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; dRVVT confirm; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Neut; Neutr; p hep neut; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1001800	dRVVT confirm p hep neut PPP	4180186
1001800	稀释蝰蛇毒诱导型凝血过程.过量磷脂^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1001801	Dark rod adaptation tm; EYE.PX; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Rod intercept (TM); Vision; Visual	4180186
1001801	L eye Dark rod adaptation tm	4180186
1001801	黑暗介导的视杆细胞适应时间:时间:时间点:眼睛.左侧:定量型	4182948
1001806	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001808	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001815	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GADO; Gadolium; Gd; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
1001815	Gadolinium/Creat Ur	4180186
1001815	钆/肌酐:质量比率:时间点:尿液:定量型	4182948
1001816	Elevation climbed 24h lRate	4180186
1001816	1 day; 24 hours; 24HR; Elevation gain; Elevation gained; H+P; H+P.HX; lRate; P prime; QNT; Quan; Quant; Quantitative	4180186
1001816	攀登高度:长度速率:24小时:^患者:定量型	4182948
1001817	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
1001817	分项账单:发现:时间点:^患者:文档型	4182948
1001818	Antigen; Antigens; BLOOD BANK; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1001818	VS Ag RBC Ql	4180186
1001818	VS 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001820	Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NC_000010.10:g.96405502G&gt;A; NC_000010.11:g.94645745G&gt;A; Nominal; PCR; Point in time; Random; rs12777823; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001820	10q23 g.94645745G>A Geno Bld/T	4180186
1001820	10q23 g.94645745G>A:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1001824	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Nominal; Report period; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
1001826	Lg B-cell Lymph Pnl Tiss	4180186
1001826	大B细胞淋巴瘤分类组套:-:时间点:组织与涂片:-	4182948
1001826	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; DLBCL; Lg B-cell lymph; Lg B-cell Lymph Pnl; Pan; PANEL.PATH; Panl; Pathology; PMBCL; Pnl; Point in time; Random; Tissue; Tissue, unspecified	4180186
1001827	GN resist Pnl Islt/Spm	4180186
1001827	ANTIBIOTIC SUSCEPTIBILITIES; Bact; GN resist Pnl; Islt; Islt/Spm; Isol; Molecular genetics; NEG; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001827	革兰氏阴性细菌耐药性组套:-:时间点:分离株/标本:-:分子遗传学类实验室方法	4182948
1001828	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D immitis; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; Heartworm; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1001828	D immitis IgG Ser Ql IA	4180186
1001828	犬恶丝虫 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1001830	1,3-Beta-D-Glucan; B; Beta glucan; i; III; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
1001830	1,3 beta glucan Ser Ql	4180186
1001830	1,3 Beta 葡聚糖:存在情况或阈值:时间点:血清:序数型	4182948
1001834	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; SUD consistency score	4180186
1001834	SUD consistency score	4180186
1001834	物质使用障碍问题一致性评分:评分:时间点:^患者:定量型	4182948
1001837	CHIKV IgG+IgM Pnl SerPl	4180186
1001837	CHIKV; CHIKV IgG+IgM Pnl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001837	基孔肯亚病毒抗体.IgM 与 IgG 组套:-:时间点:血清/血浆:-	4182948
1001840	DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV6; HPV6+11; HPV6+11 E6+E7 mRNA; Human papillomavirus; Microbiology; Ordinal; Papilloma virus low risk; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
1001840	HPV6+11 E6+E7 mRNA Tiss Ql Probe	4180186
1001840	人乳头瘤病毒 6+11 E6+E7 mRNA:存在情况或阈值:时间点:组织与涂片:序数型:DNA探针	4182948
1001842	c; Cath; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; LMTED; LTD; LVs thpy or emb or inf^W c v ex cath; Misc; Miscellaneous; Other; Point in time; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; View; Views Ltd; Vs Ltd; VWS; W contr via exist cath; WC	4180186
1001842	RFA Vs Ltd W contr via exist cath	4180186
1001842	针对治疗或栓塞术或输注的局部多重视图^采用经已有导管的对比剂:发现:时间点:XXX:文档型:放射荧光透视法.血管造影术	4182948
1001843	Chloride 2h p Vaso SerPl-sCnc	4180186
1001843	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Cl; Cl-; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1001843	氯^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001844	ABO Gp^p stem trnsplt; After; Blood; BLOOD BANK; Nominal; p HSCT; Point in time; PST; Random; Typ; WB; Whole blood	4180186
1001844	ABO Group p HSCT Bld	4180186
1001844	ABO 血型^在造血干细胞移植之后:类型:时间点:全血:名义型	4182948
1001845	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
1001847	Blood; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; PH Multigene Anl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001847	PH Multigene Anl Bld/T	4180186
1001847	原发性高草酸尿症多基因分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001848	GABABR IgG Titr CSF IF	4180186
1001848	Gamma 氨基丁酸 B 受体 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1001848	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; ACIF; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Piperidic acid; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1001849	Imi+Rel Islt Grad strip	4180186
1001849	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; Imi+Rel; Imipeneum; Imp; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1001849	亚胺培南+瑞雷巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
1001851	Nortrip Ur Ql Scn	4180186
1001851	Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; Nortrip; Nortriptylene; Nortriptyln; Ordinal; Pamelor; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001851	去甲阿米替林:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001852	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1001854	E Ag infant RBC Ql	4180186
1001854	Antigen; Antigens; BLOOD BANK; E Ag^infant; Erythrocytes; infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Screen	4180186
1001854	E 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1001857	XR Thumb.prox phlnx Bone dev stage	4180186
1001857	1st metacarpal; Arm; Bone dev stage; EXT; First finger; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; Thumb.prox phlnx; UE; Up; Xray; X-ray	4180186
1001857	骨骼发育阶段:评分:时间点:上肢>拇指.近节指骨:定量型:X射线摄影术	4182948
1001859	A1AT Cl Pnl SerPl+Stl	4180186
1001859	A1; A1A; A1AT; A-1-AT; A1-AT; A1AT Cl Pnl; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Faecal; Faeces; Fecal; Feces; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPl+Stl; SerPlas; Serum; Serum or plasma; Serum or plasma and stool; SR; Stl; Stool = Fecal	4180186
1001859	Alpha 1 抗胰蛋白酶粪便清除组套:-:时间点:血清/血浆+便:定量型	4182948
1001863	HPV16+18 E6+E7 mRNA Tiss Ql Probe	4180186
1001863	DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV16; HPV16 and 18; HPV16+18; HPV16+18 E6+E7; HPV16+18 E6+E7 mRNA; Human papillomavirus; Microbiology; Ordinal; Papilloma virus high risk; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
1001863	人乳头瘤病毒 16+18 E6+E7 mRNA:存在情况或阈值:时间点:组织与涂片:序数型:DNA探针	4182948
1001864	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; ED vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001864	LV ED vol A4C SP A-L	4180186
1001864	心脏舒张末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1001867	Jk3 Ag RBC Ql	4180186
1001867	Antigen; Antigens; BLOOD BANK; Erythrocytes; Jk3; Jk3 Ag; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001867	Jk3 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001868	Moxifloxacin 3 ug/mL Islt SlowMyco	4180186
1001868	3 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Avelox; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
1001868	莫西沙星 3.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
1001870	PPT1 + TPP1 Pnl Fib	4180186
1001870	Chemistry; Fib; Fibr; i; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PPT; PPT1 + TPP1 Pnl; PR; Prot; Random	4180186
1001870	棕榈酰蛋白硫酯酶 1 与三肽基肽酶 1 组套:-:时间点:成纤维细胞:-	4182948
1001871	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TLCA	4180186
1001871	TLCA SerPl-sCnc	4180186
1001871	牛磺石胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001873	DPYD gene Mut Anl Bld/T	4180186
1001873	Blood; DHP; DHPDHase; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; Document; DPD; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001873	DPYD 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001874	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1001874	今天已上学:发现:时间点:^患者:序数型	4182948
1001876	Color Me Healthy panel	4180186
1001876	Appearance; Color Me Healthy panel; Colour; H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; S prime; Sx	4180186
1001878	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001879	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1001879	GABABR IgG CSF Ql CBA IFA	4180186
1001879	Gamma 氨基丁酸 B 受体 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1001881	10M p 1 ug/kg CRH IV; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001881	Cortis 10M p 1 ug/kg CRH IV SerPl-mCnc	4180186
1001881	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1001882	Pref vaccine	4180186
1001882	Ident; Identifier; Nominal; Point in time; Pref vaccine; Random	4180186
1001882	首选疫苗类型:标识符:时间点:^患者:名义型	4182948
1001884	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1001886	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
1001886	Hantavirus IgM SerPl Ql IF	4180186
1001886	汉坦病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
1001887	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey; Sx	4180186
1001890	Antigen; Antigens; BLOOD BANK; C Ag^infant; Erythrocytes; infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1001890	C Ag infant RBC Ql	4180186
1001890	C 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1001891	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
1001891	注意力缺陷多动障碍类型:类型:时间点:^患者:名义型	4182948
1001892	acryloylfentanyl; Addiction; C22H26N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Egyptenyl; GCMS; Illicit; Level; Mass concentration; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001892	Acrylfentanyl Ur Cfm-mCnc	4180186
1001892	丙烯酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001893	Plt CD42b Act/Nor Bld FC	4180186
1001893	Act/Nor; Blood; CELL MARKERS; Control; Dynamic; FC; Glycocalicin; Glycoprotein Ib alpha; GPIba; GPIbalpha; Pl; Platelets; Platelt; Plt; Plt CD42b; Plt CD42b Act/Nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1001893	血小板 CD42b 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1001894	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial inhA drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001894	Bacterial inhA drug res mut Islt/Spm	4180186
1001894	细菌 inhA 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001896	Addiction; B; Beta hydroxy thiofentanyl; B-OH thiofentanyl; C20H26N2O2S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-[1-(2-hydroxy-2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001896	B-OH thiofentanyl Ur Cfm-mCnc	4180186
1001896	Beta 羟基硫代芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001898	P aeruginosa DNA Bld Pos Ql NAA+probe	4180186
1001898	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P aeruginosa; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001898	铜绿假单胞菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001899	Durat; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001900	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001902	Blood; Document; EDS Multigene Anl; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001902	EDS Multigene Anl Bld/T	4180186
1001902	埃勒斯-当洛斯综合征多基因分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001903	Temp setting Vet cage	4180186
1001903	CLIN; CLIN.VET; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temp setting; Temperature; Vet cage	4180186
1001903	温度设置:温度:时间点:兽医用病畜隔离笼:定量型	4182948
1001906	CYP4F2 c.1297G>A Geno Bld/T	4180186
1001906	Blood; CYP4F2 c.1297G&gt;A; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NC_000019.10:g.15879621C&gt;T; NC_000019.9:g.15990431C&gt;T; NG_007971.2:g.23454G&gt;A; NM_001082.4:c.1297G&gt;A; Nominal; NP_001073.3:p.Val433Met; p.V433M; PCR; Point in time; Random; rs2108622; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001906	CYP4F2 基因.c.1297G>A:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1001907	Compare; Compare prior test exam; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Prev; Random	4180186
1001907	与既往结果之间的比较:发现:时间点:^患者:文档型	4182948
1001908	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001909	Chemistry; CR; Crea; Creat; Hepacarboxyporph; Heptacarbox; Heptacarboxyl porphyrin; Heptacarboxylate porphyrin; Heptacarboxylporphyrins; Heptacarboxyporph; Heptacarboxyporphyrin; Hepta-CP; Hepta-CP I; Heptaporphyrin; Heptaporphyrine I; Hexacarboxyl porphyrin; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1001909	Hepta-CP I/Creat Ur-sRto	4180186
1001909	七羧基卟啉 I/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001910	Finding; Findings; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; Work	4180186
1001911	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Mec; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite	4180186
1001911	N-nortramadol Mec Cfm-mCnt	4180186
1001911	N-去甲基曲吗多:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
1001912	Chr 12 copy num/nucleus EntNum Tiss FISH	4180186
1001912	Chr 12 copy num; Chromosom; Chromosomes; Entitic; Entitic number; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001912	染色体 12 拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
1001917	LV ED vol A2C SP A-L	4180186
1001917	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; ED vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001917	心脏舒张末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1001918	Insulin p meal SerPl-sCnc	4180186
1001918	After; Chemistry; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
1001918	胰岛素^在进餐之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001922	Cl; Clear; Clearanc; Clearances; Clr; DRUG/TOXICOLOGY; Drugs; Myleran; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Studies; Study; Sutdies; Volume rate content	4180186
1001922	Busulfan Cl from Plas	4180186
1001922	白消安 清除:体积速率含量:检查过程持续时间:血浆:定量型	4182948
1001925	Alc; alcoholic; Drug; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.MTLHLTH	4180186
1001927	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1001927	XR Capitate Bone dev stage	4180186
1001927	骨骼发育阶段:评分:时间点:上肢>腕部.头状骨:定量型:X射线摄影术	4182948
1001929	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1001930	FLUAV PB2 gene Islt-Seq	4180186
1001930	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV PB2 gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1001930	流感病毒 A PB2 基因:序列:时间点:分离株:名义型:序列测定	4182948
1001932	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001932	深度睡眠持续时间:时间:时间点:^患者:定量型	4182948
1001933	FLUAV PA gene Islt-Seq	4180186
1001933	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV PA gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Postero-Anterior; Random	4180186
1001933	流感病毒 A PA 基因:序列:时间点:分离株:名义型:序列测定	4182948
1001935	LA ES vol A4C SP A-L	4180186
1001935	2D US; A4C SP A-L; Atrial; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume	4180186
1001935	心脏收缩末期容积:体积型属性:时间点:心脏.心房.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1001937	Anxiety screen report	4180186
1001937	Anxiety screen report; Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn	4180186
1001937	焦虑筛查报告:发现:时间点:^患者:文档型	4182948
1001939	CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
1001939	自我照顾能力:发现:时间点:^患者:名义型	4182948
1001941	Cortis 5M pre 1 ug/kg CRH IV SerPl-mCnc	4180186
1001941	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001941	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前5分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1001943	PHH3 Tiss Ql ImStn	4180186
1001943	IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; PHH3; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
1001943	磷酸化组蛋白 H3:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
1001944	LV ED sphericity index US	4180186
1001944	CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED sphericity index; Hrt; Hrt ventr; L; Length Ratio; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1001944	球形指数.舒张末期:长度比率:时间点:心脏.心室.左侧:定量型:超声	4182948
1001946	5th; 5th finger; Arm; Bone dev stage; EXT; Finger.5th; Finger.5th.prox phlnx; Imaging; little finger; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001946	XR Finger.5th.prox phlnx Bone dev stage	4180186
1001946	骨骼发育阶段:评分:时间点:上肢>手指.第五.近节指骨:定量型:X射线摄影术	4182948
1001948	FOXO1 gene Rear Tiss FISH	4180186
1001948	13q14.1; Document; Finding; Findings; FKH; FKH1; FKHR; Fluorescent in situ hybridization; Forkhead box O1A; Forkhead in rhabdomyosarcoma; FOXO1A; Molecular pathology; MOLPATH; Point in time; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified	4180186
1001948	FOXO1 基因重排:发现:时间点:组织与涂片:文档型:FISH	4182948
1001953	Activ; Actvty; Blood; Catechol-O-Methyltransferase; COMT gene prod met activ imp; Drug metabolism; Gene prod met act imp; HEL-S-98n; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001953	COMT gene prod met activ Bld/T-Imp	4180186
1001953	COMT 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
1001955	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001956	XR Finger.3rd.mid phlnx Bone dev stage	4180186
1001956	3rd; 3rd finger; Arm; Bone dev stage; EXT; Finger.3rd; Finger.3rd.mid phlnx; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001956	骨骼发育阶段:评分:时间点:上肢>手指.第三.中节指骨:定量型:X射线摄影术	4182948
1001957	M. morganii DNA Bld Pos Ql NAA+probe	4180186
1001957	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enterobacteriaceae; Gram Negative Bacteria; Gram-Negative Bacterial Infection; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M. morganii; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001957	摩根摩根菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001958	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TCA	4180186
1001958	TCA SerPl-sCnc	4180186
1001958	牛磺胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001961	dRVVT confirm Act/Nor p hep neut PPP	4180186
1001961	Act/Nor; After; Clot; Clottable; Coag; Coagulation assay; Coagulation dilute Russell viper venom induced confirmatory test; Control; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; dRVVT confirm; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Neut; Neutr; p hep neut; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; RlTm; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1001961	稀释蝰蛇毒诱导型凝血过程.过量磷脂 实际的/正常的^在肝素中和之后:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1001962	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001963	4-chloro-N-[[1-(dimethylamino)cyclohexyl]methyl]-benzamide; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001963	AH-8529 Ur Cfm-mCnc	4180186
1001963	AH-8529:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001965	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001968	Copper Dial fld-sCnc	4180186
1001968	Chemistry; Cu; Diaf; Dialysate; Dialysis fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1001968	铜:物质的量浓度:时间点:透析液:定量型	4182948
1001969	M hyorhinis IgG/Pos cntrl Ser IA	4180186
1001969	猪鼻支原体 抗体.IgG/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
1001969	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; M hyorhinis; M hyorhinis Ab.IgG; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
1001972	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001973	RV Major axis dias A4C	4180186
1001973	2D US; CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; Hrt; Hrt ventr; LAX; Length; Long axis; Major axis dias; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
1001973	主轴.舒张期:长度:时间点:心脏.心室.右侧:定量型:超声.2D.A4C	4182948
1001978	4-Chloro-N-(1-(4-nitrophenethyl)piperidin-2-ylidene)benzenesulfonamide; Addiction; C19H20ClN3O4S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001978	W-18 Ur Cfm-mCnc	4180186
1001978	W-18:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001979	Personnel Funeral service licensee	4180186
1001979	ADMIN; bod; Bodies; Nominal; Othr; Person name; Point in time; Random	4180186
1001979	丧葬服务持照方或者其他负责保管逝者遗体的机构:人员姓名:时间点:工作人员:名义型	4182948
1001981	HTLV I+II IgG Pnl CSF	4180186
1001981	2; Cerebral spinal fluid; Cerebrospinal Fl; HTLV I+II; HTLV I+II IgG Pnl; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; Immune globulin G; Immunoglobulin G; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1001981	HTLV I & II 抗体.IgG 组套:-:时间点:脑脊液:-	4182948
1001984	After; Antigen; Antigens; BLOOD BANK; Erythrocytes; K Ag^p stem trnsplt; KEL1; Kell Blood Group System; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001984	K Ag p HSCT RBC Ql	4180186
1001984	K 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1001987	dPAP by Cardiac cath	4180186
1001987	Art; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP diastolic; BP end dias; DBP; Dias; Dias BP; Diast; Diastoli; ED; Intravenous; IV; PA; PAP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
1001987	血管内心脏舒张期末期:压力或压强:时间点:肺动脉:定量型:心导管插入术	4182948
1001991	SUD screen report	4180186
1001991	Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; Subs; SUD screen report	4180186
1001991	物质使用障碍筛查报告:发现:时间点:^患者:文档型	4182948
1001993	THDCA SerPl-sCnc	4180186
1001993	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; THDCA	4180186
1001993	牛磺猪去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001994	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Colistin res mcr-2; Colmycin; Colymycin; II; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
1001994	Colistin res mcr-2 Islt/Spm Ql	4180186
1001994	细菌粘菌素耐药 mcr-2 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
1001996	MYCN copy num/Chr 2 copy num Tiss FISH	4180186
1001996	Chr 2 copy num; Chromosom; Chromosomes; Fluorescent in situ hybridization; II; Molecular pathology; MOLPATH; MYCN copy num; No; Num; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001996	MYCN 基因拷贝数/染色体 2 拷贝数:计数型比率:时间点:组织与涂片:定量型:FISH	4182948
1001997	Calc; Calculation; CARD.US; Cardiology; DOP; DUPLEX; Echography; Point in time; Proximal Isovelocity Surface Area; QNT; Quan; Quant; Quantitative; Random; Reg vol; Sonogram; Sonograph; Sonography; TV; ULS; Ultrasound; Vol; Volume	4180186
1001997	TV Reg vol PISA	4180186
1001997	反流体积:体积型属性:时间点:三尖瓣:定量型:超声.多普勒+近端等速表面积计算法	4182948
1001999	RFA Vs for dial fistula W contr IA	4180186
1001999	Arteriogram; c; Contr; Contra; Contrst; Dialy; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Imaging; Misc; Miscellaneous; Other; Point in time; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX; View; Vs dial fistula^W cont IA; Vs for dial fistula; VWS; W contr IA; WC	4180186
1001999	针对透析瘘管的多重视图^采用动脉注射对比剂:发现:时间点:XXX>血管类:文档型:放射荧光透视法.血管造影术	4182948
1002000	2D US; A2C MOD; Calculated; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1002000	LV Output A2C MOD	4180186
1002000	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+圆盘单平面计算法	4182948
1002003	Blood; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; Variant interaction summary; WB; Whole blood; Whole blood or Tissue	4180186
1002003	Variant interaction summary Bld/T-Imp	4180186
1002003	遗传变异相互作用摘要:印象:时间点:全血/组织:叙述型	4182948
1002007	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002009	After; Antigen; Antigens; BLOOD BANK; c; C Ag^p stem trnsplt; Erythrocytes; little c Ag^p stem trnsplt; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1002009	little c Ag p HSCT RBC Ql	4180186
1002009	c 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002017	Act/Nor; Blood; CELL MARKERS; Control; Dynamic; FC; gG; Glycoprot; Glycoproteins; GP; GPVI; Pl; Plat Gp; Platelet glycoprotein VI; Platelet GPVI Act/Nor; Platelets; Platelt; Plt; Plt GPVI; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1002017	Plt GPVI Act/Nor Bld FC	4180186
1002017	血小板糖蛋白 VI 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1002018	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 4h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002018	Osmolality p 4h FFST SerPl	4180186
1002018	渗透压^在液体型禁食之后4小时:渗透压:时间点:血清/血浆:定量型	4182948
1002019	Eravacycline Islt Grad strip	4180186
1002019	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1002019	厄伐环素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
1002020	2D US; Calc; Calculation; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1002020	LV Output Biplane area-length	4180186
1002020	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D+双平面面积-长度计算法	4182948
1002025	Diff Lg B-cell lymph COO Tiss	4180186
1002025	弥漫性大B细胞淋巴瘤细胞起源:类型:时间点:组织与涂片:名义型	4182948
1002025	ABC; B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; COO; Diff Lg B-cell lymph; Diff Lg B-cell lymph COO; DLBCL; GCB; Lg B-cell lymph; Nominal; Pathology; Point in time; Random; Tissue; Tissue, unspecified; Typ	4180186
1002026	Heparan sulfate SerPl-mCnc	4180186
1002026	Chemistry; HS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
1002026	硫酸类肝素:质量浓度:时间点:血清/血浆:定量型	4182948
1002027	Blood; Cell; Cells w cytogenetic abnl; Cellularity; Cnt; Count; Molecular genetics; Molecular pathology; MOLPATH; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002027	Cells w cytogenetic abnl Bld/T	4180186
1002027	细胞.细胞遗传学异常:数量(计数):时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
1002029	Residual vol/Predicted Plethysmograph	4180186
1002029	bod; Bodies; Breathing; Lungs; Percent; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; Residual vol; RS; RV; V Res/Predicted; Vol; Volfr; Volume fraction	4180186
1002029	体积.残余/预计法:体积分数:时间点:呼吸系统:定量型:体积描记器.体箱计	4182948
1002031	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1002031	病程记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
1002031	Navigator Prog note	4180186
1002032	Addiction; Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; Hypnogen; Illicit; Ivedal; Lioran; Myslee; Nasen; Nytamel; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
1002032	Zolpidem Ur Ql Scn	4180186
1002032	唑吡坦:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002033	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS; Valley fever	4180186
1002033	Coccidioides IgM CSF IA-aCnc	4180186
1002033	球孢子菌属单个未知种 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1002034	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Blood urea nitrogen; BUN; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; N; N2; Nit; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN; VP	4180186
1002034	BUN 2h p Vaso SerPl-mCnc	4180186
1002034	尿素氮^在给予剂量后叶加压素之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
1002035	Antigen; Antigens; BLOOD BANK; Erythrocytes; infant; K Ag^infant; KEL1; Kell Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1002035	K Ag infant RBC Ql	4180186
1002035	K 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1002037	Addiction; Drugs; Drugs of abuse; Illicit; Nominal; Point in time; PotentialForAbuse; Random; Survey; Typ	4180186
1002043	ADHD hyperactive severity; H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
1002043	ADHD hyperactive severity	4180186
1002043	注意力缺陷多动障碍极度活跃症状严重程度:印象:时间点:^患者:序数型	4182948
1002045	little c Ag RBCCo Ql	4180186
1002045	Antigen; Antigens; BLOOD BANK; c; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Rh; Rh Blood Group System; Screen	4180186
1002045	c 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1002047	Addiction; Butyrfentanyl; Butyr-fentanyl; Butyryl fentanyl; C23H30N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002047	Butyrylfentanyl Ur Cfm-mCnc	4180186
1002047	丁酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002048	4 weeks; Job; Occupation; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1002056	After; Clot; Clottable; Coag; Coagulation assay; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; Hep; Hepar; Heparin Nt; Heparn; Neut; Neutr; p hep neut; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1002056	dRVVT p hep neut PPP	4180186
1002056	稀释蝰蛇毒诱导型凝血过程^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002058	mGluR1 IgG CSF Ql CBA IFA	4180186
1002058	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c707; Cerebral spinal fluid; Cerebrospinal Fl; Glu; Glutamic acid; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; mGluR1; mGluR1 Ab; mGluR1 IgG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002058	代谢型谷氨酸受体 1 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1002059	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002061	HAdV A+B+C+D+E DNA Resp Ql NAA+probe	4180186
1002061	腺病毒 A+B+C+D+E DNA:存在情况或阈值:时间点:呼吸道:序数型:探针法.基因扩增.靶向	4182948
1002061	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Adeno virus; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; HAdV A+B+C+D+E; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1002063	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1002065	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
1002065	Eating disorders Diag study note	4180186
1002065	诊断性检查记录:发现:时间点:{环境}:文档型:进食障碍	4182948
1002067	O2/Total gas setting VFr Vet cage	4180186
1002067	CLIN; CLIN.VET; Gases; O2; O2/gas .tot set; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Total gas setting; Totl; Vet cage; Volfr; Volume fraction	4180186
1002067	氧/气体.总计设置:体积分数:时间点:兽医用病畜隔离笼:定量型	4182948
1002071	Finding; Findings; Mult; Multi; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002072	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SSD score; Sx	4180186
1002072	SSD score	4180186
1002072	躯体症状障碍评分:评分:时间点:^患者:定量型	4182948
1002073	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002078	Continuity assessment record and evaluation; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note; WOC	4180186
1002078	WOC Diag study note	4180186
1002078	诊断性检查记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
1002088	DRUG/TOXICOLOGY; Drugs; Horizant; Neurontin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified	4180186
1002088	Gabapentin Tiss Ql Scn	4180186
1002088	加巴喷丁:存在情况或阈值:时间点:组织与涂片:序数型:毒理学筛查试验	4182948
1002089	Date and time; Date+time; Date+time OB delivery; OB; OBGYN; Obstetrical; Obstetrics; Point in time; Pregnancy; Prenatal; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1002089	Date+time OB delivery	4180186
1002089	产科分娩日期和时间:时间戳:时间点:^患者:定量型	4182948
1002091	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002093	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002093	Haem influ DNA Bld Pos Ql NAA+probe	4180186
1002093	流感嗜血杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002101	little e Ag p HSCT RBC Ql	4180186
1002101	After; Antigen; Antigens; BLOOD BANK; e; E Ag^p stem trnsplt; Erythrocytes; little e Ag^p stem trnsplt; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Screen	4180186
1002101	e 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002102	B; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Chorionic gonadotropin.intact; HCG; HCG Intact; HCG Intact+B; Human chorionic gonadotropin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002102	HCG Intact+B SerPl-mCnc	4180186
1002102	绒毛膜促性腺激素.完整型+Beta 亚单位:质量浓度:时间点:血清/血浆:定量型	4182948
1002106	T gondii IgG pnl Ser Donr	4180186
1002106	Donr; Immune globulin G; Immunoglobulin G; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; T gondii; T gondii IgG pnl; Toxo; Toxoplasmosis	4180186
1002106	刚地弓形虫抗体.IgG 组套:-:时间点:血清^供体:-	4182948
1002108	Antigen; Antigens; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; spp; SUDS; UA; UR; Urn; Valley fever	4180186
1002108	Coccidioides Ag Ur IA-mCnc	4180186
1002108	球孢子菌属单个未知种 抗原:质量浓度:时间点:尿液:定量型:免疫测定法	4182948
1002112	GFAP alpha IgG Titr Ser IF	4180186
1002112	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
1002112	ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Pituitary glycoproteins; Point in time; PR; Prot; Random; Serology; Serum; SmQn; SR; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Titer; Titered; Titre; Traumatic Brain Injuries; TRF; Ttr	4180186
1002117	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Persons; Pnl; Point in time; Random; SDOH; Survey; SURVEY.GNHLTH	4180186
1002119	Blood; CELL MARKERS; Dynamic; FC; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; Neut; Neut.CD64; Neut.CD64/100 Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1002119	Neut.CD64/100 Neut NFr Bld FC	4180186
1002119	嗜中性粒细胞.CD64/100 个嗜中性粒细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
1002122	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DFS70; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1002122	DFS70 IgG SerPl Ql IA	4180186
1002122	致密细斑 70 蛋白 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
1002124	Centers for Medicare and Medicaid Assessment; Finding; Findings; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
1002127	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max long strain rate sys; Max strain rate sys; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Sys.max; Syst; ULS; Ultrasound; Ventricular	4180186
1002127	LV Max long strain rate sys 3D US	4180186
1002127	纵向应变速率.收缩期.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002130	Finding; Findings; Nominal; Survey; SURVEY.CSSRS	4180186
1002135	Blood; Drugs; Finding; Findings; Genetics; Genomic; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; Variant drug sens effect; WB; Whole blood; Whole blood or Tissue	4180186
1002135	Variant drug sens effect Nar	4180186
1002135	遗传变异对药物敏感性的影响:发现:时间点:全血/组织:叙述型	4182948
1002136	Pulm valve Regurg PHT DOP	4180186
1002136	Bld flow; CARD.US; Cardiology; DOP; DUPLEX; Dynamic; Echography; P1/2T; PHT; Point in time; Pulm valve; Pulmonic valvular; QNT; Quan; Quant; Quantitative; Random; Regurg PHT; Sonogram; Sonograph; Sonography; T1/2; ULS; Ultrasound	4180186
1002136	反流血流压力减半时间:时间:时间点:肺动脉瓣:定量型:超声.多普勒	4182948
1002140	Home access mod responsible party	4180186
1002140	CLIN; Finding; Findings; Home access mod responsible party; Nominal; Point in time; Random	4180186
1002140	住宅无障碍改造责任方:发现:时间点:^患者:名义型	4182948
1002141	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1002143	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; HF+TC; notes; Point in time; Random; Study report; TC; Visit note	4180186
1002143	HF+TC Diag study note	4180186
1002143	诊断性检查记录:发现:时间点:{环境}:文档型:心力衰竭+移植心脏病学	4182948
1002144	ABG; Amm; Ammon; Amon; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Level; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1002144	Ammonia BldA-sCnc	4180186
1002144	氨:物质的量浓度:时间点:动脉全血:定量型	4182948
1002147	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002150	Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CSSRS	4180186
1002151	C16 ceramide; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1002151	C16 ceramide Plas-sCnc	4180186
1002151	N-棕榈酰基神经鞘氨醇:物质的量浓度:时间点:血浆:定量型	4182948
1002152	H capsul IgG CSF IA-aCnc	4180186
1002152	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
1002152	荚膜组织胞浆菌 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1002154	Act/Nor; Antigen, CD42a; Blood; CD42a Antigen; CELL MARKERS; Control; Dynamic; FC; GPIX; Pl; Platelet Glycoprotein IX; Platelets; Platelt; Plt; Plt CD42a; Plt CD42a Act/Nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1002154	Plt CD42a Act/Nor Bld FC	4180186
1002154	血小板 CD42a 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1002156	2-OH-Ethylfluraz Ur Ql Scn	4180186
1002156	2-OH-Ethylfluraz; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Hydroxy ethylflurazepam; II; OH-Ethylfluraz; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1002156	2-羟乙基氟西泮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002157	Lg B-cell lymph Tiss	4180186
1002157	大B细胞淋巴瘤:类型:时间点:组织与涂片:名义型	4182948
1002157	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; Lg B-cell lymph; Nominal; Pathology; Point in time; Random; Tissue; Tissue, unspecified; Typ	4180186
1002158	Advanced; CLIN; directives; Finding; Findings; Nominal; Point in time; Random	4180186
1002158	事前指示文档格式:发现:时间点:^患者:名义型	4182948
1002159	D Ag p HSCT RBC Ql	4180186
1002159	After; Antigen; Antigens; BLOOD BANK; D Ag^p stem trnsplt; Dextro; Erythrocytes; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rhesus; Screen	4180186
1002159	D 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002161	BM; BON; Bone marrow; Deoxyribonucleic acid; DNA content; Dynamic; FC; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Monotypic PC DNA ploidy; Nominal; Point in time; Random; Typ	4180186
1002161	Monotypic PC DNA ploidy Mar FC	4180186
1002161	单型浆细胞 DNA 倍性:类型:时间点:骨髓:名义型:流式细胞测量术	4182948
1002162	HMGCR IgG Ser IA-aCnc	4180186
1002162	3-羟基-3-甲基戊二酰-辅酶 A 还原酶 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
1002162	3-OH-3-Methylglutaryl-coA reductase Ab; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; HMGCR; Hydrox; IAA; III; Immune globulin G; Immunoglobulin G; MEIA; NAM; Necrotizing autoimmune myopathy; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
1002163	Blood; Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MYCN amplification; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002163	MYCN amplification Bld/T FISH	4180186
1002163	MYCN 基因扩增:发现:时间点:全血/组织:文档型:FISH	4182948
1002165	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; VP	4180186
1002165	Osmolality 1h p Vaso Ur	4180186
1002165	渗透压^在给予剂量后叶加压素之后1小时:渗透压:时间点:尿液:定量型	4182948
1002166	Bacterial gyrA drug res mut Islt/Spm	4180186
1002166	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial gyrA drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1002166	细菌 gyrA 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1002167	Citrobac sp DNA Bld Pos Ql NAA+probe	4180186
1002167	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Citrobac sp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002167	柠檬酸杆菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002168	N men DNA Bld Pos Ql NAA+probe	4180186
1002168	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002168	脑膜炎奈瑟菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002169	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Substance abuse; Visit note	4180186
1002169	Addiction med Prog note	4180186
1002169	病程记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
1002173	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002174	H+P; H+P.PX; Nominal; P prime; Point in time; Random; Wnd; Wnd shape	4180186
1002174	Wnd shape	4180186
1002174	伤口形状:形状:时间点:伤口:名义型	4182948
1002177	Blood; ECGF1; Endothelial cell growth factor 1 (platelet-derived); full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Identity or presence; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Nominal; Point in time; Random; sequencing of entire coding region; Thymidine phosphorylase; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002177	TYMP Full Mut Anl Bld/T Seq	4180186
1002177	TYMP 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
1002180	mGluR1 IgG Titr CSF IF	4180186
1002180	代谢型谷氨酸受体 1 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1002180	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; c707; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Glu; Glutamic acid; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; mGluR1; mGluR1 Ab; mGluR1 IgG; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002182	Admin info; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002183	BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Identity or presence; Leukemia; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Monoclonal; Monotypic plasma cells; Multiple myeloma; Myeloma cells; Nominal; Plasma cell myeloma; Plasmacyte; Plasmacytes; Point in time; Random	4180186
1002183	Monotypic plasma cells Mar FC	4180186
1002183	浆细胞.单型群:存在与否或特征标识:时间点:骨髓:名义型:流式细胞测量术	4182948
1002184	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002185	Exercise distance 24h	4180186
1002185	1 day; 24 hours; 24HR; CLIN; EXCZ; Length; QNT; Quan; Quant; Quantitative	4180186
1002185	运动距离:长度:24小时:^患者:定量型	4182948
1002186	120 min; 120 minutes; 120min; 2 hours; 2h p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002186	Breath H2 2h p carb	4180186
1002186	氢/已呼出的气体^在给予剂量碳水化合物之后2小时:体积分数:时间点:呼出的气体:定量型	4182948
1002190	GN Bld Culture Pnl Bld Pos NAA+probe	4180186
1002190	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GN Bld Culture Pnl; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; NEG; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002190	革兰氏阴性细菌血液培养组套:-:时间点:血液.生长阳性:-:探针法.基因扩增.靶向	4182948
1002195	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Vomitus	4180186
1002195	已发生的呕吐:发现:时间点:^患者:序数型	4182948
1002196	Gyn Onc Phone Note	4180186
1002196	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Point in time; Random; Visit note	4180186
1002196	记录:发现:时间点:电话就医:文档型:妇科肿瘤学	4182948
1002197	GABABR Ab Ser Ql CBA IFA	4180186
1002197	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1002197	Gamma 氨基丁酸 B 受体 抗体:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1002200	After; Blood; BLOOD BANK; D phenotyping; D typing; K Ag^p stem trnsplt; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; PST; Random; Rh Ags+K Ag Pnl p stem trnsplt; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002200	Rh Ags+K Ag Pnl p stem trnsplt Bld	4180186
1002200	造血干细胞移植后Rh抗原与K抗原组套:-:时间点:全血:-	4182948
1002201	GABABR IgG Titr SerPl IF	4180186
1002201	Gamma 氨基丁酸 B 受体 抗体.IgG:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
1002201	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; ACIF; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Piperidic acid; Pl; Plasma; Plsm; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002202	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume; Wnd	4180186
1002202	Wound vol	4180186
1002202	伤口体积:体积型属性:时间点:伤口:定量型	4182948
1002204	Blood; Genetic variant diag sig; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002204	Genetic variant diag sig Bld/T-Imp	4180186
1002204	遗传变异诊断意义:印象:时间点:全血/组织:叙述型	4182948
1002205	LA ES vol/BSA A2C MOD	4180186
1002205	2D US; A2C MOD; Atrial; Bdy surface; bod; Bodies; BSA; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LAVI; Left Atrial Volume Index; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume/area	4180186
1002205	心脏收缩末期容积/体表面积:体积/面积:时间点:心脏.心房.左侧:定量型:超声.2D.A2C+圆盘单平面计算法	4182948
1002206	Plt CD61 Act/Nor Bld FC	4180186
1002206	Act/Nor; Beta 3; Beta 3 integrin chain; Beta3; Beta-3 integrin; Blood; CD61 Antigen; CD61A; CELL MARKERS; Control; Dynamic; FC; GPIIb/IIIa; GPIIIa; Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); Pl; Platelet Glycoprotein IIIa; Platelet GPIIIa; Platelets; Platelt; Plt; Plt CD61; Plt CD61 act/nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1002206	血小板 CD61 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1002209	Arterial Stenosis; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
1002210	Centers for Medicare and Medicaid Assessment; Finding; Findings; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
1002211	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002212	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1002221	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Othr; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002222	CT Head+C-spine WO+W contr IV	4180186
1002222	Brain; c; C/sp; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; C-spine; CT scan; Document; Finding; Findings; Head+C-spine; Head+Neck; Imaging; Intracranial; Point in time; Radiology; Random; Skull; Spinal; Spinal Cord; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1002222	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部 & 颈部>脊椎.颈段:文档型:CT	4182948
1002225	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002226	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; NASH interpretation; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002226	NASH interpretation SerPl-Imp	4180186
1002226	非酒精性脂肪变性肝炎解释:印象:时间点:血清/血浆:序数型	4182948
1002229	XR Finger.3rd.distl phlnx Bone dev stage	4180186
1002229	3rd; 3rd finger; Arm; Bone dev stage; EXT; Finger.3rd; Finger.3rd.distl phlnx; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1002229	骨骼发育阶段:评分:时间点:上肢>手指.第三.远节指骨:定量型:X射线摄影术	4182948
1002230	Glucose Mean SerPl-mCnc	4180186
1002230	Average; Avg; Chemistry; Glu; Gluc; Glucoseur; Level; Mass concentration; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Studies; Study; Sutdies	4180186
1002230	葡萄糖:质量浓度:检查过程持续时间^平均值:血清/血浆:定量型	4182948
1002231	Liver steatosis score SerPl	4180186
1002231	Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002231	肝脂肪变性评分:评分:时间点:血清/血浆:定量型	4182948
1002232	2; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002232	HTLV I+II IgG CSF Ql Line blot	4180186
1002232	HTLV I+II 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
1002236	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002238	5th; Arm; Bone dev stage; EXT; Imaging; Metacarpal.5th; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1002238	XR Metacarpal.5th Bone dev stage	4180186
1002238	骨骼发育阶段:评分:时间点:上肢>手.掌骨.第五:定量型:X射线摄影术	4182948
1002239	Entitic; Entitic number; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MYCN copy num; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1002239	MYCN copy num/nucleus EntNum Tiss FISH	4180186
1002239	MYCN 基因拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
1002240	ABO + Rh infant Bld	4180186
1002240	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; ABO+Rh Gp^infant; Blood; BLOOD BANK; D phenotyping; D typing; infant; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood	4180186
1002240	ABO与Rh血型^婴儿期期间:类型:时间点:全血:名义型	4182948
1002242	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1002246	Bdy weight; bod; Bodies; BW; EXCZ; O2; O2 consumption; O2 consumption/BW; peak W exer; Point in time; Post; Postdose; Post-dose; PULMONARY; QNT; Quan; Quant; Quantitative; Random; tO2; Volume rate content; W exercise; Wt	4180186
1002246	VO2/BW max dur exercise	4180186
1002246	氧消耗/体重^运动过程中的峰值:体积速率含量:时间点:^患者:定量型	4182948
1002247	Anaerobic Thresholds; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; Threshold, Anaerobic; Volume rate content	4180186
1002247	Ventilatory threshold	4180186
1002247	通气阈值:体积速率含量:时间点:^患者:定量型	4182948
1002248	AMPAR2 Ab Ser Ql CBA IFA	4180186
1002248	ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GluA2; GluR2; GluR-B; Hydrox; II; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1002248	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1002249	B miyamotoi IgG+IgM SerPl-Imp	4180186
1002249	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B miyamotoi; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBRF; Tick Borne Diseases; tick-borne relapsing fever	4180186
1002249	宫本疏螺旋体 抗体.IgG+IgM:印象:时间点:血清/血浆:名义型	4182948
1002250	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002251	SSD severity	4180186
1002251	H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; SSD severity; Sx	4180186
1002251	躯体症状障碍严重程度:印象:时间点:^患者:序数型	4182948
1002252	LV Max circ atrial contract st rt 3D US	4180186
1002252	3D US; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; Length Ratio; LT; LV; Max circ atrial contract st rt; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1002252	心房收缩应变速率.周向.最大值:长度比率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002261	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1002263	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Cl; Cl-; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002263	Chloride 1h p Vaso SerPl-sCnc	4180186
1002263	氯^在给予剂量后叶加压素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002264	After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002264	Breath H2 p carb	4180186
1002264	氢/已呼出的气体^在给予剂量碳水化合物之后:体积分数:时间点:呼出的气体:定量型	4182948
1002265	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P mirabilis; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002265	P mirabilis DNA Bld Pos Ql NAA+probe	4180186
1002265	奇异变形杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002267	GRS for CHD	4180186
1002267	CLIN; CLIN.RISK; Coronary Artery Diseases; Dis; Disease, Coronary Artery; Diseases; Dz; Genetics; Genomic; Genomic risk score; GRS for CHD; Polygenic risk score; QNT; Quan; Quant; Quantitative; Scale	4180186
1002267	冠心病遗传风险评分:评分:一生:^患者:定量型	4182948
1002268	CARD.US; Cardiology; Dias; Dias.max; Diast; Diastoli; DOP; DUPLEX; Echography; Grad; Largest; Maximal; Maximum; Peak; Point in time; Pres grad.early dias.max; Press grad; PV; PVG; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
1002268	PV Pres grad.early dias.max DOP	4180186
1002268	压力梯度.舒张早期.最大值:压差:时间点:肺动脉瓣:定量型:超声.多普勒	4182948
1002269	Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; Clot; Clottable; Coag; Coagulation assay; Hep; Hepar; Heparin Nt; Heparn; Little(A)PTT; Neut; Neutr; p hep neut; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
1002269	aPTT-LA p hep neut PPP	4180186
1002269	表面诱导型凝血过程.狼疮敏感性^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002271	Appt legal guardian	4180186
1002271	ADMIN; ADMIN.PATIENT; Appt legal guardian; Finding; Findings; Nominal; Point in time; Random	4180186
1002271	法定监护人委任情况:发现:时间点:^患者:名义型	4182948
1002273	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; F tular; F tularensis; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Tularemia	4180186
1002273	F tular IgG Ser Ql IA	4180186
1002273	土拉弗朗西斯菌 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1002276	XR Triquetrum Bone dev stage	4180186
1002276	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1002276	骨骼发育阶段:评分:时间点:上肢>腕部.三角骨:定量型:X射线摄影术	4182948
1002280	FDA label Index - drug interactions	4180186
1002280	DOCUMENT.REGULATORY; Drugs; FDA label; Index - drug interactions; Narrative; Report	4180186
1002280	索引 - 药物相互作用:-:-:^FDA 产品标签:叙述型	4182948
1002282	Cortis 1M pre 1 ug/kg CRH IV SerPl-mCnc	4180186
1002282	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002282	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前1分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1002283	Adverse drug seq var interp Bld/T-Imp	4180186
1002283	Adverse drug rxn; Adverse drug seq var interp; Blood; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Narrative; Point in time; Random; React; Report; Rxn; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002283	药物不良反应序列变异风险解释:印象:时间点:全血/组织:叙述型	4182948
1002284	K pneumon DNA Bld Pos Ql NAA+probe	4180186
1002284	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; K pneumon; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002284	肺炎克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002286	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
1002288	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Gestation; Gestations; Gravida; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Pregnancies; Random; Study report; Survey; SURVEY.MTLHLTH	4180186
1002289	Metamyelocytes.neut/leuk NFr Mar Manual	4180186
1002289	100WBC; BM; BON; Bone marrow; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; MAR; Marrow (bone); Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
1002289	晚幼粒细胞.嗜中性/100 个白细胞:计数型分数:时间点:骨髓:定量型:手工计数方法	4182948
1002291	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Astro virus; DNA NUCLEIC ACID PROBE; DNA probe; HAstV; III; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PoAstV3; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1002291	PoAstV3 RNA Ct Spec Qn NAA+probe	4180186
1002291	猪星状病毒 3 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1002293	3-alpha,6-alpha-dihydroxy-5-beta-cholan-24-oate; 6alpha-Hydroxylithocholate; Chemistry; HDCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1002293	HDCA SerPl-sCnc	4180186
1002293	猪去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002294	Breath H2 45M p carb	4180186
1002294	45M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002294	氢/已呼出的气体^在给予剂量碳水化合物之后45分钟:体积分数:时间点:呼出的气体:定量型	4182948
1002296	HEDIS 2020 Mammography	4180186
1002296	HEDIS 2020 Mammography; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1002296	HEDIS 2020 取值集合 - 乳房X线照相术:-:时间点:^患者:-	4182948
1002298	C18 Cer; C18 ceramide; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1002298	C18 ceramide Plas-sCnc	4180186
1002298	N-硬脂酰基神经鞘氨醇:物质的量浓度:时间点:血浆:定量型	4182948
1002299	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002300	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Porphyrin Fract Pnl; Random; UA; UR; Urn	4180186
1002300	Porphyrin Fract Pnl Ur	4180186
1002300	卟啉类成分组套:-:时间点:尿液:-	4182948
1002303	ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn; Vasopressin chal p H2O deprivation Pnl; VP	4180186
1002303	Vasopressin chal p H2O depr Pnl U+SerPl	4180186
1002303	限制饮水之后后叶加压素刺激组套:-:时间点:尿液+血清/血浆:-	4182948
1002311	Document; Finding; Findings; Fluorescent in situ hybridization; MDM2 amplification; Molecular pathology; MOLPATH; Point in time; Random; Tissue; Tissue, unspecified	4180186
1002311	MDM2 amplification Tiss FISH	4180186
1002311	MDM2 基因扩增:发现:时间点:组织与涂片:文档型:FISH	4182948
1002313	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EMCV; EMCV RNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1002313	EMCV RNA Ct Spec Qn NAA+probe	4180186
1002313	脑心肌炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1002315	Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SDOH; Survey; T prime	4180186
1002316	Centers for Medicare and Medicaid Assessment; Form version; Othr; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002317	4h p busulfan; After; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
1002317	Busulfan 4h p busulfan Plas-mCnc	4180186
1002317	白消安^在完成白消安输注之后4小时:质量浓度:时间点:血浆:定量型	4182948
1002318	AMPAR2 IgG Titr CSF IF	4180186
1002318	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1002318	ABS; Aby; ACIF; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GluA2; GluR2; GluR-B; Hydrox; IFA; II; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalitis; OH; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002320	Home access mod date	4180186
1002320	CLIN; Home access mod date; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1002320	住宅无障碍改造日期:日期:时间点:^患者:定量型	4182948
1002321	120 min; 120 minutes; 120min; 2 hours; 2h p busulfan; After; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
1002321	Busulfan 2h p busulfan Plas-mCnc	4180186
1002321	白消安^在完成白消安输注之后2小时:质量浓度:时间点:血浆:定量型	4182948
1002322	Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Noiafren; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sederlona; UA; UR; Urbadan; Urbanol; Urbanyl; Urn	4180186
1002322	cloBAZam Ur Ql Scn	4180186
1002322	氯巴詹:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002323	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; Survey	4180186
1002324	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass Content; Mec; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite	4180186
1002324	O-nortramadol Mec Cfm-mCnt	4180186
1002324	O-去甲基曲马多:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
1002325	Bld flow; Bld flow vel; Bld flow.velocity; CARD.US; Cardiac; Cardiology; DOP; DUPLEX; Dynamic; Echography; Hrt; L; Largest; LT; LVOT; LVOT/AV Vmax; Maximal; Maximum; Peak; Peak velocity; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity ratio; Vmax	4180186
1002325	Hrt LVOT/Aortic valve DOP	4180186
1002325	血流速度.最大值.左心室流出道/血流.最大值.主动脉瓣:速度比率:时间点:心脏:定量型:超声.多普勒	4182948
1002327	4-Hydroxycoumarin; Blood; Coumadin; Coumarin; Coumarins; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Pan; Panel.molpath; Panel.molpath.pharmg; Panl; Panwarfin; PCR; Pnl; Point in time; Random; Sofarin; Tissue; Tissue, unspecified; Warfarin genotype pnl; WB; Whole blood; Whole blood or Tissue	4180186
1002327	Warfarin genotype pnl Bld/T	4180186
1002327	华法林反应基因型组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
1002328	B duncani IgG Titr Ser IF	4180186
1002328	邓肯巴贝斯虫 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
1002328	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B duncani; Babesia WA1; Babesiosis; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Microbiology; Piroplasmosis; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002329	Centers for Medicare and Medicaid Assessment; Drugs; Nominal; Point in time; Random; Survey; Typ	4180186
1002332	Flights climbed 24h nRate	4180186
1002332	1 day; 24 hours; 24HR; Count/time; H+P; H+P.HX; nRate; Number rate; Number Rate = Count/Time; P prime; QNT; Quan; Quant; Quantitative	4180186
1002332	攀登楼层数:计数型速率:24小时:^患者:定量型	4182948
1002333	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TUDCA	4180186
1002333	TUDCA SerPl-sCnc	4180186
1002333	牛磺熊去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002335	Breath H2 15M p carb	4180186
1002335	15M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002335	氢/已呼出的气体^在给予剂量碳水化合物之后15分钟:体积分数:时间点:呼出的气体:定量型	4182948
1002336	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002343	LV SV A4C SP A-L	4180186
1002343	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002343	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1002344	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS; Valley fever	4180186
1002344	Coccidioides IgM SerPl IA-aCnc	4180186
1002344	球孢子菌属单个未知种 抗体.IgM:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1002346	1-cyclohexyl-4-(1,2-diphenylethyl)piperazine; Addiction; C24H32N2; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002346	MT-45 Ur Cfm-mCnc	4180186
1002346	MT-45:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002348	Radiology Team Conf eval note	4180186
1002348	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Radiology Team; Random; Visit note	4180186
1002348	会议记录:发现:时间点:{环境}:文档型:放射医学.团队	4182948
1002350	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Ag; AnGAP; Anion Gap3; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; III; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002350	Anion Gap3 2h p Vaso SerPl-sCnc	4180186
1002350	阴离子间隙 3^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002354	2; Bands; bnd; Cerebral spinal fluid; Cerebrospinal Fl; HTLV I + II ab band; HTLV I+II; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; Immune globulin G; Immunoglobulin G; Microbiology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Typ	4180186
1002354	HTLV I + II ab band CSF Line blot	4180186
1002354	HTLV I & II 抗体.IgG 条带:类型:时间点:脑脊液:名义型:线点印迹法	4182948
1002355	XR Radius Bone dev stage	4180186
1002355	Arm; Bone dev stage; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1002355	骨骼发育阶段:评分:时间点:上肢>桡骨:定量型:X射线摄影术	4182948
1002356	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002359	Busulfan Plas-AUC	4180186
1002359	AUC; DRUG/TOXICOLOGY; Drugs; Myleran; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Studies; Study; Sutdies	4180186
1002359	白消安:曲线下面积:检查过程持续时间:血浆:定量型	4182948
1002360	Arm; Bone dev stage; EXT; Imaging; Metacarpal.1st; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1002360	XR Metacarpal.1st Bone dev stage	4180186
1002360	骨骼发育阶段:评分:时间点:上肢>手.掌骨.第一:定量型:X射线摄影术	4182948
1002370	HTR2C c.551-3008C>G Geno Bld/T	4180186
1002370	5-HT1C; 5HT-1C; 5-HT2C; 5-HT-2C; 5HTR2C; 5-HTR2C; 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled; 5-hydroxytryptamine receptor 2C gene; Blood; HTR1C; HTR2C c.551-3008C&gt;G; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs1414334; serotonin receptor 2C gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002370	HTR2C 基因.c.551-3008C>G:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1002371	Plastic surgery Diag study note	4180186
1002371	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Surg; Visit note	4180186
1002371	诊断性检查记录:发现:时间点:{环境}:文档型:成形外科学	4182948
1002374	NuPDQ Concurrent SA Version; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Pregnancy distressed questionnaire; Random; Survey; SURVEY.MTLHLTH	4180186
1002375	2D US; Calc; Calculation; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002375	LV SV Biplane area-length	4180186
1002375	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D+双平面面积-长度计算法	4182948
1002376	aPTT-LA confirm Act/Nor p hep neut PPP	4180186
1002376	Act/Nor; Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; aPTT-LA confirm; aPTT-LA confirm actual; Clot; Clottable; Coag; Coagulation assay; Control; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Little(A)PTT; Neut; Neutr; p hep neut; Partial Thromboplastin Time; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; RlTm; Surf; Tilt tube	4180186
1002376	表面诱导型凝血过程.狼疮敏感性.过量磷脂 实际的/正常的^在肝素中和之后:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002380	UGT1A1 gene Full Mut Anl Bld/T Seq	4180186
1002380	BILIQTL1; Blood; Crigler-Najjar syndrome, type I; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Gilbert Syndrome; GNT1; high-throughput sequencing; HTS; HUG-BR1; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 1 family, polypeptide A1; UDP glycosyltransferase 1 family, polypeptide A1 gene; UDPGT; UDPGT 1-1; UGT1; UGT1A; UGT1A5; WB; Whole blood; Whole blood or Tissue	4180186
1002380	UGT1A1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1002382	Exchange; Finding; Findings; Nominal; Persons; Point in time; Random; Replace; Survey; SURVEY.MTLHLTH; World Heatlth Organization	4180186
1002384	Antigen; Antigens; BLOOD BANK; c; C Ag^infant; Erythrocytes; infant; little c Ag^infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1002384	little c Ag infant RBC Ql	4180186
1002384	c 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1002385	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1002385	LV Output A2C SP A-L	4180186
1002385	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1002386	Arbitrary concentration; Beta 1 E-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002386	C4.functional SerPl-aCnc	4180186
1002386	补体 C4.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
1002389	Alc; alcoholic; Drug; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1002390	Breath methane 1.5h p carb	4180186
1002390	1 1/2 hours; 1 1/2 HR; 1.5h p carb; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002390	甲烷/已呼出的气体^在给予剂量碳水化合物之后1.5小时:体积分数:时间点:呼出的气体:定量型	4182948
1002391	Lu 20 Ag RBC Ql	4180186
1002391	Antigen; Antigens; BLOOD BANK; Erythrocytes; Left; Levo; Lu 20; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1002391	Lu 20 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1002392	3 months; Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1002393	TMB Tumor-Imp	4180186
1002393	Cancer; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TMB; Tumor mutational load; tumors; tumour; tumours	4180186
1002393	肿瘤突变负荷:印象:时间点:肿瘤:序数型	4182948
1002396	Busulfan Gvn ?Tm Dose	4180186
1002396	?Tm; Dose med or substance; DRUG DOSES; Gvn; Myleran; QNT; Quan; Quant; Quantitative	4180186
1002396	白消安 给予的:质量:XXX:剂量药物或剂量物质:定量型	4182948
1002397	FLUAV NS1 gene Islt-Seq	4180186
1002397	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV NS1 gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1002397	流感病毒 A NS1 基因:序列:时间点:分离株:名义型:序列测定	4182948
1002399	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002400	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002400	HSV2 DNA Bld Ql NAA+non-probe	4180186
1002400	单纯疱疹病毒 2 型 DNA:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
1002401	4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide; Addiction; C19H21ClN2O2S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002401	W-15 Ur Cfm-mCnc	4180186
1002401	W-15:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002402	MH screen report	4180186
1002402	Asympt; Asymptomatic; DOC.MISC; Document; Emotional stability; Finding; Findings; MH screen report; MISC; Point in time; Random; Scn	4180186
1002402	心理健康筛查报告:发现:时间点:^患者:文档型	4182948
1002404	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Echography; EF; Frac; Fract; Fractionation; Fractions; Hrt; Hrt ventr; L; LT; LV; LVEF; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volfr; Volume fraction	4180186
1002404	LV EF A4C SP A-L	4180186
1002404	射血分数:体积分数:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1002407	RAF Score	4180186
1002407	CLIN; CLIN.RISK; CMS-HCC; Fac; Fact; Point in time; QNT; Quan; Quant; Quantitative; RAF; Random; Risk adjustment model; Scale	4180186
1002407	风险调整因素:评分:时间点:^患者:定量型	4182948
1002408	EBV VCA IgM Ser Donr Ql IA	4180186
1002408	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; Donr; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Mono; Mononucleosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; VCA; Viral capsid	4180186
1002408	Epstein Barr 病毒衣壳 抗体.IgM:存在情况或阈值:时间点:血清^供体:序数型:免疫测定法	4182948
1002409	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 DNA Pnl; HSV1; HSV1+2; i; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002409	HSV 1+2 DNA Pnl Bld NAA+non-probe	4180186
1002409	单纯疱疹病毒 1 与 2 型组套:-:时间点:全血:-:非探针法.基因扩增.靶向	4182948
1002410	Blood; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); D phenotyping; D typing; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh Ags+K Ag Pnl; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002410	Rh Ags+K Ag Pnl Bld BPU	4180186
1002410	Rh抗原与K抗原组套:-:时间点:全血^血液制品单位:-	4182948
1002412	Chr 12 copy num; Chromosom; Chromosomes; Fluorescent in situ hybridization; MDM2 copy num; Molecular pathology; MOLPATH; No; Num; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1002412	MDM2 copy num/Chr 12 copy num Tiss FISH	4180186
1002412	MDM2 基因拷贝数/染色体 12 拷贝数:计数型比率:时间点:组织与涂片:定量型:FISH	4182948
1002414	4 weeks; Finding; Findings; Job; Last; LMTED; LTD; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002415	Sodium 2h p Vaso SerPl-sCnc	4180186
1002415	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Na; Na+; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002415	钠^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002417	LV ES vol A4C SP A-L	4180186
1002417	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002417	心脏收缩末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1002418	Chrom analy Bld/T Microarray	4180186
1002418	arrCGH; Blood; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Karyotype; Molecular pathology; MOLPATH; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002418	染色体分析:发现:时间点:全血/组织:文档型:微阵列	4182948
1002420	HEDIS 2020 CT Colongrphy	4180186
1002420	HEDIS 2020 CT Colongrphy; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1002420	HEDIS 2020 取值集合 - CT 结肠成像:-:时间点:^患者:-	4182948
1002421	GABABR IgG SerPl Ql CBA IFA	4180186
1002421	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002421	Gamma 氨基丁酸 B 受体 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:CBA IFA	4182948
1002424	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; F tular; F tularensis; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Tularemia	4180186
1002424	F tular IgM Ser Ql IA	4180186
1002424	土拉弗朗西斯菌 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1002426	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002427	XR Hamate Bone dev stage	4180186
1002427	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1002427	骨骼发育阶段:评分:时间点:上肢>腕部.钩状骨:定量型:X射线摄影术	4182948
1002428	Ang; Angio; Angiography; c; Contr; Contra; Contrst; Document; Finding; Findings; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR + MRA; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr + W contr; WO+W contr IV; WWO	4180186
1002428	MR Chest WO+W contr IV+MRA W contr IV	4180186
1002428	多层^WO & W contrast IV && Multisection^W contrast IV:发现:时间点:胸部:文档型:MR && MR.血管造影术	4182948
1002429	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002430	Carbonic anhydride; cO2; EXCZ; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; VEqCO2; Volume ratio	4180186
1002430	VEqCO2 W exercise	4180186
1002430	二氧化碳通气当量^采用运动:体积比率:时间点:^患者:定量型	4182948
1002432	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002432	NMDAR1 IgG CSF Ql CBA IFA	4180186
1002432	N-甲基-D-天冬氨酸受体亚单位 1 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1002435	?Tm; dur cycle; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
1002435	Calories burned dur cycle ?Tm	4180186
1002435	已消耗的热量^在骑行的过程中:功率:XXX:^患者:定量型	4182948
1002438	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1002439	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; III; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; PCV; PCV3; PCV3 DNA; Point in time; Polymerase chain reaction; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1002439	PCV3 DNA Spec Ql NAA+probe	4180186
1002439	猪圆环病毒 3 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
1002440	Arterial Stenosis; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
1002441	5 hours; 5.0Hr; 5HR; Chemistry; CR; Crea; Creat; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UCr; UR; Urn	4180186
1002441	Creat 5h Ur-sCnc	4180186
1002441	肌酐:物质的量浓度:5小时:尿液:定量型	4182948
1002443	aPTT-LA confirm p hep neut PPP	4180186
1002443	Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; aPTT-LA confirm; Clot; Clottable; Coag; Coagulation assay; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Little(A)PTT; Neut; Neutr; p hep neut; Partial Thromboplastin Time; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
1002443	表面诱导型凝血过程.狼疮敏感性.过量磷脂^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002444	Calories burned dur running ?Tm	4180186
1002444	?Tm; CLIN; dur running; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
1002444	已消耗的热量^在跑行的过程中:功率:XXX:^患者:定量型	4182948
1002446	A. oryzae IgE Qn	4180186
1002446	A oryzae IgE; A. oryzae; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; k87; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1002446	米曲霉 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1002447	C-SSRS Lifetime/Recent; Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1002451	EV RNA Spec Ql NAA+non-probe	4180186
1002451	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1002451	肠道病毒 RNA:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
1002452	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baxdela; DLX; Epsilometer; Estrip; E-strip; Fluoroquinolone; Grad strip; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1002452	DLX Islt Grad strip	4180186
1002452	德拉沙星:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
1002453	Variant interaction assoc therapy resist	4180186
1002453	Blood; Genetics; Genomic; Identity or presence; Interaction assoc tx resist; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Tissue; Tissue, unspecified; Tx; WB; Whole blood; Whole blood or Tissue	4180186
1002453	因为遗传变异之间的相互作用而导致耐受的治疗:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1002456	LV SV A2C MOD	4180186
1002456	2D US; A2C MOD; Calculated; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002456	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+圆盘单平面计算法	4182948
1002457	1OH-midazolam Ur Ql Scn	4180186
1002457	1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1002457	1-羟基咪达唑仑:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002458	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H seoul; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seoul orthohantavirus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR	4180186
1002458	H seoul IgG SerPl Ql Line blot	4180186
1002458	汉坦病毒 汉城型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:线点印迹法	4182948
1002460	Lg B-cell lymph+COO Tiss	4180186
1002460	大B细胞淋巴瘤和细胞起源:类型:时间点:组织与涂片:名义型	4182948
1002460	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; Lg B-cell lymph; Lg B-cell lymph+COO; Nominal; Pathology; Point in time; Random; Tissue; Tissue, unspecified; Typ	4180186
1002664	CHAL.ROUTINE	4180186
1002670	BDYWGT.MOLEC	4180186
1002709	RESP.TIMED.MOLEC	4180186
1002795	RESP.MOLEC	4180186
1002800	What Y was building built	4180186
1002979	HRTRATE.PSTN.MOLEC	4180186
1003043	BDYTMP.ATOM	4180186
1003106	HRTRATE.ATOM	4180186
1003116	BDYHGT.ATOM	4180186
1003260	Pelvis>Coccyx	4180186
1003380	HEMODYN.MOLEC	4180186
1003398	BDYTMP.TIMED.MOLEC	4180186
1003530	BP.CENT.MOLEC	4180186
1003545	What Y did you turn 18	4180186
1003605	BP.PSTN.MOLEC	4180186
1003761	BDYCRC.MOLEC	4180186
1003912	BDYHGT.MOLEC	4180186
1003929	BP.TIMED.MOLEC	4180186
1004039	BDYCRC.ATOM	4180186
1004079	DOC.ONTOLOGY	4180186
1004165	Liver+Biliary ducts+Pancreas	4180186
1004166	Special treatments &or programs - none of above - while a resident	4180186
1004167	Special treatments &or programs - none of above - while NOT a resident	4180186
1004170	History of falling; immediate or within 3Mo	4180186
1004218	Flag for Date 1st cancer Rx (any).SEERS not populated	4180186
1004338	Extracellular fld	4180186
1004339	EngRatFr	4180186
1004392	PPresDiff	4180186
1004422	VFrDiff	4180186
1004436	BCP	4180186
1004463	How often did you eat bread, toast or dinner rolls, including bread as part of a sandwich in past 30D	4180186
1004466	When you ate cold cereal, how much did you usually eat in the past 30D	4180186
1004468	Each time you ate cheese, how much did you usually eat in the past 30D	4180186
1004469	How often did you eat ice cream, ice cream bars, milk shakes, or frozen yogurt in the past 30D	4180186
1004470	Each time you ate ice cream, ice cream bars, milkshakes, or frozen yogurt, how much did you usually eat in the past 30D	4180186
1004473	How often did you eat mexican foods such as tacos, tostados, burritos, tamales, fajitas, enchiladas, quesadillas, or chimichangas in the past 30D	4180186
1004475	How often did you drink milk as a beverage in the past 30D	4180186
1004478	How often was the orange juice you drank calcium fortified in the past 30D	4180186
1004479	How often did you drink 100 percent orange juice in the past 30D	4180186
1004481	How often did you eat pizza in the past 30D	4180186
1004482	Each time you ate pizza, how much did you usually eat in past 30D	4180186
1004485	How often did you eat cooked dried beans, such as refried beans, baked beans, bean soup, and pork and beans in past 30D	4180186
1004487	When you ate cereal, which kinds did you usually eat in past 30D	4180186
1004488	How often did you eat any kind of cheese in past 30D	4180186
1004489	How often did you eat french fries, home fries, or hash brown potatoes in past 30D	4180186
1004490	How often did you drink 100 percent fruit juice, such as orange, mango, apple, and grape juices in past 30D	4180186
1004492	How often did you have salsa in past 30D	4180186
1004493	How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30D	4180186
1004494	How often did you have tomato sauces such as spaghetti sauce or pizza with tomato sauce in past 30D	4180186
1004495	How often did you eat whole grain bread including toast, rolls and in sandwiches in past 30D	4180186
1004501	How often did you drink decaffeinated coffee (instant & brewed)	4180186
1004502	What is your serving size for decaffeinated coffee (instant & brewed)	4180186
1004524	How many Y did you take zinc	4180186
1004526	Not counting lettuce salads, white potatoes, cooked dried beans, and not counting rice, how often did you eat other vegetables in past 30D	4180186
1004532	Did you take any dietary supplements during the past Y, at least once a W	4180186
1004537	How many Y did you take garlic, as a pill, tablet, or capsule	4180186
1004542	How often did you take fish oil or omega 3 fatty acids	4180186
1004543	How many Y did you take fish oil or omega 3 fatty acids	4180186
1004546	How often did you take coenzyme Q 10	4180186
1004564	How many Y did you take Folic acid, Folate	4180186
1004568	How often did you drink fruit flavored drinks with sugar (such as kool aid, hi C, lemonade, or cranberry cocktail) in past 30D	4180186
1004569	How often did you eat fruit in past 30D	4180186
1004575	How often did you eat cold cereal in the past 12Mo	4180186
1004576	About how often did you drink skim milk, on cereal or to drink in past 12Mo	4180186
1004578	About how often did you eat sausage or bacon, regular fat, in past 12Mo	4180186
1004579	About how often did you eat margarine or butter on bread, rolls, pancakes in past 12Mo	4180186
1004580	About how often did you drink orange juice or grapefruit juice in past 12Mo	4180186
1004582	About how often did you eat beef or pork hot dogs, regular fat, in past 12Mo	4180186
1004583	About how often did you eat cheese or cheese spread, regular fat, in past 12Mo	4180186
1004585	About how often did you eat margarine or butter on vegetables, including potatoes in past 12Mo	4180186
1004586	About how often did you eat mayonnaise, regular fat, in past 12Mo	4180186
1004590	When you prepared foods with margarine or ate margarine in past 12Mo, how often did you use reduced fat margarine	4180186
1004591	Overall, when you think about the foods you ate over the past 12Mo, would you say your diet was high, medium, or low in fat	4180186
1004600	How would you rate your pain on average in past 7D	4180186
1004601	How would you rate your fatigue on average in past 7D	4180186
1004603	How often have you been bothered by emotional problems such as feeling anxious, depressed or irritable in past 7D	4180186
1004721	When I was in pain I became irritable in past 7D	4180186
1004724	When I was in pain I moved extremely slowly in past 7D	4180186
1004725	When I was in pain I became angry in past 7D	4180186
1004726	When I was in pain I clenched my teeth in past 7D	4180186
1004727	When I was in pain I tried to stay very still in past 7D	4180186
1004728	When I was in pain I appeared upset or sad in past 7D	4180186
1004729	When I was in pain I gasped in past 7D	4180186
1004732	Pain caused me to bend over while walking in past 7D	4180186
1004734	When I was in pain I moved stiffly in past 7D	4180186
1004735	When I was in pain I called out for someone to help me in past 7D	4180186
1004736	Pain caused me to curl up in a ball in past 7D	4180186
1004740	I limped because of pain in past 7D	4180186
1004742	When I was in pain I frowned in past 7D	4180186
1004743	When I was in pain I asked for help when walking or changing positions in past 7D	4180186
1004744	When I was in pain I groaned in past 7D	4180186
1004745	When I was in pain I isolated myself from others in past 7D	4180186
1004746	When I was in pain I drew my knees up in past 7D	4180186
1004748	When I was in pain I flung my arms or limbs around in past 7D	4180186
1004749	When I was in pain I screamed in past 7D	4180186
1004751	When I was in pain I walked carefully in past 7D	4180186
1004752	When I was in pain I bit or pursed my lips in past 7D	4180186
1004754	When I was in pain I protected the part of my body that hurt in past 7D	4180186
1004755	When I was in pain my body became stiff in past 7D	4180186
1004756	When I was in pain I clenched my jaw or gritted my teeth in past 7D	4180186
1004757	When I was in pain I winced in past 7D	4180186
1004758	When I was in pain I moved my limbs protectively in past 7D	4180186
1004761	How difficult was it for you to take in new information because of pain in past 7D	4180186
1004763	How much did pain interfere with your close personal relationships in past 7D	4180186
1004766	How much did pain interfere with your enjoyment of recreational activities in past 7D	4180186
1004767	How often did you feel emotionally tense because of your pain in past 7D	4180186
1004770	How much did pain interfere with doing your tasks away from home (e.g., getting groceries, running errands)in past 7D	4180186
1004775	How much did pain interfere with work around the home in past 7D	4180186
1004777	How often did pain keep you from socializing with others in past 7D	4180186
1004780	How often did pain make you feel discouraged in past 7D	4180186
1004781	How much did pain interfere with your household chores in past 7D	4180186
1004783	How much did pain interfere with your enjoyment of social activities in past 7D	4180186
1004784	How often did pain make you feel anxious in past 7D	4180186
1004786	How often did pain make simple tasks hard to complete in past 7D	4180186
1004789	How often did pain make it difficult for you to plan social activities in past 7D	4180186
1004790	How often did pain prevent you from standing for more than 30 minutes in past 7D	4180186
1004791	How much did pain interfere with your ability to do household chores in past 7D	4180186
1004793	How often did pain prevent you from sitting for more than 30 minutes in past 7D	4180186
1004794	How often did pain prevent you from sitting for more than 10 minutes in past 7D	4180186
1004795	How often was it hard to plan social activities because you didn't know if you would be in pain in past 7D	4180186
1004798	How often did pain prevent you from sitting for more than one hour in past 7D	4180186
1004804	How often did you have to push yourself to get things done because of your fatigue in past 7D	4180186
1004805	How often did your fatigue interfere with your social activities in past 7D	4180186
1004808	How often were you too tired to watch television in past 7D	4180186
1004809	How often did your fatigue make it difficult to plan activities ahead of time in past 7D	4180186
1004810	How often did your fatigue make it difficult to start anything new in past 7D	4180186
1004811	How often did your fatigue make you more forgetful in past 7D	4180186
1004813	How often did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7D	4180186
1004816	How often did your fatigue make it difficult to make decisions in past 7D	4180186
1004819	How often did your fatigue make you feel less alert in past 7D	4180186
1004822	How often did you have trouble starting things because of your fatigue in past 7D	4180186
1004824	How often were you too tired to socialize with your family in past 7D	4180186
1004825	To what degree did you have trouble starting things because of your fatigue in past 7D	4180186
1004826	How hard was it for you to carry on a conversation because of your fatigue in past 7D	4180186
1004827	How often were you too tired to leave the house in past 7D	4180186
1004828	How often were you too tired to think clearly in past 7D	4180186
1004830	To what degree did you have to limit your social activities because of your fatigue in past 7D	4180186
1004831	To what degree did your fatigue make it difficult to organize your thoughts when doing things at home in past 7D	4180186
1004832	To what degree did your fatigue make it difficult to start anything new in past 7D	4180186
1004833	Due to your fatigue were you less effective at work (include work at home) in past 7D	4180186
1004834	To what degree did your fatigue make it difficult to make decisions in past 7D	4180186
1004837	To what degree did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7D	4180186
1004840	To what degree did you have to force yourself to get up and do things because of your fatigue in past 7D	4180186
1004841	To what degree did your fatigue interfere with your social activities in past 7D	4180186
1004843	Did fatigue make you less effective at home in past 7D	4180186
1004846	How often were you too tired to take a short walk in past 7D	4180186
1004847	How often did you have to force yourself to get up and do things because of your fatigue in past 7D	4180186
1004848	How often were you too tired to socialize with your friends in past 7D	4180186
1004849	How often did you feel run-down in past 7D	4180186
1004851	How often did you feel tired even when you hadn't done anything in past 7D	4180186
1004853	To what degree did you feel tired even when you hadn't done anything in past 7D	4180186
1004854	How bushed were you on average in past 7D	4180186
1004857	How often were you physically drained in past 7D	4180186
1004859	How fatigued were you when your fatigue was at its worst in past 7D	4180186
1004860	How often were you bothered by your fatigue in past 7D	4180186
1004862	How often were you too tired to enjoy life in past 7D	4180186
1004864	How often did you feel totally drained in past 7D	4180186
1004865	How often were you energetic in past 7D	4180186
1004867	How much were you bothered by your fatigue on average in past 7D	4180186
1004869	How fatigued were you on the day you felt most fatigued in past 7D	4180186
1004871	How run-down did you feel on average in past 7D	4180186
1004872	How much mental energy did you have on average in past 7D	4180186
1004874	How energetic were you on average in past 7D	4180186
1004875	How sluggish were you on average in past 7D	4180186
1004877	How often did you find yourself getting tired easily in past 7D	4180186
1004878	How often did you think about your fatigue in past 7D	4180186
1004880	How easily did you find yourself getting tired on average in past 7D	4180186
1004881	How wiped out were you on average in past 7D	4180186
1004882	How often did you have physical energy in past 7D	4180186
1004883	What was the level of your fatigue on most D in past 7D	4180186
1004885	I felt weak all over in past 7D	4180186
1004886	I felt listless (washed out) in past 7D	4180186
1004889	I had trouble finishing things because I was tired in past 7D	4180186
1004890	I needed to sleep during the day in past 7D	4180186
1004893	I was frustrated by being too tired to do the things I want to do in past 7D	4180186
1004894	I had to limit my social activity because I was tired in past 7D	4180186
1004895	I had energy in past 7D	4180186
1004896	I am able to do my usual activities in past 7D	4180186
1004898	When I was frustrated, I let it show in past 7D	4180186
1004899	I was irritated more than people knew in past 7D	4180186
1004900	I felt envious of others in past 7D	4180186
1004901	I disagreed with people in past 7D	4180186
1004902	I made myself angry about something just by thinking about it in past 7D	4180186
1004905	When I was mad at someone, I gave them the silent treatment in past 7D	4180186
1004907	I felt like I was ready to explode in past 7D	4180186
1004909	I felt resentful when I didn't get my way in past 7D	4180186
1004910	I felt guilty about my anger in past 7D	4180186
1004912	I felt people are trying to anger me in past 7D	4180186
1004913	I stayed angry for hours in past 7D	4180186
1004914	I held grudges towards others in past 7D	4180186
1004916	I was grouchy in past 7D	4180186
1004920	I had trouble controlling my temper in past 7D	4180186
1004921	I was angry when I was delayed in past 7D	4180186
1004922	Even when I expressed my anger, I had trouble forgetting about it in past 7D	4180186
1004924	I was angry when something blocked my plans in past 7D	4180186
1004925	I felt like yelling at someone in past 7D	4180186
1004926	Just being around people irritated me in past 7D	4180186
1004928	I felt fearful in past 7D	4180186
1004933	I was concerned about my mental health in past 7D	4180186
1004936	I was anxious if my normal routine was disturbed in past 7D	4180186
1004938	Easily startled in past 7D	4180186
1004940	I avoided public places or activities in past 7D	4180186
1004943	I felt worried in past 7D	4180186
1004944	I felt terrified in past 7D	4180186
1004947	My worries overwhelmed me in past 7D	4180186
1004948	I had twitching or trembling muscles in past 7D	4180186
1004952	I had difficulty sleeping in past 7D	4180186
1004953	I had trouble relaxing in past 7D	4180186
1004954	I felt uneasy in past 7D	4180186
1004956	I had difficulty calming down in past 7D	4180186
1004959	I felt helpless in past 7D	4180186
1004961	I felt that nothing could cheer me up in past 7D	4180186
1004966	I felt like a failure in past 7D	4180186
1004967	I had trouble feeling close to people in past 7D	4180186
1004970	I felt lonely in past 7D	4180186
1004972	I had trouble making decisions in past 7D	4180186
1004975	I felt I had no reason for living in past 7D	4180186
1004976	I felt hopeless in past 7D	4180186
1004977	I felt ignored by people in past 7D	4180186
1004979	I felt pessimistic in past 7D	4180186
1004985	My sleep was deep in past 7D	4180186
1004987	My sleep was refreshing in past 7D	4180186
1004992	I woke up too early and could not fall back asleep in past 7D	4180186
1004993	Trouble staying asleep in past 7D	4180186
1004994	I had trouble sleeping in past 7D	4180186
1004996	My sleep was light in past 7D	4180186
1004999	I had a problem with my sleep 7D	4180186
1005000	I had difficulty falling asleep in past 7D	4180186
1005001	I felt physically tense at bedtime in past 7D	4180186
1005006	I had trouble getting into a comfortable position to sleep in past 7D	4180186
1005007	I tried hard to get to sleep in past 7D	4180186
1005008	Stress disturbed my sleep in past 7D	4180186
1005010	I was afraid I would not get back to sleep after waking up in past 7D	4180186
1005014	I was sleepy during the daytime in past 7D	4180186
1005015	I had trouble staying awake during the day in past 7D	4180186
1005020	I felt irritable because of poor sleep in past 7D	4180186
1005021	I had a hard time controlling my emotions because of poor sleep in past 7D	4180186
1005022	I had difficulty waking up in past 7D	4180186
1005025	I felt alert when I woke up in past 7D	4180186
1005026	When I woke up I felt ready to start the day in past 7D	4180186
1005029	I was satisfied with my current level of social activity in past 7D	4180186
1005030	I was satisfied with my ability to do all of the community activities that are really important to me in past 7D	4180186
1005031	I was satisfied with my ability to do things for my friends in past 7D	4180186
1005033	I was satisfied with my current level of activities with my friends in past 7D	4180186
1005034	I was satisfied with my ability to do things for fun outside my home in past 7D	4180186
1005035	I felt good about my ability to do things for my friends in past 7D	4180186
1005037	I was satisfied with the amount of time I spend visiting friends in past 7D	4180186
1005038	I was satisfied with my ability to do things for fun at home (like reading, listening to music, etc.) in past 7D	4180186
1005039	I was satisfied with my ability to do all of the leisure activities that Are really important to me in past 7D	4180186
1005044	I was satisfied with my ability to do the work that is really important to me (include work at home) in past 7D	4180186
1005045	I was satisfied with the amount of time I spend doing work (include work at home) in past 7D	4180186
1005048	The quality of my work is as good as I want it to be (include work at home) in past 7D	4180186
1005049	I was satisfied with the amount of time I spend performing my daily routines in past 7D	4180186
1005051	I was satisfied with my ability to do regular personal and household responsibilities in past 7D	4180186
1005054	I was satisfied with my ability to run errands in past 7D	4180186
1005056	I felt like something awful might happen in past 7D	4180186
1005057	I got scared really easy in past 7D	4180186
1005060	I was worried I might die in past 7D	4180186
1005061	I woke up at night scared in past 7D	4180186
1005063	I worried when I was away from home in past 7D	4180186
1005064	I worried when I was at home in past 7D	4180186
1005065	I thought about scary things in past 7D	4180186
1005066	I was afraid of going to school in past 7D	4180186
1005070	My chest felt tight because of my asthma in past 7D	4180186
1005075	My asthma bothered me in past 7D	4180186
1005077	I got tired easily because of my asthma in past 7D	4180186
1005079	I had trouble walking because of my asthma in past 7D	4180186
1005080	I missed school because of asthma in past 7D	4180186
1005083	My asthma bothered me when I was with my friends in past 7D	4180186
1005084	My body felt bad when I was out of breath in past 7D	4180186
1005086	I felt too sad to eat in past 7D	4180186
1005090	It was hard for me to have fun in past 7D	4180186
1005093	I felt like I couldn't do anything right in past 7D	4180186
1005095	I felt stressed in past 7D	4180186
1005098	Being tired kept me from having fun in past 7D	4180186
1005099	Being tired made it hard for me to keep up with my schoolwork in past 7D	4180186
1005102	I felt too tired to spend time with my friends in past 7D	4180186
1005104	I got tired easily in past 7D	4180186
1005105	I had trouble finishing things because I was too tired in past 7D	4180186
1005106	I had trouble starting things because I was too tired in past 7D	4180186
1005107	I was so tired it was hard for me to focus on my work in past 7D	4180186
1005109	I was too tired to do sports or exercise in past 7D	4180186
1005111	I was too tired to enjoy the things I like to do in past 7D	4180186
1005112	I was too tired to go out with my family in past 7D	4180186
1005119	I could get in and out of a car in past 7D	4180186
1005121	I could do sports and exercise that other kids my age could do in past 7D	4180186
1005124	I could get into bed by myself in past 7D	4180186
1005126	I could get down on my knees without holding on to something in past 7D	4180186
1005128	I used a wheelchair to get around in past 7D	4180186
1005133	I could get up from the floor in past 7D	4180186
1005136	I could turn my head all the way to the side in past 7D	4180186
1005139	I could bend over to pick something up in past 7D	4180186
1005140	I could walk across the room in past 7D	4180186
1005145	I hurt a lot in past 7D	4180186
1005148	It was hard for me to run when I had pain in past 7D	4180186
1005150	I missed school when I had pain in past 7D	4180186
1005151	It was hard to get along with other people when I had pain in past 7D	4180186
1005156	I felt accepted by other kids my age in past 7D	4180186
1005158	I liked being around other kids my age in past 7D	4180186
1005159	I played alone and kept to myself in past 7D	4180186
1005160	I shared with other kids (food, games, pens, etc) in past 7D	4180186
1005161	I spent time with my friends in past 7D	4180186
1005162	I was a good friend in past 7D	4180186
1005163	I was able to count on my friends in past 7D	4180186
1005164	I was able to have fun with my friends in past 7D	4180186
1005167	My friends and I helped each other out in past 7D	4180186
1005169	Other kids wanted to be with me in past 7D	4180186
1005170	Other kids wanted to talk to me in past 7D	4180186
1005172	I could button my shirt or pants in past 7D	4180186
1005173	I could open a jar by myself in past 7D	4180186
1005174	I could open the rings in school binders in past 7D	4180186
1005177	I could pull open heavy doors in past 7D	4180186
1005178	I could put on my shoes by myself in past 7D	4180186
1005179	I could use a key to unlock a door in past 7D	4180186
1005181	I felt fed up in past 7D	4180186
1005185	When I got mad, I stayed mad in past 7D	4180186
1005186	PROMIS pediatric short form - emotional distress - anxiety 8a - version 1.0	4180186
1005187	I was afraid that I would make mistakes in past 7D	4180186
1005201	Each time you ate cold cereal, how much did you usually eat in the past 30D	4180186
1005208	It was hard for me to get out of bed in the morning because I was too tired in past 7D	4180186
1005219	I could put toothpaste on my toothbrush by myself in past 7D	4180186
1005220	I could lift a cup to drink in past 7D	4180186
1005221	I could zip up my clothes in past 7D	4180186
1005222	I could pull on and fasten my seatbelt in past 7D	4180186
1005223	I could open my clothing drawers in past 7D	4180186
1005225	I could cut paper with scissors in past 7D	4180186
1005226	I could dry my back with a towel in past 7D	4180186
1005228	I used a pencil with a special grip to write in past 7D	4180186
1005230	I could tie shoelaces by myself in past 7D	4180186
1005231	I could put on my clothes by myself in past 7D	4180186
1005232	I could turn door handles by myself in past 7D	4180186
1005233	I could use a mouse or touch pad for the computer in past 7D	4180186
1005234	I could hold a full cup in past 7D	4180186
1005235	I could hold an empty cup in past 7D	4180186
1005236	I could brush my teeth by myself in past 7D	4180186
1005265	Krabbe disease newborn screening comment-discussion	4180186
1005266	Gaucher disease newborn screening comment-discussion	4180186
1005362	PhenX domain - Alcohol, tobacco & other substances	4180186
1005367	PhenX measure - alcohol - 30D quantity - frequency	4180186
1005640	PhenX measure - physical activity - readiness	4180186
1005876	Pompe disease newborn screening comment-discussion	4180186
1005878	Where were you born	4180186
1005882	Where was your father's father born	4180186
1005890	What was your best estimate of the total income of all family members from all sources, before taxes, in last Y	4180186
1005913	At what age did you begin to drink regularly - that is, drinking at least once a month for 6Mo or more	4180186
1005915	In your lifetime, what is the largest number of drinks you have ever had in a 24H period, including all types of alcohol	4180186
1005921	Has there ever been a period in your life when you smoked cigarettes every day for at least 6Mo	4180186
1005923	Whole body scan image name	4180186
1005929	During the past 30D, have you smoked part or all of a cigarette	4180186
1005937	During the past 30D, on how many D did you drink one or more drinks of an alcoholic beverage	4180186
1005938	On the D that you drank during the past 30D, how many drinks did you usually have each D	4180186
1005957	Did you continue to drink after you knew it caused you any of these emotional or psychological problems	4180186
1005961	Has drinking ever caused you this emotional or psychological problem for more than 24H to the point that it interfered with your functioning or relationships	4180186
1005962	When you stopped, cut down or went without drinking, did you ever experience this problem for most of the day for 2D or longer	4180186
1005964	On the number of D you reported you smoked cigarettes during the past 30D, how many cigarettes did you smoke per D, on average	4180186
1005981	During the past 30D, on how many D did you use drugs	4180186
1005984	Problem, related to marijuana use, that occurred for more than 24H to the point that it interfered with functioning or relationships	4180186
1005991	When you stopped, cut down, or went without marijuana, did you ever experience any of these problems for most of the day for 2D or longer	4180186
1006019	Has use of this drug ever caused you emotional or psychological problems for more than 24H to the point that it interfered with your functioning or relationships	4180186
1006025	Problem when you stopped, cut down or went without marijuana for 2D or longer	4180186
1006031	What Y did you start living there	4180186
1006033	What Mo did you move from there	4180186
1006034	What Y did you move from there	4180186
1006045	During which Mo do you usually stop using air conditioning	4180186
1006049	During which Mo do you usually stop using heating devices	4180186
1006050	In the last 12Mo, did any dogs, cats or other small furry animals, such as a rabbit, guinea pig or hamster, live or spend time inside your home	4180186
1006069	How many Y were you regularly exposed to this material	4180186
1006076	Which of the following best describes the H you usually work at you main job or business	4180186
1006084	What was the name of the company where you first or next worked, for 6Mo or longer	4180186
1006086	In what Y did you start working at this job	4180186
1006095	Have you participated for 6Mo or longer in this hobby	4180186
1006096	In what Y were you first involved in this hobby	4180186
1006097	In what Y were you last involved in in this hobby	4180186
1006099	On average, about how many hours per W, Mo, or Y have you participated in this hobby	4180186
1006103	How many cigarettes per D do you usually smoke anywhere inside the home	4180186
1006104	At this job or business, that is at your employer, in your occupation, how many H per D can you smell the smoke from other peoples cigarettes, cigars, or pipes	4180186
1006114	In what Mo and Y did child end the first or next attendance of day care or preschool	4180186
1006115	About how many H per W did or does child attend day care or preschool outside the home	4180186
1006118	In the past Y has there been a major renovation to this house or apartment, such as adding a room, putting up or taking down a wall, replacing windows, or refinishing floors	4180186
1006121	Within the last 6Mo were rugs, drapes or furniture professionally cleaned	4180186
1006125	In the past Y, was the inside of this house or apartment painted	4180186
1006130	Air contaminant in the home	4180186
1006131	Have you, or has someone near you, used this air contaminant in the last 48H	4180186
1006140	During the last 48H, the study period, have you operated or been near diesel engines, e.g. bus terminal, truck stop	4180186
1006157	On a typical weekday in the summer, about how many H did you generally spend in the mid-day sun	4180186
1006158	On a typical weekend D in the summer, about how many H did you generally spend in the mid-day sun	4180186
1006165	Has there been renovation in your home during the past 12Mo	4180186
1006184	How many Mo a Y did you usually have a tan	4180186
1006186	Have you ever consumed alcoholic beverages, such as beer, wine, or liquor at least once a W for 6Mo or more	4180186
1006192	Average H per W you participated in moderate exercise activities or sports like brisk walking, golf, volleyball, cycling on level streets, recreational tennis, or softball during this age range	4180186
1006196	Average D per W did you spend doing this activity	4180186
1006198	For how many Y were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location	4180186
1006199	At the present time, how many H per D are you exposed to the smoke of others	4180186
1006208	How many Y in total did you take estrogens other than premarin pills - exclude any time when you temporarily stopped	4180186
1006212	How many Y in total did you take progesterone or a progestin - excluding any time when you temporarily stopped	4180186
1006250	During the past 12Mo, did any doctor, dentist, nurse, or any other health professional advise you to quit smoking	4180186
1006273	Age range for lifetime alcohol exposure	4180186
1006274	How many drinks per D, W, Mo, or Y did you usually have	4180186
1006284	How often was your baby put to bed with a bottle of formula, breast milk, juice drink, or any other kind of milk in past 2W	4180186
1006285	Did you give your baby a bottle in the past 2W	4180186
1006290	Did your child consume this beverage during the past W	4180186
1006315	Did you have painful sores or irritations around the lips or on the tongue, cheeks, or gums more than once in past 6Mo	4180186
1006316	Did you first have the sores or irritations more than 6Mo ago	4180186
1006322	Did you have this pain or toothache more than once, in past 6Mo	4180186
1006339	Post-bronchodilator forced expiratory volume in 1 second attempt	4180186
1006340	Post-bronchodilator forced vital capacity attempt	4180186
1006346	Repair done in your home during the past 12Mo if other	4180186
1006358	Critical care medicine.medical student	4180186
1006385	Do you usually cough as much as 4 to 6 times a D, 4 or more D out of the W	4180186
1006393	Do you usually bring up phlegm at all during the rest of the D or at night	4180186
1006395	For how many Y have you had trouble with phlegm	4180186
1006400	For how many Y has this wheezing been present	4180186
1006443	Have you ever worked full time, 30H per W or more, for 6Mo or more	4180186
1006449	Total Y worked in job or industry with gas or chemical fume	4180186
1006452	Do you now smoke cigarettes, as of 1Mo ago	4180186
1006459	On the average over the entire time you smoked a pipe, how much pipe tobacco did you smoke per W	4180186
1006465	On the average over the entire time you smoked cigars, how many cigars did you smoke per W	4180186
1006481	In the last 12Mo, does your chest ever sound wheezy or whistling more than once a W	4180186
1006482	In the last 12Mo, does your chest ever sound wheezy or whistling most Ds and nights	4180186
1006483	In the last 12Mo, have you been awakened from sleep by coughing, apart from a cough associated with a cold or chest infection	4180186
1006484	In the last 12Mo, have you been awakened from sleep by shortness of breath or a feeling of tightness in your chest	4180186
1006487	In the past 12Mo, have you had periods or episodes of cough with phlegm that lasted 1 W or more	4180186
1006488	For how many Y have you had at least one such episode of cough with phlegm that lasted 1 W or more per Y	4180186
1006489	About how many such episodes of cough with phlegm that lasted 1 W or more have you had in the past 12Mo	4180186
1006492	In the past Y, have you been treated with antibiotics for a chest illness	4180186
1006494	In the past Y, have you been treated with steroid pills or injections, such as predniSONE or solumedrol, for a chest illness	4180186
1006499	In the last 12Mo, how often, on average, has your sleep been disturbed due to wheezing	4180186
1006500	In the last 12Mo, has wheezing ever been severe enough to limit your speech to only one or two words at a time between breaths	4180186
1006504	In the past 12Mo, have you had a problem with sneezing, or a runny or blocked nose, when you did not have a cold or the flu	4180186
1006505	In the past 12Mo, has this nose problem been accompanied by itchy or watery eyes	4180186
1006506	In which of the past 12Mo did this nose problem occur	4180186
1006507	In the past 12Mo, how much did this nose problem interfere with your daily activities	4180186
1006508	Have you ever had an itchy rash which was coming and going for at least 6Mo	4180186
1006515	Has your child had wheezing or whistling in the chest in the last 12Mo	4180186
1006516	How many attacks of wheezing has your child had in the last 12Mo	4180186
1006529	Full time advanced practice nurse staff positions vacant at end of period	4180186
1006542	End stage renal disease facility survey - OMB CMS form 2744	4180186
1006589	Dialysis patients age 18 to 54 Y attending school full-time or part-time at end of reporting period	4180186
1006616	In the last 12Mo, has wheezing ever been severe enough to limit your childs speech to only one or two words at a time between breaths	4180186
1006618	In the last 12Mo, has your childs chest sounded wheezy during or after exercise	4180186
1006625	Has your child ever had an itchy rash that was coming and going for at least 6Mo	4180186
1006626	Has your child had this itchy rash at any time in the last 12Mo	4180186
1006628	In the last 12Mo, how often, on average, has your child been kept awake at night by this itchy rash	4180186
1006704	Does your child describe restlessness of the legs when in bed	4180186
1006724	Does your child have nightmares once a W or more on average	4180186
1006759	Does your child drink caffeinated beverages on a typical D - cola, tea, coffee	4180186
1006760	How many cups or cans of caffeinated beverages per D	4180186
1006834	How many Mo have you used evista	4180186
1006840	How many Mo did you use prescription hormones	4180186
1006841	Are you currently using them - within the last Mo	4180186
1006849	What was your D per Mo pattern of oral or patch estrogen use	4180186
1006864	What Y was your most recent treatment or medication, if any	4180186
1006870	Over the past 4W when you had erections with sexual stimulation, how often were your erections hard enough for penetration	4180186
1006872	Over the past 4W during sexual intercourse, how often were you able to maintain your erection after you had penetrated - entered your partner	4180186
1006876	Over the past 4W how much have you enjoyed sexual intercourse	4180186
1006878	Over the past 4W when you had sexual stimulation or intercourse, how often did you have the feeling of orgasm or climax	4180186
1006879	Over the past 4W how often have you felt sexual desire	4180186
1006883	Over the past 4W how do you rate your confidence that you could get and keep an erection	4180186
1006885	Since the age of 18, have you ever experienced a time interval of 3 or more Mo when you did not have a menstrual period	4180186
1006889	On average, during the last Y, how many D were there in a typical menstrual cycle, that is, from the beginning of bleeding of one menstrual period to the beginning of bleeding of the next period	4180186
1006895	Has the force of your urinary stream or water decreased over the Y	4180186
1006906	During the last 3Mo of your pregnancy, how many times did you drink 4 alcoholic drinks or more in one sitting	4180186
1006912	How many Mo did it take for your partner to achieve pregnancy	4180186
1006919	With how many different partners have you had vaginal intercourse in the past 12Mo	4180186
1006920	How many times have you had vaginal intercourse in the past 12Mo	4180186
1006930	In the last 12Mo, have you noticed this eye problem	4180186
1006934	During the last 12Mo have you noticed your child frequently squinting	4180186
1006965	During the past 12Mo, if child less than 12Mo, the childs age in Mos, has your child appeared to have any difficulty seeing	4180186
1006971	When did your child first have this type of operation	4180186
1006975	In the 3Mo before you got pregnant, how many cigarettes did you smoke on an average D	4180186
1006977	During the 3Mo before you got pregnant, how many alcoholic drinks did you have in an average W	4180186
1006979	What Y did you move from that city or town	4180186
1006983	When you were living in your city or town in your occupation, how many H each D during a typical 5D work week in April through September did you spend outside in direct sunlight between 10 AM and 4 PM	4180186
1007237	Was your child speaking by 2Y old	4180186
1007326	During the past 30D, about how often did you feel so depressed that nothing could cheer you up	4180186
1007330	During the past 30D, about how often did you feel that everything was an effort	4180186
1007331	During the past 30D, how many times did you see a doctor or other health professional about these feelings	4180186
1007332	During the past 30D, about how often did you feel worthless	4180186
1007333	During the past 30D, how often have physical health problems been the main cause of these feelings	4180186
1007467	Because of your headaches on how many Ds in the last 3Mo did you miss work or school	4180186
1007468	Because of your headaches on how many Ds in the last 3Mo was your productivity at work or school reduced by half or more	4180186
1007470	Because of your headaches on how many Ds in the last 3Mo was your productivity in house-hold work reduced by half or more	4180186
1007471	Because of your headaches on how many Ds in the last 3Mo did you miss family, social, or leisure activities	4180186
1007493	Hands resting in lap for 15S	4180186
1007494	Arms held at 90 degrees for 15S - arm sustention	4180186
1007495	Arms held in wing position for 15S	4180186
1007506	Head while patient is seated for 10S	4180186
1007531	Has your child experienced periods of several Ds or more when he or she was unable to sit still, and had to keep moving or jumping from one activity to another	4180186
1007534	Has your child had periods of extreme happiness and intense energy lasting several Ds or more when he or she also felt much more anxious	4180186
1007535	Have there been times of several Ds or more when, although your child was feeling unusually happy and intensely energetic, he or she also had to struggle very hard to control rage	4180186
1007536	Has your child had periods of extreme happiness and intense energy, when it took him or her over an H to get to sleep at night	4180186
1007564	Have you ever had a time in your life when you felt sad, blue, or depressed for 2W or more in a row	4180186
1007565	Have you ever had a time in your life lasting 2W or more when you lost interest in most things like hobbies, work, or activities that usually give you pleasure	4180186
1007566	How much of the D did these feelings usually last	4180186
1007576	About how many Ws altogether did you feel this way - the total period of depression or loss of interest was	4180186
1007577	How many periods like this did you have in your life, lasting 2 or more Ws	4180186
1007579	About how old were you the last time you had a period of 2Ws like this	4180186
1007587	Feeling sad in past 7D	4180186
1007589	Increased appetite in past 7D	4180186
1007590	Increased weight within the last 2W	4180186
1007594	Energy level in past 7D	4180186
1007596	Feeling restless in past 7D	4180186
1007601	During the past 6Mo have there been times when you felt you have eaten what other people would regard as an unusually large amount of food - a quart of ice cream - given the circumstances	4180186
1007603	How many D per W on average over the past 6Mo have you eaten an unusually large amount of food and experienced a loss of control	4180186
1007604	How many times per W on average over the past 3Mo have you eaten an unusually large amount of food and experienced a loss of control	4180186
1007611	Did you worry most D	4180186
1007620	How many Mo have you had any of these fears	4180186
1007631	About how many M does it usually take for you to fall asleep	4180186
1007633	How many H and M does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning	4180186
1007642	Do you usually follow the same sleep schedule, that is, no more than a 1H difference in sleep and wake times, on both work or school and non-work or school D	4180186
1007647	At what time of the D do you usually take naps	4180186
1007648	How many H and Ms of sleep do you usually get when you take a nap	4180186
1007652	How difficult is it for you to adapt to a sleep loss of 3H or more - sleeping 3 or more H less than you normally do the night before	4180186
1007675	In the past Y, have you had difficulty getting to sleep	4180186
1007677	In the past Y, have you awakened too early in the morning and couldn't get back to sleep	4180186
1007683	Has your difficulty with sleeping occurred or worsened during a few Ds before menstruation	4180186
1007684	How many separate times in your life have you had difficulty getting to sleep, staying asleep or falling back to sleep after waking up during the night, for at least 1Mo	4180186
1007686	How old were you the last time you experienced this insomnia, for at least 1Mo	4180186
1007690	How often do you feel so sleepy during the D that it interrupts your normal activities	4180186
1007691	What is the longest period of time that you have felt so sleepy during the D that it interrupts your normal activities on most Ds	4180186
1007734	What Mo and Y did child first begin wearing glasses or contact lenses	4180186
1007784	Have you ever had any sudden loss or changes in speech lasting 24 H or longer	4180186
1007799	Have you ever had sudden numbness, tingling, or loss of feeling on one side of your body, including your face, arm, or leg which lasted 24H or longer	4180186
1007808	Have you had any sudden spells of dizziness, loss of balance, or sensation of spinning which lasted 24H or longer	4180186
1007814	View for cyst	4180186
1007815	Sagittal sinus vein.left+Jugular vein.left	4180186
1007816	Sagittal sinus vein.left	4180186
1007817	Sagittal sinus vein.right	4180186
1007818	Sagittal sinus vein.right+Jugular vein.right	4180186
1007912	How many times per W on average over the past 3Mo have you engaged in excessive exercise specifically to counteract the effects of overeating episodes	4180186
1007913	Over the past 3Mo, how many menstrual periods have you missed	4180186
1007945	How many Hs do you normally sleep	4180186
1007989	Delusions and hallucinations last for one W	4180186
1008013	Hands hanging at sides for 10S	4180186
1008022	Hand dominance - 42Mo	4180186
1008040	Have you ever used oral contraceptives for 2Mo or more for any reason - contraception, acne, menstrual irregularity, etc	4180186
1008082	On the average during the last 2W, how many of these pills, or medication items, did you take a D, W, or Mo	4180186
1008162	6M	4180186
1008187	Were you employed in the last 7D	4180186
1008188	If yes, which Ds	4180186
1008197	Compared to your physical activity over the past 3Mo, was last week's physical activity more, less, or about the same	4180186
1008204	Problem with 7D interview	4180186
1008227	How many of the Ds that the actiGraph was worn were valid	4180186
1008237	Records how many Ds the actigraph was worn on actigraph return and reading form	4180186
1008238	Records how many valid Ds the actigraph was worn on actigraph return and reading form	4180186
1008260	How much difficulty do you have sitting for about 2H	4180186
1008269	It is within a 10-15M walk to a transit stop, such as bus, train, trolley, or tram, from my home	4180186
1008274	I can be physically active during my free time on most Ds	4180186
1008276	I can be physically active during my free time on most Ds even if I could watch TV or play video games instead	4180186
1008279	I can be physically active during my free time on most Ds even if I have a lot of homework	4180186
1008280	I have the coordination I need to be physically active during my free time on most Ds	4180186
1008282	Circumstances in which you could exercise 3 time per W in the next 3Mos	4180186
1008283	Degree of confidence for exercising 3 times per W in the next 3Mo	4180186
1008301	Is the child or teen pregnant, or is there a chance she could become pregnant during the next Mo	4180186
1008302	Has the child received vaccinations in the past 4W	4180186
1008312	Travelled to country last Y	4180186
1008314	Travelled to country 3Ys ago	4180186
1008318	Stay was longer than 30 consecutive Ds last Y	4180186
1008321	Stay was longer than 30 consecutive Ds 4Ys ago	4180186
1008350	Physical &or occupational therapy sequence	4180186
1008351	Physical &or occupational therapy type	4180186
1008400	Did you live for more than 1Y in a country where sunshine is high - africa, french west indies, south of united states, australia	4180186
1008417	Have you had sexual intercourse in the past 7Ds	4180186
1008435	Proteinuria greater than or equal to 3.5 gm in 24H	4180186
1008445	Pericarditis for 6Mo, or pericardiectomy	4180186
1008602	In the last Mo, how often have you been upset because of something that happened unexpectedly	4180186
1008606	In the last Mo, how often have you felt that things were going your way	4180186
1008607	In the last Mo, how often have you found that you could not cope with all the things that you had to do	4180186
1008608	In the last Mo, how often have you been able to control irritations in your life	4180186
1008609	In the last Mo, how often have you felt that you were on top of things	4180186
1008610	In the last Mo, how often have you been angered because of things that were outside of your control	4180186
1008654	Albumin.pericard fld	4180186
1008655	Albumin.periton fld	4180186
1008697	Before you turned 12Y old (when you were in grade school), did anyone ever hit you, kick you, beat you, punch you, slap you around, or hurt your body in some other way	4180186
1008719	How many times in the last Y have you purposely damaged or destroyed property that did not belong to you	4180186
1008727	How many times in the last Y have you stolen or tried to steal money or things worth 100 dollars or more	4180186
1008728	How many times in the last Y have you taken something from a store without paying for it	4180186
1008730	How many times in the last Y have you taken something from a car that did not belong to you	4180186
1008734	How many times in the last Y have you used checks illegally or used a slug or fake money to pay for something	4180186
1008738	How many times in the last Y have you hit someone with the idea of hurting them, other than the events just mentioned	4180186
1008741	How many times in the last Y have you been involved in gang fights	4180186
1008743	How many times in the last Y have you physically hurt or threatened to hurt someone to get them to have sex with you	4180186
1008746	How many times in the last Y have you sold hard drugs such as heroin, cocaine, and LSD	4180186
1008750	How many times in the last Y have you run away from home	4180186
1008751	How many times in the last Y have you skipped classes or school without an excuse	4180186
1008752	How many times in the last Y have you been suspended or sent home from school for bad behavior	4180186
1008755	How many times in the last Y have you hitchhiked where it was illegal to do so	4180186
1008758	How many times in the last Y have you begged for money or things from strangers	4180186
1008761	How many times in the last Y did you run away from your home and stay away overnight	4180186
1008762	How many times in the last Y did you break into, or try to break into a building, to steal something	4180186
1008765	How many times in the last Y did you steal, or try to steal, money or things worth over 500 dollars	4180186
1008768	How many times in the last Y have you stolen, or tried to steal, a motor vehicle such as a car or motorcycle to keep or sell	4180186
1008769	How many times in the last Y have you used worthless checks or fake money to pay for something	4180186
1008770	How many times in the last Y have you tried to cheat someone by selling them something that was worthless, or not what you said it was	4180186
1008771	How many times in the last Y have you been so angry with a child that you attacked them with a weapon, or with the idea of seriously hurting them	4180186
1008776	How many times in the last Y have you committed a serious driving offense, such as driving while drunk, driving recklessly, or speeding 50 km per hour over the posted speed limit	4180186
1008778	How many times in the last Y have you lied about your age	4180186
1008779	How many times in the last Y have you made obscene telephone calls, such as calling someone and saying rude things	4180186
1008785	How many times in the last Y did you interfere with the work of the law by trying to get away from police, by hiding someone that the police were looking for, or by telling a lie to a police officer or judge	4180186
1008786	How many times in the last Y have you driven a vehicle when you did not have a driver's license or after your license had been suspended or disqualified	4180186
1008787	How many times in the last Y have you sold marijuana or hashish	4180186
1008788	How many times in the last Y have you used marijuana	4180186
1008792	How many times in the last Y did you threaten or hurt someone to get them to have sex with you	4180186
1008793	How many times in the last Y have you contributed to the delinquency of a person under age 17	4180186
1008794	How many times in the last Y have you failed to obey the courts	4180186
1008882	During the past 12Mo, what is the longest time that one episode of this pain has lasted	4180186
1008883	On how many Ds in the past 12Mo have you had this pain	4180186
1008975	How often did you have difficulty getting a good night's sleep because of your heartburn or regurgitation in the past 7D	4180186
1008976	How often did you take additional medications for your heartburn or regurgitation other than what your physician told you to take, such as tums, rolaids, maalox in the past 7D	4180186
1008979	Have you had a cold, sinus problem or earache in the last 24H	4180186
1008998	My child's ability to understand what others say to him or her is-	4180186
1009133	Do you ever get noises in your head or ears, tinnitus, which usually last longer than 5M	4180186
1009167	Have you ever been treated for a serious infection with an antibiotic, other than penicillin, which was administered by injection or drip for a W or more	4180186
1009194	NEMSIS	4180186
1009221	Cardiopulmonary resuscitation technique	4180186
1009399	Have you been exposed to solvents such as thrichloroethylene, toluene, evaporations from paints or lacquers, for more than one Y in one of your jobs	4180186
1009403	Have you ever worked for more than 1Y in a place where you had to raise your voice to make yourself heard by someone standing 1 mile away from you	4180186
1009410	How many Ys did you smoke up to now	4180186
1009428	RelMRat	4180186
1009452	fentaNYL & Norfentanyl	4180186
1009467	Employment status - 6Mo prior to renal failure	4180186
1009475	{Transplant}	4180186
1009535	I felt nervous when my normal routine was disturbed in the past 7D	4180186
1009536	I felt fearful about my future in the past 7D	4180186
1009538	I felt that I had no energy in the past 7D	4180186
1009539	I felt fatigued in the past 7D	4180186
1009542	I was frustrated by being too tired to do the things I wanted to do in the past 7D	4180186
1009543	I had to limit my social activity because I was tired in the past 7D	4180186
1009544	I needed help doing my usual activities because of my fatigue in the past 7D	4180186
1009545	I needed to sleep during the day in the past 7D	4180186
1009546	I had trouble starting things because I was too tired in the past 7D	4180186
1009548	I was too tired to take a short walk in the past 7D	4180186
1009551	I felt weak all over in the past 7D	4180186
1009554	I had to force myself to get up and do things because I was physically too weak in the past 7D	4180186
1009568	How much difficulty do you currently have taking a 20M brisk walk, without stopping to rest	4180186
1009580	How much difficulty do you currently have planning an activity several D in advance, like a meal, trip, or visit to friends	4180186
1009586	I had trouble keeping track of what I was doing if I was interrupted in the past 7D	4180186
1009587	I had difficulty doing more than one thing at a time in the past 7D	4180186
1009589	I had trouble thinking clearly in the past 7D	4180186
1009591	I had to work really hard to pay attention or I would make a mistake in the past 7D	4180186
1009592	I had trouble concentrating in the past 7D	4180186
1009594	Words I wanted to use seemed to be on the tip of my tongue in the past 7D	4180186
1009596	I walked into a room and forgot what I meant to get or do there in the past 7D	4180186
1009597	I had trouble remembering the name of a familiar person in the past 7D	4180186
1009600	I had trouble getting started on very simple tasks in the past 7D	4180186
1009603	It was hard to control my behavior in the past 7D	4180186
1009604	I said or did things without thinking in the past 7D	4180186
1009608	I became easily upset in the past 7D	4180186
1009615	It was hard to adjust to unexpected changes in the past 7D	4180186
1009616	I had a hard time accepting criticism from other people in the past 7D	4180186
1009618	Lately I had a sense of well being	4180186
1009643	I was sleepy during the daytime in the past 7D	4180186
1009645	I had difficulty falling asleep in the past 7D	4180186
1009646	Pain woke me up in the past 7D	4180186
1009651	I am able to socialize with my friends in the past 7D	4180186
1009660	I am able to do all of the family activities that I want to do in the past 7D	4180186
1009664	I feel limited in my ability to visit friends in the past 7D	4180186
1009666	I have to limit the things I do for fun at home, like reading, listening to music, etc in the past 7D	4180186
1009668	I have to limit my hobbies or leisure activities in the past 7D	4180186
1009670	I am able to do all of the community activities that I want to do in the past 7D	4180186
1009671	I am able to do all of the leisure activities that people expect me to do in the past 7D	4180186
1009672	I have to do my hobbies or leisure activities for shorter periods of time than usual for me in the past 7D	4180186
1009674	I have trouble keeping in touch with others in the past 7D	4180186
1009676	I am able to do all of the community activities that people expect me to do in the past 7D	4180186
1009677	I am able to go out for entertainment as much as I want in the past 7D	4180186
1009678	I have to limit the things I do for fun outside my home in the past 7D	4180186
1009679	I am doing fewer social activities with groups of people than usual for me in the past 7D	4180186
1009680	I am able to run errands without difficulty in the past 7D	4180186
1009682	I am accomplishing as much as usual at work for me in the past 7D	4180186
1009684	I can do everything for work that I want to do in the past 7D	4180186
1009685	I have trouble doing my regular chores or tasks in the past 7D	4180186
1009688	I have to do my work for shorter periods of time than usual for me in the past 7D	4180186
1009690	I am disappointed in my ability to socialize with my family in the past 7D	4180186
1009692	I am disappointed in my ability to meet the needs of my friends in the past 7D	4180186
1009693	I am satisfied with my ability to do household chores or tasks in the past 7D	4180186
1009694	I feel that my family is disappointed in my ability to socialize with them in the past 7D	4180186
1009695	I am disappointed in my ability to meet the needs of my family in the past 7D	4180186
1009697	I feel that my friends are disappointed in my ability to socialize with them in the past 7D	4180186
1009698	I am disappointed in my ability to do things for my friends in the past 7D	4180186
1009700	I am disappointed in my ability to keep in touch with others in the past 7D	4180186
1009704	I feel that I am disappointing other people at work in the past 7D	4180186
1009705	I am disappointed in my ability to perform my daily routines in the past 7D	4180186
1009708	I am disappointed in my ability to take care of personal and household responsibilities in the past 7D	4180186
1009709	I am bothered by limitations in performing my work in the past 7D	4180186
1009710	I am satisfied with my ability to take care of personal and household responsibilities in the past 7D	4180186
1009711	I am satisfied with my ability to work in the past 7D	4180186
1009742	NeuroQol.Peds	4180186
1009778	I was less interested in doing things I usually enjoy in the past 7D	4180186
1009779	It was hard for me to care about anything in the past 7D	4180186
1009782	My mood swings from good feelings to bad feelings in the past 7D	4180186
1009787	I felt afraid to go out alone in the past 7D	4180186
1009789	It was hard to do schoolwork because I was nervous or worried in the past 7D	4180186
1009790	I felt afraid in the past 7D	4180186
1009791	I worry that my health might get worse in the past 7D	4180186
1009792	I worry about doing well in school in the past 7D	4180186
1009793	I become anxious when I go back to the hospital or clinic in the past 7D	4180186
1009796	I worry about getting a good job because of my medical condition in the past 7D	4180186
1009798	I worried when I was away from my family in the past 7D	4180186
1009799	I got scared easily in the past 7D	4180186
1009800	I was worried that I might die in the past 7D	4180186
1009801	Because of my health, I worry about being able to go to college in the past 7D	4180186
1009802	Because of my health, I worry about getting a job to support myself in the past 7D	4180186
1009803	Being angry made it hard for me to be with my friends in the past 7D	4180186
1009808	I was so mad that I felt like yelling at someone in the past 7D	4180186
1009809	I was so mad that I felt like breaking things in the past 7D	4180186
1009811	I felt close to my friends in the past 7D	4180186
1009812	I felt comfortable with others my age in the past 7D	4180186
1009820	I wanted to spend time with my friends in the past 7D	4180186
1009821	I did things with other kids my age in the past 7D	4180186
1009823	I felt loved by my parents or guardians in the past 7D	4180186
1009825	My parents or guardians spent enough time with me in the past 7D	4180186
1009827	My teachers accepted me in the past 7D	4180186
1009828	My teachers respected me in the past 7D	4180186
1009845	Being tired makes me sad in the past 7D	4180186
1009846	Being tired makes me mad in the past 7D	4180186
1009849	I got upset by being too tired to do things I wanted to do in the past 7D	4180186
1009852	I had so much pain that I had to stop what I was doing in the past 7D	4180186
1009856	It was hard for me to play or hang out with my friends when I had pain in the past 7D	4180186
1009858	I could get on and off the toilet without using my arms in the past 7D	4180186
1009859	I could get on and off a low chair in the past 7D	4180186
1009862	I could stand on my tiptoes to reach for something in the past 7D	4180186
1009863	I could stand on my tiptoes to put something, like a 5 lb bag of sugar, on a shelf in the past 7D	4180186
1009864	I fall down easily in the past 7D	4180186
1009865	I could walk on slightly uneven surfaces such as cracked pavement in the past 7D	4180186
1009867	I could walk up and down ramps or hills in the past 7D	4180186
1009868	I could walk up and down curbs in the past 7D	4180186
1009873	I could move up and down inclines or ramps using a wheelchair in the past 7D	4180186
1009874	I could move on rough, uneven surfaces like lawns or gravel driveway using a wheelchair in the past 7D	4180186
1009875	I could move between my wheelchair and another seat such as a chair or bed in the past 7D	4180186
1009876	I could move around within a room, including making turns in my wheelchair in the past 7D	4180186
1009881	I could walk for 15M in the past 7D	4180186
1009883	I could park a wheelchair in a narrow space like in an elevator in the past 7D	4180186
1009884	I could back out of an elevator in a wheelchair if there was no room to turn around in the past 7D	4180186
1009887	I could reverse direction in my wheelchair in the past 7D	4180186
1009893	I could move for 15M using a wheelchair in the past 7D	4180186
1009896	With a walking aid, I could walk on slightly uneven surfaces, cracked pavement in the past 7D	4180186
1009901	With a walking aid, I could walk within a room in the past 7D	4180186
1009902	With a walking aid, I could walk across the room in the past 7D	4180186
1009904	With a walking aid I could get in and out of a car in the past 7D	4180186
1009905	I was able to use my fingers to point to something in the past 7D	4180186
1009906	I was able to take off my socks in the past 7D	4180186
1009907	I was able to put on and fasten my pants by myself in the past 7D	4180186
1009908	I was able to button and unbutton my shirt in the past 7D	4180186
1009910	I was able to wipe myself thoroughly after using the toilet in the past 7D	4180186
1009914	I was able to take a shower by myself in the past 7D	4180186
1009916	I was able to make a phone call using a touch tone key-pad in the past 7D	4180186
1009917	I was able to get out of bed by myself in the past 7D	4180186
1009919	I was able to open a jar by myself in the past 7D	4180186
1009920	I was able to put toothpaste on my toothbrush by myself in the past 7D	4180186
1009922	I was able to dry my back with a towel in the past 7D	4180186
1009929	I am able to do all of the activities with friends that I want to do in the past 7D	4180186
1009942	Cause of death.primary	4180186
1009945	Cause of death.other	4180186
1009958	End stage renal disease death notification - OMB CMS form 2746	4180186
1009962	Dialysis setting.primary	4180186
1009967	Dialysis sessions per W	4180186
1009971	Vitr fld.spun	4180186
1009973	Allergies &or adverse reactions	4180186
1009980	Dialysis Hs per session	4180186
1009985	Live births.now dead	4180186
1009995	Not able to stop or control worrying in the last 2W	4180186
1009997	How many servings of fruits-vegetables did you eat each D in past 7D	4180186
1010001	How many D of moderate to strenuous exercise, like a brisk walk, did you do in the last 7D	4180186
1010008	To what extent did the following common sources contributed to your overall stress in the last W	4180186
1010010	How many times in the past Y have you used an illegal drug or used a prescription medication for non-medical reasons	4180186
1010022	Have you used smokeless tobacco product in the last 30D	4180186
1010031	Neurology w special qualifications in child neuro	4180186
1010058	Views 5 + Swimmers	4180186
1010060	Views PA + lateral + Waters + Towne	4180186
1010075	Neuro & emotional & behavioral status - start of care	4180186
1010107	RatDiff	4180186
1010167	OPTIMAL	4180186
1010224	Citharexylum caudatum	4180186
1010316	Bothered by stomach pain in last 4W	4180186
1010319	Bothered by menstrual cramps or other problems with your period in last 4W	4180186
1010325	Bothered by shortness of breath in last 4W	4180186
1010327	Bothered by nausea, gas, or indigestion in last 4W	4180186
1010328	Feeling nervous, anxious, on edge, or worrying a lot about different things in last 4W	4180186
1010334	Becoming easily annoyed or irritable in last 4W	4180186
1010338	How many times per W on average over the past 3Mo have you made yourself vomit to prevent weight gain or counteract the effects of eating	4180186
1010340	Fasted - not eaten anything at all for at least 24H - often in last 3Mo in order to avoid gaining weight	4180186
1010344	You missed or were late for work, school, or other activities because you were drinking or hung over, more than once in last 6Mo	4180186
1010345	You had a problem getting along with other people while you were drinking more than once in last 6Mo	4180186
1010359	In the last 4W, have you had an anxiety attack - suddenly feeling fear or panic	4180186
1010365	If you checked yes to any of these ways of avoiding gaining weight, were any as often, on average, as twice a W	4180186
1010370	Feeling nervous, anxious or on edge in last 2W	4180186
1010371	Tissue transglutaminase Ab.IgA+gliadin peptides Ab.IgA & IgG panel	4180186
1010374	Feeling tired or having low energy level in past 4W	4180186
1010376	Worrying too much about different things in last 2W	4180186
1010377	Trouble relaxing in last 2W	4180186
1010378	Being so restless that it is hard to sit still in last 2W	4180186
1010402	HHS.ACA Section 4302	4180186
1010419	VRtoPctDiff	4180186
1010420	VPctDiff	4180186
1010438	AFr	4180186
1010464	Avoid thinking about or talking about a stressful experience from the past or avoid having feelings related to it in the last Mo	4180186
1010465	Avoid activites or situations because they remind you of a stressful experience from the past in the last Mo	4180186
1010468	Feeling distant or cut off from other people in the last Mo	4180186
1010469	Feeling as if your future will somehow be cut short in the last Mo	4180186
1010470	Trouble falling or staying asleep in the last Mo	4180186
1010471	Feeling irritable or having angry outbursts in the last Mo	4180186
1010472	Having difficulty concentrating in the last Mo	4180186
1010474	Feeling jumpy or easily startled in the last Mo	4180186
1010488	I have pain in my stomach area in the past 7D	4180186
1010491	I need help doing my usual activities in the past 7D	4180186
1010494	I am self-conscious about the way I dress in the past 7D	4180186
1010495	One or more of my arms are swollen or tender in the past 7D	4180186
1010498	I worry that other members of my family might someday get the same illness I have in the past 7D	4180186
1010500	I am bothered by a change in weight in the past 7D	4180186
1010505	I am interested in sex in the past 7D	4180186
1010506	For men only - I am able to have and maintain an erection in the past 7D	4180186
1010507	I have emotional ups and downs in the past 7D	4180186
1010510	I have bone pain in the past 7D	4180186
1010512	I am bothered by the change in my personality in the past 7D	4180186
1010513	I am able to make decisions and take responsibility in the past 7D	4180186
1010514	I am bothered by the drop in my contribution to the family in the past 7D	4180186
1010515	I am able to put my thoughts together in the past 7D	4180186
1010516	I am able to put my thoughts into action in the past 7D	4180186
1010518	I am able to write like I used to in the past 7D	4180186
1010520	I have trouble feeling sensation in my arms, hands or legs in the past 7D	4180186
1010521	I have had seizures - convulsions - in the past 7D	4180186
1010522	I have weakness in my arms or legs in the past 7D	4180186
1010523	I have trouble with coordination in the past 7D	4180186
1010528	I feel independent in the past 7D	4180186
1010529	I am able to find the right words to say what I mean in the past 7D	4180186
1010530	I have difficulty expressing my thoughts in the past 7D	4180186
1010531	I am bothered by fevers - episodes of high body temperature - in the past 7D	4180186
1010532	I have swelling or cramps in my stomach area in the past 7D	4180186
1010534	I have control of my bowels in the past 7D	4180186
1010538	I like the appearance of my body in the past 7D	4180186
1010539	I am embarrassed by my ostomy appliance in the past 7D	4180186
1010541	I am able to maintain my balance in the past 7D	4180186
1010542	I am able to walk in the past 7D	4180186
1010543	I have strength in my arms in the past 7D	4180186
1010544	I have strength in my legs in the past 7D	4180186
1010545	I have numbness in my legs in the past 7D	4180186
1010547	I am bothered by discharge or bleeding from my vagina in the past 7D	4180186
1010549	I am afraid to have sex in the past 7D	4180186
1010550	My vagina feels too narrow or short in the past 7D	4180186
1010555	I have difficulty swallowing soft or mashed foods in the past 7D	4180186
1010556	I have difficulty swallowing liquids in the past 7D	4180186
1010557	I have a pain in my chest when I swallow in the past 7D	4180186
1010558	I choke when I swallow in the past 7D	4180186
1010560	I wake at night because of coughing in the past 7D	4180186
1010561	I have trouble digesting food in the past 7D	4180186
1010562	I have discomfort or pain in my pelvic area in the past 7D	4180186
1010563	I have hot flashes in the past 7D	4180186
1010565	I have cold sweats in the past 7D	4180186
1010566	I have night sweats in the past 7D	4180186
1010568	I have pain or discomfort with intercourse in the past 7D	4180186
1010570	My digestive problems interfere with my usual activities in the past 7D	4180186
1010573	I am bothered by reflux or heartburn in the past 7D	4180186
1010575	I have discomfort or pain when I eat in the past 7D	4180186
1010576	I have stomach problems that worry me in the past 7D	4180186
1010578	I feel sad in the past 7D	4180186
1010581	I feel nervous in the past 7D	4180186
1010582	I worry about dying in the past 7D	4180186
1010583	I worry that my condition will get worse in the past 7D	4180186
1010585	My work - include work at home - is fulfilling in the past 7D	4180186
1010587	I have accepted my illness in the past 7D	4180186
1010588	I am sleeping well in the past 7D	4180186
1010590	I am content with the quality of my life right now in the past 7D	4180186
1010592	I have nausea in the past 7D	4180186
1010596	I feel ill in the past 7D	4180186
1010597	I am forced to spend time in bed in the past 7D	4180186
1010598	I feel close to my friends in the past 7D	4180186
1010602	I am satisfied with family communication about my illness in the past 7D	4180186
1010604	I am satisfied with my sex life in the past 7D	4180186
1010605	I am unhappy about a change in my appearance in the past 7D	4180186
1010610	I have discomfort or pain in my stomach area in the past 7D	4180186
1010611	I feel weak all over in the past 7D	4180186
1010615	I can eat solid foods in the past 7D	4180186
1010618	I have trouble breathing in the past 7D	4180186
1010619	My voice has its usual quality and strength in the past 7D	4180186
1010620	I am able to eat as much food as I want in the past 7D	4180186
1010622	I can swallow naturally and easily in the past 7D	4180186
1010623	I smoke cigarettes or other tobacco products in the past 7D	4180186
1010625	I have to limit my social activity because of my condition in the past 7D	4180186
1010626	I have to limit my physical activity because of my condition in the past 7D	4180186
1010627	My thinking is clear in the past 7D	4180186
1010628	I have been coughing in the past 7D	4180186
1010631	I regret my smoking in the past 7D	4180186
1010632	Because of my illness, I have difficulty planning for the future in the past 7D	4180186
1010635	I need help caring for myself - bathing, dressing, eating, etc in the past 7D	4180186
1010636	I am bothered by lumps or swelling in certain part of my body - neck, armpits, or groin - in the past 7D	4180186
1010637	I feel isolated from others because of my illness or treatment in the past 7D	4180186
1010638	I am bothered by itching in the past 7D	4180186
1010640	I have pain at my melanoma site or surgical site in the past 7D	4180186
1010642	I have swelling as a result of surgery in the past 7D	4180186
1010644	Movement of my swollen area is painful in the past 7D	4180186
1010645	Swelling keeps me from doing the things I want to do in the past 7D	4180186
1010647	I feel numbness at my surgical site in the past 7D	4180186
1010650	I worry about the appearance of surgical scars in the past 7D	4180186
1010654	I have difficulty thinking clearly - remembering, concentrating - in the past 7D	4180186
1010655	I have trouble walking because of the pain in the past 7D	4180186
1010656	I feel overwhelmed by my condition in the past 7D	4180186
1010658	I have difficulty moving my neck and shoulders because of stiffness in the past 7D	4180186
1010659	I am bothered by ringing in my ears in the past 7D	4180186
1010661	I have trouble smelling the in past 7D	4180186
1010662	I can enjoy the taste of food in the past 7D	4180186
1010663	I am bothered by having a blocked nose in the past 7D	4180186
1010666	I have been vomiting in the past 7D	4180186
1010672	I bruise easily in the past 7D	4180186
1010674	I am bothered by odor coming from my vulva in the past 7D	4180186
1010677	I am bothered by itching - burning in my vulva area in the past 7D	4180186
1010679	I have trouble bending in the past 7D	4180186
1010686	I have vaginal discharge in the past 7D	4180186
1010688	Functional assessment of cancer therapy for patients with breast cancer questionnaire - version 4	4180186
1010693	Functional well being	4180186
1010696	Functional assessment of chronic illness therapy - general measures panel	4180186
1010697	Functional assessment of chronic illness therapy - cancer specific measures panel	4180186
1010719	I am bothered by the chills in the past 7D	4180186
1010722	I feel discouraged about my illness in the past 7D	4180186
1010729	I have joint pain or muscle cramps in the past 7D	4180186
1010750	My pain keeps me from doing things I want to do in the past 7D	4180186
1010751	My problems with urinating limit my activities in the past 7D	4180186
1010753	I have mouth sores in the past 7D	4180186
1010755	I have pain in my hands or feet when I am exposed to cold temperatures in the past 7D	4180186
1010756	I have had blood in my urine in the past 7D	4180186
1010758	I have difficulty urinating in the past 7D	4180186
1010773	I believe that waiting up to 60M before eating breakfast in the morning will be inconvenient	4180186
1010777	I experience a pleasant feeling of fullness during or after my tube feeding in the past 7D	4180186
1010779	I feel uncomfortably full during or after my tube feeding in the past 7D	4180186
1010780	I have constipation during or after my tube feeding in the past 7D	4180186
1010782	Tube feeding limits what I can do inside the house - for example housework, watching TV or reading - in the past 7D	4180186
1010786	I miss being able to take more food or drink by mouth now that I have a feeding tube in the past 7D	4180186
1010789	I worry about the tube coming out by accident in the past 7D	4180186
1010794	I feel dependent on others because I have a feeding tube in the past 7D	4180186
1010796	I feel left out when others are eating in the past 7D	4180186
1010797	I am more confident about my nutrition because of my feeding tube in the past 7D	4180186
1010800	My skin or scalp feels irritated in the past 7D	4180186
1010801	My skin or scalp is dry or flaky in the past 7D	4180186
1010802	My skin or scalp itches in the past 7D	4180186
1010803	My skin bleeds easily in the past 7D	4180186
1010808	I am embarrassed by my skin condition in the past 7D	4180186
1010810	I feel unattractive because of how my skin looks in the past 7D	4180186
1010812	The skin side effects from treatment have interfered with household tasks in the past 7D	4180186
1010821	I get a ringing or buzzing in my ears in the past 7D	4180186
1010822	I have trouble buttoning buttons in the past 7D	4180186
1010823	I have trouble feeling the shape of small objects when they are in my hand in the past 7D	4180186
1010826	I have difficulty breathing when I am exposed to cold temperatures in the past 7D	4180186
1010831	I am concerned about keeping my job - include work at home - in the past 7D	4180186
1010832	I feel distant from other people in the past 7D	4180186
1010833	I worry that the transplant will not work in the past 7D	4180186
1010838	My eyesight is blurry in the past 7D	4180186
1010841	The cost of my treatment is a burden on me or my family in the past 7D	4180186
1010843	I am bothered by sweating in the past 7D	4180186
1010848	I feel motivated to do things in the past 7D	4180186
1010850	I feel bloated in the past 7D	4180186
1010856	I can remember things in the past 7D	4180186
1010857	MCPctDiff	4180186
1010858	18 deg C incubation	4180186
1010861	I am bothered by a change in the way food tastes in the past 7D	4180186
1010862	I have trouble with my bowels in the past 7D	4180186
1010863	I have pain in my joints in the past 7D	4180186
1010866	Functional assessment of chronic illness therapy - treatment specific measures panel	4180186
1010867	Functional assessment of chronic illness therapy - non cancer specific measures panel	4180186
1010871	The amount I eat is sufficient to meet my needs in the past 7D	4180186
1010874	I am concerned about how thin I look in the past 7D	4180186
1010875	My interest in food drops as soon as I try to eat in the past 7D	4180186
1010880	My general health is improving in the past 7D	4180186
1010882	Stomach pain interferes with my daily functioning in the past 7D	4180186
1010889	I have to limit my sexual activity because of the infection in the past 7D	4180186
1010894	I have accepted that I have this infection in the past 7D	4180186
1010895	I worry that the infection will get worse in the past 7D	4180186
1010896	I have hidden this problem so others will not notice in the past 7D	4180186
1010898	I worry about other peoples attitudes towards me in the past 7D	4180186
1010899	I feel embarrassed about the infection in the past 7D	4180186
1010901	I was careful who I told about the infection in the past 7D	4180186
1010903	I am frustrated by the infection in the past 7D	4180186
1010908	I get emotional support from family members in the past 7D	4180186
1010913	I have to limit my social activity because of diarrhea in the past 7D	4180186
1010914	I have to limit my physical activity because of diarrhea in the past 7D	4180186
1010915	I have to limit my sexual activity because of diarrhea in the past 7D	4180186
1010916	I am embarrassed by having diarrhea in the past 7D	4180186
1010919	I must move my bowels frequently to avoid accidents in the past 7D	4180186
1010924	I have trouble finishing things because I am tired in the past 7D	4180186
1010925	I have energy in the past 7D	4180186
1010929	I am frustrated by being too tired to do the things I want to do in the past 7D	4180186
1010930	I have to limit my social activity because I am tired in the past 7D	4180186
1010931	Functional assessment of chronic illness therapy - fatigue questionnaire -13 items - version 4	4180186
1010938	I have a poor range of arm movements on this side in the past 7D	4180186
1010943	It hurts when I put weight or pressure on the place where I have bone pain in the past 7D	4180186
1010945	I need help doing my usual activities because of bone pain in the past 7D	4180186
1010946	I am forced to rest during the day because of bone pain in the past 7D	4180186
1010947	I have trouble walking because of bone pain in the past 7D	4180186
1010948	Bone pain interferes with my ability to care for myself - bathing, dressing, eating, etc - in the past 7D	4180186
1010949	Bone pain interferes with my social activities in the past 7D	4180186
1010951	I am frustrated by my bone pain in the past 7D	4180186
1010952	I feel depressed about my bone pain in the past 7D	4180186
1010953	I worry that my bone pain will get worse in the past 7D	4180186
1010958	I have had trouble concentrating in the past 7D	4180186
1010959	I have had trouble finding my way to a familiar place in the past 7D	4180186
1010963	I have had trouble finding the right words to express myself in the past 7D	4180186
1010967	I have had to work really hard to pay attention or I would make a mistake in the past 7D	4180186
1010968	I have forgotten names of people soon after being introduced in the past 7D	4180186
1010970	My reactions in everyday situations have been slow in the past 7D	4180186
1010975	I have had to work harder than usual to express myself clearly in the past 7D	4180186
1010977	I have trouble keeping track of what I am doing if I am interrupted in the past 7D	4180186
1010979	Other people have told me I seemed to have trouble speaking clearly in the past 7D	4180186
1010981	Other people have told me I seemed confused in the past 7D	4180186
1010983	I have been able to concentrate in the past 7D	4180186
1010990	I am able to shift back and forth between two activities that require thinking in the past 7D	4180186
1010991	I am able to keep track of what I am doing, even if I am interrupted in the past 7D	4180186
1010996	These problems have interfered with my ability to do things I enjoy in the past 7D	4180186
1010999	I have vaginal itching - irritation - in the past 7D	4180186
1011000	I have vaginal dryness in the past 7D	4180186
1011001	I have lost interest in sex in the past 7D	4180186
1011002	I have breast sensitivity - tenderness - in the past 7D	4180186
1011006	I worry about getting sick due to low blood counts in the past 7D	4180186
1011007	I avoid public places for fear of getting an infection in the past 7D	4180186
1011008	I get aches and pains that bother me in the past 7D	4180186
1011011	My low blood counts interfere with my intimate relationships in the past 7D	4180186
1011016	I am bothered by nosebleeds in the past 7D	4180186
1011017	I am bothered by pinpoint bruising beneath my skin in the past 7D	4180186
1011021	I worry that my treatment will be delayed, because of low blood counts, in the past 7D	4180186
1011023	I worry about the possibility of serious bleeding in the past 7D	4180186
1011025	I am inconvenienced by platelet transfusions in the past 7D	4180186
1011026	I avoid or limit social activity, because of concern with bleeding or bruising, in the past 7D	4180186
1011032	I am embarrassed by my condition in the past 7D	4180186
1011033	My condition wakes or keeps me up at night in the past 7D	4180186
1011034	I can be far from home - work without fearing soilage in the past 7D	4180186
1011036	My condition wakes me up at night in the past 7D	4180186
1011038	I wear protection for leakage of urine in the past 7D	4180186
1011044	My doctor gave me explanations that I could understand in the past 7D	4180186
1011045	My doctor explained the possible benefits of my treatment in the past 7D	4180186
1011046	I feel that I received the treatment that was right for me in the past 7D	4180186
1011118	Arm.right	4180186
1011122	Bacillus subtilis Ab.IgE	4180186
1011124	Parakeet+Parrot droppings Ab.IgE	4180186
1011125	Toxocara canis Ab.IgE	4180186
1011138	Why you did not do this in the past 7D	4180186
1011143	How short of breath did you get putting on socks or stockings in the past 7D	4180186
1011145	How short of breath did you get walking 10 steps - paces on flat ground at a normal speed without stopping in the past 7D	4180186
1011147	How short of breath did you get walking up 5 stairs without stopping in the past 7D	4180186
1011148	How short of breath did you get walking up 10 stairs, 1 flight, without stopping in the past 7D	4180186
1011152	How short of breath did you get lifting something weighing more than 20 lbs, about 9 kg, like a medium-sized suitcase in the past 7D	4180186
1011160	How short of breath did you get walking, faster than your usual speed, for at least 1 mile, a little more than 1.5 km, without stopping in the past 7D	4180186
1011161	How short of breath did you get singing or humming in the past 7D	4180186
1011168	I have a reason for living in the past 7D	4180186
1011169	My life has been productive in the past 7D	4180186
1011170	I have trouble feeling peace of mind in the past 7D	4180186
1011171	I am able to reach down deep into myself for comfort in the past 7D	4180186
1011173	My life lacks meaning and purpose in the past 7D	4180186
1011174	I find strength in my faith or spiritual beliefs in the past 7D	4180186
1011175	My illness has strengthened my faith or spiritual beliefs in the past 7D	4180186
1011177	Functional assessment of chronic illness therapy - spiritual well being, expanded version questionnaire - version 4	4180186
1011178	I feel connected to a higher power, or God, in the past 7D	4180186
1011179	I feel connected to other people in the past 7D	4180186
1011181	I feel love for others in the past 7D	4180186
1011182	I am able to forgive others for any harm they have ever caused me in the past 7D	4180186
1011186	I feel a sense of appreciation for the beauty of nature in the past 7D	4180186
1011187	I feel compassion for others in the difficulties they are facing in the past 7D	4180186
1011190	My pharmacist advises me on the proper use of my medicines in the past 7D	4180186
1011191	My pharmacist advises me on the adverse - side - effects of my medicines in the past 7D	4180186
1011194	My pharmacist helps with the arrangements necessary to obtain my medicines in the past 7D	4180186
1011250	I have trouble getting around in public places in the past 7D	4180186
1011254	Emotional well being - FAMS	4180186
1011255	I feel trapped by my condition in the past 7D	4180186
1011257	I feel useless in the past 7D	4180186
1011262	I feel left out of things in the past 7D	4180186
1011265	I am bothered by muscle spasms in the past 7D	4180186
1011266	Difficult times have strengthened my faith or spiritual beliefs in the past 7D	4180186
1011267	Even during difficult times, I know that things will be okay in the past 7D	4180186
1011268	Walking 50 steps - paces on flat ground at a normal speed without stopping in the past 7D	4180186
1011272	I feel like a burden to my family in the past 7D	4180186
1011275	My mouth and throat are dry in the past 7D	4180186
1011276	I feel useful in the past 7D	4180186
1011279	I feel hopeful in the past 7D	4180186
1011280	I am able to make decisions in the past 7D	4180186
1011281	I have been able to reconcile, make peace, with other people in the past 7D	4180186
1011284	Physical well being - FAHI	4180186
1011291	I am unhappy with my appearance in the past 7D	4180186
1011293	I worry about spreading my infection in the past 7D	4180186
1011294	I am concerned about what the future holds for me in the past 7D	4180186
1011297	I have trouble learning new tasks or directions in the past 7D	4180186
1011315	I have been throwing up in the past 7D	4180186
1011316	I have pain in my stomach in the past 7D	4180186
1011318	I have energy or strength in the past 7D	4180186
1011319	I lose balance or fall down easily in the past 7D	4180186
1011320	I have trouble getting myself dressed in the past 7D	4180186
1011322	My arms or legs feel weak in the past 7D	4180186
1011324	I have trouble writing with a pen or pencil in the past 7D	4180186
1011330	I worry about getting another cancer-tumor in the past 7D	4180186
1011336	I worry about being able to go to college because of my illness in the past 7D	4180186
1011337	I worry about getting a job because of my illness in the past 7D	4180186
1011338	Other people pick on - tease me in the past 7D	4180186
1011339	I think I have fewer friends than others in the past 7D	4180186
1011342	I would rather do something by myself than with other people in the past 7D	4180186
1011344	My parents spoil me in the past 7D	4180186
1011351	My child loses balance or falls down easily in the past 4W	4180186
1011352	My child has trouble getting dressed on his-her own in the past 4W	4180186
1011353	My child has trouble running like other people in the past 4W	4180186
1011354	My child gets tired easily in the past 4W	4180186
1011356	My child gets ill easily in the past 4W	4180186
1011358	My child has pain in the past 7D	4180186
1011359	My child seems happy in the past 4W	4180186
1011361	The cancer-tumor experience makes my child a stronger person in the past 7D	4180186
1011362	The cancer-tumor experience has taught my child to appreciate life in the past 7D	4180186
1011364	My child worries about getting another cancer-tumor in the past 4W	4180186
1011366	My child worries when we go back to the hospital or clinic in the past 4W	4180186
1011369	My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 7D	4180186
1011370	My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 4W	4180186
1011372	My child worries about getting a job because of his-her illness in the past 4W	4180186
1011373	Physical well being - FACIT-peds	4180186
1011375	Social - family well being - FAACT-peds	4180186
1011377	My child has fewer friends than others in the past 4W	4180186
1011381	My child thinks I worry too much about him-her in the past 7D	4180186
1011382	My child thinks I spoil him-her in the past 7D	4180186
1011391	My child seems happy in the past 7D	4180186
1011399	My child worries about being able to go to college because of his-her illness in the past 7D	4180186
1011404	My child prefers to do something alone in the past 7D	4180186
1011406	My child eats as much as s-he wants in the past 7D	4180186
1011409	Most food tastes bad to my child in the past 7D	4180186
1011410	My child is worried about how thin s-he is in the past 7D	4180186
1011412	My child is afraid to eat because it may make her-him sick in the past 7D	4180186
1011413	Family or friends try to get my child to eat more in the past 7D	4180186
1011415	When my child eats, s-he seems to get full quickly in the past 7D	4180186
1011416	My child has pain in his-her stomach in the past 7D	4180186
1011418	Social - family well being - FAACT-parent_adoles	4180186
1011419	My child loses balance or falls down easily in the past 7D	4180186
1011423	My child's arms or legs seem weak in the past 7D	4180186
1011424	My child gets ill easily in the past 7D	4180186
1011425	My child has trouble writing with a pen or pencil in the past 7D	4180186
1011429	Other children avoid playing with my child because s-he is different in the past 7D	4180186
1011431	I lose my balance or fall down easily in the past 4W	4180186
1011432	I have trouble getting myself dressed in the past 4W	4180186
1011437	I have trouble writing with a pen or pencil in the past 4W	4180186
1011439	When I try to do something, I usually believe I will do it well in the past 4W	4180186
1011440	The illness experience makes me a stronger person in the past 4W	4180186
1011443	I worry about being sick again in the past 4W	4180186
1011444	I often switch from good moods to bad moods in the past 4W	4180186
1011445	I worry when I go back to the hospital or clinic in the past 4W	4180186
1011450	I worry about getting a job to support myself because of my illness history in the past 4W	4180186
1011451	Other people pick on - tease me in the past 4W	4180186
1011452	I think I have fewer friends than others in the past 4W	4180186
1011453	Other people avoid hanging out with me because of my illness history in the past 4W	4180186
1011454	I feel lonely in the past 4W	4180186
1011455	I would rather do something by myself than with other people in the past 4W	4180186
1011456	I am bothered by being shorter than other people in the past 4W	4180186
1011457	I am bothered by being unable to see well in the past 4W	4180186
1011458	I am bothered by being unable to hear well in the past 4W	4180186
1011459	I am bothered by headaches in the past 4W	4180186
1011460	When I speak, people have trouble understanding me in the past 4W	4180186
1011461	I need to work harder than other people to get my school work done in the past 4W	4180186
1011462	My grades are worse than they were before I was sick in the past 4W	4180186
1011463	I forget things easily in the past 4W	4180186
1011465	I have to read things several times so I can understand them in the past 4W	4180186
1011466	When I play games or sports, I react more slowly than most people my age in the past 4W	4180186
1011467	It is hard for me to find the right words to say what I mean in the past 4W	4180186
1011469	Emotional well being and illness experience - FACT-Br -peds-child	4180186
1011474	Social and family well being - FACT-Br -peds-parent_child	4180186
1011476	My child is bothered by being shorter than his-her peers in the past 4W	4180186
1011477	My child is bothered by poor vision in the past 4W	4180186
1011480	My child's speech is hard for others to understand in the past 4W	4180186
1011487	My child has difficulty using the right words in the past 4W	4180186
1011488	My child often feels inferior to other children in the past 4W	4180186
1011489	I feel weak in the past 7D	4180186
1011491	Being tired made me mad-angry in the past 7D	4180186
1011495	I have been able to laugh and see the funny side of things in the past 7D	4180186
1011496	EPDS	4180186
1011499	I have been anxious or worried for no good reason in the past 7D	4180186
1011500	I have felt scared or panicky for no very good reason in the past 7D	4180186
1011502	I have been so unhappy that I have had difficulty sleeping in the past 7D	4180186
1011504	I have been so unhappy that I have been crying in the past 7D	4180186
1011505	The thought of harming myself has occurred to me in the past 7D	4180186
1011506	Edinburgh Postnatal Depression Scale	4180186
1011549	I have aches and pains that bother me in the past 7D	4180186
1011551	I am able to feel like a man in the past 7D	4180186
1011552	I am able to have and maintain an erection in the past 7D	4180186
1011556	Aggl.ring test.heat inact	4180186
1011565	NFr.DF	4180186
1011567	CSub	4180186
1011573	Received scheduled pain medication regimen in last 5D	4180186
1011575	Received non-medication intervention for pain in last 5D	4180186
1011607	SLUMS	4180186
1011608	IQCODE	4180186
1011645	I feel sad, down in the dumps or unhappy in the last 2W or more	4180186
1011648	I feel tired - have no energy in the last 2W or more	4180186
1011652	I have lost some appetite in the last 2W or more	4180186
1011655	I feel worried or fearful in the last 2W or more	4180186
1011656	I have attacks of anxiety or panic in the last 2W or more	4180186
1011657	I worry about dying or losing control in the last 2W or more	4180186
1011658	I am nervous or shaky in social situations in the last 2W or more	4180186
1011659	I have nightmares or flashbacks in the last 2W or more	4180186
1011662	I can't get certain things out of my mind in the last 2W or more	4180186
1011663	I feel I must repeat certain acts or rituals in the last 2W or more	4180186
1011664	I feel the need to check and recheck things in the last 2W or more	4180186
1011695	Prostatic fld	4180186
1011697	VFr.DF	4180186
1011759	Feeling emotionally numb or being unable to have loving feelings for those close to you in the last Mo	4180186
1011773	Did you feel tired during the past 4W	4180186
1011775	Did you feel worn out during the past 4W	4180186
1011777	Did you have a lot of energy during the past 4W	4180186
1011778	Have you felt calm and peaceful during the past 4W	4180186
1011779	Have you felt so down in the dumps that nothing could cheer you up during the past 4W	4180186
1011780	Have you been a very nervous person during the past 4W	4180186
1011783	How much bodily pain have you had during the past 4W	4180186
1011785	As a result of any emotional problems, have you accomplished less than you would like in the past 4W	4180186
1011786	As a result of any emotional problems, have you cut down the amount of time you spent on work or other activities in the past 4W	4180186
1011787	As a result of your physical health, have you had difficulty performing the work or other activities - for example, it took extra effort in the past 4W	4180186
1011788	As a result of your physical health, were you limited in the kind of work in the past 4W	4180186
1011790	As a result of your physical health, have you cut down the amount of time you spent on work or other activities in the past 4W	4180186
1011800	During the past 4W, how much of the time has your physical health or emotional problems interfered with your social activities - like visiting with friends, relatives, etc.	4180186
1011829	PROMIS-10 Global Mental Health score	4180186
1011832	VR-36 Role emotion score - oblique method	4180186
1011833	VR-36 Social functioning score - oblique method	4180186
1011836	VR-36 Bodily pain score - oblique method	4180186
1011837	VR-36 Role physical score - oblique method	4180186
1011840	VR-36 Mental component summary score - oblique method	4180186
1011842	VR-36 Role emotion score - orthogonal method	4180186
1011847	VR-36 Bodily pain score - orthogonal method	4180186
1011848	VR-36 Role physical score - orthogonal method	4180186
1011849	VR-36 Physical functioning score - orthogonal method	4180186
1011852	VR-12 Social functioning score - oblique method	4180186
1011860	VR-12 Mental component summary score - oblique method	4180186
1011863	VR-12 Mental component summary score - orthogonal method	4180186
1011897	Sodium profiling-modeling prescribed for any dialysis sessions in the reporting Mo	4180186
1011908	Did prescribed dialysate sodium concentration exceed 138 mEq/L for any dialysis session during the Mo	4180186
1011930	Vital signs & oximetry - admission, home health, interim, discharge	4180186
1011932	Alcohol use disorder identification test-consumption	4180186
1011937	AUDIT	4180186
1011941	BS II	4180186
1011945	MAST-G	4180186
1011946	CRAFFT	4180186
1011947	P.E.D.S.	4180186
1011948	P.E.D.S.-DM	4180186
1011951	IDI	4180186
1011952	HAQ	4180186
1011954	ASQ	4180186
1011962	MLHFQ	4180186
1011963	Total score - Ages and stages questionnaires 2 Mo	4180186
1011965	Total score - Ages and stages questionnaires 6 Mo	4180186
1011968	Total score - Ages and stages questionnaires 10 Mo	4180186
1011970	Total score - Ages and stages questionnaires 14 Mo	4180186
1011971	Total score - Ages and stages questionnaires 16 Mo	4180186
1011974	Total score - Ages and stages questionnaires 22 Mo	4180186
1011975	Total score - Ages and stages questionnaires 24 Mo	4180186
1011979	Total score - Ages and stages questionnaires 36 Mo	4180186
1012000	Ser/Plas+Synv fld	4180186
1012010	Given pyrimethamine sulfadoxine - starting at 4th Mo	4180186
1012026	Albumin.CSF	4180186
1012035	Surgical operation note - recommended C-CDA R1.1 & R2.0 & R2.1 sections	4180186
1012039	Mini-Cog	4180186
1012042	Glucose.serum	4180186
1012043	Glucose.synv fld	4180186
1012045	Neutrophil oxidative burst stimulated/unstimulated	4180186
1012047	Wound tunneling & undermining panel	4180186
1012064	Neutrophil oxidative burst stimulated	4180186
1012070	Severity of pain on average over the past Mo	4180186
1012071	Level of fatigue on average over the past Mo	4180186
1012089	CFr.DF	4180186
1012095	Guidance for repair of central venous catheter without port or pump	4180186
1012096	Guidance for repair of central venous catheter with port or pump	4180186
1012103	I got drunk in last W	4180186
1012104	I took drugs in last W	4180186
1012105	I took medication that had not been prescribed or if had been prescribed, I took more than the prescribed dose in last W	4180186
1012109	I felt as if I was far away from myself in last W	4180186
1012110	I felt worthless in last W	4180186
1012112	Now we would like to know in addition the quality of your overall personal state in the course of the last W	4180186
1012114	I told other people that I was going to kill myself in last W	4180186
1012116	I had episodes of binge eating in last W	4180186
1012117	I induced vomiting in last W	4180186
1012123	I was absent-minded and unable to remember what I was actually doing in last W	4180186
1012125	I thought of hurting myself in last W	4180186
1012126	I didn't trust other people in last W	4180186
1012134	My mood rapidly cycled in terms of anxiety, anger, and depression in last W	4180186
1012137	I felt vulnerable in last W	4180186
1012138	Everything seemed senseless to me in last W	4180186
1012139	I was afraid of losing control in last W	4180186
1012140	BSL-23	4180186
1012141	cfDNA	4180186
1012143	The idea of death had a certain fascination for me in last W	4180186
1012155	Multisection for physiologic artery study	4180186
1012158	Stalwart of Standardization + Vocabulary Curator Virtuoso	4180186
1012179	NDC labeler code request.animal drug	4180186
1012180	Tscore	4180186
1012181	Bld/Tiss/Sal	4180186
1012202	PctDiff	4180186
1012208	Reagin Ab & Treponema pallidum Ab	4180186
1012215	MFrDiff	4180186
1012216	EntSRto	4180186
1012266	Dosage of chromosome specific cf DNA	4180186
1012297	Arm.left	4180186
1012304	Surg	4180186
1012308	Problem alleviating &or exacerbating factors	4180186
1012322	Number of Y alcohol consumed	4180186
1012342	Injury severity score body region	4180186
1012344	Blood group 8	4180186
1012346	Cytokeratin 7 & Thyroid transcription factor 1	4180186
1012405	Work Ds per W	4180186
1012410	NMMDS	4180186
1012427	interRAI contact assessment	4180186
1012428	interRAI home care	4180186
1012430	interRAI emergency screener for psychiatry	4180186
1012431	interRAI acute care	4180186
1012432	interRAI palliative care	4180186
1012433	interRAI community health assessment - deafblind supplement	4180186
1012434	interRAI community health assessment - assisted living supplement	4180186
1012445	Weight difference pre dialysis & post dialysis panel	4180186
1012449	VP shunt	4180186
1012464	How many times in the last Y did you use a false name or alias so you couldn't be	4180186
1012466	Streptococcus pneumoniae DNA & Haemophilus influenza DNA & Streptococcus agalactiae	4180186
1012474	Antibody screen.autologous	4180186
1012475	Antibody screen.cell II	4180186
1012476	Antibody screen.cells I+II+III	4180186
1012493	Patient safety event report - hospital - healthcare event reporting form - version 1.2	4180186
1012514	Patient safety event report - hospital - summary of initial report - version 1.2	4180186
1012521	Event discovery date & time	4180186
1012544	Health information technology device was involved	4180186
1012545	Best characterization of health information technology device	4180186
1012565	Staphylococcus aureus.methicillin resistant isolate	4180186
1012570	Vital signs, weight, height, head circumference, oximetry, BMI, & BSA panel	4180186
1012633	CSF Venereal Disease Research Laboratory test was performed & test findings	4180186
1012634	Leukocyte count or protein test was performed on CSF & test findings	4180186
1012658	Norton scale score.total	4180186
1012668	How intense was your pain at its worse in the past 7D	4180186
1012717	Amnio fld/CVS	4180186
1012720	Plas/Bld	4180186
1012723	Plas.cfDNA	4180186
1012741	Social work.case manager	4180186
1012743	Mental health.nurse	4180186
1012744	Preventive medicine.nurse	4180186
1012745	Primary care.nurse	4180186
1012748	Primary care.physician	4180186
1012751	Primary care.team	4180186
1012765	HIV 1+2 Ab & HIV1 p24	4180186
1012768	Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma actual	4180186
1012782	Patient seen in this ED in last 72H and discharged	4180186
1012787	TimeFr	4180186
1012801	Over the past W, are you able to shampoo your hair	4180186
1012802	Over the past W, are you able to stand up from a straight chair	4180186
1012803	Over the past W, are you able to get in and out of bed	4180186
1012806	Over the past W, are you able to walk outdoors on flat ground	4180186
1012807	Over the past W, are you able to climb up five steps	4180186
1012819	Over the past W, are you able to take a tub bath	4180186
1012820	Over the past W, are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head	4180186
1012821	Over the past W, are you able to bend down and pick up clothing from the floor	4180186
1012825	Over the past W, are you able to run errands and shop	4180186
1012826	Over the past W, are you able to get in and out of a car	4180186
1012829	Over the past W, are you able to wait in line for 15 minutes	4180186
1012830	Over the past W, are you able to do outside work (such as yard work)	4180186
1012831	Over the past W, are you able to lift heavy objects	4180186
1012832	Over the past W, are you able to move heavy objects	4180186
1012833	Over the past W, are you able to go up two or more flights of stairs	4180186
1012835	During the past 2Ws, what was the hardest physical activity you could do for at least 2 minutes	4180186
1012848	During the past 2Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health	4180186
1012851	How would you rate your overall health now compared to 2Ws ago	4180186
1012854	How have things been going for you during the past 2Ws	4180186
1012856	CDAI	4180186
1012859	Number of falls in the past 12Mo	4180186
1012861	AXIN2 gene deletion+duplication &	4180186
1012868	Guidance for percutaneous aspiration of fluid	4180186
1012877	Thoughts on cardiopulmonary resuscitation	4180186
1012893	Bld/Urine	4180186
1012896	During the past 4Ws, how would you rate your health in general	4180186
1012897	How would you rate your overall health now compared to 4Ws ago	4180186
1012898	During the past 4Ws, how much bodily pain have you generally had	4180186
1012899	During the past 4Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups	4180186
1012900	During the past 4Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health	4180186
1012901	During the past 4Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue	4180186
1012902	During the past 4Ws, what was the hardest physical activity you could do for at least 2 minutes	4180186
1012926	AAAM	4180186
1012930	My child felt uneasy in past 7D	4180186
1012937	How many D in the past W did your child miss taking one or more medications	4180186
1012974	CNAP	4180186
1012981	IEEE Rosetta central nervous system panel	4180186
1012984	IEEE Rosetta temperature panel	4180186
1012985	IEEE Rosetta skin transcutaneous panel	4180186
1012986	IEEE Rosetta laboratory panel	4180186
1012994	IEEE Rosetta body measurement panel	4180186
1012998	Freq	4180186
1013001	ScoreRange	4180186
1013002	Bld/Tiss^Donor	4180186
1013063	I have trouble starting things because I am tired during the past 7D	4180186
1013073	Licensed nursing staff & sex panel	4180186
1013421	How often in the past 12Mo would you say the patient was worried or stressed about having enough money to buy nutritious meals	4180186
1013422	On a typical weekday in the past W, how much time did the patient spend watching TV &or DVDs	4180186
1013431	Within the last Y, have you been humiliated or emotionally abused in other ways by your partner or ex-partner	4180186
1013432	Within the last Y, have you been afraid of your partner or ex-partner	4180186
1013433	Within the last Y, have you been raped or forced to have any kind of sexual activity by your partner or ex-partner	4180186
1013441	In a typical W, how many times do you talk on the telephone with family, friends, or neighbors	4180186
1013457	Prosigna	4180186
1013459	On a typical weekday in the past W, how much time did the patient spend playing video games and computer games	4180186
1013461	Calculated.Prosigna	4180186
1013463	Calculated.VectraDA	4180186
1013467	In the past W, how many times were dinners prepared at home and eaten together	4180186
1013470	How much formula does the patient drink per D	4180186
1013478	Total combined household income range in last 12Mo	4180186
1013484	Yesterday, how many times did the patient eat food from any type of restaurant	4180186
1013485	30D	4180186
1013492	Ds per W of moderate to vigorous physical activity	4180186
1013544	Salivary gland protein 1 & Carbonic anhydrase 6 & Parotid secretory protein Ab.IgA & IgG & IgM	4180186
1013548	UPDRS	4180186
1013575	Females & males of reproductive potential	4180186
1013581	Nursing staff job positions, quantity, turnover, & retention panel	4180186
1013595	Mean number of nursing staff	4180186
1013606	Management, administrative, &or support staff	4180186
1013613	RptPeriod	4180186
1013628	HLA-DP & DQ & DR (class II)	4180186
1013632	I could rely on my family in past 4W	4180186
1013636	I could trust others in my family in past 4W	4180186
1013640	I felt I really belonged in my family in past 4W	4180186
1013641	I felt important in my family in past 4W	4180186
1013645	I felt really respected by my family in past 4W	4180186
1013648	I felt that I had similar values and beliefs as others in my family in past 4W	4180186
1013650	I felt that my family really respected me in past 4W	4180186
1013651	I felt that my family understood me in past 4W	4180186
1013659	I have been able to concentrate in past 7D	4180186
1013661	I have been able to form thoughts clearly in past 7D	4180186
1013665	I have been able to keep track of what I am doing, even if I am interrupted in past 7D	4180186
1013668	I have been able to multi-task as easily as usual without extra effort in past 7D	4180186
1013669	I have been able to pay attention and keep track of what I am doing without extra effort in past 7D	4180186
1013670	I have been able to remember telephone numbers in past 7D	4180186
1013673	I have been able to remember things as easily as usual without extra effort in past 7D	4180186
1013674	I have been able to remember to do things, like take medicine or buy something I needed in past 7D	4180186
1013676	I have been able to think as clearly as usual without extra effort in past 7D	4180186
1013677	I have been able to think clearly in past 7D	4180186
1013679	I have been upset about my problems with memory, concentration, or making mental mistakes in past 7D	4180186
1013680	I have forgotten names of people soon after being introduced in past 7D	4180186
1013682	I have had more problems conversing with others in past 7D	4180186
1013685	I have had to work harder than usual to keep track of what I was doing in past 7D	4180186
1013686	I have had to work really hard to pay attention or I would make a mistake in past 7D	4180186
1013687	I have had trouble adding or subtracting numbers in my head in past 7D	4180186
1013692	I have had trouble recalling the name of an object while talking to someone in past 7D	4180186
1013697	I have had trouble speaking fluently in past 7D	4180186
1013702	I knew my family would help me if I needed it in past 4W	4180186
1013708	My ability to concentrate has been good in past 7D	4180186
1013709	My ability to count money has been as good as usual in past 7D	4180186
1013710	My ability to follow driving directions has been as good as usual in past 7D	4180186
1013711	My ability to keep track of lists has been as good as usual in past 7D	4180186
1013712	My ability to remember important dates has been as good as usual in past 7D	4180186
1013713	My ability to remember names has been as good as usual in past 7D	4180186
1013716	My child felt a sense of togetherness with our family in past 4W	4180186
1013718	My child felt everyone in our family loved him or her in past 4W	4180186
1013721	My child felt he or she got all the help he or she needed from our family in past 4W	4180186
1013725	My child felt he or she was really important to our family in past 4W	4180186
1013729	My child felt our family treated him or her fairly in past 4W	4180186
1013730	My child felt really respected by our family in past 4W	4180186
1013737	My child felt that our family understood him or her in past 4W	4180186
1013739	My child felt totally accepted by our family in past 4W	4180186
1013741	My child knew everyone in our family loved him or her in past 4W	4180186
1013746	My child knew our family was interested in what he or she was doing in past 4W	4180186
1013747	My child knew our family would help if he or she needed it in past 4W	4180186
1013748	My child knew that everyone in our family could be completely trusted in past 4W	4180186
1013749	My child knew that our family would be there if he or she needed them in past 4W	4180186
1013751	My child wanted to help our family however he or she could in past 4W	4180186
1013754	My family was interested in what I was doing in past 4W	4180186
1013759	My problems with memory, concentration, or making mental mistakes have interfered with the quality of my life in past 7D	4180186
1013762	My thinking has been clear in past 7D	4180186
1013763	My thinking has been foggy in past 7D	4180186
1013764	My thinking has been slow in past 7D	4180186
1013766	Other people have told me I seemed to have trouble remembering information in past 7D	4180186
1013767	People in my family helped each other in past 4W	4180186
1013769	People in our family made my child feel good about himself or herself in past 4W	4180186
1013774	Everyone in my family could be completely trusted in past 4W	4180186
1013850	Falling scale	4180186
1013889	Can pronounce naive	4180186
1013917	Chest>Vessels	4180186
1013918	Neck>Vessels	4180186
1013934	Being tired made it hard for me to remember things in past 7D	4180186
1013936	I could jump up and down in past 7D	4180186
1013937	I could pick up coins from a table in past 7D	4180186
1013939	I could thread a needle in past 7D	4180186
1013940	I could wash my hair by myself in past 7D	4180186
1013941	I felt sad for no reason in past 7D	4180186
1013942	I felt tired even when I had not done anything in past 7D	4180186
1013944	I needed help walking when I was in pain in past 7D	4180186
1013945	I walked carefully when I was in pain in past 7D	4180186
1013947	I was angry when things didn't go my way in past 7D	4180186
1013949	I worried that something might happen to my parents or guardians in past 7D	4180186
1013950	It was hard for me to be away from home because I had pain in past 7D	4180186
1013951	It was hard to do things with my family because I had pain in past 7D	4180186
1013953	My pain was so bad that I needed to take medicine to treat it in past 7D	4180186
1013971	Heart.ventricle.left.mid anterior lateral	4180186
1013974	Mitral valve.annulus.lateral	4180186
1013978	During the past 24H, how has pain interfered with your general activity	4180186
1013979	During the past 24H, how has pain interfered with your mood	4180186
1013982	During the past 24H, how has pain interfered with your relations with other people	4180186
1013983	During the past 24H, how has pain interfered with your sleep	4180186
1013984	During the past 24H, how has pain interfered with your enjoyment of life	4180186
1014024	How much time did you usually spend on one of those D doing moderate physical activities	4180186
1014026	During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling for at least 10M at a time	4180186
1014031	Salmo salar roe	4180186
1014049	Unified Parkinson's Disease Rating Scale panel	4180186
1014050	Mean time to access a patient	4180186
1014115	PROMIS alcohol - negative expectancies - version 1.0 T-score	4180186
1014116	PROMIS alcohol - positive outcomes - version 1.0 T-score	4180186
1014119	PROMIS alcohol - positive expectancies - version 1.0 T-score	4180186
1014121	PROMIS instrumental support - version 2.0 T-score	4180186
1014123	PROMIS emotional support - version 2.0 T-score	4180186
1014125	PROMIS ability to participate in social roles and activities - version 2.0 T-score	4180186
1014128	PROMIS satisfaction with participation in roles - version 1.0 T-score	4180186
1014132	PROMIS emotional distress - depression - version 1.0 T-score	4180186
1014135	PROMIS fatigue - version 1.0 T-score	4180186
1014136	PROMIS pain interference - version 1.0 T-score	4180186
1014141	PROMIS pediatric physical function - mobility - version 1.0 T-score	4180186
1014143	PROMIS pediatric asthma - version 1.0 T-score	4180186
1014144	PROMIS pediatric emotional distress - anxiety - version 1.0 T-score	4180186
1014167	Hospitalized for condition of interest	4180186
1014185	Bld MC	4180186
1014187	EntLogNum	4180186
1014200	Excursion distance.systole	4180186
1014204	CT.perfusion	4180186
1014227	Does your health now limit you in doing 2H of physical labor	4180186
1014230	Does your health now limit you in doing 8H of physical labor	4180186
1014244	Views GE 2	4180186
1014247	PPresRto	4180186
1014248	BldA+Resp.alv	4180186
1014278	Posterior descending from left circumflex artery	4180186
1014279	Ramus intermedius from left main coronary artery	4180186
1014280	Dothiepin+nordothiepin & dothiepin sulfoxide panel	4180186
1014283	Cardiovascular disease+Pulmonary disease	4180186
1014287	GPCOG	4180186
1014290	AreaFr	4180186
1014301	Calculated.AlloMap	4180186
1014302	Intravenous contrast	4180186
1014313	Myocardial infarction in past 24H	4180186
1014319	Posterolateral from right coronary artery	4180186
1014320	Diagonal artery 1a	4180186
1014321	Diagonal artery 2a	4180186
1014328	Multisection for leg measurement	4180186
1014329	Vessels.right	4180186
1014331	Multisection by reconstruction	4180186
1014333	CT.densitometry	4180186
1014338	Superficial biopsy.needle	4180186
1014340	CT.scanogram	4180186
1014361	Compared to a few Y ago, is the patient less able to manage money and financial affairs (e.g. paying bills, budgeting)	4180186
1014362	Compared to a few Y ago, when speaking, does the patient have more difficulty in finding the right word or tend to use the wrong words more often	4180186
1014369	Fluid intake.intravascular.lipids	4180186
1014373	Fluid output.enteral tube	4180186
1014375	Fluid output.musculoskeletal drain	4180186
1014382	N-methyl-D-aspartate receptor Ab	4180186
1014385	Objective refraction	4180186
1014390	Snellen eye chart	4180186
1014394	ERG device	4180186
1014401	Reese-Ellsworth system	4180186
1014406	Conjunctiva+Sclera.right	4180186
1014407	Conjunctiva+Sclera.left	4180186
1014408	Eyelid & Lashes & Adnexa	4180186
1014409	Pupil.right	4180186
1014411	ElpotRto	4180186
1014415	Optic nerve.left	4180186
1014418	Macula.right	4180186
1014420	Confrontation	4180186
1014433	LogInvPct	4180186
1014434	Multivitamin &or mineral supplement intake	4180186
1014436	Breast milk &or formula intake panel	4180186
1014468	Meal &or snack pattern panel	4180186
1014500	VR-12 Physical component summary score change - oblique method	4180186
1014502	VR-12 Mental component summary score change - orthogonal method	4180186
1014503	TscoreDiff	4180186
1014533	180D	4180186
1014539	Fat.saturated intake	4180186
1014556	Amino acid.essential intake	4180186
1014569	Enteral tube.nutritional intake panel	4180186
1014598	Vitamin B7 intake	4180186
1014599	Vitamin B9 intake	4180186
1014605	US.2D.A2C+Calc by single plane method of disks	4180186
1014610	Vitamin B1 intake	4180186
1014619	Symptoms & diseases of genitourinary system	4180186
1014629	Mineral &or trace element intake panel	4180186
1014678	Heart.ventricle.right.base	4180186
1014679	Heart.ventricle.right.mid-cavity	4180186
1014685	ArArea	4180186
1014691	Retinal vessels.right	4180186
1014692	Retinal vessels.left	4180186
1014693	Chorioretina.left	4180186
1014696	SCncSq	4180186
1014699	ICRB	4180186
1014701	LogLenRto	4180186
1014734	Fluid intake.enteral tube.nutritional formula composition	4180186
1014735	EngCnc	4180186
1014737	Number of W postpartum	4180186
1014760	7D	4180186
1014762	D per W alcoholic drinks consumed	4180186
1014769	MR	4180186
1014774	Pelvis>Veins	4180186
1014777	Multisection for high grade tumor	4180186
1014778	TmStpRange	4180186
1014781	Multisection for new diagnosis tumor	4180186
1014787	Multisection for motor function	4180186
1014788	Multisection endovaginal	4180186
1014790	Multisection for implant	4180186
1014801	Coag.kaolin induced	4180186
1014802	Coag.diatomaceous earth induced	4180186
1014830	How often have you found it difficult to postpone urination over the past Mo	4180186
1014831	How often have you had a weak urinary stream over the past MO	4180186
1014832	How often have you had to push or strain to begin urination over the past MO	4180186
1014833	How many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning over the past Mo	4180186
1014836	Multisection limited for graft	4180186
1014837	Multisection for pregnancy+fetal abnormality	4180186
1014839	Multisection for pregnancy+second or third trimester	4180186
1014840	Umbilical artery^fetus	4180186
1014841	Multisection transabdominal + transvaginal for pregnancy+first trimester	4180186
1014843	Guidance for biopsy.vacuum	4180186
1014844	Multisection for torsion	4180186
1014846	Multisection for transplanted kidney	4180186
1014849	Multisection for multiple gestation pregnancy+second or third trimester	4180186
1014850	Multisection transabdominal + transvaginal for multiple gestation pregnancy+first trimester	4180186
1014851	Multisection transvaginal for pregnancy	4180186
1014854	Multisection for multiple gestation pregnancy+fetal abnormality	4180186
1014856	Guidance for placement of central venous catheter	4180186
1014857	Guidance for placement of large bore central venous catheter	4180186
1014858	Guidance for removal of central venous catheter	4180186
1014861	Multisection limited for transplanted kidney	4180186
1014867	Multisection for motion	4180186
1014870	Multisection for transplanted liver	4180186
1014874	Umbilical vessels^fetus	4180186
1014875	Gastrointestinal tract.upper	4180186
1014876	AUASI	4180186
1014877	ExtendedID	4180186
1014883	Cardiogenic shock within 24H prior to procedure	4180186
1014887	DXA	4180186
1014898	EngDiff	4180186
1014900	Acute & chronic leukemia	4180186
1014901	US && MG	4180186
1014903	Breast.left & ^Breast specimen.left	4180186
1014905	Multisection for pediatrics	4180186
1014912	Metabolic equivalent of task & Resting metabolic rate panel	4180186
1014922	Source used for reported activity metabolic rate	4180186
1014926	Metabolic equivalent of task by standard resting metabolic rate panel	4180186
1014928	Population resting metabolic rate	4180186
1014942	Goals &or preferences in order of priority	4180186
1014987	Non-probe.amp.tar	4180186
1014997	Multisection limited for simulation	4180186
1014998	Multisection for amyloidosis	4180186
1015002	Multisection for infection or inflammation	4180186
1015003	PT.perfusion	4180186
1015013	Views for blood flow+kidney function	4180186
1015016	Views limited for thyroid tumor metastasis	4180186
1015019	Views gated+blood pool+ejection fraction+wall motion	4180186
1015020	Views for blood flow GE 4	4180186
1015021	Views for blood flow LT 4	4180186
1015027	XR	4180186
1015029	Views first pass+blood pool	4180186
1015030	Multisection for tissue viability	4180186
1015032	Multisection metabolic	4180186
1015040	Views for thyroid tumor metastasis	4180186
1015047	Scope.modifier.doc template	4180186
1015050	Tobacco smoking status.tobacco smoker	4180186
1015051	3-Hydroxyoctanoylcarnitine	4180186
1015059	Sukharev	4180186
1015060	Progress note - recommended C-CDA R2.0 & R2.1 sections	4180186
1015061	Procedure note - recommended C-CDA R2.0 & R2.1 sections	4180186
1015062	Referral note - recommended C-CDA R2.0 & R2.1 sections	4180186
1015069	Care plan - recommended C-CDA R2.0 & R2.1 sections	4180186
1015078	Gestational age in W at onset of illness	4180186
1015086	Enhanced procedure note - recommended CDP Set 1 R1.0 & R1.1 sections	4180186
1015088	Enhanced surgical operation note - recommended CDP Set 1 R1.0 & R1.1 sections	4180186
1015093	Probe.amp.tar.primer-probe set H5b	4180186
1015094	Reference source	4180186
1015105	How often did anyone at least 5Y older than you or an adult, ever touch you sexually	4180186
1015106	How often did anyone at least 5Y older than you or an adult, force you to have sex	4180186
1015107	BRFSS Adverse Childhood Experience Module	4180186
1015136	FGFR3 gene p.Gly380Arg	4180186
1015149	Symptoms & diseases	4180186
1015153	Diagnosis.secondary	4180186
1015155	RelTime	4180186
1015158	Episode of care diagnosis.primary	4180186
1015160	Bld.dot	4180186
1015164	Overall Plan of Care &or Advance Care Directives panel	4180186
1015170	How often did anyone at least 5Y older than you or an adult, try to make you touch sexually	4180186
1015172	Views limited for tumor	4180186
1015177	IA	4180186
1015178	IA.rapid	4180186
1015197	Metabolic equivalent of task by predicted resting metabolic rate panel	4180186
1015208	Blood transfusion &or organ transplant	4180186
1015217	RF.angio	4180186
1015219	XR.tomography	4180186
1015221	Level 3 emergency medical services patient care report - recommended CDA R1 & R2 sections	4180186
1015223	KOOSJR	4180186
1015227	Amount of knee pain experienced while going up or down stairs in the last W	4180186
1015229	Degree of difficulty experienced due to your knee while bending to floor &or pick up an object in the last W	4180186
1015232	Amount of knee pain experienced while twisting &or pivoting on your knee in the last W	4180186
1015233	Amount of knee pain experienced while straightening knee fully in the last W	4180186
1015234	How severe is your knee stiffness after first wakening in the morning during the last W	4180186
1015243	(View AP	4180186
1015244	(Views AP	4180186
1015252	Indexing - risk evaluation & mitigation strategies	4180186
1015257	How often have you used your rescue inhaler or nebulizer medication (such as albuterol) during the past 4W	4180186
1015260	DAST-10	4180186
1015261	Views & AP	4180186
1015262	(View oblique) + (views^W R-bending + W L-bending)	4180186
1015263	Views AP + axillary + Y	4180186
1015266	(Views) + (view AP^W standing)	4180186
1015267	(Views) + (view^W manual stress)	4180186
1015270	(Views 2) + (View tunnel^W standing)	4180186
1015276	Views lateral & PA	4180186
1015277	Views for blood flow+function	4180186
1015279	Chest>Ribs.right & Chest	4180186
1015282	Obstetrics.midwife	4180186
1015285	Chest & Abdomen	4180186
1015287	Views ventilation+equilibrium+washout	4180186
1015288	Views ventilation+perfusion	4180186
1015291	(Views) + (view	4180186
1015307	Mitral valve.leaflet.tip	4180186
1015314	Dopamine receptor D2 long Ab	4180186
1015383	BSL-SUPP	4180186
1015397	Amyotrophic lateral sclerosis functional rating scale - revised (ALSFRS-R)	4180186
1015398	ACE	4180186
1015400	A little n W little j Ab	4180186
1015403	CMS Assessment	4180186
1015435	Transplant surgery.case manager	4180186
1015436	Vascular surgery.nurse	4180186
1015439	Vascular surgery.technician	4180186
1015442	Surgery.case manager	4180186
1015443	Plastic surgery.nurse	4180186
1015445	Orthopaedic surgery.nurse practitioner	4180186
1015454	Infectious disease.nurse	4180186
1015455	Pulmonary disease.nurse	4180186
1015456	Orthopaedic surgery.nurse	4180186
1015459	Dentistry.nurse	4180186
1015461	Dermatology.nurse	4180186
1015462	Dermatology.nurse practitioner	4180186
1015464	Diabetology.nurse	4180186
1015489	IRF-PAI - Mobility - admission performance during 3D assessment period	4180186
1015499	Multisection for pulmonary embolus+deep vein thrombosis	4180186
1015501	IRF-PAI - Mobility - discharge performance during 3D assessment period	4180186
1015505	Multisection for calcium score^WO contrast && Multisection^W contrast IV	4180186
1015506	D-3-phosphoglycerate dehydrogenase Ab.IgG	4180186
1015510	LCDS v3.00 - Mobility - admission performance during 3D assessment period	4180186
1015517	Injection drug use in the past Y	4180186
1015519	Sexual activity while intoxicated &or high on drugs in the past Y	4180186
1015521	Sexual activity with anonymous partner in the past Y	4180186
1015522	Sexual activity with a male in the past Y	4180186
1015523	Sexual activity with a female in the past Y	4180186
1015527	Treatment stopped for at least 1W	4180186
1015541	Geriatric medicine.pharmacist	4180186
1015542	Geriatric medicine.team	4180186
1015548	Hepatology.nurse	4180186
1015550	Interventional radiology.nurse	4180186
1015553	Mental health.interdisciplinary	4180186
1015561	Nephrology.nurse practitioner	4180186
1015562	Nephrology.team	4180186
1015563	Neurology.nurse	4180186
1015564	Neurology.team	4180186
1015570	AP postural sway score^eyes open+on solid surface	4180186
1015572	eyes open+on foam surface	4180186
1015579	Additional [ft_i] past last 10 [ft_i] mark	4180186
1015580	Remainder [in_i] past last 10 [ft_i] mark	4180186
1015598	Nutrition and dietetics.nurse	4180186
1015607	(Views AP + lateral + Merchants) + (views^W standing)	4180186
1015612	BIMS	4180186
1015615	Spinal cord injury medicine.physician	4180186
1015616	Spinal cord injury medicine.physician assistant	4180186
1015617	Spinal cord injury medicine.team	4180186
1015618	Urology.interdisciplinary	4180186
1015620	Urology.nurse practitioner	4180186
1015623	Obstetrics and gynecology.nurse	4180186
1015624	Obstetrics and gynecology.nurse practitioner	4180186
1015625	Occupational medicine.nurse	4180186
1015631	Views GE 3 AP + oblique + cone	4180186
1015633	(Views GE 5) + (Views GE 1^W R-bending + W L-bending)	4180186
1015635	(Views 2 or 3) + (Views^W flexion + W extension) + (Views oblique)	4180186
1015638	Pelvis && Lower extremity.left>Hip	4180186
1015641	Views 2 && View AP	4180186
1015645	Views LE 3 AP + lateral	4180186
1015650	Neutrophil membrane Ab.IgG	4180186
1015651	Thymus Ab.IgG	4180186
1015652	XR && RF	4180186
1015662	Eating - functional goal recorded during 3D assessment period	4180186
1015664	Oral hygiene - functional goal recorded during 3D assessment period	4180186
1015665	Toileting hygiene - functional ability during 3D assessment period	4180186
1015666	Toileting hygiene - functional goal recorded during 3D assessment period	4180186
1015667	Shower &or bathe self - functional ability during 3D assessment period	4180186
1015673	Putting on and taking off footwear - functional ability during 3D assessment period	4180186
1015675	Roll left and right - functional ability during 3D assessment period	4180186
1015677	Sit to lying - functional ability during 3D assessment period	4180186
1015678	Sit to lying - functional goal recorded during 3D assessment period	4180186
1015680	Lying to sitting on side of bed - functional goal recorded during 3D assessment period	4180186
1015681	Sit to stand - functional ability during 3D assessment period	4180186
1015683	Bed-to-chair transfer - functional ability during 3D assessment period	4180186
1015684	Bed-to-chair transfer - functional goal recorded during 3D assessment period	4180186
1015686	Toilet transfer - functional goal recorded during 3D assessment period	4180186
1015695	Walking 10 feet on uneven surfaces - functional ability during 3D assessment period	4180186
1015697	1 step (curb) - functional ability during 3D assessment period	4180186
1015703	Picking up object - functional ability during 3D assessment period	4180186
1015704	Picking up object - functional goal recorded during 3D assessment period	4180186
1015706	Wheel 50 feet with two turns - functional goal recorded during 3D assessment period	4180186
1015707	Wheel 150 feet - functional ability during 3D assessment period	4180186
1015708	Wheel 150 feet - functional goal recorded during 3D assessment period	4180186
1015709	Bladder continence during 3D assessment period	4180186
1015710	Bowel continence during 3D assessment period	4180186
1015713	IRF-PAI v3.0 - Swallowing &or nutritional status - admission	4180186
1015714	Usual ability to swallow during 3D assessment period	4180186
1015719	Spinal cord injury medicine.interdisciplinary	4180186
1015720	Speech-language pathology.team	4180186
1015721	Social work.interdisciplinary	4180186
1015722	Social work.team	4180186
1015723	Social work.nurse	4180186
1015724	Research.nurse	4180186
1015726	Radiation oncology.nurse	4180186
1015727	Radiation oncology.therapist	4180186
1015731	Psychiatry.nurse	4180186
1015733	Psychiatry.case manager	4180186
1015735	Primary care.nurse practitioner	4180186
1015736	Primary care.interdisciplinary	4180186
1015737	Primary care.case manager	4180186
1015740	Physical therapy.team	4180186
1015744	Physical medicine and rehab.physician	4180186
1015745	Physical medicine and rehab.nurse	4180186
1015746	Physical medicine and rehab.case manager	4180186
1015747	Pathology.nurse	4180186
1015749	Palliative care.team	4180186
1015750	Palliative care.physician	4180186
1015752	Palliative care.nurse	4180186
1015753	Pain medicine.team	4180186
1015758	Podiatry.nurse	4180186
1015760	MG.tomosynthesis	4180186
1015765	AP postural sway score^eyes open+on foam surface	4180186
1015768	(Views AP + oblique) + (View lateral^W flexion + W extension)	4180186
1015771	(Views 2) + (view tunnel	4180186
1015774	(Views AP + oblique) + (View lateral	4180186
1015780	Views GE 4 && Views	4180186
1015781	Views 4 && Views	4180186
1015782	Views 2 && Views	4180186
1015784	Views PA + lateral && Views	4180186
1015786	View AP && Views	4180186
1015789	ePCAM	4180186
1015815	Acupuncture.nurse	4180186
1015821	Pharmacology.technician	4180186
1015825	Physical medicine and rehab	4180186
1015842	Inner City Asthma Survey	4180186
1015844	MESA Air Pollution	4180186
1015852	PEG Study	4180186
1016184	Positive Affect Survey - scale score	4180186
1016185	Positive Affect Survey - national percentile	4180186
1016186	Positive Affect Survey - unadjusted scale score	4180186
1016189	Positive Affect Survey version 2.0 - CAT item bank - ages 13-17	4180186
1016191	Positive Affect Survey version 2.0 - parent report - fixed length form - ages 3-7	4180186
1016203	General Life Satisfaction Survey version 2.0 - CAT item bank - ages 8-12	4180186
1016212	Emotional Support Survey version 2.0 - fixed length form - ages 8-17	4180186
1016214	Positive Affect Survey version 2.0 - fixed length form - ages 13-17	4180186
1016225	Friendship Survey version 2.0 - fixed length form - ages 8-17	4180186
1016239	10Y	4180186
1016245	Prior functioning.indoor mobility-ambulation	4180186
1016291	UPPS-R-C	4180186
1016317	Internal medicine.nurse	4180186
1016318	Internal medicine.interdisciplinary	4180186
1016324	Dopamine receptor D1 Ab.IgG	4180186
1016325	Dopamine receptor D2 long Ab.IgG	4180186
1016351	Mo of pregnancy when rubella-like symptoms appeared	4180186
1016379	Treated for Chlamydia trachomatis or Neisseria gonorrhoeae in last 3 to 12Mo	4180186
1016415	Blood establishment registration & product listing	4180186
1016451	Blood establishment registration & product listing change in information	4180186
1016452	Human cell and tissue establishment registration & product listing change in information	4180186
1016457	Anorectal/isolate	4180186
1016463	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by causing swelling in your ankles or legs	4180186
1016465	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your walking about or climbing stairs difficult	4180186
1016468	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your sleeping well at night difficult	4180186
1016469	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your relating to or doing things with your friends or family difficult	4180186
1016470	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your working to earn a living difficult	4180186
1016477	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your sexual activities difficult	4180186
1016478	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you eat less of the foods you like	4180186
1016482	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by costing you money for medical care	4180186
1016483	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by giving you side effects from treatments	4180186
1016484	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel you are a burden to your family or friends	4180186
1016485	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel a loss of self-control in your life	4180186
1016486	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you worry	4180186
1016487	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making it difficult for you to concentrate or remember things	4180186
1016488	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel depressed	4180186
1016510	Womens health.nurse practitioner	4180186
1016513	Thoracic and cardiac surgery.interdisciplinary	4180186
1016529	Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during 3D assessment period	4180186
1016530	Level of consciousness - Alert (normal) during 3D assessment	4180186
1016531	Level of consciousness - Vigilant or lethargic or stupor or coma during 3D assessment	4180186
1016534	Wash upper body - functional ability during 3D assessment period	4180186
1016535	Wash upper body - functional goal during 3D assessment period	4180186
1016537	Indicate the patient's primary medical condition category during 3D assessment period	4180186
1016540	KFRE	4180186
1016555	LCDS v3.00 - Mobility - discharge performance during 3D assessment period	4180186
1016563	Streptococcus pneumoniae Danish serotype 6A Ab,IgG	4180186
1016575	Guidance for removal of tunneled central venous catheter	4180186
1016583	Arthralgia &or arthritis	4180186
1016585	Walking 1 block on level ground was limited by heart failure over the past 2W	4180186
1016586	Doing yardwork, housework or carrying groceries was limited by heart failure over the past 2W	4180186
1016587	Climbing a flight of stairs without stopping was limited by heart failure over the past 2W	4180186
1016591	Bothered by swelling in your feet, ankles or legs over the past 2W	4180186
1016592	Fatigue limited your ability to do what you wanted over the past 2W	4180186
1016593	Bothered by fatigue over the past 2W	4180186
1016595	Bothered by shortness of breath over the past 2W	4180186
1016596	Sleep sitting up in a chair or with at least 3 pillows to prop you up because of shortness of breath over the past 2W	4180186
1016599	Enjoyment of life limited by heart failure over the past 2W	4180186
1016601	Felt discouraged or down in the dumps because of heart failure over the past 2W	4180186
1016602	Participation in hobbies, recreational activities limited by heart failure over the past 2W	4180186
1016603	Participation in working or doing household chores limited by heart failure over the past 2W	4180186
1016624	Senecavirus A Ab.IgG	4180186
1016627	MG.stereotactic	4180186
1016628	Guidance for percutaneous aspiration.fine needle &or biopsy.core needle	4180186
1016630	Community health care.nurse	4180186
1016635	MG	4180186
1016642	OASIS C2 - Integumentary status - start of care or resumption of care	4180186
1016643	OASIS C2 - Current number of unhealed pressure injuries at each stage - start of care or resumption of care	4180186
1016646	Head+Neck>Carotid artery.bilateral+Vertebral artery.bilateral	4180186
1016647	OASIS C2 - Respiratory status - start of care or resumption of care	4180186
1016697	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your recreational pastimes, sports or hobbies difficult	4180186
1016700	Does the patient use a wheelchair or scooter during 3D assessment period	4180186
1016726	Ebola & Marburg virus	4180186
1016730	Neuro & emotional & behavioral status - start of care or resumption of care	4180186
1016736	MG.FFD	4180186
1016756	Vision.ability to see in adequate light in last 7D	4180186
1016761	Head+Neck>Jugular vein.left	4180186
1016762	Head+Neck>Jugular vein.right	4180186
1016764	Reported.PHQ-9.CMS	4180186
1016774	Diagnostic mammogram & ultrasound panel	4180186
1016785	Views & Guidance for injection of non-vascular shunt	4180186
1016787	Breast.bilateral && ^Breast specimen.bilateral	4180186
1016799	Sexual activity in the last Y	4180186
1016823	When anxious within the last 14D	4180186
1016827	Ostomy for bowel elimination in the last 14D	4180186
1016852	MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge goal during 3D assessment period	4180186
1016855	MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge performance during 3D assessment period	4180186
1016862	Tobacco use in last 7D	4180186
1016868	MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status	4180186
1016873	Mean fluid intake per day by IV or tube feeding in last 7D - while not a resident	4180186
1016874	Mean fluid intake per day by IV or tube feeding in last 7D - while a resident	4180186
1016875	Mean fluid intake per day by IV or tube feeding during entire 7D	4180186
1016883	HIV 1 & 2 tests - FPAR 2.0 set	4180186
1016896	Nutritional approaches during last 7D - while not a resident	4180186
1016897	Nutritional approaches during last 7D - while a resident	4180186
1016899	Number of D antipsychotic received in last 7D or since admission &or reentry if less than 7D	4180186
1016900	Number of D antianxiety received in last 7D or since admission &or reentry if less than 7D	4180186
1016902	Number of D hypnotic received in last 7D or since admission &or reentry if less than 7D	4180186
1016903	Number of D anticoagulant received in last 7D or since admission &or reentry if less than 7D	4180186
1016904	Number of D antibiotic received in last 7D or since admission &or reentry if less than 7D	4180186
1016912	Speech-language pathology and audiology services - co-treatment minutes during 7D assessment period	4180186
1016913	Distinct calendar days of therapy in last 7D	4180186
1016921	Occupational therapy - individual minutes in the last 7D	4180186
1016922	Physical therapy - concurrent minutes in the last 7D	4180186
1016926	Speech-language pathology and audiology services - group minutes in the last 7D	4180186
1016927	Speech-language pathology and audiology services - individual minutes in the last 7D	4180186
1016928	Number of D of active range of motion in last 7 calendar D	4180186
1016929	Number of D of splint or brace assistance in last 7 calendar D	4180186
1016931	Number of D of training & skill practice in bed mobility in last 7 calendar D	4180186
1016937	Number of D of training & skill practice in eating or swallowing in last 7 calendar D	4180186
1016946	Breast.bilateral &&	4180186
1016955	Occupational therapy - co-treatment minutes during 7D assessment period	4180186
1016957	Previous rehabilitation therapy regimen (speech, occupational, &or physical therapy) ended, & regimen now resumed at exactly the same level for each discipline	4180186
1016962	Cause of death+related information	4180186
1016974	MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NO, SO	4180186
1016992	MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) & Nursing home quarterly (NQ) item set	4180186
1016995	MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set	4180186
1016998	MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed tracking (NT & ST) item set	4180186
1017005	Ser^fetus	4180186
1017008	Resident mood interview (PHQ-9) - symptom presence in the last 2W	4180186
1017009	Resident mood interview (PHQ-9) - symptom frequency in the last 2W	4180186
1017011	Staff assessment of resident mood (PHQ-9-OV) - symptom frequency in the last 2W	4180186
1017013	Cytolethal distending toxin B & Vinculin	4180186
1017067	Age range for infant less than 1Mo old	4180186
1017111	Symptoms present for at least 24H	4180186
1017128	NACA	4180186
1017146	Lower extremity>Lower leg vessel	4180186
1017162	Guidance for conversion of gastrostomy tube to gastrojejunostomy tube	4180186
1017171	Guidance for exchange of jejunostomy tube	4180186
1017189	Guidance for paracentesis+insertion of tube	4180186
1017200	Guidance for placement of gastrostomy tube	4180186
1017211	Guidance for removal of gastrojejunostomy tube	4180186
1017222	Guidance therapeutic for puncture+drainage	4180186
1017227	Guidance GE 21 for stab phlebectomy	4180186
1017233	Guidance for transjugular biopsy+venography	4180186
1017234	Guidance for transjugular biopsy+hemodynamic evaluation	4180186
1017246	Thyroglobulin & thyroperoxidase Ab panel	4180186
1017268	Dialysis.nurse	4180186
1017269	Dialysis.physician	4180186
1017270	Dialysis.interdisciplinary	4180186
1017278	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 1.5	4180186
1017279	(Multisection^WO contrast) + (Multisection for left ventricular function	4180186
1017280	IRF-PAI v3.0 - Medical information	4180186
1017281	Estimated body mass index greater than 40	4180186
1017294	Understanding verbal and non-verbal content during 3D assessment period	4180186
1017312	Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay	4180186
1017315	LCDS v4.00 - Special treatments, procedures, and programs - discharge	4180186
1017342	Determination of pressure injury risk in last 7D	4180186
1017344	Number of pressure injuries present upon admission &or reentry - stage 2	4180186
1017345	Number of pressure injuries present upon admission &or reentry - stage 3	4180186
1017346	Number of pressure injuries present upon admission &or reentry - stage 4	4180186
1017349	Number of pressure injuries - unstageable due to coverage of wound bed by slough &or eschar	4180186
1017352	Number of pressure injuries present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution	4180186
1017364	Stage 3 pressure injuries not present or at a lesser stage on admission &or reentry	4180186
1017365	Stage 4 pressure injuries not present or at a lesser stage on admission &or reentry	4180186
1017367	Unstageable pressure injury due to slough &or eschar not present or at a lesser stage on admission &or reenty	4180186
1017370	Lower extremity.unilateral>Femoral artery+Popliteal artery	4180186
1017386	H little y Ag	4180186
1017398	HVS	4180186
1017399	Within the past 12Mo we worried whether our food would run out before we got money to buy more	4180186
1017413	Blood pressure with exercise & post exercise panel	4180186
1017415	U.S. Food Security Survey	4180186
1017418	Chemotherapy infusion start & stop date and time panel	4180186
1017421	Cornea/Conjunctiva	4180186
1017425	Guidance for aspiration.fine needle	4180186
1017430	Calcidiol+ercalcidiol goal	4180186
1017433	Intravascular systolic goal	4180186
1017463	MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA (NO & SO) item set	4180186
1017469	MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set	4180186
1017478	Date specimen sent to public health laboratory	4180186
1017480	How supplied & storage & handling section	4180186
1017492	Memory &or recall ability during 3D assessment period	4180186
1017493	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 2.0	4180186
1017495	SAQ	4180186
1017496	Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W	4180186
1017497	Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W	4180186
1017499	Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W	4180186
1017501	How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W	4180186
1017513	Polytrauma.nurse	4180186
1017514	Polytrauma.case manager	4180186
1017532	How much time did you usually spend on one of those D doing vigorous physical activities as part of your work during the last 7D	4180186
1017534	How much time did you usually spend on one of those D doing moderate physical activities as part of your work during the last 7D	4180186
1017535	OASIS D - Patient history and diagnoses - start of care or resumption of care	4180186
1017536	During the last 7D, on how many D did you walk for at least 10M at a time as a part of your work, not counting any walking you did to travel to or from work	4180186
1017539	During the last 7D, on how many D did you travel in a motor vehicle like a train, bus, car, or tram	4180186
1017541	During the last 7D, on how many D did you bicycle for at least 10M at a time to go from place to place	4180186
1017543	During the last 7D, on how many D did you walk for at least 10M at a time to go from place to place	4180186
1017546	During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10M at a time	4180186
1017547	How much time did you usually spend on one of those D doing vigorous physical activities in the garden or yard during the last 7D	4180186
1017548	During the last 7D, on how many D did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10M at a time	4180186
1017549	How much time did you usually spend on one of those D doing moderate physical activities in the garden or yard during the last 7D	4180186
1017550	During the last 7D, on how many D did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10M at a time	4180186
1017553	Not counting any walking you have already mentioned, during the last 7D, on how many D did you walk for at least 10M at a time in your leisure time	4180186
1017557	During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time	4180186
1017561	During the last 7D, how much time did you usually spend sitting on a weekend D	4180186
1017578	How much time did you usually spend doing vigorous physical activities on one of those D	4180186
1017591	Sleep medicine.physician	4180186
1017598	Guidance for dilation of stricture+placement of stent	4180186
1017602	Have you modified your life style to avoid activities potentially damaging to your knee	4180186
1017603	How much are you troubled with lack of confidence in your knee	4180186
1017604	In general, how much difficulty do you have with your knee	4180186
1017607	Difficulties to stride out when walking during the last W	4180186
1017608	How severe is your hip joint stiffness after first wakening in the morning during the last W	4180186
1017630	OASIS D - Respiratory status - start of care or resumption of care	4180186
1017632	OASIS E - Bladder and Bowel - DC	4180186
1017634	OASIS D - ADL and IADLs - start of care or resumption of care	4180186
1017655	Amount of hip pain experienced at night while in bed in the last W	4180186
1017657	Amount of hip pain experienced while standing upgright in the last W	4180186
1017661	Degree of difficulty experienced due to your hip while twisting or pivoting on loaded leg during the last W	4180186
1017680	Ulcers, wounds and skin problems in the last 7D	4180186
1017683	Timed Up and Go test & physical findings of gait panel	4180186
1017689	Degree of difficulty experienced due to your hip while running during the last W	4180186
1017691	Amount of hip pain experienced while straightening your hip fully in the last W	4180186
1017693	Degree of difficulty experienced due to your hip while getting in or out of car in the last W	4180186
1017696	Degree of difficulty experienced due to your hip while ascending stairs in the last W	4180186
1017699	Degree of difficulty experienced due to your hip while getting on or off toilet in the last W	4180186
1017700	Degree of difficulty experienced due to your hip while getting in or out of bath in the last W	4180186
1017703	Degree of difficulty experienced due to your hip while descending stairs in the last W	4180186
1017710	Melanoma-associated antigen A4 Ab	4180186
1017715	Degree of difficulty experienced due to your knee while twisting or pivoting on your injured knee during the last W	4180186
1017716	Degree of difficulty experienced due to your knee while jumping during the last W	4180186
1017719	How severe is your knee stiffness after sitting, lying or resting later in the day during the last W	4180186
1017720	Can you bend your knee fully during the last W	4180186
1017721	Can you straighten your knee fully during the last W	4180186
1017722	Does your knee catch or hang up when moving during the last W	4180186
1017724	Do you have swelling in your knee during the last W	4180186
1017725	Amount of knee pain experienced while sitting or lying in the last W	4180186
1017726	Amount of knee pain experienced at night while in bed in the last W	4180186
1017732	Degree of difficulty experienced due to your knee while getting in or out of car in the last W	4180186
1017733	Degree of difficulty experienced due to your knee while walking on a flat surface in the last W	4180186
1017734	Degree of difficulty experienced due to your knee while standing in the last W	4180186
1017735	Degree of difficulty experienced due to your knee while ascending stairs in the last W	4180186
1017739	Degree of difficulty experienced due to your knee while sitting in the last W	4180186
1017740	Degree of difficulty experienced due to your knee while getting in or out of bath in the last W	4180186
1017742	Degree of difficulty experienced due to your knee while taking off socks or stockings in the last W	4180186
1017743	Degree of difficulty experienced due to your knee while rising from bed in the last W	4180186
1017750	I have been able to add and subtract numbers in my head without difficulty in past 7D	4180186
1017766	Medication follow-up in the last 3D	4180186
1017775	Reported.PHQ.Teen	4180186
1017780	ADAPTABLE	4180186
1017793	BRAF gene.p.Val600 mutations	4180186
1017794	MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set	4180186
1017795	MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set	4180186
1017802	MDS v3.0 - RAI v1.16.1 - Nursing home & Swing bed tracking (NT & ST) item set	4180186
1017815	BDI	4180186
1017822	Isolate/Specimen	4180186
1017823	Cells.CD38+ IgM-	4180186
1017827	Mobility - discharge performance during 3D assessment period	4180186
1017828	Mobility - admission performance during 3D assessment period	4180186
1017829	Mobility - discharge goal during 3D assessment period	4180186
1017844	Compared to 10Y ago, has there been any change in remembering where he or she has placed objects	4180186
1017846	Compared to 10Y ago, has there been any change in remembering the current date or day of the week	4180186
1017847	Compared to 10Y ago, has there been any change in remembering he or she has already told someone something	4180186
1017848	Compared to 10Y ago, has there been any change in remembering appointments, meetings, or engagements	4180186
1017849	Compared to 10Y ago, has there been any change in forgetting the names of objects	4180186
1017851	Compared to 10Y ago, has there been any change in finding the right words to use in a conversation	4180186
1017853	Compared to 10Y ago, has there been any change in following a story in a book or on TV	4180186
1017854	Compared to 10Y ago, has there been any change in understanding the point of what other people are trying to say	4180186
1017855	Compared to 10Y ago, has there been any change in remembering the meaning of common words	4180186
1017857	Compared to 10Y ago, has there been any change in understanding spoken directions or instructions	4180186
1017863	Compared to 10Y ago, has there been any change in finding his or her way around a familiar store	4180186
1017864	Compared to 10Y ago, has there been any change in finding his or her way around a house visited many times	4180186
1017865	Compared to 10Y ago, has there been any change in planning the sequence of stops on a shopping trip	4180186
1017869	Compared to 10Y ago, has there been any change in thinking ahead	4180186
1017872	Compared to 10Y ago, has there been any change in keeping financial records organized	4180186
1017873	Compared to 10Y ago, has there been any change in prioritizing tasks by importance	4180186
1017876	Compared to 10Y ago, has there been any change in returning to a task after being interrupted	4180186
1017877	Compared to 10Y ago, has there been any change in the ability to concentrate on a task without being distracted by external things in the environment	4180186
1017878	Compared to 10Y ago, has there been any change in cooking or working and talking at the same time	4180186
1017886	ECog.Partner	4180186
1017888	ECog	4180186
1017924	Compared to 10Y ago, has there been any change in finding my way around a familiar store	4180186
1017927	Compared to 10Y ago, has there been any change in finding my car in a parking lot	4180186
1017929	Compared to 10Y ago, has there been any change in remembering I have already told someone something	4180186
1017932	Compared to 10Y ago, has there been any change in keeping mail and papers organized	4180186
1017935	Compared to 10Y ago, has there been any change in the ability to anticipate weather changes and plan accordingly (i.e. bring a coat or umbrella)	4180186
1017958	Chair &or bed-to-chair transfer - functional goal	4180186
1017974	Shower &or bathe self - functional goal	4180186
1017999	Cardiopulmonary resuscitation flowsheet	4180186
1018000	Cardiopulmonary resuscitation note	4180186
1018015	CUBS	4180186
1018023	Gynecology.nurse	4180186
1018025	Obstetrics.nurse practitioner	4180186
1018026	Obstetrics.nurse	4180186
1018096	CDC.EOC	4180186
1018107	PERC	4180186
1018109	Wells PE risk	4180186
1018110	Geneva.Revised	4180186
1018113	How many D per W did you engage in moderate to strenuous physical activity in the last 30D	4180186
1018123	Ethics.team	4180186
1018125	Wound care management.team	4180186
1018126	Cardiac surgery.team	4180186
1018127	Vascular surgery.team	4180186
1018142	I had unpleasant thoughts that wouldn't leave my mind in past 7D	4180186
1018145	I felt lonely even when I was with other people in past 7D	4180186
1018150	I felt like I needed help for my depression in past 7D	4180186
1018153	I had mood swings in past 7D	4180186
1018159	Are you able to do 2H of physical labor	4180186
1018169	Condition triggering emergency operation center response termination	4180186
1018186	NuPDQ	4180186
1018188	POEM	4180186
1018189	Over the last W, on how many D has your or your child's skin been itchy because of eczema	4180186
1018191	Over the last W, on how many D has your or your child's skin been bleeding because of the eczema	4180186
1018193	Over the last W, on how many D has your or your child's skin been cracked because of the eczema	4180186
1018215	CRQ-SAS	4180186
1018225	PROMIS pain interference - version 1.1 T-score	4180186
1018238	It was hard for my child to walk one block when he or she had pain in past 7D	4180186
1018240	It was hard for my child to get along with other people when he or she had pain in past 7D	4180186
1018242	It was hard for my child to run when he or she had pain in past 7D	4180186
1018243	It was hard for my child to pay attention when he or she had pain in past 7D	4180186
1018246	My child felt angry when he or she had pain in past 7D	4180186
1018269	PsoSat	4180186
1018286	Over the past W, are you able to get in and out of a car, bus, train, or airplane	4180186
1018287	Over the past W, are you able to walk two miles or three kilometers, if you wish	4180186
1018289	Over the past W, are you able to get a good night's sleep	4180186
1018292	Pain severity in the past W - 0-10 (0.5 increments) numeric rating	4180186
1018296	During the past Mo, how often did you eat hot or cold cereals	4180186
1018300	It is hard for your child to add or subtract numbers in his or her head in past 4W	4180186
1018303	It is hard for your child to find his or her way to a place that he or she has visited several times before in past 4W	4180186
1018306	It is hard for your child to pay attention to one thing for more than 5-10 minutes in past 4W	4180186
1018307	It is hard for your child to pay attention to something boring he or she has to do in past 4W	4180186
1018311	When your child has a big project to do, he or she has trouble deciding where to start in past 4W	4180186
1018312	Your child forgets things easily in past 4W - frequency	4180186
1018313	Your child forgets to bring things to and from school that he or she needs for homework in past 4W - frequency	4180186
1018316	Your child has a hard time keeping track of his or her homework in past 4W - frequency	4180186
1018321	Your child has trouble paying attention to the teacher in past 4W - frequency	4180186
1018323	Your child has trouble remembering the names of people he or she knows in past 4W	4180186
1018325	Your child has trouble remembering where he or she put things, like his or her watch or his or her homework in past 4W	4180186
1018327	Your child walks into a room and forgets what he or she wanted to get or do in past 4W	4180186
1018328	Your child reacts slower than most people his or her age when he or she plays games in past 4W - severity	4180186
1018329	Your child has trouble remembering to do things like school projects or chores in past 4W - severity	4180186
1018330	Your child has trouble paying attention to the teacher in past 4W - severity	4180186
1018331	Your child has to work really hard to pay attention or he or she makes mistakes in past 4W - severity	4180186
1018332	Your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4W - severity	4180186
1018337	Your child forgets things easily in past 4W - severity	4180186
1018340	It is hard for your child to concentrate in school in past 4W - severity	4180186
1018374	It is hard for me to concentrate in school in past 4W - frequency	4180186
1018376	I forget to bring things to and from school that I need for homework in past 4W - frequency	4180186
1018377	It takes me longer than other people to get my school work done in past 4W - frequency	4180186
1018378	I have trouble paying attention to the teacher in past 4W - frequency	4180186
1018380	It is hard for me to concentrate in school in past 4W - severity	4180186
1018381	I have a hard time keeping track of my homework in past 4W - severity	4180186
1018383	It takes me longer than other people to get my school work done in past 4W - severity	4180186
1018385	It is hard for me to find my way to a place that I have visited several times before in past 4W	4180186
1018387	I have trouble remembering the names of people I have just met in past 4W	4180186
1018389	I have trouble recalling the names of things in past 4W	4180186
1018391	It is hard for me to do more than one thing at a time in past 4W	4180186
1018393	I walk into a room and forget what I wanted to get or do in past 4W	4180186
1018395	I have trouble remembering the date or day of the week in past 4W	4180186
1018397	I have to read things several times to understand them in past 4W - frequency	4180186
1018398	I react slower than most people my age when I play games in past 4W - frequency	4180186
1018399	It is hard for me to find the right words to say what I mean in past 4W - frequency	4180186
1018400	I forget things easily in past 4W - frequency	4180186
1018401	I forget what I am going to say in past 4W - frequency	4180186
1018403	I have trouble remembering to do things like school projects or chores in past 4W - frequency	4180186
1018405	It is hard for me to learn new things in past 4W	4180186
1018406	It is hard for me to understand pictures that show how to make something in past 4W	4180186
1018408	It is hard for me to add or subtract numbers in my head in past 4W	4180186
1018411	It is hard for me to find the right words to say what I mean in past 4W - severity	4180186
1018412	I forget things easily in past 4W - severity	4180186
1018415	I have trouble remembering to do things like school projects or chores in past 4W - severity	4180186
1018422	FRAX	4180186
1018423	Major osteoporotic fracture 10Y probability	4180186
1018591	Hip fracture 10Y probability	4180186
1018593	100 Cells.235a	4180186
1018597	CT && CT.perfusion && CT.angio	4180186
1018606	Estimated from physical examination	4180186
1018608	During the past Mo, how often did you drink regular soda or pop that contains sugar	4180186
1018609	During the past Mo, how often did you drink coffee or tea that had sugar or honey added to it	4180186
1018610	During the past Mo, how often did you eat a green leafy or lettuce salad, with or without other vegetables	4180186
1018612	During the past Mo, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad	4180186
1018613	During the past Mo, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans	4180186
1018614	During the past Mo, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet	4180186
1018616	During the past Mo, how often did you eat any kind of cheese	4180186
1018618	During the past Mo, how often did you eat ice cream or other frozen desserts	4180186
1018619	Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past Y	4180186
1018620	Frequency of anabolic steroids used to improve muscle mass or strength in past Y	4180186
1018621	Frequency of creatine used to improve muscle mass or strength in past Y	4180186
1018624	Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC	4180186
1018625	Aerobic culture+Antimicrobial neutralizer	4180186
1018635	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking 50 steps or paces on flat ground at a normal speed without stopping	4180186
1018638	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when washing dishes	4180186
1018639	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when sweeping or mopping	4180186
1018640	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when making a bed	4180186
1018642	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another	4180186
1018644	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when taking a bath without help	4180186
1018645	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when taking a shower	4180186
1018647	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when standing for at least 5 minutes	4180186
1018649	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking a half mile (almost 1 km) on flat ground at a normal speed without stopping	4180186
1018650	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 5 stairs without stopping	4180186
1018651	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 10 stairs (1 flight) without stopping	4180186
1018653	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when scrubbing the floor or counter	4180186
1018657	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another	4180186
1018659	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when getting in or out of a car	4180186
1018660	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when dining out	4180186
1018661	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when low-intensity leisure activity (gardening, etc.)	4180186
1018662	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when moderate-intensity leisure activity (bicycling on level terrain, etc.)	4180186
1018668	PROMIS dyspnea functional limitations - version 1.0 T-score	4180186
1018669	Words I wanted to use have seemed to be on the tip of my tongue in past 7D	4180186
1018670	I have had trouble finding the right words to express myself in past 7D	4180186
1018671	What number best describes how pain has interfered with your enjoyment of life during the past W	4180186
1018672	What number best describes how pain has interfered with your general activity during the past W	4180186
1018683	Thinking about the past 4W, my child's life was outstanding	4180186
1018684	Thinking about the past 4W, my child's life was excellent	4180186
1018686	Thinking about the past 4W, my child's life was good	4180186
1018687	Thinking about the past 4W, my child's life was going very well	4180186
1018688	Thinking about the past 4W, my child's life was just right	4180186
1018690	Thinking about the past 4W, my child's life situation was excellent	4180186
1018691	Thinking about the past 4W, my child was happy with the way things were	4180186
1018692	Thinking about the past 4W, my child had what he or she wanted in life	4180186
1018693	Thinking about the past 4W, my child had what he or she needed in life	4180186
1018694	Thinking about the past 4W, my child got the things he or she wanted in life	4180186
1018695	Thinking about the past 4W, my child felt that his or her life was better than most kids' lives	4180186
1018696	Thinking about the past 4W, my child enjoyed his or her life more than most kids enjoyed their lives	4180186
1018698	Thinking about the past 4W, my child's life was as good as most kids' lives	4180186
1018699	Thinking about the past 4W, my child was satisfied with the friends he or she has	4180186
1018702	Thinking about the past 4W, my child was happy with his or her life at school	4180186
1018704	Thinking about the past 4W, my child was happy with life in his or her neighborhood	4180186
1018705	Thinking about the past 4W, my child was happy with life in his or her community	4180186
1018707	Thinking about the past 4W, my child was satisfied with his or her skills and talents	4180186
1018708	Thinking about the past 4W, my child was satisfied with his or her life	4180186
1018709	Thinking about the past 4W, my child felt extremely positive about his or her life	4180186
1018711	Thinking about the past 4W, my child felt very good about his or her life	4180186
1018715	Thinking about the past 4W, my child had fun	4180186
1018716	Thinking about the past 4W, my child had a lot of fun	4180186
1018717	Thinking about the past 4W, my child enjoyed his or her life	4180186
1018719	Thinking about the past 4W, my child's life was worthwhile	4180186
1018721	Thinking about the past 4W, my child felt he or she lived his or her life well	4180186
1018722	Thinking about the past 4W, my child was satisfied with his or her life in general	4180186
1018726	Thinking about the past 4W, my life was the best	4180186
1018730	Thinking about the past 4W, my life was good	4180186
1018732	Thinking about the past 4W, my life was just right	4180186
1018734	Thinking about the past 4W, my life situation was excellent	4180186
1018739	Thinking about the past 4W, my life was better than most kids' lives	4180186
1018742	Thinking about the past 4W, my life was as good as most kids' lives	4180186
1018743	Thinking about the past 4W, I was satisfied with the friends I have	4180186
1018744	Thinking about the past 4W, I was happy with my social life	4180186
1018745	Thinking about the past 4W, I was happy with my family life	4180186
1018746	Thinking about the past 4W, I was happy with my life at school	4180186
1018747	Thinking about the past 4W, I was happy with my life at home	4180186
1018750	Thinking about the past 4W, I was satified with my free time	4180186
1018751	Thinking about the past 4W, I was satisfied with my skills and talents	4180186
1018753	Thinking about the past 4W, I felt extremely positive about my life	4180186
1018754	Thinking about the past 4W, I was happy with my life	4180186
1018755	Thinking about the past 4W, I felt very good about my life	4180186
1018758	Thinking about the past 4W, I felt positive about my life	4180186
1018759	Thinking about the past 4W, I had fun	4180186
1018760	Thinking about the past 4W, I had a lot of fun	4180186
1018761	Thinking about the past 4W, I enjoyed my life	4180186
1018762	Thinking about the past 4W, I liked the way I lived my life	4180186
1018763	Thinking about the past 4W, my life was worthwhile	4180186
1018764	Thinking about the past 4W, my life went well	4180186
1018765	Thinking about the past 4W, I lived my life well	4180186
1018814	MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status	4180186
1018816	MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status - OSA	4180186
1018822	Number of D with at least 15M of occupational therapy during assessment period	4180186
1018823	Number of D with at least 15M of physical therapy during assessment period	4180186
1018824	Number of D with at least 15M of speech language pathology and audiology services during assessment period	4180186
1018832	Percent intake by artificial route while a resident and during the last 7D	4180186
1018837	Physical therapy since the start date of the residents most recent Medicare Part A stay	4180186
1018845	Speech-language pathology and audiology services since the start date of the residents most recent Medicare Part A stay	4180186
1018853	Other kids wanted to be my child's friend in past 7D	4180186
1018856	My child shared with other kids (food, games, pens, etc.) in past 7D	4180186
1018860	My child was good at making friends in past 7D	4180186
